{"meta":{"query_hash":"3c87b132f7a2","filters":{"topic":"Multiple and Secondary Primary Cancers"},"cohort_total":277,"direct_labels_cover":1,"predictions_cover":277,"exported":277,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3c87b132f7a2","api":"https://metacan.xera.ac/api/v1/cohort?topic=Multiple+and+Secondary+Primary+Cancers"},"results":[{"id":"W147364354","doi":"10.1200/jco.2009.27.15_suppl.6531","title":"The effect of a cancer diagnosis on disability status","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Marital status; Breast cancer; Cancer; Epidemiology; Logistic regression; Colorectal cancer; Cohort; Prostate cancer; Stage (stratigraphy); Retrospective cohort study; Pediatrics; Internal medicine; Population","score_opus":0.08197772579326319,"score_gpt":0.5138553629723824,"score_spread":0.43187763717911926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W147364354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744357,0.001467584,0.0000026284104,0.019308172,0.0011046946,0.00019159412,0.0000066020893,0.0000033945205,0.0034796149],"genre_scores_gemma":[0.9900826,0.0054515167,0.0000929704,0.003443886,0.0008440061,0.00000895997,6.3448846e-7,0.000005015717,0.000070401664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99724483,0.0005840441,0.0015664725,0.00011492357,0.0002896873,0.00020005008],"domain_scores_gemma":[0.98804957,0.010279347,0.0010540909,0.00020853245,0.0001389441,0.00026950243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031216252,0.0000944763,0.0011494225,0.000024073724,0.000040364623,0.0000036237038,0.00012813105,0.00017923057,0.0002836156],"category_scores_gemma":[0.0055442452,0.00004530085,0.0005563377,0.000078389996,0.0003330927,0.000044218792,0.000013545473,0.00080331945,0.0000032890628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009588322,0.00033949994,0.4171598,0.000013053961,0.00012528029,0.000030522362,0.000019823623,0.000011284216,0.000026399599,0.000015939613,0.0059482916,0.5667218],"study_design_scores_gemma":[0.00594855,0.04536068,0.74527335,0.000058355035,0.00021664852,0.000010304818,0.000013996763,0.000019992573,0.0005505123,0.000080342266,0.20243208,0.00003517505],"about_ca_topic_score_codex":0.000049371145,"about_ca_topic_score_gemma":0.000085463376,"teacher_disagreement_score":0.56668663,"about_ca_system_score_codex":0.00027206482,"about_ca_system_score_gemma":0.0008638546,"threshold_uncertainty_score":0.66373795},"labels":[],"label_agreement":null},{"id":"W1517769802","doi":"","title":"Poster Introductions III--The Lifecourse of Esophageal Cancer Patients Traced by Means of the Lifegrid","year":2009,"lang":"en","type":"article","venue":"Scholarship@Western (Western University)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Medicine; Esophageal cancer; General surgery; Internal medicine","score_opus":0.03946696887264465,"score_gpt":0.30164166407267895,"score_spread":0.2621746952000343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517769802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514675,0.000328293,0.000014116049,0.0029178192,0.0005308349,0.00057407713,0.00017433417,0.000031689633,0.00028209705],"genre_scores_gemma":[0.99408984,0.00012864356,0.000005865944,0.0014219584,0.00018325457,0.0000013499188,0.000035359182,0.000021472004,0.0041122753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827105,0.00018416463,0.00038312326,0.00036433333,0.00048065544,0.00031670002],"domain_scores_gemma":[0.9984364,0.00006245465,0.0003504623,0.0006749433,0.00030642148,0.00016935647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019868431,0.00024637903,0.0004275385,0.0001788889,0.0001967751,0.000025837753,0.0005719365,0.00014779202,0.00012064955],"category_scores_gemma":[0.000042275777,0.00017837508,0.00026451342,0.0004823453,0.00024698584,0.00051890145,0.000112014415,0.0005777619,0.0000078874555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005326942,0.00033922747,0.9904304,0.000050130653,0.00015471475,0.0000068239174,0.0008889805,0.000021801596,0.0054101185,0.00001390483,0.00009147294,0.0020597237],"study_design_scores_gemma":[0.003103925,0.00035030453,0.9718118,0.00014307322,0.00035694253,0.000009813158,0.00016142076,3.8777594e-7,0.020157054,0.000007769093,0.0037362834,0.00016123238],"about_ca_topic_score_codex":0.000023215307,"about_ca_topic_score_gemma":0.0004611916,"teacher_disagreement_score":0.018618613,"about_ca_system_score_codex":0.00022698686,"about_ca_system_score_gemma":0.00026823592,"threshold_uncertainty_score":0.7273925},"labels":[],"label_agreement":null},{"id":"W1534958170","doi":"10.1002/cncr.11824","title":"Cancer Medicine 6","year":2003,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Index (typography); Alternative medicine; Cancer; Family medicine; Pathology; Internal medicine; Computer science; World Wide Web","score_opus":0.04114090055147159,"score_gpt":0.34740022255028535,"score_spread":0.3062593219988138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534958170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5234301,0.054996178,0.00016638258,0.013340922,0.0032630714,0.0006362561,0.00003818907,0.00016824146,0.40396065],"genre_scores_gemma":[0.9383715,0.0069832513,0.00027007083,0.021293895,0.0010298919,0.00023213374,0.000014977653,0.000045890156,0.03175844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991256,0.000021283882,0.00017683466,0.00023768279,0.00018994758,0.0002486278],"domain_scores_gemma":[0.9994223,0.000025189986,0.000047054946,0.00023893095,0.00008213901,0.00018438535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009484033,0.0001302062,0.00027851007,0.00006087083,0.000054391436,0.000003962098,0.00005319483,0.000062725056,0.032247867],"category_scores_gemma":[0.00005325528,0.00009854658,0.000057323257,0.00017866926,0.000112221074,0.000058638478,0.000007355598,0.00016018977,0.000044018136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039339464,0.000093933915,0.16074966,0.00039943575,0.00044592764,0.000118867654,0.0014664537,0.00006415599,0.04479865,0.0037385789,0.50760543,0.2801255],"study_design_scores_gemma":[0.002351096,0.00008857543,0.016463209,0.00014643342,0.00010498686,0.000019352496,0.00010021263,0.000029650675,0.008646653,0.00009645997,0.9718139,0.0001394249],"about_ca_topic_score_codex":0.00039000434,"about_ca_topic_score_gemma":0.00010203987,"teacher_disagreement_score":0.4642085,"about_ca_system_score_codex":0.00027181822,"about_ca_system_score_gemma":0.00045888923,"threshold_uncertainty_score":0.9686368},"labels":[],"label_agreement":null},{"id":"W1635162237","doi":"10.1186/1742-7622-3-17","title":"Identifying related cancer types based on their incidence among people with multiple cancers","year":2006,"lang":"en","type":"article","venue":"Emerging Themes in Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Michael Smith Health Research BC","keywords":"Cancer; Medicine; Medical diagnosis; Population; Incidence (geometry); Epidemiology; Demography; Cancer registry; Epidemiology of cancer; Internal medicine; Pathology; Environmental health; Breast cancer; Mathematics","score_opus":0.026936019743799323,"score_gpt":0.3129361068558759,"score_spread":0.2860000871120766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1635162237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884573,0.0020845155,0.00067098485,0.0024981014,0.0004602231,0.00043864394,0.0000148214895,0.00013071587,0.005244671],"genre_scores_gemma":[0.99509615,0.00025996778,0.0012809369,0.0023617297,0.000157445,0.00015591658,0.00006759237,0.00004938388,0.00057088316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976104,0.00032594646,0.0006562085,0.0006049425,0.00015560599,0.0006468871],"domain_scores_gemma":[0.99760956,0.0014638687,0.00028806046,0.00047294845,0.00006283994,0.000102740225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009090169,0.00030048648,0.00079892296,0.00028949254,0.00012305914,0.000005682114,0.00019468636,0.0001826532,0.0005939875],"category_scores_gemma":[0.00059925526,0.00022419039,0.00012099373,0.00046306272,0.00023672674,0.00012186961,0.000034212826,0.0005549137,0.000011450749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045755255,0.000039638624,0.8909745,0.00006806223,0.00005372333,0.000032306194,0.0004875396,0.10375114,0.0006385954,0.0001371018,0.0013924881,0.0019673281],"study_design_scores_gemma":[0.0024828145,0.00018564379,0.87695384,0.0005610782,0.00004972311,0.000013853979,0.00025971397,0.11519659,0.0010642015,0.00066112156,0.0022555802,0.00031582362],"about_ca_topic_score_codex":0.021842485,"about_ca_topic_score_gemma":0.021326419,"teacher_disagreement_score":0.0140206795,"about_ca_system_score_codex":0.00065593864,"about_ca_system_score_gemma":0.0003318286,"threshold_uncertainty_score":0.99653184},"labels":[],"label_agreement":null},{"id":"W1642111304","doi":"10.1158/1538-7445.sabcs14-p3-12-01","title":"Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre hospitalier universitaire de Québec; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Clinical endpoint; Randomized controlled trial; Surgery; Gynecology","score_opus":0.21759885467456136,"score_gpt":0.44223123032071143,"score_spread":0.22463237564615007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1642111304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838251,0.011888993,0.000005281584,0.0002544549,0.00010817521,0.0028278835,0.00015752215,0.000009159021,0.00092341757],"genre_scores_gemma":[0.9953619,0.0040401025,0.00012644049,0.0000677149,0.000109410816,0.00019547963,0.00001824267,0.000029668152,0.000050992054],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995703,0.0008750366,0.0014591919,0.0005144202,0.00096601737,0.00048233249],"domain_scores_gemma":[0.9955835,0.002501334,0.0005599827,0.00054834224,0.00032707772,0.00047981116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005140961,0.00034054273,0.0022879227,0.00040871682,0.000059755737,0.000013342345,0.00020805313,0.00014806293,0.00011089147],"category_scores_gemma":[0.0014050633,0.00022996141,0.00024865067,0.00025799556,0.0010190469,0.00013901407,0.00011238887,0.00040825777,5.1396484e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9018516,0.0008961405,0.022767354,0.00079923525,0.00065647846,0.000027474664,0.011132858,0.00028592383,0.036428835,0.00009501222,0.0008765624,0.024182541],"study_design_scores_gemma":[0.79808104,0.007289468,0.17421716,0.00072130695,0.000218541,0.000011894536,0.002942705,0.00046102286,0.015238483,0.00012876028,0.00036059303,0.00032902395],"about_ca_topic_score_codex":0.046835046,"about_ca_topic_score_gemma":0.002301869,"teacher_disagreement_score":0.15144981,"about_ca_system_score_codex":0.0011909732,"about_ca_system_score_gemma":0.0020570243,"threshold_uncertainty_score":0.9595122},"labels":[],"label_agreement":null},{"id":"W1782486205","doi":"10.1186/1471-2407-5-48","title":"Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database","year":2005,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Saskatchewan","funders":"Magyar Tudományos Akadémia; Saskatchewan Cancer Agency","keywords":"Medicine; Surgical oncology; Cancer; Estimation; Covariate; Database; Oncology; Statistics; Internal medicine; Computer science; Mathematics","score_opus":0.10333607717145535,"score_gpt":0.38303699919548817,"score_spread":0.27970092202403285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1782486205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619994,0.0056175813,0.007942436,0.0011654467,0.0003658725,0.0015075739,0.021338778,0.000012101638,0.0000508178],"genre_scores_gemma":[0.98173726,0.00081676035,0.010051555,0.0009419446,0.0004855709,0.0003500503,0.0053916434,0.00003596826,0.00018926301],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985382,0.0000697329,0.00049122015,0.000340968,0.00036247514,0.00019743315],"domain_scores_gemma":[0.99817395,0.00057473424,0.0002864142,0.000750893,0.00017134343,0.000042648036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003009967,0.00015000829,0.00031702244,0.000054610275,0.00006480509,0.000012892158,0.0003231009,0.000067830224,0.0012616268],"category_scores_gemma":[0.00022961806,0.000098299686,0.00005229136,0.00019034799,0.00012447896,0.0003153531,0.000060319322,0.00011866339,0.0000028317604],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01276443,0.0012057094,0.31611097,0.0021656617,0.0010904474,0.0000024061155,0.010319188,0.03260007,0.13667935,0.00020849898,0.21390948,0.2729438],"study_design_scores_gemma":[0.0069691055,0.00010127322,0.13879521,0.00052366627,0.00094077946,4.798915e-7,0.00031773868,0.829201,0.005421693,0.000030507175,0.017458703,0.00023988842],"about_ca_topic_score_codex":0.009311425,"about_ca_topic_score_gemma":0.010305307,"teacher_disagreement_score":0.7966009,"about_ca_system_score_codex":0.00028060167,"about_ca_system_score_gemma":0.0007528446,"threshold_uncertainty_score":0.9996514},"labels":[],"label_agreement":null},{"id":"W1968486363","doi":"10.1016/j.canep.2010.06.015","title":"Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry","year":2010,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Cancer registry; Relative survival; Cancer; Internal medicine; Population; Bladder cancer; Oncology; Pancreatic cancer; Lung cancer; Environmental health","score_opus":0.4495041018642483,"score_gpt":0.4763173160602888,"score_spread":0.026813214196040547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968486363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97914577,0.010788579,0.000049216662,0.006027721,0.0023776446,0.000543655,0.00072094373,0.000016643578,0.00032985638],"genre_scores_gemma":[0.995363,0.0006293391,0.0002555536,0.002368673,0.0010672178,0.00008861584,0.00016236013,0.000032924443,0.00003232925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969897,0.0008474407,0.00068354054,0.0006311061,0.00019066976,0.0006574907],"domain_scores_gemma":[0.9925447,0.0051540392,0.00041404951,0.0015702203,0.000084049156,0.00023290311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032087527,0.0002756884,0.0010305647,0.00011468108,0.0003063803,0.000010371847,0.00093515037,0.00026072544,0.000463008],"category_scores_gemma":[0.0044143414,0.00016032392,0.00013286198,0.0003298952,0.0005992071,0.00012213274,0.00023101082,0.0011835439,0.000002539211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027763878,0.0000034266257,0.9717852,0.000064031796,0.00028414602,0.000011678658,0.0002191839,0.005819155,0.013550052,0.000009922669,0.0024520927,0.005523464],"study_design_scores_gemma":[0.0029873305,0.00007927009,0.8721923,0.00043562523,0.00058507745,0.000013329174,0.00027487407,0.08652891,0.004042282,0.000066824054,0.032429367,0.00036478133],"about_ca_topic_score_codex":0.96368563,"about_ca_topic_score_gemma":0.9864707,"teacher_disagreement_score":0.09959289,"about_ca_system_score_codex":0.0012305496,"about_ca_system_score_gemma":0.0032486864,"threshold_uncertainty_score":0.653782},"labels":[],"label_agreement":null},{"id":"W1970748307","doi":"10.1016/j.ygyno.2012.04.002","title":"Second primary malignancies among women with uterine sarcoma","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; BC Cancer Agency","funders":"","keywords":"Medicine; Uterine sarcoma; Etiology; Incidence (geometry); Cancer; Internal medicine; Breast cancer; Sarcoma; Uterine cancer; Gynecology; Relative risk; Oncology; Gastroenterology; Pathology; Confidence interval","score_opus":0.018174972133007727,"score_gpt":0.27725286256773074,"score_spread":0.259077890434723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970748307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86020184,0.00036229426,0.000032167005,0.0004996906,0.0004942464,0.0004877431,0.000016447244,0.00012821685,0.13777734],"genre_scores_gemma":[0.9771379,0.00008245397,0.0028590322,0.009627732,0.00035484444,0.00028146326,0.00004902259,0.00003099278,0.009576536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803257,0.0001170508,0.0003431815,0.00033562205,0.00017929022,0.0009922684],"domain_scores_gemma":[0.99865097,0.00029870006,0.00016977362,0.0003762084,0.00007295997,0.00043141312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004801746,0.00026304406,0.0007345983,0.00012918033,0.0001133623,0.000010823885,0.00015310834,0.00027714708,0.018129148],"category_scores_gemma":[0.000069740585,0.00019074601,0.00006498493,0.00017674579,0.00037638945,0.00027701864,0.00012477559,0.00036256912,0.00016497912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002254578,0.0012528157,0.8657868,0.00046123832,0.00042300072,0.0008324301,0.0031199462,0.000005026009,0.01676909,0.00028860074,0.018291315,0.09051516],"study_design_scores_gemma":[0.0023169578,0.0030717978,0.62322694,0.000007976546,0.00003448482,0.00032038058,0.00039442405,0.000003967145,0.00042784834,0.000026106323,0.3699972,0.00017188865],"about_ca_topic_score_codex":0.000011894259,"about_ca_topic_score_gemma":0.0000854985,"teacher_disagreement_score":0.3517059,"about_ca_system_score_codex":0.0014131553,"about_ca_system_score_gemma":0.00052845455,"threshold_uncertainty_score":0.9827684},"labels":[],"label_agreement":null},{"id":"W1971883350","doi":"10.1016/s1091-255x(02)00228-7","title":"27","year":2003,"lang":"en","type":"article","venue":"Journal of Gastrointestinal Surgery","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Explant culture; Ablation; Transplantation; Liver transplantation; Carcinoma; Oncology; Pathology; Surgery; Internal medicine","score_opus":0.029877649758285618,"score_gpt":0.26278220613458086,"score_spread":0.23290455637629526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971883350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98209924,0.00057083333,0.0022663833,0.0010185528,0.00071463163,0.00006379881,0.0000016546883,0.0000150349615,0.013249873],"genre_scores_gemma":[0.97951424,0.000051879793,0.018010577,0.0010607995,0.00035655117,4.953095e-7,0.0000016903434,0.000020004672,0.0009837834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988385,0.0000560912,0.0005197571,0.000083115876,0.0002835274,0.00021901904],"domain_scores_gemma":[0.99879414,0.0002741968,0.0003160113,0.00011512702,0.00025127304,0.00024925824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067231467,0.00010499366,0.00040423044,0.00019134472,0.00002834183,0.00001231524,0.00004381523,0.000019316585,0.0010051822],"category_scores_gemma":[0.0012264065,0.00008217835,0.00032760444,0.0001353769,0.0000480637,0.00012665059,0.000005875416,0.00030364766,0.000024394825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090753107,0.0002073165,0.8897834,0.000085358515,0.00006728924,0.003061678,0.000031964722,0.000021432685,0.0145283,0.0001247271,0.08514651,0.006034486],"study_design_scores_gemma":[0.0040163123,0.002428738,0.35377124,0.0021829868,0.00030346762,0.33377647,0.0005032038,0.00005518597,0.008312994,0.00039909518,0.29380947,0.00044080173],"about_ca_topic_score_codex":0.0000021470983,"about_ca_topic_score_gemma":5.6063857e-7,"teacher_disagreement_score":0.5360122,"about_ca_system_score_codex":0.00010063473,"about_ca_system_score_gemma":0.0006797232,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W1971967254","doi":"10.4236/jct.2012.326125","title":"After the Treatment Phase of Colorectal Cancer Care: Survivorship and Follow-Up","year":2012,"lang":"en","type":"article","venue":"Journal of Cancer Therapy","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Survivorship curve; Colorectal cancer; Psychological intervention; Cancer; Adverse effect; Cancer survivorship; Health care; Intensive care medicine; Oncology; Internal medicine; Nursing","score_opus":0.03878705072068587,"score_gpt":0.3561638229495027,"score_spread":0.31737677222881683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971967254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8363417,0.16146082,0.0000043220243,0.00079307304,0.0009816295,0.00021422635,0.00003343292,0.00000296576,0.00016783558],"genre_scores_gemma":[0.94593614,0.052160174,0.00004643982,0.0007868901,0.0007697196,0.000045872453,0.0000015060272,0.000017849106,0.00023539076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908805,0.00006176368,0.00031504617,0.00007940829,0.00024896528,0.00020674027],"domain_scores_gemma":[0.99922365,0.00007561697,0.00025876943,0.0001157798,0.00016885158,0.00015731837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018539905,0.00014341703,0.0003959387,0.00006351119,0.000042567746,0.0000093088765,0.00006737663,0.000054582626,0.0007798032],"category_scores_gemma":[0.0000051489674,0.000076114324,0.00019111116,0.00008777617,0.00009596574,0.00013778431,0.000005583792,0.00014248898,4.6659147e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028059814,0.00041446992,0.44304693,0.000069644935,0.0013133388,0.000018529963,0.024755912,0.000007019593,0.030708527,0.00000675448,0.00086473423,0.47073433],"study_design_scores_gemma":[0.04367154,0.006634028,0.40405956,0.00025172762,0.0007394176,0.00013826299,0.0021470543,0.000018966979,0.13344783,0.00001770558,0.4085837,0.00029019848],"about_ca_topic_score_codex":0.0007867036,"about_ca_topic_score_gemma":0.0005338852,"teacher_disagreement_score":0.47044414,"about_ca_system_score_codex":0.0003135885,"about_ca_system_score_gemma":0.0003763141,"threshold_uncertainty_score":0.85382986},"labels":[],"label_agreement":null},{"id":"W1975696113","doi":"10.1023/a:1023926401227","title":"Risk Factors for Colorectal Cancer Following Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Colorectal cancer; Family history; Cancer; Oncology; Internal medicine; Odds ratio; Gynecology; Cancer registry; Population; Epidemiology; Epidemiology of cancer; Body mass index","score_opus":0.05558737688816778,"score_gpt":0.3786550019926228,"score_spread":0.323067625104455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975696113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840408,0.0065989406,0.000011094195,0.0017253219,0.00039323085,0.0017513736,0.0045849467,0.000051182036,0.00084313395],"genre_scores_gemma":[0.9839949,0.010412937,0.00009229059,0.000110117675,0.0003492502,0.0028398621,0.00007439788,0.00006423074,0.00206199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740237,0.00012261611,0.00026870632,0.00070072524,0.0005232388,0.0009823492],"domain_scores_gemma":[0.9985092,0.0002514739,0.00007701486,0.00026024692,0.00027194293,0.0006300943],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028233466,0.00035606272,0.0005597939,0.00020425674,0.0005785689,0.00007249045,0.00009025518,0.0001290832,0.001549202],"category_scores_gemma":[0.000029759365,0.00025522412,0.00025993295,0.00032447546,0.00019005379,0.00016638718,0.000032188636,0.0002770053,0.000006154914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035229546,0.00052676635,0.84804696,0.0001182236,0.0018517907,0.00006047818,0.00082714844,0.00003112224,0.0022927988,0.000114052775,0.0019483207,0.14065938],"study_design_scores_gemma":[0.01545111,0.0015167284,0.9358333,0.00030277748,0.00060955714,0.00015563147,0.0010323817,0.00019539736,0.010890053,0.00013340231,0.033351857,0.00052781345],"about_ca_topic_score_codex":0.033420973,"about_ca_topic_score_gemma":0.005762062,"teacher_disagreement_score":0.14013158,"about_ca_system_score_codex":0.002204754,"about_ca_system_score_gemma":0.0017985713,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W1982077008","doi":"10.5045/kjh.2012.47.1.1","title":"The premier statistical report of hematologic malignancies in Korea","year":2012,"lang":"en","type":"article","venue":"The Korean Journal of Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Hematologic malignancy; Hematologic Neoplasms; Disease; Statistics; Cancer; Environmental health; Pathology","score_opus":0.025270532227357364,"score_gpt":0.300460601014497,"score_spread":0.27519006878713964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982077008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689324,0.0047497503,0.00046074355,0.0034402371,0.0003916222,0.00017986074,0.0000042396414,0.000005367458,0.0038749154],"genre_scores_gemma":[0.9981359,0.00021165643,0.0011221207,0.0002715314,0.000093387105,0.0000037214365,0.0000029645366,0.000010750692,0.00014795881],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982024,0.00018536113,0.00094552484,0.00007958629,0.0002468691,0.00034024916],"domain_scores_gemma":[0.9979822,0.00085976714,0.0005920083,0.00031848514,0.0001355926,0.00011193399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015888484,0.000116111536,0.00060204824,0.00008012071,0.00006065434,0.0000047215935,0.00020685782,0.00007754773,0.00015174429],"category_scores_gemma":[0.0007323916,0.000053651052,0.00011600125,0.00011034039,0.0004626709,0.0000804096,0.00004521186,0.0003654961,0.000005552335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026690129,0.00055475795,0.8336698,0.00040055625,0.00053164805,0.0051909504,0.0049029835,0.0000124477665,0.004808232,0.113313034,0.028748993,0.005197597],"study_design_scores_gemma":[0.006342708,0.001490368,0.38593754,0.0006254233,0.0006278643,0.49451435,0.0061756857,0.00013303776,0.04950203,0.015347998,0.03888742,0.00041559784],"about_ca_topic_score_codex":0.000015023358,"about_ca_topic_score_gemma":0.000013877797,"teacher_disagreement_score":0.48932338,"about_ca_system_score_codex":0.00006629287,"about_ca_system_score_gemma":0.00023860487,"threshold_uncertainty_score":0.21878265},"labels":[],"label_agreement":null},{"id":"W1989412643","doi":"10.1200/jco.2012.41.8681","title":"Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cancer; Epidemiology; Oncology; Host factors; Family history; Internal medicine; Bioinformatics; Immunology; Biology","score_opus":0.3038633936729731,"score_gpt":0.5563747030338985,"score_spread":0.25251130936092536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989412643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009818523,0.98989564,0.000272381,0.00024342783,0.0042848005,0.0007210982,0.000058151556,0.00000665413,0.0035359913],"genre_scores_gemma":[0.00023473038,0.9853175,0.0090687005,0.00025470075,0.004554982,0.000025356028,0.000024992085,0.000034782315,0.00048425604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949752,0.00066977734,0.0036007673,0.00025711648,0.0002193442,0.00027777272],"domain_scores_gemma":[0.991175,0.0027627798,0.0051178057,0.00020618268,0.00027850864,0.00045973776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051381118,0.00027757662,0.005044173,0.00017858764,0.000058866113,0.00002259778,0.0001276379,0.0009685587,0.00048725706],"category_scores_gemma":[0.0004105768,0.00017570263,0.0013466851,0.00006872534,0.00019978019,0.00023295013,0.000041470586,0.0019350922,0.0000049941195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047666035,0.00030500008,0.00010322689,0.005232361,0.0011424836,0.000050931096,0.00003321903,3.6876446e-7,7.6622825e-7,0.00015061142,0.004935592,0.9875688],"study_design_scores_gemma":[0.003213606,0.007406436,0.00072358205,0.0017132296,0.0070842495,0.002225083,0.00016934525,0.0000066309335,2.018353e-7,0.00022333981,0.9770795,0.00015476363],"about_ca_topic_score_codex":0.000004715134,"about_ca_topic_score_gemma":0.000014468351,"teacher_disagreement_score":0.987414,"about_ca_system_score_codex":0.00039169664,"about_ca_system_score_gemma":0.011330644,"threshold_uncertainty_score":0.9942742},"labels":[],"label_agreement":null},{"id":"W1996730611","doi":"10.1016/j.jvir.2009.12.014","title":"Abstract No. 229 EE: Changes in hepatic arterial vasculature in HCC patients on sorafenib","year":2010,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Sorafenib; Concomitant; Internal medicine; Hepatocellular carcinoma; Cardiology; Pathology","score_opus":0.009261949081930237,"score_gpt":0.2655922532022293,"score_spread":0.25633030412029906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996730611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722326,0.00050574745,0.0000054416,0.00039927158,0.0012331028,0.00014401079,0.0000081028675,0.000002461555,0.00047858074],"genre_scores_gemma":[0.99860334,0.00030323822,0.0001622717,0.0003537546,0.00049849605,0.000004585882,0.000034934317,0.000009861315,0.00002952317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989113,0.00007434499,0.00048891583,0.00015245755,0.00020240784,0.0001705434],"domain_scores_gemma":[0.99941725,0.000065779124,0.00019177968,0.000109783614,0.000120002005,0.000095419586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005001748,0.00012536693,0.00046409172,0.00032132206,0.00001916705,0.000010728464,0.00008077106,0.00017273414,0.0008904234],"category_scores_gemma":[0.00022090832,0.000097771204,0.00030571572,0.00006264371,0.00007011668,0.00010768723,0.000017331866,0.0007059083,0.000008119116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007134875,0.0036003704,0.9014212,0.0008374119,0.0011902511,0.00090394035,0.00081724476,0.00008447998,0.04522288,0.00061045616,0.005048264,0.033128656],"study_design_scores_gemma":[0.0074488097,0.0013463246,0.9839678,0.00028159295,0.000034260385,0.00022284195,0.000021302752,0.000054741857,0.00014740421,0.0001550436,0.006229576,0.000090331734],"about_ca_topic_score_codex":0.000032196564,"about_ca_topic_score_gemma":0.00034743614,"teacher_disagreement_score":0.0825466,"about_ca_system_score_codex":0.000073577234,"about_ca_system_score_gemma":0.00007336407,"threshold_uncertainty_score":0.9749512},"labels":[],"label_agreement":null},{"id":"W1998087959","doi":"10.1038/sj.bjc.6605616","title":"Risks of second primary cancer among patients with major histological types of lung cancers in both men and women","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Manitoba; Manitoba Health; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; European Commission; Centre International de Recherche sur le Cancer","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Cancer; Incidence (geometry); Lung; Carcinoma; Etiology; Gynecology","score_opus":0.010131867342530949,"score_gpt":0.2672691298764386,"score_spread":0.2571372625339076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998087959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865615,0.010280265,0.000002147174,0.000051671992,0.00023139533,0.00023931116,0.00013314316,0.0000033581957,0.0024972546],"genre_scores_gemma":[0.99663824,0.0024380516,0.0002478137,0.0002480051,0.00010797409,0.000023833301,0.0000046807477,0.000019920279,0.0002714801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986349,0.000035339104,0.00056377146,0.00017058705,0.00034954297,0.00024590731],"domain_scores_gemma":[0.9988117,0.00004715983,0.00058631727,0.000101900434,0.00027119223,0.00018172058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024203034,0.0001320481,0.000686103,0.0001342053,0.000028510489,0.0000102616905,0.000112675305,0.00011160238,0.0021473274],"category_scores_gemma":[0.000035117177,0.000116022056,0.00006266348,0.00013639875,0.00031254208,0.00021437721,0.00002796588,0.0005383858,7.187428e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015051478,0.00009306884,0.92151326,0.0003699842,0.0002932671,0.00008862743,0.0006831239,0.000032250544,0.0022130476,0.0000013366148,0.0012332594,0.07197364],"study_design_scores_gemma":[0.0060993456,0.00036522187,0.9892181,0.00062756124,0.00012881844,0.00006781936,0.00009764346,0.00002303474,0.0005907702,0.00000908774,0.0026464604,0.00012609921],"about_ca_topic_score_codex":0.005635158,"about_ca_topic_score_gemma":0.0132178245,"teacher_disagreement_score":0.071847536,"about_ca_system_score_codex":0.00057315506,"about_ca_system_score_gemma":0.0009986466,"threshold_uncertainty_score":0.9987649},"labels":[],"label_agreement":null},{"id":"W2009552685","doi":"10.1002/ijc.21284","title":"Associations between small intestine cancer and other primary cancers: An international population‐based study","year":2005,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cancer; Medicine; Internal medicine; Overdiagnosis; Gastroenterology; Rectum; Pancreatic cancer; Adenocarcinoma; Population; Small intestine; Pancreas; Incidence (geometry); Prostate cancer; Oncology; Large intestine; Pathology","score_opus":0.05464943692917048,"score_gpt":0.37959089819061675,"score_spread":0.3249414612614463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009552685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031156,0.00072847307,0.00020984268,0.0060658013,0.0011926461,0.00025070005,0.00044810152,0.000024793491,0.0007680695],"genre_scores_gemma":[0.98766357,0.000160257,0.0020924287,0.005325295,0.0042635216,0.000025369534,0.00011461109,0.000034706,0.00032023995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979854,0.000053928798,0.00075598963,0.00023743503,0.00079028227,0.00017696449],"domain_scores_gemma":[0.99798554,0.000111432055,0.0006550806,0.00014127762,0.00090628205,0.00020037698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035613327,0.00018679547,0.00040967943,0.00037821557,0.000060535094,0.000083196595,0.00034622362,0.00007449942,0.0010814489],"category_scores_gemma":[0.00009914592,0.00016644904,0.00011434509,0.000116811265,0.00003672617,0.00053749164,0.00004833279,0.00034695055,0.0000026973157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039736883,0.000214188,0.8881673,0.0000064307865,0.0009873833,0.000017942171,0.00051721995,0.0011727043,0.0003236197,0.000013836594,0.0003407178,0.10784128],"study_design_scores_gemma":[0.0049895393,0.00026996477,0.9708501,0.00016040406,0.0002923959,0.000019709487,0.000101762766,0.00067174603,0.00023852345,0.000032181364,0.022203268,0.00017038078],"about_ca_topic_score_codex":0.0026705044,"about_ca_topic_score_gemma":0.0032841498,"teacher_disagreement_score":0.1076709,"about_ca_system_score_codex":0.0023445338,"about_ca_system_score_gemma":0.00083065155,"threshold_uncertainty_score":0.9998317},"labels":[],"label_agreement":null},{"id":"W2021695117","doi":"10.1016/s1098-3015(10)70232-1","title":"PCN54 A COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS SECONDARY PROPHYLAXIS WITH COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH DIFFUSE AGGRESSIVE LYMPHOMA RECEIVING CURATIVE-INTENT CHEMOTHERAPY USING ONTARIO HEALTH ECONOMIC DATA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secondary prophylaxis; Lymphoma; Chemotherapy; Intensive care medicine; Oncology; Internal medicine","score_opus":0.09503515220976427,"score_gpt":0.31487770632662865,"score_spread":0.21984255411686437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021695117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951147,0.0004584397,0.00013415494,0.0001689194,0.00014316422,0.0033366715,0.0005343164,0.000030330051,0.00007933435],"genre_scores_gemma":[0.9932826,0.00019742758,0.0051795826,0.00043212474,0.000028113758,0.00004352927,0.00076432584,0.000054203043,0.000018067316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957523,0.00045360462,0.001402793,0.0010974744,0.00054892554,0.0007449235],"domain_scores_gemma":[0.99647367,0.00037617894,0.0015209932,0.0011156986,0.00016544721,0.0003480001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006436678,0.00044530243,0.0018301606,0.000774556,0.00021837061,0.000019700934,0.0003146789,0.00014144841,0.0001634848],"category_scores_gemma":[0.00011160804,0.00036681493,0.00011239333,0.0009834445,0.00025776436,0.00048574794,0.00010984486,0.0006125551,9.218331e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008682744,0.0008712157,0.9229995,0.0006276221,0.00053400197,0.000045068697,0.009489653,0.005659872,0.000014518006,6.229911e-7,0.000012529868,0.051062677],"study_design_scores_gemma":[0.018816441,0.0074907416,0.936972,0.0008260503,0.000060711645,0.00001189815,0.00032808297,0.035075236,0.000023154893,0.000001035878,0.000085773245,0.000308827],"about_ca_topic_score_codex":0.25802973,"about_ca_topic_score_gemma":0.12828507,"teacher_disagreement_score":0.12974468,"about_ca_system_score_codex":0.009348418,"about_ca_system_score_gemma":0.013676158,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W2025635422","doi":"10.1007/s10269-007-0720-3","title":"Comprendre le cancer du sein: guide d’information SOR SAVOIR PATIENT à destination des patientes et de leurs proches","year":2007,"lang":"fr","type":"article","venue":"ONCOLOGIE","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Humanities; Gynecology; Philosophy","score_opus":0.07920725349131706,"score_gpt":0.3515427472914021,"score_spread":0.27233549380008504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025635422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8709812,0.010117229,0.01844036,0.006369261,0.0030848659,0.001354498,0.0001704195,0.00021541936,0.089266725],"genre_scores_gemma":[0.96810263,0.003789558,0.014983619,0.009499383,0.00071298744,0.00016383722,0.00038457575,0.000039250557,0.0023241811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977849,0.0001526168,0.000715112,0.0002589273,0.000338201,0.00075022],"domain_scores_gemma":[0.9981135,0.00061474694,0.00036420222,0.00021910983,0.00043132907,0.00025709334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008880321,0.00028475042,0.00036074864,0.00016076084,0.00027094944,0.00005373253,0.00016154771,0.00026365512,0.00036131515],"category_scores_gemma":[0.0011905023,0.0002781509,0.0001176128,0.00024630615,0.00035147282,0.0009811552,0.00009395766,0.00035861155,0.00006801369],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040201744,0.00037497058,0.08556945,0.0005957149,0.00008446552,0.00007180804,0.008601712,0.0020951852,0.0012346037,0.00066783465,0.0301291,0.87017316],"study_design_scores_gemma":[0.0039307484,0.002355804,0.2763917,0.00093502464,0.0001909786,0.000100528356,0.007121479,0.0047111646,0.018481826,0.0004367018,0.6848424,0.0005016246],"about_ca_topic_score_codex":0.0027989757,"about_ca_topic_score_gemma":0.0022585327,"teacher_disagreement_score":0.8696715,"about_ca_system_score_codex":0.004858484,"about_ca_system_score_gemma":0.0037682753,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W2026506094","doi":"10.1016/j.ejcsup.2014.05.001","title":"Current knowledge and future research directions in treatment-related second primary malignancies","year":2014,"lang":"en","type":"article","venue":"European Journal of Cancer Supplements","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Psychological intervention; Population; Radiation therapy; Survivorship curve; Biobank; Intensive care medicine; Oncology; Bioinformatics; Internal medicine; Environmental health; Biology","score_opus":0.039514428619312245,"score_gpt":0.3603125424734014,"score_spread":0.32079811385408913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026506094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89376944,0.07433408,0.000007836166,0.0013502372,0.0015126516,0.00033496314,0.00006175693,0.000012491157,0.028616553],"genre_scores_gemma":[0.9286117,0.06579451,0.000310361,0.0002436825,0.002058479,0.000015922451,0.000051352275,0.000063205225,0.0028507602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980478,0.0005845958,0.00056806486,0.00020269438,0.00028395947,0.00031287695],"domain_scores_gemma":[0.99916255,0.00007018927,0.00016933148,0.00016796205,0.00021589972,0.00021406537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011956779,0.00015648837,0.00035659093,0.00041720728,0.00011000532,0.000028503258,0.00011200364,0.000023506162,0.0017463736],"category_scores_gemma":[0.000020306135,0.00012124585,0.00009049882,0.00028263783,0.00008759011,0.00016443829,0.00005344488,0.00043716797,0.000015802809],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043915343,0.00032344126,0.10388808,0.00018842048,0.00021573354,0.00011617531,0.0031524505,0.0000018083608,0.0025366761,0.000047203997,0.022789743,0.8663011],"study_design_scores_gemma":[0.0050664702,0.00073622033,0.25301978,0.00020200723,0.000045858003,0.00005096768,0.00015174359,0.000009721617,0.00036767893,0.00001149138,0.7402589,0.000079207166],"about_ca_topic_score_codex":0.000021177344,"about_ca_topic_score_gemma":0.00020628306,"teacher_disagreement_score":0.8662219,"about_ca_system_score_codex":0.00050738803,"about_ca_system_score_gemma":0.00037010858,"threshold_uncertainty_score":0.9991662},"labels":[],"label_agreement":null},{"id":"W2033297297","doi":"10.1089/thy.2008.0392","title":"Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis","year":2009,"lang":"en","type":"review","venue":"Thyroid","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"University of Toronto; University Health Network; Canadian Institutes of Health Research; American Thyroid Association","keywords":"Medicine; Thyroid cancer; Relative risk; Meta-analysis; Confidence interval; Internal medicine; Cancer; Oncology; Thyroid; Incidence (geometry)","score_opus":0.06571723558180188,"score_gpt":0.3507970186731116,"score_spread":0.2850797830913097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033297297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027452788,0.97758836,0.000045670906,0.0002083226,0.00005161341,0.01427642,0.006759198,0.00007014011,0.0009975275],"genre_scores_gemma":[0.0000037126438,0.97156686,0.0007619103,0.0027611605,0.00015456637,0.012244825,0.0012641037,0.00011481666,0.011128044],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99525887,0.0005468956,0.001917207,0.0012802684,0.00038686264,0.0006099194],"domain_scores_gemma":[0.99587876,0.00049627473,0.0015900577,0.0014791118,0.0001723735,0.00038341005],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00067970576,0.0013346465,0.020624794,0.00052260084,0.00013699333,0.000055170563,0.00024974666,0.00035722702,0.0020910755],"category_scores_gemma":[0.000068353824,0.00080228865,0.007176957,0.0007227105,0.0000907448,0.00015218667,0.00005311771,0.00042515213,0.000031833413],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009795305,0.000107502856,9.886297e-7,0.69788706,0.27649796,0.000054966556,0.000085438885,1.8562278e-7,5.628477e-7,0.000003376817,0.0018640629,0.02339993],"study_design_scores_gemma":[0.0009999988,0.0006458001,0.000005065396,0.020099202,0.74864453,0.000105709485,0.0000059475624,0.0000026527978,0.0000016463422,0.0000067298724,0.228938,0.0005447309],"about_ca_topic_score_codex":0.0000725401,"about_ca_topic_score_gemma":0.00011644524,"teacher_disagreement_score":0.6777879,"about_ca_system_score_codex":0.0013802751,"about_ca_system_score_gemma":0.00084503944,"threshold_uncertainty_score":0.99994045},"labels":[],"label_agreement":null},{"id":"W2037321725","doi":"10.1097/01.coc.0000258084.55036.9e","title":"A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Cancer registry; Prostate cancer; Population; Cancer; Internal medicine; Incidence (geometry); Colorectal cancer; Cohort; Confidence interval; Oncology; Prostate; Epidemiology; Gynecology; Urology","score_opus":0.04742313306440697,"score_gpt":0.45107602988796874,"score_spread":0.40365289682356176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037321725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948097,0.000323449,0.0020197537,0.0011507941,0.0006614293,0.00021058193,0.00006635054,0.0000053418316,0.00075261097],"genre_scores_gemma":[0.98105407,0.00012294404,0.009892513,0.008178901,0.0006018479,0.000012181796,0.000042462634,0.000015718015,0.00007938277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970828,0.00015807198,0.002053146,0.00019846557,0.0002690071,0.00023846226],"domain_scores_gemma":[0.99402994,0.002667019,0.0023792444,0.00016545985,0.00046748942,0.00029082806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022011644,0.00012398254,0.0018250414,0.0004982207,0.000024383504,0.000003073538,0.00010104217,0.00013420997,0.00075687736],"category_scores_gemma":[0.00054269127,0.000102813836,0.0009049784,0.00065025396,0.00026499448,0.00008230577,0.000009040243,0.0003560922,4.9676106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013323166,0.00016616446,0.6043904,0.000035431643,0.0018297299,0.000028876591,0.000105557796,0.00065984967,0.00020977392,0.0000037759457,0.00036933887,0.37887797],"study_design_scores_gemma":[0.0037190972,0.0055737956,0.9677724,0.000032547516,0.0024420612,0.000008783766,0.00011171719,0.0008831611,0.000051665254,0.000009489918,0.0192974,0.00009785828],"about_ca_topic_score_codex":0.00056610204,"about_ca_topic_score_gemma":0.002734137,"teacher_disagreement_score":0.3787801,"about_ca_system_score_codex":0.000887296,"about_ca_system_score_gemma":0.0031231588,"threshold_uncertainty_score":0.8287276},"labels":[],"label_agreement":null},{"id":"W2039389176","doi":"10.1016/j.ejso.2014.08.071","title":"74. GIST may have a higher incidence of second primary cancers which negatively impact upon survival","year":2014,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"GiST; Incidence (geometry); Medicine; Malignancy; Internal medicine; Oncology; Cancer; Overall survival; Stromal cell","score_opus":0.0308668197235944,"score_gpt":0.3200661809953261,"score_spread":0.2891993612717317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039389176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71425986,0.00042648238,0.00009184388,0.0016810629,0.0007518863,0.00012549286,0.000018830637,0.000011612178,0.2826329],"genre_scores_gemma":[0.9951692,0.00044068534,0.0007705726,0.0008367427,0.0009955005,9.1640004e-7,0.000011105146,0.000044583667,0.0017306703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621576,0.0014864842,0.0011557146,0.00026485647,0.0004851599,0.00039204382],"domain_scores_gemma":[0.9969123,0.0007482384,0.0010448194,0.0002608243,0.00053521007,0.0004986238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002695024,0.00025829018,0.0012085382,0.0002085151,0.000058572532,0.00001477731,0.00031536815,0.000098936995,0.0036515365],"category_scores_gemma":[0.00014176391,0.0001881177,0.0003685127,0.0002114389,0.00028770685,0.00020603667,0.000095634576,0.0008578865,0.00003950759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062123377,0.002057318,0.15387893,0.0012652875,0.0037401675,0.02851318,0.004586404,0.0025075942,0.07648177,0.001054777,0.074034974,0.58975625],"study_design_scores_gemma":[0.0080302665,0.0061367652,0.27777588,0.00015734349,0.00012612593,0.0013429624,0.000085626925,0.00006676383,0.00045340534,0.000017757837,0.7056133,0.00019379576],"about_ca_topic_score_codex":0.000063821055,"about_ca_topic_score_gemma":0.000095928226,"teacher_disagreement_score":0.6315783,"about_ca_system_score_codex":0.0009609235,"about_ca_system_score_gemma":0.0014861086,"threshold_uncertainty_score":0.99725926},"labels":[],"label_agreement":null},{"id":"W2044790512","doi":"10.1016/j.juro.2011.02.448","title":"362 UROTHELIAL CANCER AND RISK OF SUBSEQUENT MALIGNANCIES","year":2011,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Urothelial cancer; Bladder cancer; Cancer; Malignancy; Cancer registry; Incidence (geometry); Prostate cancer; Cohort; Population; Oncology; Gynecology; Renal pelvis; Internal medicine; Urinary system","score_opus":0.0335505936553123,"score_gpt":0.26361883761783655,"score_spread":0.23006824396252426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044790512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223304,0.005462766,0.00008440498,0.0006956549,0.00022371342,0.00006833097,0.00000986512,0.0000021972353,0.0012200301],"genre_scores_gemma":[0.9876284,0.011150421,0.00017053049,0.0007861501,0.00013782746,8.695941e-7,1.7447037e-7,0.000006722655,0.0001188969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938965,0.00009518474,0.000264242,0.000044295863,0.00009713592,0.00010951039],"domain_scores_gemma":[0.99935275,0.0000780865,0.00030665493,0.000107825465,0.00009769559,0.000056988283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044886523,0.00006197341,0.00024389164,0.000056926496,0.00002737301,9.4449086e-7,0.0000862907,0.000044386732,0.00052833155],"category_scores_gemma":[0.000048016904,0.00003456229,0.000057209603,0.000035489586,0.00021053704,0.000037073394,0.000020643587,0.00021206962,0.0000014635397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021804731,0.00027673182,0.7439249,0.00017131238,0.0019837632,0.00025165253,0.01984677,0.0001056842,0.15537779,0.00081573817,0.004574205,0.050866697],"study_design_scores_gemma":[0.005511888,0.0046338844,0.9293548,0.000046819998,0.0018602381,0.0024337126,0.0005220014,0.00010434254,0.031292878,0.001367379,0.022734966,0.00013713099],"about_ca_topic_score_codex":0.0003434657,"about_ca_topic_score_gemma":0.00006292767,"teacher_disagreement_score":0.18542984,"about_ca_system_score_codex":0.000018496678,"about_ca_system_score_gemma":0.00016363311,"threshold_uncertainty_score":0.578486},"labels":[],"label_agreement":null},{"id":"W2047213739","doi":"10.1097/01.jto.0000263708.08332.76","title":"Does Intensive Follow-up Alter Outcome in Patients with Advanced Lung Cancer?","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Clinical trial; Asymptomatic; Stage (stratigraphy); Randomized controlled trial; Cancer; Internal medicine; Surgery","score_opus":0.016433774239267823,"score_gpt":0.4023726481106881,"score_spread":0.3859388738714203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047213739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935267,0.0003868965,0.00024207796,0.0023977193,0.0023453133,0.00029744618,0.0000063649777,0.0000072663656,0.00079022767],"genre_scores_gemma":[0.9924207,0.00007469079,0.002325298,0.0041389433,0.0002745766,0.0000040902682,0.000005192124,0.00002107925,0.0007354449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837357,0.000061929044,0.00077399425,0.00016438775,0.00029354583,0.00033256318],"domain_scores_gemma":[0.9981523,0.00015648892,0.000593222,0.00015371633,0.0007459599,0.00019831007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586054,0.00015625464,0.0007313498,0.00032819342,0.00003076516,0.000005635215,0.00012011199,0.00012977386,0.00025835854],"category_scores_gemma":[0.00018357181,0.00008340332,0.00012263049,0.00018513243,0.00007534411,0.00021481504,0.000030582505,0.00060615427,0.0000024246335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01857063,0.00014101458,0.78338873,0.00008217208,0.00015237562,0.00051495165,0.0007082212,0.00003283263,0.00041429198,0.000002560633,0.0006832651,0.19530894],"study_design_scores_gemma":[0.009812409,0.003323992,0.9667764,0.00031729855,0.0002746079,0.00009470711,0.0010342762,0.000031309784,0.0011517543,0.00001748785,0.016990926,0.00017488905],"about_ca_topic_score_codex":0.00003064456,"about_ca_topic_score_gemma":0.0003893141,"teacher_disagreement_score":0.19513404,"about_ca_system_score_codex":0.0011711331,"about_ca_system_score_gemma":0.00049595186,"threshold_uncertainty_score":0.34010887},"labels":[],"label_agreement":null},{"id":"W2049938619","doi":"10.1016/s0360-3016(01)02077-6","title":"Second malignancies after prostate radiation: results from a linked tumour - radiation registry in a stable population base","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Prostate; Incidence (geometry); Population; Cancer registry; Malignancy; Relative risk; Cancer; Oncology; Adenocarcinoma; Rectum; Urology; Nuclear medicine; Internal medicine; Confidence interval","score_opus":0.019554513968195224,"score_gpt":0.30255952276260384,"score_spread":0.2830050087944086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049938619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896789,0.0012122904,0.0009807546,0.0041290345,0.002034372,0.00044065062,0.0005587174,0.000042268755,0.0009229772],"genre_scores_gemma":[0.98976934,0.0014105107,0.0018660203,0.0022306384,0.0024949003,0.000034799974,0.0017685296,0.00003727787,0.00038797097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997107,0.00029195024,0.0014658266,0.00040803012,0.0003977097,0.000329484],"domain_scores_gemma":[0.9969913,0.00042434415,0.0015987334,0.00024898222,0.0005520628,0.00018462627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007754468,0.00027719152,0.0006431773,0.00035811,0.00006891669,0.000058880007,0.0002707295,0.00033722934,0.00053237466],"category_scores_gemma":[0.0005419821,0.00026973104,0.0002262072,0.000311539,0.000100389865,0.0008568974,0.00004422352,0.00064038805,0.000037414706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009135447,0.000620602,0.8038786,0.000024005609,0.00044704162,0.00051475165,0.0021630514,0.0019971693,0.008414108,0.00050177315,0.0035868173,0.16871662],"study_design_scores_gemma":[0.025839232,0.0009066344,0.8627547,0.00018730377,0.00013812458,0.00026761633,0.00020396523,0.007404814,0.0021518837,0.0046819346,0.09507194,0.00039185854],"about_ca_topic_score_codex":0.00027018497,"about_ca_topic_score_gemma":0.00015636667,"teacher_disagreement_score":0.16832477,"about_ca_system_score_codex":0.0018578576,"about_ca_system_score_gemma":0.0009394038,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W2051415992","doi":"10.1089/thy.2007.0171","title":"Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis","year":2007,"lang":"en","type":"review","venue":"Thyroid","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Occupational Cancer Research Centre; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Thyroid cancer; Meta-analysis; Malignancy; Oncology; Cancer; Internal medicine; Thyroid","score_opus":0.08179582737510323,"score_gpt":0.363010182609424,"score_spread":0.2812143552343208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051415992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000929601,0.9876868,0.000015514366,0.00007780746,0.00007303611,0.006341413,0.0010639632,0.000066591005,0.004665563],"genre_scores_gemma":[0.000004138881,0.9866636,0.000191525,0.0031550468,0.0000880458,0.0015317128,0.0005283667,0.0001265281,0.007711077],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99357074,0.0010093176,0.0028460296,0.0012193673,0.0006388703,0.0007156547],"domain_scores_gemma":[0.9955181,0.0006667417,0.00165196,0.001662123,0.00013976885,0.00036132976],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028460186,0.0011376514,0.020228649,0.0011481026,0.00008510682,0.000047095033,0.0004200501,0.0004994502,0.0044497447],"category_scores_gemma":[0.00016877265,0.0007568133,0.004140431,0.0021643785,0.00011995515,0.0001712707,0.00016276124,0.0012273481,0.000088298984],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001270491,0.000055880842,0.000013709919,0.8793725,0.11287383,0.00013700136,0.00007227438,2.8996712e-7,4.0206035e-7,0.000007108945,0.00086473225,0.006589579],"study_design_scores_gemma":[0.00038499004,0.00007981918,0.000022316251,0.04708982,0.7683982,0.00010223727,0.000010615046,0.0000018353602,3.9853458e-7,0.000004515794,0.18330711,0.0005981084],"about_ca_topic_score_codex":0.00094280514,"about_ca_topic_score_gemma":0.0036698251,"teacher_disagreement_score":0.83228266,"about_ca_system_score_codex":0.0006860344,"about_ca_system_score_gemma":0.000786755,"threshold_uncertainty_score":0.9994883},"labels":[],"label_agreement":null},{"id":"W2053283856","doi":"10.5114/wo.2010.975","title":"Novel systemic approaches to treatment of HCC","year":2010,"lang":"pl","type":"article","venue":"Współczesna Onkologia","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.14629441178402433,"score_gpt":0.28439116610882315,"score_spread":0.13809675432479881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053283856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740065,0.0025107597,0.00055729237,0.0014409124,0.003347832,0.0019122497,0.00035244133,0.00010391842,0.015768114],"genre_scores_gemma":[0.98629653,0.0002620653,0.005104761,0.00053800276,0.0009436088,0.00013376582,0.000121096295,0.00006854996,0.0065316167],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969169,0.000072997456,0.0009331157,0.00087416044,0.00041344596,0.00078939344],"domain_scores_gemma":[0.99745095,0.00024897873,0.00034224038,0.0013083087,0.000117100266,0.00053242536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036500394,0.0005902135,0.001409774,0.00031674135,0.000116374686,0.00003019232,0.00039765317,0.00057889964,0.0015493685],"category_scores_gemma":[0.00016765961,0.0004762453,0.00036890028,0.00039786735,0.00030965736,0.00010243487,0.00010392407,0.00046860674,0.00048397094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019105905,0.0032179693,0.049813725,0.0015145974,0.0013138006,0.00014678444,0.0075631235,0.00020491316,0.78723615,0.0049639298,0.0026327095,0.13948172],"study_design_scores_gemma":[0.05049994,0.036416054,0.3368533,0.002325886,0.0050775874,0.00279919,0.010508581,0.007106875,0.2654393,0.00017900122,0.27759123,0.0052030827],"about_ca_topic_score_codex":0.00074058905,"about_ca_topic_score_gemma":0.00025789143,"teacher_disagreement_score":0.5217968,"about_ca_system_score_codex":0.00042421103,"about_ca_system_score_gemma":0.00079589896,"threshold_uncertainty_score":0.9997689},"labels":[],"label_agreement":null},{"id":"W2057985610","doi":"10.1158/1078-0432.ccr-10-2224","title":"The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Histology; Primary tumor; Lung cancer; Pathology; Cancer; Epidermal growth factor receptor; Oncology; Stage (stratigraphy); Cancer research; Internal medicine; Metastasis; Biology","score_opus":0.06839996388077083,"score_gpt":0.4448765100299225,"score_spread":0.3764765461491517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057985610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921916,0.0012443683,0.000015336082,0.00091409497,0.0004801776,0.0025231715,0.0012578962,0.000013378978,0.0013599693],"genre_scores_gemma":[0.99471295,0.0031321547,0.0001860634,0.0005020334,0.00035029155,0.00069728214,0.000015257271,0.000031271782,0.00037268994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958238,0.00052655686,0.0011881948,0.0007329353,0.0010182677,0.0007102272],"domain_scores_gemma":[0.9938049,0.0029032675,0.00030803512,0.0011837173,0.00095194456,0.000848187],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005746442,0.00021115465,0.0007069783,0.00019385494,0.00015869703,0.000020933681,0.00064707693,0.00015804516,0.0005820271],"category_scores_gemma":[0.002617608,0.00015158397,0.00028798621,0.0007938338,0.0011518573,0.000117504744,0.0003765158,0.0024028064,0.000006112254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012304078,0.0004958214,0.9650639,0.0010177948,0.00006633766,0.000014708405,0.0008854443,0.00001582723,0.0026325595,0.0000055123874,0.002619132,0.014878862],"study_design_scores_gemma":[0.0030820488,0.00085281214,0.98588884,0.00033616184,0.000088671026,1.7490302e-7,0.00012447702,0.0011947288,0.0036180182,0.000057528887,0.004608835,0.00014768325],"about_ca_topic_score_codex":0.017949734,"about_ca_topic_score_gemma":0.0056940597,"teacher_disagreement_score":0.020824937,"about_ca_system_score_codex":0.00040569296,"about_ca_system_score_gemma":0.005056588,"threshold_uncertainty_score":0.9998987},"labels":[],"label_agreement":null},{"id":"W2073107050","doi":"10.5489/cuaj.244","title":"L’AUC dirige des initiatives pour les survivants de cancers génito-urinaires","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Urological Association","funders":"","keywords":"Medicine; Humanities; Art","score_opus":0.02601672722003579,"score_gpt":0.25760147951802076,"score_spread":0.23158475229798497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073107050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8873333,0.018150136,0.00017270172,0.059135105,0.0025774566,0.0003882665,0.0002827264,0.000041487525,0.031918872],"genre_scores_gemma":[0.97415066,0.004476398,0.0005069252,0.008404495,0.0035262995,0.000028062703,0.000030850835,0.00003797425,0.008838329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594456,0.00089344,0.00063095766,0.0003324068,0.00044368234,0.0017549272],"domain_scores_gemma":[0.995787,0.00071299437,0.00045669597,0.00015187377,0.0005974115,0.0022939774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001108108,0.00034613852,0.00054932403,0.0002765359,0.00087316753,0.00026598043,0.00029013873,0.00065033784,0.025166187],"category_scores_gemma":[0.0022660957,0.00032134337,0.00027152782,0.00028262055,0.00030918984,0.00068668416,0.000030207293,0.0015049207,0.00060585246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004318848,0.00005445276,0.8520792,0.000042883163,0.00044332093,0.00028875578,0.0010577098,0.00019485067,0.0001452752,0.00027504528,0.07630243,0.06907289],"study_design_scores_gemma":[0.0013547337,0.00033681994,0.8821459,0.00012549962,0.00015290841,0.0002395987,0.0014352131,0.00068251736,0.00005453993,0.002592873,0.11056355,0.00031587895],"about_ca_topic_score_codex":0.08884119,"about_ca_topic_score_gemma":0.03002854,"teacher_disagreement_score":0.08681742,"about_ca_system_score_codex":0.013378904,"about_ca_system_score_gemma":0.006343777,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W2078040239","doi":"10.1503/cmaj.110167","title":"Associations between first and second primary cancers: a population-based study","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Herlev Hospital; Gentofte Hospital; Kræftens Bekæmpelse","keywords":"Medicine; Cancer; Confidence interval; Absolute risk reduction; Hazard ratio; Population; Internal medicine; Cancer registry; Proportional hazards model; Demography; Oncology; Environmental health","score_opus":0.023710453799702748,"score_gpt":0.25494502716068634,"score_spread":0.2312345733609836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078040239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834466,0.00014841276,0.000027297048,0.004900239,0.00041258187,0.00038343598,0.00021319874,0.00002940672,0.010438818],"genre_scores_gemma":[0.9873457,0.000019033956,0.00023580767,0.010754577,0.00095039647,0.000011970788,0.0001304529,0.000022377062,0.000529698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976643,0.00013721395,0.000561435,0.00021583971,0.0009925775,0.00042864907],"domain_scores_gemma":[0.9973434,0.00022972487,0.00029561692,0.00012812107,0.00027346282,0.0017296552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012722651,0.00015089141,0.0004228443,0.0002708659,0.00045442843,0.000055837158,0.000119796416,0.00030052805,0.012618277],"category_scores_gemma":[0.0007523372,0.00014654468,0.00009602669,0.0002237381,0.000022652193,0.00017837631,0.000012417753,0.0008397019,0.000027454802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000014264062,0.000042961834,0.9799404,0.000011773176,0.00023514428,0.0001338387,0.00087664695,7.77607e-7,5.811809e-7,0.0000074278173,0.010181557,0.008554641],"study_design_scores_gemma":[0.002465261,0.00020027829,0.9705197,0.000040756255,0.00012724342,0.000025725112,0.00027903306,0.00005046737,0.0000021593232,0.00003420792,0.02611034,0.00014480909],"about_ca_topic_score_codex":0.023351582,"about_ca_topic_score_gemma":0.22192334,"teacher_disagreement_score":0.19857174,"about_ca_system_score_codex":0.0045565087,"about_ca_system_score_gemma":0.0059496523,"threshold_uncertainty_score":0.9996857},"labels":[],"label_agreement":null},{"id":"W2080190730","doi":"10.1002/cncr.23315","title":"Dying with cancer","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Comorbidity; Cancer; Disease; Population; Cause of death; Cancer registry; Proportional hazards model; Hazard ratio; Internal medicine; Oncology; Environmental health","score_opus":0.044648505685659715,"score_gpt":0.3009720211619447,"score_spread":0.256323515476285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080190730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97075224,0.0054765493,0.000079376434,0.0014023649,0.00027017528,0.0001968132,0.000014452981,0.00006796169,0.02174009],"genre_scores_gemma":[0.9788232,0.0032393779,0.00040139412,0.0059454744,0.0004676547,0.00015155246,0.000010582531,0.00002954449,0.010931218],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932367,0.000006435016,0.000099175406,0.00019813515,0.00016321326,0.00020939589],"domain_scores_gemma":[0.9995899,0.000011531644,0.000035992387,0.00017591823,0.000066161156,0.00012049463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000022242657,0.00010504536,0.00019298376,0.000039985665,0.00009415913,0.000003893584,0.000046599438,0.000039892748,0.0042536315],"category_scores_gemma":[0.0000036785946,0.0000770325,0.000037596394,0.00012866985,0.0000910861,0.000080435864,0.000010917687,0.00014024835,0.000023186853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013172254,0.0000744014,0.774631,0.00024475507,0.00038794894,0.0005704801,0.0022249871,0.00033033252,0.017424062,0.00002870579,0.08628558,0.11648052],"study_design_scores_gemma":[0.0061173975,0.00029681387,0.3931658,0.00036560078,0.00017955573,0.00042999253,0.00013655533,0.00029927917,0.02527335,0.000006228158,0.5732631,0.00046633685],"about_ca_topic_score_codex":0.000567253,"about_ca_topic_score_gemma":0.00013450414,"teacher_disagreement_score":0.4869775,"about_ca_system_score_codex":0.00023812233,"about_ca_system_score_gemma":0.0006514819,"threshold_uncertainty_score":0.9966566},"labels":[],"label_agreement":null},{"id":"W2084478582","doi":"10.5489/cuaj.234","title":"Urothelial Cancer and the Diagnosis of Subsequent Malignancies","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Cancer; Cancer registry; Prostate cancer; Malignancy; Male breast cancer; Relative risk; Breast cancer; Prostate; Incidence (geometry); Oncology; Population; Internal medicine; Confidence interval; Lung cancer; Gynecology; Bladder cancer","score_opus":0.016831745070149964,"score_gpt":0.23283087321071852,"score_spread":0.21599912814056854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084478582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91748685,0.0014054507,0.000004403457,0.079205535,0.00018424093,0.0002430879,0.000028637567,0.000004924023,0.0014368691],"genre_scores_gemma":[0.9856777,0.0014742728,0.000043596738,0.011983872,0.00024379644,0.000059678838,0.000002556885,0.0000051230872,0.0005093688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991491,0.00009282068,0.00023955888,0.00008653722,0.00019238303,0.0002396345],"domain_scores_gemma":[0.9990493,0.00019403498,0.00017378805,0.000061108876,0.00020687746,0.00031489035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039032448,0.00007396599,0.0002254299,0.000059802354,0.00013891024,0.000041306983,0.000067433306,0.00009754281,0.0029363164],"category_scores_gemma":[0.00039973087,0.000042674095,0.000088918554,0.00007660353,0.000107390166,0.00007441108,0.000009075852,0.00027117113,0.00001185406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006031317,0.000009872563,0.9725828,0.0000062063204,0.00010497609,0.000008449154,0.00023390258,0.0000104665105,0.00014629003,0.00047585968,0.017460424,0.00890042],"study_design_scores_gemma":[0.002208734,0.000100852165,0.9383577,0.000012962281,0.000072719864,0.000050665174,0.00009035964,0.00011250179,0.00011847153,0.0007933006,0.058017217,0.00006452625],"about_ca_topic_score_codex":0.013076654,"about_ca_topic_score_gemma":0.0014696728,"teacher_disagreement_score":0.06819088,"about_ca_system_score_codex":0.0004314507,"about_ca_system_score_gemma":0.0004739843,"threshold_uncertainty_score":0.9979751},"labels":[],"label_agreement":null},{"id":"W2084846190","doi":"10.1016/j.ejca.2005.01.003","title":"Active and passive smoking and risk of renal cell carcinoma in Canada","year":2005,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Renal cell carcinoma; Passive smoking; Medicine; Oncology; Carcinoma; Internal medicine; Environmental health","score_opus":0.008782710567018053,"score_gpt":0.22202083486845106,"score_spread":0.21323812430143302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084846190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002486,0.004840231,0.0000074508807,0.0004301979,0.00008179545,0.000048369442,0.000020247278,7.254675e-7,0.0045461073],"genre_scores_gemma":[0.99693793,0.0022777712,0.00013594225,0.0003301251,0.00021657595,2.911053e-7,4.525634e-7,0.000011807194,0.000089104666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99923694,0.00010161891,0.0002951032,0.00008442707,0.0001721946,0.0001097139],"domain_scores_gemma":[0.99936545,0.000043452004,0.00032313447,0.000059918064,0.00008848812,0.00011954915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442056,0.000077308425,0.00022814792,0.00007357691,0.000020003028,0.0000041435264,0.00004283535,0.000009555871,0.00011764119],"category_scores_gemma":[0.000023968874,0.000062032836,0.000027957825,0.00005114923,0.000038297745,0.00008651079,0.000019765102,0.00028295137,1.1700157e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007542452,0.000016624204,0.47152337,0.0000559836,0.00011101828,0.00047291143,0.0016950128,0.00039444986,0.0037557713,9.090602e-7,0.0019031696,0.5193165],"study_design_scores_gemma":[0.0035722961,0.00021728987,0.9549172,0.00013570985,0.00012723177,0.00007562607,0.00055938435,0.000118558906,0.019083833,0.0000011519479,0.021116385,0.00007531181],"about_ca_topic_score_codex":0.08045265,"about_ca_topic_score_gemma":0.19547786,"teacher_disagreement_score":0.5192412,"about_ca_system_score_codex":0.00033290483,"about_ca_system_score_gemma":0.00089089776,"threshold_uncertainty_score":0.9256707},"labels":[],"label_agreement":null},{"id":"W2085673437","doi":"10.1007/s11764-013-0278-6","title":"Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Journal of Cancer Survivorship","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Prostate cancer; Breast cancer; Oncology; Meta-analysis; Colorectal cancer; Cervical cancer; Internal medicine; Cancer screening; Epidemiology of cancer; Survivorship curve; Odds ratio; Gynecology","score_opus":0.20519415239253339,"score_gpt":0.4218015501701301,"score_spread":0.21660739777759672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085673437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042068084,0.98529524,0.00081859773,0.001946425,0.00058994663,0.010471496,0.0007164839,0.00001949083,0.00010027325],"genre_scores_gemma":[0.000045891695,0.98283035,0.0011496294,0.0066224677,0.0006166511,0.0055356296,0.000060118935,0.00017929217,0.0029599587],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914681,0.00079777936,0.0046924106,0.00094560056,0.0011465441,0.00094957446],"domain_scores_gemma":[0.99119323,0.0014186891,0.0044838456,0.00086588104,0.0008913566,0.0011469987],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030223108,0.001317785,0.025528781,0.0017171979,0.00010240128,0.00014014081,0.00080616557,0.00044576742,0.0017684101],"category_scores_gemma":[0.00031965176,0.00088966393,0.0055923797,0.0023618585,0.0000939611,0.00041709412,0.0001126725,0.0012304381,0.000004505151],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029139285,0.000046888952,0.00035054822,0.76074904,0.20540959,0.000029289133,0.0002666965,0.00030710883,0.000001433704,0.000002602941,0.0040217564,0.028523669],"study_design_scores_gemma":[0.0016482469,0.00018586239,0.00012629578,0.13630292,0.73613185,0.000033837285,0.000054794302,0.00006123707,0.0000010750556,0.0000037825112,0.12465997,0.00079013157],"about_ca_topic_score_codex":0.083255775,"about_ca_topic_score_gemma":0.11404947,"teacher_disagreement_score":0.6244461,"about_ca_system_score_codex":0.0026721628,"about_ca_system_score_gemma":0.00558842,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W2091893234","doi":"10.4236/crcm.2014.32016","title":"Metachronous double malignancy involving the kidney and the breast: A case report","year":2014,"lang":"en","type":"article","venue":"Case Reports in Clinical Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Malignancy; Nephrectomy; Biopsy; Renal cell carcinoma; Disease; Breast cancer; Etiology; Adenocarcinoma; Metastasis; Radiology; Cancer; Kidney; Pathology; Oncology; Internal medicine","score_opus":0.05011163079091641,"score_gpt":0.37346731231141167,"score_spread":0.32335568152049526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091893234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94287866,0.0047823633,0.00014925006,0.03505006,0.002114919,0.001579935,0.0000048007855,0.00007597089,0.01336404],"genre_scores_gemma":[0.985973,0.00051556487,0.00019769062,0.010173521,0.001994389,0.000088320485,0.000022416534,0.000034314933,0.0010007737],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99566305,0.00039043243,0.0024444174,0.0007202216,0.0004023863,0.000379495],"domain_scores_gemma":[0.99442124,0.0025242488,0.0007747375,0.0015614592,0.00016898502,0.0005493005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011604731,0.0002785392,0.0011364626,0.00009090273,0.00023936454,0.00002200809,0.000075722724,0.00019162665,0.0003416765],"category_scores_gemma":[0.008141399,0.0001302069,0.00020765874,0.00027310223,0.0016776813,0.000092823204,0.00013953,0.0009500488,0.0000031650593],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006614601,0.00008522363,0.023547892,0.00015272194,0.00013774975,0.94728523,0.0005462323,0.0000022639756,0.000015331318,0.00037979303,0.006398866,0.020787222],"study_design_scores_gemma":[0.009278613,0.00026996311,0.0030840964,0.0004187703,0.00052063284,0.95704955,0.0005728619,0.000788289,0.000012528423,0.00049370044,0.027361933,0.00014904872],"about_ca_topic_score_codex":0.0024632232,"about_ca_topic_score_gemma":0.0003169751,"teacher_disagreement_score":0.04309435,"about_ca_system_score_codex":0.000084567546,"about_ca_system_score_gemma":0.00046545017,"threshold_uncertainty_score":0.9746603},"labels":[],"label_agreement":null},{"id":"W2098179714","doi":"10.1200/jco.2002.09.038","title":"Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Population; Relative risk; Cancer; Confidence interval; Internal medicine; Breast cancer; Thyroid; Esophagus; Gastroenterology","score_opus":0.10419795874937252,"score_gpt":0.44187201657280184,"score_spread":0.3376740578234293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098179714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959225,0.0006059741,0.00005397876,0.0007040252,0.0013138703,0.00031003729,0.000017099126,0.000006690946,0.0010658277],"genre_scores_gemma":[0.9969702,0.00017067206,0.00041262808,0.0014689864,0.0005562493,0.000004844732,0.000026446856,0.000018577683,0.00037144503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615026,0.00055830047,0.0021900188,0.00020479214,0.00069632375,0.0002002891],"domain_scores_gemma":[0.99553806,0.0014180548,0.0019291872,0.00025701293,0.00040467226,0.00045303407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027930713,0.00013524141,0.0011133412,0.00019771843,0.000026591619,0.000007684517,0.00013938708,0.00027636203,0.010294772],"category_scores_gemma":[0.0018344274,0.0001093052,0.00057482044,0.00013842132,0.00015089348,0.00017004069,0.000021486741,0.0005464093,0.000012018027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015019622,0.0007052633,0.9199517,0.00007803504,0.00019886081,0.00029088452,0.00005762375,0.00024278685,0.000059601545,0.000008614366,0.001662795,0.07524191],"study_design_scores_gemma":[0.008544686,0.002319414,0.9799295,0.00014830762,0.00048764324,0.000023945859,0.000011538315,0.0058798916,0.00002095774,0.000040567673,0.002491769,0.00010179286],"about_ca_topic_score_codex":0.00006301063,"about_ca_topic_score_gemma":0.00047881005,"teacher_disagreement_score":0.07514012,"about_ca_system_score_codex":0.00028253417,"about_ca_system_score_gemma":0.0012284431,"threshold_uncertainty_score":0.99060994},"labels":[],"label_agreement":null},{"id":"W2119752536","doi":"10.3748/wjg.v19.i27.4443","title":"Triple metachronous colon cancer","year":2013,"lang":"en","type":"letter","venue":"World Journal of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Colonoscopy; Colorectal cancer; Descending colon; Cecum; Stage (stratigraphy); Cancer; Asymptomatic; Regimen; Internal medicine; Gastroenterology; Sigmoid colon; Oncology; Rectum","score_opus":0.020103493039553267,"score_gpt":0.2763352947629662,"score_spread":0.2562318017234129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119752536","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046845026,0.0037081928,0.00012540653,0.94201034,0.005110335,0.0005257092,0.00006441552,0.000022528482,0.0015880741],"genre_scores_gemma":[0.0095751975,0.0010896606,0.0010483579,0.95641685,0.010594186,0.000037095462,0.00008436658,0.00009006816,0.021064203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735934,0.00022759917,0.0010272096,0.0002905263,0.00042797386,0.00066737947],"domain_scores_gemma":[0.9978185,0.00007765568,0.0012105689,0.00034329385,0.00034904727,0.00020087835],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024324388,0.00038423296,0.0016662461,0.0008000911,0.00004874782,0.000025188665,0.00034487198,0.00034835062,0.006925056],"category_scores_gemma":[0.00002807819,0.0003055205,0.00061910844,0.00012337437,0.00018213729,0.00013202954,0.00005962281,0.00345434,0.000053324053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00187242,0.00005900227,0.009862103,0.00018152747,0.0011692529,0.0020943033,0.000043044012,0.000012101716,0.00031776936,6.4937797e-7,0.9823878,0.0020000446],"study_design_scores_gemma":[0.0046795895,0.0030106127,0.004366151,0.00020610797,0.0009248925,0.0024590981,0.000008127193,0.000023005858,0.000043428267,0.000011019302,0.98414266,0.00012530625],"about_ca_topic_score_codex":0.00009087946,"about_ca_topic_score_gemma":0.00021820603,"teacher_disagreement_score":0.037269827,"about_ca_system_score_codex":0.0005750156,"about_ca_system_score_gemma":0.00052179146,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W2127646700","doi":"10.1007/978-3-319-12505-3_24","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2014,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Malignancy; Lung cancer; Oncology; Relative risk; Population; Absolute risk reduction; Radiation therapy","score_opus":0.01940116088779189,"score_gpt":0.23645098463569467,"score_spread":0.21704982374790277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127646700","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09546359,0.031040955,0.00013086697,0.00016111253,0.0006398554,0.0016592834,0.0010816529,0.0002194431,0.8696032],"genre_scores_gemma":[0.27649102,0.007248392,0.0013236523,0.0007282478,0.00028926387,0.00022047112,0.00026951017,0.00014823665,0.7132812],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719363,0.0000494429,0.0010215234,0.00080547493,0.00042082192,0.0005091248],"domain_scores_gemma":[0.99743956,0.00019620427,0.0008395495,0.0011095626,0.00018982502,0.00022528855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014829684,0.00083681865,0.0022751233,0.00028881687,0.00007978664,0.000017384436,0.00016282672,0.00075409363,0.01609021],"category_scores_gemma":[0.00004038171,0.0006333503,0.0008251232,0.000045908877,0.00040018465,0.000047707344,0.00007347845,0.00015825688,0.00034494395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012360562,0.0025233594,0.07949721,0.030151764,0.011340353,0.01791572,0.0069286358,0.000009762275,0.0048532286,0.38677692,0.120676465,0.32696602],"study_design_scores_gemma":[0.004285212,0.002477501,0.005496393,0.0013867255,0.0011129108,0.001060825,0.00005028182,0.000015202074,0.007545707,0.00453376,0.9710991,0.0009363891],"about_ca_topic_score_codex":0.000031997562,"about_ca_topic_score_gemma":0.00007262198,"teacher_disagreement_score":0.8504226,"about_ca_system_score_codex":0.00033265687,"about_ca_system_score_gemma":0.00040853056,"threshold_uncertainty_score":0.9996118},"labels":[],"label_agreement":null},{"id":"W2128439362","doi":"10.1023/a:1008356806417","title":"Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG)","year":2000,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Melphalan; Radiation therapy; Ovarian cancer; Cancer; Surgery; Stage (stratigraphy); Malignancy; Internal medicine; Uterine cancer; Oncology; Chemotherapy","score_opus":0.1861734927056167,"score_gpt":0.45525544891664477,"score_spread":0.26908195621102804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128439362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526263,0.0033779826,0.000002305727,0.004207308,0.0005086487,0.0011755439,0.0012669951,0.0000045758566,0.0041939854],"genre_scores_gemma":[0.9908573,0.003639961,0.000054433243,0.003095269,0.0001861155,0.0001525857,0.000044091903,0.000014602719,0.0019556158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967196,0.0006373301,0.0015803038,0.0002642125,0.0005337406,0.00026484366],"domain_scores_gemma":[0.99750787,0.0009209498,0.00087848253,0.0003103869,0.00029090268,0.00009140003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025580362,0.00018999573,0.0014784818,0.00006188427,0.00007893429,0.0000036010026,0.00025749745,0.000117662974,0.0019406534],"category_scores_gemma":[0.00015817833,0.00011093427,0.0003705101,0.00019508245,0.0003522119,0.00010158636,0.000028725832,0.00015310664,4.5894046e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020233143,0.008344243,0.16461228,0.0005037258,0.014588283,0.00011892597,0.011138901,0.0006076927,0.019567067,0.0004060004,0.11939685,0.6404829],"study_design_scores_gemma":[0.011350898,0.008971283,0.280878,0.000093099225,0.0006064928,0.000004887914,0.0006571904,0.000030496045,0.006692234,0.00003642668,0.69051397,0.00016500293],"about_ca_topic_score_codex":0.17503382,"about_ca_topic_score_gemma":0.26187608,"teacher_disagreement_score":0.6403179,"about_ca_system_score_codex":0.0002889937,"about_ca_system_score_gemma":0.0060912585,"threshold_uncertainty_score":0.9995433},"labels":[],"label_agreement":null},{"id":"W2129571555","doi":"10.3748/wjg.v19.i44.8078","title":"Clinical characteristics and prognosis of young patients with colorectal cancer in Eastern China","year":2013,"lang":"en","type":"article","venue":"World Journal of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Multivariate analysis; Univariate analysis; Subgroup analysis; Proportional hazards model; Gastroenterology; Survival analysis; Stage (stratigraphy); Cancer; Confidence interval","score_opus":0.010422496870278049,"score_gpt":0.2691374608692679,"score_spread":0.2587149639989898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129571555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986848,0.0000612458,0.000019045372,0.0006676912,0.0002509245,0.00022806287,0.000011453037,0.0000019868746,0.00007478235],"genre_scores_gemma":[0.9989066,0.00013169245,0.00040601584,0.00038862813,0.00010568754,0.0000078233215,0.0000040457485,0.000010707341,0.00003879772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987898,0.00008486015,0.00067676493,0.00011327198,0.00014121419,0.00019410484],"domain_scores_gemma":[0.9991066,0.000030175814,0.0005008696,0.000061386345,0.00017000058,0.00013100768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017043615,0.00010333264,0.00057353626,0.00019311697,0.000011372539,0.0000058812752,0.00006673002,0.00003749482,0.00024206688],"category_scores_gemma":[0.000023726632,0.0000732294,0.00006289465,0.000064909334,0.00016141296,0.00010872569,0.000029286279,0.00032891848,7.1097776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00443535,0.00027619762,0.9824859,0.00004160398,0.00012942737,0.000022878936,0.00013697476,0.0000014067937,0.00011726129,6.410585e-7,0.00013838541,0.012213988],"study_design_scores_gemma":[0.0058138,0.004395563,0.9892356,0.00017393446,0.00007268904,0.000066749526,0.000019937163,0.0000933957,0.000015277104,0.000002290852,0.0000782787,0.000032519594],"about_ca_topic_score_codex":0.00006004553,"about_ca_topic_score_gemma":0.00049720204,"teacher_disagreement_score":0.012181468,"about_ca_system_score_codex":0.000046657413,"about_ca_system_score_gemma":0.000067216555,"threshold_uncertainty_score":0.29862082},"labels":[],"label_agreement":null},{"id":"W2130803751","doi":"10.1093/jnci/dji278","title":"Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":830,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Cancer Care Ontario","funders":"National Institutes of Health","keywords":"Medicine; Relative risk; Cancer; Relative survival; Internal medicine; Poisson regression; Confidence interval; Population; Cohort; Testicular cancer; Absolute risk reduction; Lung cancer; Bladder cancer; Gastroenterology; Cancer registry","score_opus":0.030502550960562185,"score_gpt":0.3127907066982983,"score_spread":0.2822881557377361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130803751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837446,0.0013503758,0.000021267804,0.004122189,0.004143531,0.00038535695,0.00023191152,0.000015415173,0.005985361],"genre_scores_gemma":[0.9880551,0.00057733094,0.00012003023,0.0063392418,0.0031875581,0.000038537673,0.0000144378355,0.000031735002,0.0016360361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721444,0.000055742155,0.0007048925,0.00025582142,0.0014527725,0.00031633792],"domain_scores_gemma":[0.9975995,0.00008852355,0.0007065805,0.00018635414,0.0011714483,0.00024759193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032314763,0.000267685,0.00043489135,0.00023706292,0.00021664625,0.00004029567,0.00038334704,0.00012272202,0.0017487232],"category_scores_gemma":[0.00024081612,0.00018313079,0.000338436,0.00034443426,0.00023972508,0.0006526638,0.000051870044,0.0006804363,0.000011204862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00223063,0.00047318666,0.83904713,0.00021446466,0.0012723921,0.00005981501,0.00062200305,0.045334127,0.0015478164,0.0002415534,0.051686168,0.057270687],"study_design_scores_gemma":[0.0048702797,0.0002536379,0.91403395,0.0006663614,0.00023562297,0.00005228678,0.00001010311,0.00028285698,0.0052150167,0.00008134562,0.07401755,0.00028101724],"about_ca_topic_score_codex":0.0005814044,"about_ca_topic_score_gemma":0.009830587,"teacher_disagreement_score":0.07498677,"about_ca_system_score_codex":0.0043883356,"about_ca_system_score_gemma":0.0029072983,"threshold_uncertainty_score":0.99943364},"labels":[],"label_agreement":null},{"id":"W2145046237","doi":"","title":"Radiation-induced second malignancies.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Manitoba Beekeepers' Association; Saskatchewan Health","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Thyroid cancer; Sarcoma; Etiology; Oncology; Internal medicine; Pathology","score_opus":0.06257628559922351,"score_gpt":0.2542505515920383,"score_spread":0.19167426599281479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145046237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87002605,0.00056185335,0.000014983259,0.0012636351,0.00063636224,0.00066654553,0.000010185906,0.00008106069,0.12673935],"genre_scores_gemma":[0.985013,0.000011954985,0.00009026616,0.0036686694,0.00034211035,0.0004777272,0.000032736003,0.000015710604,0.010347829],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99916995,0.0000183839,0.00016102855,0.00017548594,0.00019567674,0.00027945742],"domain_scores_gemma":[0.99925756,0.000021578524,0.00004505318,0.00022529588,0.00006987909,0.00038061058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024419837,0.00009005891,0.00017753671,0.00007156,0.000026026088,0.000015398351,0.00006106439,0.000061467945,0.0003776209],"category_scores_gemma":[0.00013265757,0.000080894126,0.00005478123,0.00012413062,0.00002147382,0.00012702457,0.000018249353,0.0001042491,0.00008063519],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030233854,0.00008743077,0.035269115,0.000072055394,0.00012598562,0.00008277151,0.0006869347,0.000003847098,0.0010191124,0.00025509062,0.14961211,0.8124832],"study_design_scores_gemma":[0.002984432,0.000049552782,0.5876026,0.0000033795743,0.00003066572,0.000040245628,0.00009954686,0.00003907607,0.007012828,0.00007557159,0.40193102,0.00013106535],"about_ca_topic_score_codex":0.000029668377,"about_ca_topic_score_gemma":0.00001493502,"teacher_disagreement_score":0.8123521,"about_ca_system_score_codex":0.00021748671,"about_ca_system_score_gemma":0.00022140995,"threshold_uncertainty_score":0.4134684},"labels":[],"label_agreement":null},{"id":"W2177715379","doi":"10.1111/bju.13351","title":"Trends in the risk of second primary cancer among bladder cancer survivors: a population‐based cohort of 10 047 patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut de Veille Sanitaire; Institut National Du Cancer","keywords":"Medicine; Bladder cancer; Poisson regression; Confidence interval; Lung cancer; Incidence (geometry); Population; Cohort; Internal medicine; Cancer; Prostate cancer; Cancer registry; Relative risk; Multivariate analysis; Oncology","score_opus":0.016606764456405177,"score_gpt":0.2698471438441277,"score_spread":0.25324037938772254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177715379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380547,0.0035086859,0.0000091291995,0.00023375102,0.00033118934,0.00016817341,0.00021011289,0.0000029373607,0.0017305694],"genre_scores_gemma":[0.99804866,0.0004702558,0.00007382968,0.00096225867,0.00014783994,0.000012912237,0.00006948233,0.000016528837,0.00019825724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980852,0.00033066634,0.00080647203,0.0001474289,0.00042471284,0.00020551517],"domain_scores_gemma":[0.9982936,0.0001325444,0.00083938375,0.00016117076,0.0004598817,0.00011344327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008014827,0.0001167662,0.0006127023,0.00028975154,0.000025154955,0.000007129976,0.0001817643,0.00012953607,0.0021839961],"category_scores_gemma":[0.00014754524,0.0001003377,0.00016925135,0.00028209947,0.00014178302,0.00014578756,0.000021026686,0.00042324743,4.4127066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079044397,0.00021878982,0.95648825,0.000042178293,0.00021041854,0.000072193194,0.0003323298,0.0008409398,0.000030990057,6.566641e-7,0.0064752223,0.0344976],"study_design_scores_gemma":[0.005045618,0.0006411368,0.9904154,0.00007428786,0.00026608232,0.00009407948,0.00004935548,0.00016756456,0.00003190237,0.000018657298,0.0031144172,0.00008151228],"about_ca_topic_score_codex":0.01795384,"about_ca_topic_score_gemma":0.02988594,"teacher_disagreement_score":0.034416087,"about_ca_system_score_codex":0.00015744152,"about_ca_system_score_gemma":0.00046416867,"threshold_uncertainty_score":0.99872816},"labels":[],"label_agreement":null},{"id":"W2210721194","doi":"10.1200/jco.2006.24.18_suppl.7009","title":"Adjuvant chemotherapy in elderly patients: An analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup BR.10","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinorelbine; Chemotherapy; Internal medicine; Toxicity; Cisplatin; Adjuvant; Young adult; Univariate analysis; Cancer; Gastroenterology; Multivariate analysis; Oncology; Surgery","score_opus":0.1391649794315419,"score_gpt":0.49661206891576,"score_spread":0.3574470894842181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210721194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574894,0.00044306286,0.00006601764,0.0015500855,0.0011455044,0.00017067592,0.000056569454,0.0000015947744,0.0008175492],"genre_scores_gemma":[0.99508166,0.0008812086,0.00083930546,0.0023590836,0.0006895638,0.0000028457432,0.000036255085,0.000008607239,0.000101456935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99222183,0.0008632618,0.0060207737,0.00021242505,0.0005201475,0.00016153023],"domain_scores_gemma":[0.9925826,0.0027229695,0.0036369672,0.00013329224,0.0006886104,0.0002355588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008688191,0.00012806461,0.0032679597,0.00032530626,0.000015291782,0.0000034179575,0.00014601281,0.00030262314,0.0005750047],"category_scores_gemma":[0.0037129421,0.000093896924,0.00057659927,0.0003042271,0.00028766098,0.00018024251,0.000022763561,0.00056838995,1.1430802e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009154133,0.0021199451,0.777764,0.000032574124,0.001631985,0.000038997267,0.000050180417,0.00025072205,0.00010220587,0.00007025416,0.005724465,0.20306052],"study_design_scores_gemma":[0.017128974,0.006748569,0.93345034,0.00006760287,0.00072926865,0.0000049544165,0.000047048085,0.00087974017,0.0000204039,0.000085766005,0.04075793,0.00007941773],"about_ca_topic_score_codex":0.044849753,"about_ca_topic_score_gemma":0.44334087,"teacher_disagreement_score":0.3984911,"about_ca_system_score_codex":0.00037642213,"about_ca_system_score_gemma":0.0056208,"threshold_uncertainty_score":0.9971057},"labels":[],"label_agreement":null},{"id":"W2227540121","doi":"10.1200/jco.2006.24.18_suppl.6093","title":"The potential for lost productivity in lung cancer patients","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Spouse; Lung cancer; Cancer; Quality of life (healthcare); Productivity; Sick leave; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.05154172580612853,"score_gpt":0.4454557059098907,"score_spread":0.39391398010376216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227540121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813385,0.0008068902,0.000096825635,0.012962398,0.0028489875,0.000368293,0.000007059565,0.0000019925344,0.0015690544],"genre_scores_gemma":[0.9942975,0.00038127255,0.00048563935,0.001157003,0.0029094252,0.000008648272,0.000003128968,0.000009054156,0.0007483455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795806,0.00016319449,0.0013718623,0.00012355196,0.00019485605,0.00018849823],"domain_scores_gemma":[0.9975867,0.0010024942,0.00085349375,0.00009942637,0.0003663396,0.00009153997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019908461,0.00007123866,0.0006309835,0.000046689514,0.00004615355,0.0000061473647,0.0001007946,0.0001549427,0.000059972936],"category_scores_gemma":[0.0013927288,0.00004158916,0.00028412603,0.00006505903,0.00012995965,0.00008749966,0.000020213478,0.0005362404,0.000001439793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010103442,0.0016568226,0.6767248,0.000049757808,0.0001490436,0.00006522235,0.000024455392,0.00018593323,0.00016160344,0.00006194366,0.051832333,0.25898466],"study_design_scores_gemma":[0.009101788,0.0025451106,0.808244,0.000026865257,0.000118252196,0.000014057626,0.000011714417,0.00047062783,0.000047255777,0.00023407697,0.17914067,0.000045599103],"about_ca_topic_score_codex":0.000077343706,"about_ca_topic_score_gemma":0.0005110455,"teacher_disagreement_score":0.25893906,"about_ca_system_score_codex":0.00025930878,"about_ca_system_score_gemma":0.0016284742,"threshold_uncertainty_score":0.28888434},"labels":[],"label_agreement":null},{"id":"W2235229882","doi":"10.1200/jco.2006.24.18_suppl.6090","title":"Systemic therapy (ST) in cancer patients ≥ 80 years of age: A Manitoba population-based assessment","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cancer; Cancer registry; Cohort; Internal medicine; Population; Breast cancer; Palliative care; Colorectal cancer; Lung cancer; Retrospective cohort study","score_opus":0.09107905903535152,"score_gpt":0.4594505018145112,"score_spread":0.3683714427791597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235229882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703974,0.0004656065,0.000022707203,0.00060099846,0.0009816695,0.0002351395,0.000009762365,0.0000033564556,0.0006410111],"genre_scores_gemma":[0.9966625,0.00033991807,0.0009228925,0.0015005855,0.0005028288,0.000005924356,0.00001895303,0.000011399581,0.000035029647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996972,0.00029466758,0.0021366682,0.000120077675,0.00033652122,0.00014001461],"domain_scores_gemma":[0.9972594,0.0008069641,0.0014775584,0.000116115654,0.00024152374,0.000098460885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154242,0.00008524869,0.0010475903,0.00015405843,0.000010814462,0.0000034256639,0.00010087918,0.00021368821,0.0001673078],"category_scores_gemma":[0.00023691688,0.00006748253,0.0002755593,0.00011407227,0.000054110187,0.00006094875,0.000010163419,0.00052002113,0.0000011861279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014170519,0.0012423672,0.8976608,0.000040256637,0.00006690522,0.00015387649,0.000015209995,0.0004309453,0.00013206716,0.000012730951,0.001079736,0.09774806],"study_design_scores_gemma":[0.013391735,0.003520812,0.9759578,0.00017029644,0.000055275745,0.000009145766,0.00002810692,0.0001860226,0.00001530749,0.00005652794,0.006552056,0.000056888188],"about_ca_topic_score_codex":0.0016338488,"about_ca_topic_score_gemma":0.0012768905,"teacher_disagreement_score":0.09769118,"about_ca_system_score_codex":0.00060790265,"about_ca_system_score_gemma":0.0019442814,"threshold_uncertainty_score":0.34490716},"labels":[],"label_agreement":null},{"id":"W2264080550","doi":"10.1200/jco.2009.27.15_suppl.6612","title":"Employment status among low-income Caucasian and Latina breast cancer survivors","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Ethnic group; Survivorship curve; Quality of life (healthcare); Cancer; Health care; Prospective cohort study; Gerontology; Longitudinal study; Demography; Family medicine; Internal medicine; Nursing; Pathology","score_opus":0.05895420993056313,"score_gpt":0.4380438941558217,"score_spread":0.37908968422525857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264080550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98037744,0.0005449676,0.000020204234,0.012116561,0.0010645031,0.0001518676,0.000015143154,0.0000100209,0.005699321],"genre_scores_gemma":[0.9884123,0.0034827276,0.00069389323,0.0057722,0.0011896349,0.0000016180369,0.000002214491,0.000012503411,0.0004328885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972588,0.00023130116,0.0016938756,0.00019186783,0.00030253443,0.00032166325],"domain_scores_gemma":[0.99725,0.00057157053,0.0010177238,0.00015429358,0.0002464155,0.00075997884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013481401,0.00014790168,0.0013087399,0.0001111167,0.00004540357,0.0000111797,0.00009259173,0.00027435212,0.00047665814],"category_scores_gemma":[0.00035435992,0.00010544604,0.00028054122,0.00010131219,0.00020830239,0.00016581702,0.000027419683,0.0009054098,0.0000041730295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020314194,0.0003723998,0.66549224,0.000019407275,0.0001506869,0.0005153353,0.00013952103,0.000011705886,0.00005340655,0.000018717612,0.0010658045,0.33012936],"study_design_scores_gemma":[0.0057819127,0.0049075997,0.9575913,0.00012639335,0.00018143447,0.00042509616,0.00010612337,0.00008185673,0.000012800685,0.00009748313,0.03058582,0.00010220302],"about_ca_topic_score_codex":0.00051153713,"about_ca_topic_score_gemma":0.001217306,"teacher_disagreement_score":0.33002713,"about_ca_system_score_codex":0.00029819406,"about_ca_system_score_gemma":0.0016886,"threshold_uncertainty_score":0.5219072},"labels":[],"label_agreement":null},{"id":"W2276562648","doi":"10.1200/jco.2007.25.18_suppl.9022","title":"Does NSCLC patient-rated performance status predict survival more accurately than physician ratings?","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Performance status; Wilcoxon signed-rank test; Proportional hazards model; Stage (stratigraphy); Overall survival; Survival analysis; Oncology; Mann–Whitney U test","score_opus":0.1029918418834251,"score_gpt":0.4452310801047796,"score_spread":0.3422392382213545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276562648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023987,0.00015971894,0.000101644604,0.0019383385,0.0042668213,0.00023920904,0.000012044045,0.00002252879,0.013019832],"genre_scores_gemma":[0.989267,0.000721772,0.0013385509,0.0059497743,0.0023810884,0.0000017572897,0.000016121943,0.000025139449,0.00029881648],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99558717,0.00026003452,0.0027969647,0.00024465343,0.00058231136,0.00052887044],"domain_scores_gemma":[0.9945992,0.0016782687,0.0021658314,0.00023440043,0.0006679957,0.00065426924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029338254,0.00020814741,0.0014626423,0.00013664334,0.00008395649,0.00001435695,0.00018572375,0.00037139407,0.00020155006],"category_scores_gemma":[0.0017106157,0.00011554303,0.00044984158,0.00021668385,0.00029591925,0.00034505693,0.000053623215,0.0014812229,0.000016640055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012358031,0.0008669488,0.34625444,0.000052794447,0.00038295382,0.0005813559,0.00050545525,0.000032937744,0.0009153819,0.0000100348125,0.0028029145,0.63523674],"study_design_scores_gemma":[0.009980384,0.015364404,0.83468384,0.000152264,0.0002291776,0.000080713195,0.0013410937,0.0005482026,0.0014290753,0.00002133527,0.13598762,0.00018189948],"about_ca_topic_score_codex":0.000023886138,"about_ca_topic_score_gemma":0.000061033523,"teacher_disagreement_score":0.6350548,"about_ca_system_score_codex":0.00026685066,"about_ca_system_score_gemma":0.0025030859,"threshold_uncertainty_score":0.64352584},"labels":[],"label_agreement":null},{"id":"W2294907556","doi":"10.1136/bmj.i851","title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"BMJ","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Meta-analysis; Internal medicine; Odds ratio; Hazard ratio; Oncology; Radiation therapy; Prostate cancer; Confidence interval; Cancer; Prostate","score_opus":0.07404702402521818,"score_gpt":0.38978192006189777,"score_spread":0.3157348960366796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294907556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.6894914e-7,0.9814641,0.00004490321,0.0012487756,0.00006614417,0.014776336,0.0021980193,0.000027156451,0.00017443443],"genre_scores_gemma":[2.1826939e-7,0.93323517,0.00039564233,0.0048421104,0.00013098292,0.021971168,0.000114145274,0.00007079848,0.03923974],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972618,0.00022263065,0.0013885212,0.0005875691,0.00022517776,0.00031429934],"domain_scores_gemma":[0.9977226,0.00028076707,0.00086770847,0.000835574,0.00013570071,0.00015764273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085575576,0.00055491773,0.01232219,0.00023843806,0.000043837284,0.00003314534,0.00013955477,0.00017191471,0.006396039],"category_scores_gemma":[0.00007376087,0.00027815285,0.0037608333,0.00029572265,0.000064045,0.000079315934,0.000026871541,0.00013461881,0.00001633119],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015647187,0.0000064059864,8.006485e-7,0.780889,0.19794331,0.00001229055,0.000026418647,1.0298358e-8,1.12749916e-7,0.0000036406584,0.008856227,0.012246183],"study_design_scores_gemma":[0.00017206247,0.00003371513,5.377958e-7,0.05259656,0.46045962,0.00003447888,0.0000012305454,4.5176333e-7,1.5913861e-7,0.0000011921294,0.4865184,0.00018157258],"about_ca_topic_score_codex":0.000008436197,"about_ca_topic_score_gemma":0.000036454043,"teacher_disagreement_score":0.7282924,"about_ca_system_score_codex":0.00022211717,"about_ca_system_score_gemma":0.0005217318,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W2314686106","doi":"10.1136/ejhpharm-2015-000639.87","title":"CP-091 Dose adjustment in cancer patients with renal or hepatic impairment","year":2015,"lang":"en","type":"article","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cancer Care Ontario","keywords":"Medicine; Tolerability; Renal function; Chemotherapy; Internal medicine; Urology; Cancer; Creatinine; Adverse effect","score_opus":0.0316036742813637,"score_gpt":0.2949776650393397,"score_spread":0.263373990757976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314686106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917365,0.00022075136,0.000016842476,0.00051660667,0.00017531484,0.00078577606,0.000013235054,0.00003412417,0.0065008844],"genre_scores_gemma":[0.99033934,0.000077166944,0.0009806459,0.003391616,0.00010012049,0.00015150722,0.00006398236,0.000020662868,0.0048749354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988722,0.000025499214,0.00023833929,0.00023381117,0.00036517825,0.000264944],"domain_scores_gemma":[0.9993624,0.000017771394,0.000051854877,0.00020548908,0.00009059511,0.0002718824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009868592,0.00014851801,0.00026409826,0.0000879972,0.000016589393,0.0000071105383,0.000056184905,0.000042294098,0.0021573906],"category_scores_gemma":[0.00001466073,0.00008467011,0.000029960413,0.00015859237,0.00003270608,0.000102559585,0.00002998091,0.000115572686,0.000030491112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008324059,0.0014347396,0.9258132,0.00013946669,0.0001475149,0.00010431503,0.001766776,0.00018713533,0.000096448464,0.000019146371,0.02674214,0.035225064],"study_design_scores_gemma":[0.025530338,0.0046159164,0.9521981,0.00022457966,0.000090736714,0.0000073492324,0.00035732,0.000712428,0.0005532215,0.000010389606,0.015435532,0.0002641071],"about_ca_topic_score_codex":0.0018703283,"about_ca_topic_score_gemma":0.002933022,"teacher_disagreement_score":0.034960955,"about_ca_system_score_codex":0.0008284403,"about_ca_system_score_gemma":0.0007621075,"threshold_uncertainty_score":0.9987548},"labels":[],"label_agreement":null},{"id":"W2335579892","doi":"10.1158/1538-7445.am2011-5092","title":"Abstract 5092: Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Genome-wide association study; Locus (genetics); Radiation therapy; Biology; Haplotype; Single-nucleotide polymorphism; Oncology; Allele; Lymphoma; Genetics; Cancer research; Internal medicine; Medicine; Gene; Genotype","score_opus":0.19379448531167243,"score_gpt":0.3958448695147185,"score_spread":0.20205038420304605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335579892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771028,0.0018778576,7.022435e-7,0.00076559116,0.00013794866,0.0008413044,0.00006104407,0.000012416684,0.01920034],"genre_scores_gemma":[0.9956157,0.00120438,0.0000318066,0.0012724533,0.000166781,0.00064267544,0.000012127491,0.00002922752,0.0010248004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978931,0.0002462825,0.0003691655,0.00041357343,0.00043826492,0.0006396005],"domain_scores_gemma":[0.9986899,0.00021829885,0.00008454613,0.0006758959,0.00021496534,0.00011641495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012563377,0.00016845172,0.0003673738,0.00023693437,0.00008915396,0.000012467673,0.0003920364,0.00017250709,0.014751966],"category_scores_gemma":[0.000050300732,0.00011227738,0.0001015092,0.00037328084,0.00033354148,0.00010585892,0.000112318216,0.00037989402,0.00008664198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008634038,0.0004320592,0.07359806,0.00042651765,0.00021738569,0.0004036147,0.014096371,6.064852e-7,0.81653404,0.00015426455,0.009237832,0.0762652],"study_design_scores_gemma":[0.002417873,0.00041624834,0.8905873,0.00008013571,0.000007765405,0.000034685745,0.00042772465,0.0000025714173,0.08681067,0.00015157509,0.018945944,0.00011755263],"about_ca_topic_score_codex":0.0018469149,"about_ca_topic_score_gemma":0.0011579231,"teacher_disagreement_score":0.8169892,"about_ca_system_score_codex":0.00035957267,"about_ca_system_score_gemma":0.00072852,"threshold_uncertainty_score":0.98614866},"labels":[],"label_agreement":null},{"id":"W2342975205","doi":"10.1097/md.0000000000003491","title":"Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma","year":2016,"lang":"en","type":"article","venue":"Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"National Institute on Alcohol Abuse and Alcoholism; Specialized Research Fund for the Doctoral Program of Higher Education of China; National Natural Science Foundation of China","keywords":"Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; Carcinoma; Primary (astronomy)","score_opus":0.012164311251336149,"score_gpt":0.2050815804179596,"score_spread":0.19291726916662344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342975205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215525,0.00041683938,0.00015645569,0.002897565,0.00015253609,0.00056834787,0.000012840212,0.000047043188,0.0035931168],"genre_scores_gemma":[0.9956317,0.000043728873,0.00024395049,0.0021830143,0.0001636574,0.000031171337,0.00007753594,0.00003102486,0.0015942287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998538,0.000030999705,0.0003212076,0.00033696133,0.00043026765,0.0003425469],"domain_scores_gemma":[0.9991441,0.00010342575,0.00007554812,0.00039093776,0.00010661491,0.0001794249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016545062,0.00019972952,0.0004713363,0.00019694847,0.00003353396,0.000002315193,0.00009416905,0.000069211754,0.0007260552],"category_scores_gemma":[0.000107900705,0.00010113097,0.00003744264,0.00021362388,0.00022368555,0.00011611024,0.000031591382,0.00012056077,0.00003480856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010043783,0.000103194354,0.97691673,0.00009596099,0.00002556181,0.000111628455,0.00022895758,1.8537965e-7,0.00795378,0.000014323869,0.0020469967,0.011498296],"study_design_scores_gemma":[0.01899017,0.0010900891,0.96515,0.00049666094,0.000047657377,0.000008808554,0.0000430596,0.000025341644,0.001209827,0.000010506194,0.012776109,0.00015177843],"about_ca_topic_score_codex":0.00015917422,"about_ca_topic_score_gemma":0.000026161058,"teacher_disagreement_score":0.017985793,"about_ca_system_score_codex":0.0002786905,"about_ca_system_score_gemma":0.00015519689,"threshold_uncertainty_score":0.7949795},"labels":[],"label_agreement":null},{"id":"W2400427989","doi":"","title":"Gastrointestinal and liver tumours and public health in Europe.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Public health; Poverty; Demography; Cancer; Epidemiology; Incidence (geometry); Environmental health; Quarter (Canadian coin); Medicine; Disease; Mortality rate; Geography; Economic growth; Pathology; Sociology; Economics","score_opus":0.034379816005071374,"score_gpt":0.2432155938077957,"score_spread":0.20883577780272433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400427989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857855,0.0004393649,0.00001151761,0.009902561,0.000070605776,0.00038581702,0.0000046997125,0.000024130082,0.0033758124],"genre_scores_gemma":[0.9956797,0.00017723652,0.0007324682,0.0028936092,0.00008248856,0.00006412847,0.000008506614,0.000010595346,0.00035130547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927485,0.000026606907,0.00012540467,0.00017893984,0.00006986052,0.00032433288],"domain_scores_gemma":[0.9994375,0.00003373076,0.00003480164,0.00010273105,0.000032962937,0.00035823978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000341383,0.00007348094,0.00015257693,0.000094246294,0.000030242492,0.000023605531,0.00003163067,0.000014031265,0.000042317577],"category_scores_gemma":[0.00024028574,0.000064452885,0.000009691151,0.00011400007,0.00009190111,0.00009562095,0.000033675435,0.00027358127,0.000002183057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005211004,0.000043997148,0.61833626,0.000056798333,0.0000036261,0.00007067137,0.00011674582,3.434585e-8,0.00014792761,0.00020439256,0.0013209985,0.37964645],"study_design_scores_gemma":[0.0010552007,0.000054518765,0.97660357,0.00000883246,0.000003014624,0.00074461993,0.000035982997,0.00006661844,0.000011300831,0.0000070156034,0.02135796,0.00005135202],"about_ca_topic_score_codex":0.00018032576,"about_ca_topic_score_gemma":0.00041724247,"teacher_disagreement_score":0.3795951,"about_ca_system_score_codex":0.000028041864,"about_ca_system_score_gemma":0.00013367787,"threshold_uncertainty_score":0.26283124},"labels":[],"label_agreement":null},{"id":"W2406868600","doi":"10.1016/j.critrevonc.2010.04.010","title":"Editorial","year":2010,"lang":"en","type":"editorial","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"European Society for Medical Oncology; European School of Oncology","keywords":"Medicine; Quality of life (healthcare); Prospective cohort study; Cohort; Activities of daily living; Mental health; Cancer; Gerontology; Internal medicine; Physical therapy; Psychiatry","score_opus":0.030418805447440956,"score_gpt":0.4148811962739988,"score_spread":0.3844623908265578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406868600","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016460555,0.029432245,0.000032179636,0.0027620397,0.94241935,0.0012589085,0.000079558704,0.00008003188,0.0239192],"genre_scores_gemma":[0.000023045965,0.021801531,0.0023597088,0.0017799657,0.9719887,0.0006121573,0.00056677015,0.00010018292,0.00076798623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402964,0.0007141196,0.0021159502,0.0012683641,0.00072454923,0.0011474025],"domain_scores_gemma":[0.9882874,0.008957385,0.00036058007,0.0012240554,0.00056076393,0.00060981204],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0022420525,0.00074016105,0.0048395693,0.00038466533,0.00009615496,0.000025195166,0.00060738256,0.008144884,0.0028123758],"category_scores_gemma":[0.057092205,0.0006368612,0.00061346416,0.00029317374,0.0011474016,0.000112109155,0.0002664515,0.009086936,0.0012412746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045784406,0.00040303727,0.000048394617,0.001845884,0.00004003384,0.00063575344,0.00005138856,1.2237408e-8,0.00007298949,0.002417485,0.9734192,0.020607958],"study_design_scores_gemma":[0.0028277973,0.0009155863,0.000004859354,0.0014157462,0.00030632745,0.00023560911,0.000014649697,0.0000048632483,0.00003354392,0.0009173666,0.9928236,0.0005000549],"about_ca_topic_score_codex":0.000040103223,"about_ca_topic_score_gemma":0.00027098323,"teacher_disagreement_score":0.054850154,"about_ca_system_score_codex":0.0009001348,"about_ca_system_score_gemma":0.004492685,"threshold_uncertainty_score":0.9996083},"labels":[],"label_agreement":null},{"id":"W2407608804","doi":"10.7150/jca.14717","title":"Surgical Management of the Primary Tumor in Stage IV Colorectal Cancer: A Confirmatory Retrospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Saskatchewan Health; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; FOLFOX; Proportional hazards model; FOLFIRI; Retrospective cohort study; Stage (stratigraphy); Chemotherapy; Surgery; Cancer; Oncology; Irinotecan; Confidence interval; Oxaliplatin","score_opus":0.010782718061243568,"score_gpt":0.2918928437994907,"score_spread":0.2811101257382471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407608804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913925,0.0019315482,0.0000023762846,0.0007155209,0.00065273145,0.0008081912,0.00004522303,0.000005061333,0.0044468245],"genre_scores_gemma":[0.9963792,0.0017407264,0.000022391647,0.0002810776,0.00021625866,0.000055241373,2.9804676e-7,0.000016791046,0.0012880386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.00010014962,0.0006528095,0.00017355106,0.00071327284,0.00020932817],"domain_scores_gemma":[0.998879,0.000057287372,0.00055102445,0.00019340469,0.00021892766,0.000100341356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005750021,0.00014220696,0.0006428983,0.000109825516,0.000032527005,0.0000057736156,0.00019304089,0.00003960617,0.0012437183],"category_scores_gemma":[0.00001367337,0.00007453144,0.00021790815,0.00020679236,0.00013745092,0.0001261391,0.000066600776,0.0002888811,0.0000011306743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023147594,0.00026262132,0.98824877,0.00011615853,0.0007031786,0.00056280755,0.00029300537,0.000011562686,0.0016390928,0.00002712959,0.0012151034,0.004605845],"study_design_scores_gemma":[0.008334709,0.00042327985,0.98021626,0.00059832045,0.00023092351,0.00004540991,0.00035276607,0.0000043396535,0.0019669887,0.000007868024,0.00772611,0.00009303712],"about_ca_topic_score_codex":0.00023352883,"about_ca_topic_score_gemma":0.00030977308,"teacher_disagreement_score":0.008032489,"about_ca_system_score_codex":0.0017247521,"about_ca_system_score_gemma":0.00076042063,"threshold_uncertainty_score":0.99966925},"labels":[],"label_agreement":null},{"id":"W2414315083","doi":"","title":"Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Cancer; Lung cancer; Skin cancer; Internal medicine; Oncology; Bladder cancer; Incidence (geometry)","score_opus":0.02544388382031402,"score_gpt":0.26292325553717283,"score_spread":0.23747937171685882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414315083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985191,0.0024857228,0.000035172354,0.00022443563,0.00055559096,0.0008938897,0.000024179106,0.000042124415,0.010547897],"genre_scores_gemma":[0.9955327,0.00007102573,0.000121493846,0.0027346564,0.00020696326,0.00097198493,0.000011514738,0.00003196543,0.00031772922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817735,0.00008185755,0.00050460506,0.0003762621,0.0003759863,0.00048391634],"domain_scores_gemma":[0.99897474,0.00022062166,0.00016646404,0.0003793764,0.000051136216,0.000207657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007595113,0.00018232694,0.0005539442,0.0002149445,0.00003753689,0.000009695859,0.00016652259,0.000114099836,0.00010568721],"category_scores_gemma":[0.0004057453,0.00017751161,0.00018155939,0.00031778903,0.000083004816,0.0002572074,0.000045876634,0.00027446108,0.0000034458415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040446065,0.00007758401,0.74811244,0.0002389189,0.00006867952,0.00004103014,0.00024297326,0.00015135921,0.0048324554,0.000012169577,0.0005906395,0.2452273],"study_design_scores_gemma":[0.0034696306,0.00006410512,0.98412794,0.00010284447,0.000056802546,0.00000387791,0.000047267455,0.00029316245,0.002815033,0.000018368028,0.008815264,0.00018573328],"about_ca_topic_score_codex":0.002066625,"about_ca_topic_score_gemma":0.0010012772,"teacher_disagreement_score":0.24504156,"about_ca_system_score_codex":0.0009688927,"about_ca_system_score_gemma":0.0005047501,"threshold_uncertainty_score":0.72387135},"labels":[],"label_agreement":null},{"id":"W2421290972","doi":"10.1016/j.ecl.2008.03.002","title":"Preface","year":2008,"lang":"en","type":"article","venue":"Endocrinology and Metabolism Clinics of North America","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.02714520905458606,"score_gpt":0.2916824997909774,"score_spread":0.2645372907363913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421290972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890095,0.007183212,0.000089633555,0.00053420395,0.00028400082,0.00016021414,0.0000248324,0.000038583312,0.0026758297],"genre_scores_gemma":[0.9626149,0.030610466,0.0028035704,0.002794995,0.00013050332,0.000011126081,0.000021425849,0.000013105239,0.0009999252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896777,0.000045073146,0.0003534584,0.0002558627,0.000107828244,0.00026998774],"domain_scores_gemma":[0.99917465,0.00012721783,0.00020343512,0.00028239656,0.00007355662,0.00013876549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003522191,0.00013105411,0.00060128275,0.000093391245,0.00007714226,0.0000010405554,0.000078267236,0.00004957223,0.0001327834],"category_scores_gemma":[0.00013791068,0.00011419159,0.00010837924,0.0001266983,0.0006068285,0.000061456034,0.00005731972,0.00026886596,0.0000220323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005111673,0.00020323419,0.7521066,0.000056828998,0.00024118497,0.000193148,0.00040217393,0.000012438336,0.00012112405,0.00014896235,0.0020671498,0.243936],"study_design_scores_gemma":[0.0011845677,0.00011609609,0.62119955,0.0000035552257,0.000074910524,0.00016512162,0.000031601885,0.000016102726,0.00015437182,0.000013682369,0.37697056,0.0000699064],"about_ca_topic_score_codex":0.000037556474,"about_ca_topic_score_gemma":0.000008461756,"teacher_disagreement_score":0.3749034,"about_ca_system_score_codex":0.0000055933497,"about_ca_system_score_gemma":0.0001426975,"threshold_uncertainty_score":0.4656598},"labels":[],"label_agreement":null},{"id":"W2466552622","doi":"10.6084/m9.figshare.36959.v1","title":"A siteXsite matrix for 21 major cancer types as reported by the National Cancer Institute of Canada","year":2011,"lang":"en","type":"article","venue":"Figshare","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.0825329902052808,"score_gpt":0.3260383168784176,"score_spread":0.2435053266731368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466552622","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062548354,0.008156088,0.0000022726836,0.0034080066,0.00078419043,0.0020284958,0.8713154,0.000063458785,0.05169369],"genre_scores_gemma":[0.8284115,0.00008912922,0.000276932,0.01449965,0.00097054354,0.002634298,0.10087044,0.0000793386,0.052168123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991795,0.000007013154,0.00021457975,0.00016885404,0.00026478886,0.00016525903],"domain_scores_gemma":[0.999226,0.0000414846,0.00016219706,0.00013427393,0.00035718398,0.00007887539],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000038934948,0.00010147546,0.00017245088,0.000026457315,0.00007467168,0.0000052434584,0.00010413744,0.000052119518,0.14225283],"category_scores_gemma":[0.00032264538,0.000073168274,0.000060688584,0.000106946296,0.00001274342,0.00007872143,0.000019655845,0.00009270249,0.0000142420595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016490476,0.000014543589,0.00048344763,0.00023808514,0.00017782568,0.000010017795,0.0001904613,0.000011948492,0.00097529055,0.000010738759,0.9965735,0.0011492028],"study_design_scores_gemma":[0.0008999393,0.00004587391,0.008362532,0.00043118143,0.00006244574,0.00001850672,0.000024998393,0.00012913151,0.01379615,0.000018332097,0.9760944,0.000116505194],"about_ca_topic_score_codex":0.18206926,"about_ca_topic_score_gemma":0.23518361,"teacher_disagreement_score":0.770445,"about_ca_system_score_codex":0.00026848397,"about_ca_system_score_gemma":0.0035921293,"threshold_uncertainty_score":0.8585313},"labels":[],"label_agreement":null},{"id":"W2488287506","doi":"10.1016/j.dld.2016.07.013","title":"Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report","year":2016,"lang":"en","type":"article","venue":"Digestive and Liver Disease","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cancer; Autopsy; Lymph node; Predictive value; Internal medicine; Tumor progression; Oncology; Gastroenterology","score_opus":0.011527254991121087,"score_gpt":0.28131300805389586,"score_spread":0.2697857530627748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488287506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943724,0.0018367663,0.0003052098,0.0012986274,0.00014582378,0.0006948966,0.0003143962,0.00007505727,0.00095678575],"genre_scores_gemma":[0.9978147,0.00025360627,0.00013653882,0.0006352499,0.00013748418,0.00020164765,0.000085798965,0.000020246858,0.00071471883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980728,0.00008597283,0.00032546514,0.0007215431,0.00044366406,0.00035055532],"domain_scores_gemma":[0.9986806,0.000096075724,0.00017094324,0.00034882547,0.00011344262,0.00059011386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017384526,0.00024904535,0.0005006682,0.0004031405,0.000091088456,0.000016981496,0.000064118874,0.000061605446,0.00030141632],"category_scores_gemma":[0.00022966368,0.00016774025,0.00018181597,0.00061195367,0.000118792006,0.00013106978,0.00003208042,0.00017682878,0.000005166665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031810533,0.00040018393,0.9796242,0.00006646424,0.00012596295,0.00457976,0.0001184156,0.000019533143,0.00045317152,0.000013624038,0.0007407233,0.010676914],"study_design_scores_gemma":[0.0026476136,0.0005788265,0.9907701,0.0004514387,0.00069040724,0.000012735437,0.000012817468,0.0026290684,0.00014868545,0.000014948015,0.0018369387,0.00020639613],"about_ca_topic_score_codex":0.0003508377,"about_ca_topic_score_gemma":0.00006221706,"teacher_disagreement_score":0.01114593,"about_ca_system_score_codex":0.0014065511,"about_ca_system_score_gemma":0.00057537196,"threshold_uncertainty_score":0.6840249},"labels":[],"label_agreement":null},{"id":"W2509624958","doi":"10.1093/jjco/hyw084","title":"Collision tumor with diffuse large B cell lymphoma and gastric cancer","year":2016,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Cancer; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.04464018578612058,"score_gpt":0.38539912885281136,"score_spread":0.3407589430666908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509624958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936191,0.00029790978,0.0000934379,0.0041772607,0.00033908244,0.00014217629,0.000006009184,0.000008427766,0.0013166268],"genre_scores_gemma":[0.99247396,0.0011064314,0.0012184156,0.0040069916,0.00054229336,0.0000052212795,4.9887046e-7,0.000014608963,0.00063155784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980465,0.00019343165,0.0010355075,0.00019244345,0.00026615188,0.00026594003],"domain_scores_gemma":[0.9968669,0.0014791223,0.0007192722,0.00015441769,0.0002812031,0.00049909565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011414731,0.0001279485,0.0008913008,0.000105086096,0.00004907754,0.000006132431,0.000104681036,0.000105647705,0.00029261943],"category_scores_gemma":[0.000526637,0.00006037728,0.0001537905,0.00012680961,0.00019659777,0.00016776971,0.000040600982,0.00022118814,0.000011253837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025644856,0.0056261215,0.76021075,0.00006441753,0.00023343654,0.0026305148,0.00041050478,0.000003019168,0.012006233,0.000021653936,0.0028722624,0.19027625],"study_design_scores_gemma":[0.112610094,0.0147062475,0.75078773,0.00018124185,0.00028404532,0.0035263551,0.0004233098,0.00008179769,0.0009133202,0.00002746149,0.11629341,0.00016496505],"about_ca_topic_score_codex":0.000017376171,"about_ca_topic_score_gemma":0.00005581039,"teacher_disagreement_score":0.1901113,"about_ca_system_score_codex":0.00018068691,"about_ca_system_score_gemma":0.001135301,"threshold_uncertainty_score":0.32039773},"labels":[],"label_agreement":null},{"id":"W2533793739","doi":"10.1017/cjn.2016.383","title":"PC3 - 164 Urban-Rural Residence and Brain Cancer Survival in Canada (1996-2008)","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Residence; Medicine; Cancer registry; Population; Demography; Cohort; Cancer; Rural area; Oligodendroglioma; Proportional hazards model; Astrocytoma; Glioma; Hazard ratio; Gerontology; Internal medicine; Environmental health; Pathology; Confidence interval","score_opus":0.04347014519426921,"score_gpt":0.2806845660962443,"score_spread":0.23721442090197511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533793739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95926285,0.0034630375,0.000005924367,0.034864597,0.0011744711,0.00015722391,0.00002848911,0.000007855855,0.0010355504],"genre_scores_gemma":[0.98819506,0.0015751749,0.00027991048,0.009538091,0.00029989175,0.0000034111338,1.7214708e-7,0.000011713903,0.00009655924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954439,0.0007231578,0.00093192013,0.000534723,0.0008933238,0.0014729664],"domain_scores_gemma":[0.995487,0.0011363243,0.0005345998,0.00015350043,0.00030042004,0.0023881856],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0029923536,0.00033381407,0.000680178,0.00076094444,0.0010414546,0.00022449813,0.0010720306,0.00014360559,0.00041416773],"category_scores_gemma":[0.0024509076,0.00019321564,0.00013127775,0.0010127298,0.00438886,0.0009704836,0.00006487643,0.0009819174,0.0000010600768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001763068,0.000008256883,0.977591,0.000008382027,0.000010086918,0.006966936,0.00014820707,0.00016887522,0.00022252592,0.00013856438,0.002848508,0.01171236],"study_design_scores_gemma":[0.00092511397,0.015209041,0.9626693,0.00018529264,0.000026388554,0.013153791,0.00034427032,0.0002508201,0.00011621374,0.0016646546,0.005139362,0.00031571632],"about_ca_topic_score_codex":0.62725097,"about_ca_topic_score_gemma":0.99379593,"teacher_disagreement_score":0.36654496,"about_ca_system_score_codex":0.0013166025,"about_ca_system_score_gemma":0.024881002,"threshold_uncertainty_score":0.99832064},"labels":[],"label_agreement":null},{"id":"W2574328762","doi":"","title":"Abstract A65: Survival of women with cancers of the breast, stomach, and esophagus in Ardabil (Iran) and British Columbia (Canada)","year":2009,"lang":"en","type":"article","venue":"Cancer Epidemiology and Prevention Biomarkers","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Relative survival; Breast cancer; Cancer; Esophagus; Internal medicine; Cancer registry; Demography; Stomach cancer; Stomach; Survival rate; Oncology; Gynecology","score_opus":0.019721064367627498,"score_gpt":0.27978972458916834,"score_spread":0.26006866022154085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574328762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394656,0.014181402,0.0000067448163,0.0010764847,0.00011495646,0.0003322031,0.00009443269,0.000004933861,0.000242302],"genre_scores_gemma":[0.9971028,0.0019268955,0.00009447438,0.0006619621,0.000023089766,0.000023059161,0.000008170994,0.0000065762683,0.00015295488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987336,0.00020222098,0.00041904426,0.0002800298,0.00009720653,0.00026792154],"domain_scores_gemma":[0.99919546,0.00023041521,0.00025731826,0.00013923203,0.0000409063,0.00013666622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009165976,0.00010601031,0.00056465674,0.00003319051,0.000060985047,0.000004743363,0.000053902717,0.000104462386,0.00017587269],"category_scores_gemma":[0.000075155636,0.00010229118,0.00003587839,0.00012082154,0.00045170123,0.00006378879,0.000018488847,0.00014909961,1.790738e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009600877,0.000017468203,0.91112375,0.00023345112,0.000160396,0.0000068329437,0.00010571066,0.0000108102195,0.00020794406,0.000009077503,0.0008829162,0.086281575],"study_design_scores_gemma":[0.0024053105,0.0002409406,0.9956783,0.0003524891,0.000052643474,0.00007674143,0.0002451264,0.000040335184,0.000022117758,0.0004971829,0.00029147678,0.00009733404],"about_ca_topic_score_codex":0.32010806,"about_ca_topic_score_gemma":0.6663514,"teacher_disagreement_score":0.34624332,"about_ca_system_score_codex":0.00027117072,"about_ca_system_score_gemma":0.0006893603,"threshold_uncertainty_score":0.6844194},"labels":[],"label_agreement":null},{"id":"W2577454460","doi":"10.1016/j.canep.2017.01.001","title":"Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut pour la Recherche en Santé Publique; Institut de Veille Sanitaire; Institut National Du Cancer","keywords":"Medicine; Cumulative incidence; Cancer; Poisson regression; Population; Breast cancer; Cancer registry; Prostate cancer; Cohort; Internal medicine; Colorectal cancer; Environmental health","score_opus":0.11244887481739872,"score_gpt":0.38687923961871185,"score_spread":0.2744303648013131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577454460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98657054,0.0034483338,0.0007551364,0.0021775402,0.00068491703,0.00091354107,0.0008039056,0.000023550374,0.0046225465],"genre_scores_gemma":[0.9799594,0.0026078317,0.0055586887,0.0037179873,0.00036790108,0.0009595929,0.000047903766,0.00006343847,0.0067172367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725425,0.00026110708,0.0011005662,0.0005893364,0.00023470004,0.00056000863],"domain_scores_gemma":[0.99645597,0.00062210823,0.0013020083,0.0010162389,0.0003393934,0.00026425836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016216198,0.00031634688,0.001368231,0.000113301474,0.00030428573,0.0000051358975,0.00055777776,0.00023059903,0.0025004612],"category_scores_gemma":[0.0007542495,0.00022008759,0.00022125043,0.00009949616,0.0007671795,0.00014397531,0.00026084052,0.00042198098,0.0000070010565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012091761,0.000048427602,0.9336794,0.00044678748,0.0009433616,0.0000020008747,0.0041246647,0.015912361,0.0020383913,0.00008751616,0.014099832,0.027408063],"study_design_scores_gemma":[0.0016248571,0.000101544734,0.94651544,0.00036038618,0.00024860987,8.239994e-7,0.00014599216,0.009303379,0.00282159,0.00014296947,0.038480576,0.00025383977],"about_ca_topic_score_codex":0.012664852,"about_ca_topic_score_gemma":0.030230774,"teacher_disagreement_score":0.027154224,"about_ca_system_score_codex":0.00065475516,"about_ca_system_score_gemma":0.0022937283,"threshold_uncertainty_score":0.9984114},"labels":[],"label_agreement":null},{"id":"W2589214874","doi":"10.1200/jco.2013.31.15_suppl.e14603","title":"Causes of urban-rural disparities in adjuvant chemotherapy (AC) for rectal cancer (RC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Quartile; Cancer; Logistic regression; Rural area; Demography; Internal medicine; Confidence interval; Pathology","score_opus":0.11501469267710429,"score_gpt":0.4710199071701964,"score_spread":0.3560052144930921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589214874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089826,0.0025499791,0.000041947857,0.013909565,0.0013548332,0.00036603442,0.000012546624,0.0000043025416,0.00086254766],"genre_scores_gemma":[0.9853664,0.004338128,0.0017874104,0.0063594985,0.0012571545,0.000028608363,0.000003258507,0.000017968707,0.0008415518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973336,0.00012829168,0.0020015056,0.000116744486,0.00018948928,0.00023035324],"domain_scores_gemma":[0.9967835,0.001431504,0.0010817661,0.00012105847,0.00037994815,0.00020220589],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010210831,0.00011624398,0.0015895026,0.0001111846,0.000015887337,0.000004676738,0.0001313609,0.00027130512,0.0009393566],"category_scores_gemma":[0.0010799404,0.00008121686,0.0004349307,0.00007487333,0.00022654566,0.00016685354,0.000018560566,0.0005622482,0.0000030329645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069729653,0.00094090955,0.63427764,0.00016344192,0.0004310345,0.00004912694,0.00035568362,0.000019644895,0.002066522,0.00006918123,0.08434323,0.27031064],"study_design_scores_gemma":[0.016427252,0.008295999,0.8811586,0.00023393723,0.00014541835,0.00006537007,0.00034076138,0.00023327889,0.0010758433,0.00035678796,0.09154556,0.00012120678],"about_ca_topic_score_codex":0.00061276794,"about_ca_topic_score_gemma":0.0003496086,"teacher_disagreement_score":0.27018943,"about_ca_system_score_codex":0.00019662961,"about_ca_system_score_gemma":0.0017653925,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W2589279080","doi":"10.1200/jco.2016.34.2_suppl.606","title":"Accuracy of kidney cancer diagnosis and histological subtype within cancer registry data.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cancer registry; Chromophobe cell; Kidney cancer; Not Otherwise Specified; Cancer; Nomogram; Population; Medical diagnosis; Pathology; Pathological; Nephrectomy; Cohort; Renal cell carcinoma; Clear cell; Internal medicine; Kidney","score_opus":0.27390759338646015,"score_gpt":0.509607140652033,"score_spread":0.2356995472655729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589279080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9061231,0.0089981835,0.000080000944,0.08047021,0.002716076,0.00017816786,0.00019069125,0.000008532649,0.0012350542],"genre_scores_gemma":[0.9004332,0.07600421,0.002931281,0.017771183,0.0019336537,0.000019702682,0.0000073131578,0.000019587407,0.00087989995],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969789,0.00026085268,0.0020147762,0.00027525326,0.00027848044,0.0001917865],"domain_scores_gemma":[0.9917069,0.0037188812,0.0030285881,0.0004248969,0.0003625204,0.0007582339],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019632925,0.0001303361,0.0014542366,0.00006793175,0.0000273158,0.0000036662898,0.00033159566,0.0003849965,0.0020893742],"category_scores_gemma":[0.022889897,0.000069747926,0.00018924961,0.00007923341,0.00058950536,0.00022744856,0.00014472667,0.00063216296,0.0000032903858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003443321,0.00033475473,0.5071581,0.0000680629,0.00032653476,0.00021323624,0.00004264539,7.8011857e-7,0.00069408567,0.00004527377,0.15488152,0.33279166],"study_design_scores_gemma":[0.008325334,0.0032848634,0.25951537,0.00046429218,0.00053847296,0.00019121631,0.000033615197,0.000029010665,0.00038263726,0.00014130416,0.7269824,0.00011147144],"about_ca_topic_score_codex":0.00027323994,"about_ca_topic_score_gemma":0.00022416943,"teacher_disagreement_score":0.5721009,"about_ca_system_score_codex":0.0002214978,"about_ca_system_score_gemma":0.008153606,"threshold_uncertainty_score":0.99882287},"labels":[],"label_agreement":null},{"id":"W2589298233","doi":"10.1200/jco.2016.34.3_suppl.161","title":"Development and evaluation of the TrueNTH-Prostate Cancer Canada electronic Library for Improved (urinary and bowel) Function post Treatment (TrueNTH-PCC-eLIFT).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Brachytherapy; Prostate cancer; Prostatectomy; Quality of life (healthcare); Cancer; Family medicine; Radiation therapy; Internal medicine; Nursing","score_opus":0.06707393764000007,"score_gpt":0.39232577570213784,"score_spread":0.32525183806213775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589298233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784569,0.003038096,0.000009141961,0.016826576,0.0008517358,0.00056913815,0.00003134391,0.0000029069222,0.00021413402],"genre_scores_gemma":[0.99214286,0.0042621796,0.0004277323,0.0024332695,0.00030779603,0.000033583,0.000004986322,0.000014062758,0.00037352764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979939,0.00020098065,0.0011010322,0.00016809734,0.0003385277,0.00019749407],"domain_scores_gemma":[0.9976408,0.00066671753,0.00092893926,0.000112023736,0.0004787447,0.0001727794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001667126,0.000117399664,0.0005955555,0.000044890076,0.00006082045,0.000004254881,0.000060214257,0.00012142459,0.00015330547],"category_scores_gemma":[0.00048961735,0.000057985424,0.000127724,0.000041858566,0.000106397754,0.00014311854,0.0000319163,0.00017413861,1.5005249e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010145247,0.0002851446,0.024192961,0.00004172882,0.0005733981,0.0000062100135,0.00012375631,0.0000030227532,0.00293799,0.000028456425,0.0024388798,0.9592232],"study_design_scores_gemma":[0.019438602,0.011439136,0.45233902,0.000115328534,0.0008401261,0.0000814628,0.00014810845,0.00022699682,0.002373923,0.0001747676,0.51272297,0.0000995457],"about_ca_topic_score_codex":0.001547578,"about_ca_topic_score_gemma":0.031265974,"teacher_disagreement_score":0.9591237,"about_ca_system_score_codex":0.0012518251,"about_ca_system_score_gemma":0.023998098,"threshold_uncertainty_score":0.9864109},"labels":[],"label_agreement":null},{"id":"W2589329894","doi":"10.1200/jco.2012.30.5_suppl.422","title":"Improving outcomes through the development of quality indicators in renal cell cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Medicine; Renal cell carcinoma; Delphi method; Disease; Multidisciplinary approach; Intensive care medicine; Cancer; Quality (philosophy); Family medicine; Medical physics; Internal medicine","score_opus":0.20895726177201457,"score_gpt":0.520540339531365,"score_spread":0.31158307775935046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589329894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889456,0.0009990501,0.00019377023,0.0036714054,0.0011495462,0.00013305554,0.000002035702,0.000002531376,0.0049029733],"genre_scores_gemma":[0.98590624,0.00022224255,0.009512833,0.0036825289,0.000493659,0.000004173676,8.8070055e-7,0.000008128056,0.00016931687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958125,0.0004179112,0.003085869,0.000097710246,0.0003376933,0.00024832296],"domain_scores_gemma":[0.99512184,0.0019994308,0.002425361,0.0001545613,0.000106505264,0.00019229871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059494604,0.0001015142,0.0012124275,0.00011023825,0.000033855926,0.0000021168132,0.00018781479,0.00022734451,0.0002489867],"category_scores_gemma":[0.00138357,0.000055581084,0.00029866403,0.00017270994,0.00017776666,0.00015005603,0.00006229616,0.0009543425,0.000003137701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096490607,0.0007286981,0.7613408,0.000057290203,0.00014423858,0.000010199919,0.002170269,0.0000057806647,0.0005718732,0.000050132352,0.00049336144,0.23346244],"study_design_scores_gemma":[0.004346304,0.0007235573,0.9105421,0.000036649668,0.00008977721,0.000009994335,0.00063844037,0.000004001907,0.0015513931,0.000025528107,0.08196859,0.00006369493],"about_ca_topic_score_codex":0.00011973613,"about_ca_topic_score_gemma":0.00020405548,"teacher_disagreement_score":0.23339875,"about_ca_system_score_codex":0.00030653097,"about_ca_system_score_gemma":0.0040485365,"threshold_uncertainty_score":0.718193},"labels":[],"label_agreement":null},{"id":"W2589747494","doi":"10.1200/jco.2012.30.34_suppl.8","title":"Follow-up of long-term young breast cancer survivors.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Cancer registry; Survivorship curve; Population; Internal medicine; Retrospective cohort study; Cohort; Pediatrics","score_opus":0.12287294610470878,"score_gpt":0.46474890756644216,"score_spread":0.3418759614617334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589747494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98214656,0.0019781727,0.000081208,0.0027585218,0.00751246,0.00011424771,0.00001694446,0.0000056300937,0.0053862343],"genre_scores_gemma":[0.9907926,0.0023554282,0.00039933986,0.0020462926,0.0034375975,0.0000021526698,0.0000032799003,0.000017635803,0.00094568636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967975,0.00027158932,0.0021461176,0.000117785006,0.00035814845,0.00030884938],"domain_scores_gemma":[0.99624366,0.00085944106,0.0016912321,0.00019383554,0.00045676925,0.00055508444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027046357,0.00012828938,0.0016056256,0.000105001476,0.000024431023,0.0000031097045,0.0001679282,0.00034178692,0.0021890332],"category_scores_gemma":[0.0006300024,0.00009036429,0.00065660867,0.00010966636,0.00021139099,0.00023681314,0.000046864876,0.00082983414,0.000014750128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003947842,0.0006710523,0.8126848,0.000062792016,0.00041435962,0.00010433177,0.00016192332,0.0000013933306,0.0003678556,0.000018583392,0.0031915861,0.17837347],"study_design_scores_gemma":[0.008127812,0.0018712811,0.9744136,0.00010486858,0.00045495175,0.0010120173,0.000057669822,0.0000081705275,0.00015482857,0.000009165679,0.013700772,0.00008487307],"about_ca_topic_score_codex":0.00021460759,"about_ca_topic_score_gemma":0.00051224313,"teacher_disagreement_score":0.17828861,"about_ca_system_score_codex":0.00020352226,"about_ca_system_score_gemma":0.0018765015,"threshold_uncertainty_score":0.9987231},"labels":[],"label_agreement":null},{"id":"W2590064272","doi":"10.1182/blood.v118.21.2068.2068","title":"Population-Based Health Care Cost Estimates Related to Non-Hodgkin Lymphoma (NHL)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; McMaster University; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cancer registry; Population; Health care; Cancer; Demography; Family medicine; Pediatrics; Emergency medicine; Gerontology; Environmental health; Internal medicine","score_opus":0.02105690599250566,"score_gpt":0.2867025262339326,"score_spread":0.26564562024142696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590064272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988832,0.0005829008,0.00011201359,0.00048263159,0.0002128239,0.00086678483,0.00005179515,0.00015024318,0.008708823],"genre_scores_gemma":[0.9862123,0.000009300299,0.008911815,0.0041060494,0.00004555785,0.000048778475,0.00047797948,0.000036251316,0.00015196642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889857,0.000023711607,0.0003116201,0.00028983102,0.00017513301,0.0003011371],"domain_scores_gemma":[0.99914587,0.000036481775,0.000082136714,0.00035337897,0.00007400714,0.000308113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009209266,0.00015971232,0.00032781472,0.00012592555,0.00010709425,0.000009635889,0.000087877255,0.0000843946,0.0004974318],"category_scores_gemma":[0.000041978943,0.00014906879,0.00007928704,0.00019876708,0.000018772009,0.00005266395,0.000019495654,0.00008225383,0.00011196678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060678297,0.00085066486,0.905072,0.0005832583,0.00021442646,0.00015377364,0.0074100746,0.00007559102,0.00095425453,0.00010654272,0.0027766316,0.08119601],"study_design_scores_gemma":[0.009427336,0.0009890817,0.97709817,0.00024558313,0.00013905758,0.00003576139,0.00033394503,0.00039213116,0.0079790065,0.000023777025,0.0030653386,0.00027080093],"about_ca_topic_score_codex":0.0020087094,"about_ca_topic_score_gemma":0.00018438081,"teacher_disagreement_score":0.08092521,"about_ca_system_score_codex":0.00019925574,"about_ca_system_score_gemma":0.0005243851,"threshold_uncertainty_score":0.6078849},"labels":[],"label_agreement":null},{"id":"W2590194247","doi":"10.1200/jco.2014.32.30_suppl.263","title":"Measuring quality of life in chronic hematologic malignancy: The QUALMS-1.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa","funders":"","keywords":"Quality of life (healthcare); Medicine; Disease; Hematologic malignancy; Cancer; Gerontology; Internal medicine","score_opus":0.3484975847992349,"score_gpt":0.4953015845341096,"score_spread":0.14680399973487468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590194247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98224837,0.0018208423,0.00022199604,0.008159456,0.00072411523,0.0001380564,9.082562e-7,0.0000045485435,0.0066817035],"genre_scores_gemma":[0.9938527,0.0006485426,0.00068480003,0.0039875344,0.00075113657,0.0000022119873,5.652269e-7,0.000008247877,0.00006429944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99436426,0.0014087276,0.003529371,0.00014171515,0.00034928476,0.00020661874],"domain_scores_gemma":[0.9921132,0.0048584426,0.0023164502,0.00027211668,0.00022383161,0.00021599529],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012053464,0.00010333539,0.0018957215,0.00008653751,0.000024051762,0.0000029693551,0.00024956287,0.00028592852,0.00023331378],"category_scores_gemma":[0.010707795,0.00005875941,0.00049579225,0.000111564,0.0002728567,0.00007164783,0.000049980757,0.0010236125,0.000009652285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007834508,0.0013639958,0.8063406,0.00057734933,0.00050882075,0.00015738248,0.00044513287,0.00034851578,0.002995411,0.0030482917,0.0036418184,0.1727382],"study_design_scores_gemma":[0.012664219,0.006559622,0.9357658,0.00022215665,0.00010782302,0.000121943594,0.00020469636,0.00038544316,0.00027007674,0.0010009846,0.042591132,0.00010612878],"about_ca_topic_score_codex":0.00008180595,"about_ca_topic_score_gemma":0.0002969293,"teacher_disagreement_score":0.17263207,"about_ca_system_score_codex":0.0002639444,"about_ca_system_score_gemma":0.0034634257,"threshold_uncertainty_score":0.9976254},"labels":[],"label_agreement":null},{"id":"W2590674004","doi":"10.1158/1055-9965.epi-16-0762-t","title":"Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC)","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; World Health Organization; American Association for Cancer Research","keywords":"Multiple myeloma; Body mass index; Medicine; Internal medicine; Anthropometry; Risk factor; Young adult; Oncology","score_opus":0.028503861057944623,"score_gpt":0.3368796144805547,"score_spread":0.3083757534226101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590674004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874064,0.0022050804,0.0015841647,0.006525691,0.00065234536,0.0008904979,0.00014581597,0.00003964066,0.000550392],"genre_scores_gemma":[0.9926705,0.0035088747,0.0011163092,0.0016181468,0.00025320268,0.0002172361,0.00030873704,0.000025018102,0.0002820237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965856,0.0007990829,0.0009439671,0.00089944666,0.00024346968,0.00052840903],"domain_scores_gemma":[0.996832,0.0010434431,0.0009595532,0.0007435306,0.00022908188,0.00019235995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021918046,0.00036113546,0.00093032996,0.0003962979,0.0004491454,0.000066308785,0.00040811856,0.00036416374,0.0001500786],"category_scores_gemma":[0.0038821585,0.000286826,0.0003179037,0.00020024396,0.0007013623,0.0003705667,0.00015645972,0.0004989669,0.000004327958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019550556,0.00007200523,0.9680583,0.00005884966,0.0029252528,0.000030130717,0.00028918328,0.000026920192,0.001687234,0.000079200734,0.0010366911,0.023781199],"study_design_scores_gemma":[0.006212058,0.00014145003,0.9318989,0.0001370222,0.0013624441,0.000036536727,0.00058141776,0.058189083,0.0001497971,0.000511086,0.00050989725,0.00027034438],"about_ca_topic_score_codex":0.007385085,"about_ca_topic_score_gemma":0.018426457,"teacher_disagreement_score":0.058162164,"about_ca_system_score_codex":0.00025969013,"about_ca_system_score_gemma":0.00016924512,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2591265870","doi":"10.1200/jco.2016.34.3_suppl.115","title":"Patterns of health care-related multimorbidity among breast cancer survivors.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cancer; Cancer registry; Cohort; Medical diagnosis; Health care; Disease; Population; Pediatrics; Diagnosis code; Family medicine; Internal medicine; Environmental health; Pathology","score_opus":0.10108717304348415,"score_gpt":0.46089851566326395,"score_spread":0.3598113426197798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591265870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828122,0.0009519974,0.00017405346,0.012549255,0.002533476,0.00017055019,0.00008854199,0.000008780231,0.0007110985],"genre_scores_gemma":[0.9930685,0.0037110758,0.00028013988,0.0019632878,0.0006697544,0.0000021884882,0.0000034389977,0.000017337416,0.0002842819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545354,0.0006303104,0.0031273742,0.00018786301,0.00033712146,0.00026380332],"domain_scores_gemma":[0.9945585,0.0012254281,0.002970998,0.00021940569,0.0005923901,0.00043329305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026184556,0.00013402064,0.0019055528,0.00011220411,0.00003119566,0.0000021085052,0.00016890107,0.000335462,0.0017422149],"category_scores_gemma":[0.0006622739,0.00007639195,0.00055974163,0.0000830564,0.00021566922,0.00014101717,0.000043720072,0.00065464,0.0000072346584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010561832,0.00029881793,0.62265617,0.00006213374,0.0002406736,0.00006604138,0.00017193191,0.0000034266875,0.00011611335,0.0000074486325,0.0013041967,0.37401685],"study_design_scores_gemma":[0.009406936,0.0033125032,0.9642565,0.0003503973,0.00012702965,0.00012897955,0.00016039904,0.000013671767,0.00008303967,0.000012801934,0.022067612,0.00008011186],"about_ca_topic_score_codex":0.0023356953,"about_ca_topic_score_gemma":0.0019337335,"teacher_disagreement_score":0.37393674,"about_ca_system_score_codex":0.00046341802,"about_ca_system_score_gemma":0.0038885141,"threshold_uncertainty_score":0.9991703},"labels":[],"label_agreement":null},{"id":"W2591325514","doi":"10.1200/jco.2013.31.4_suppl.485","title":"Natural history and outcomes in a population-based cohort of synchronous and metachronous colorectal cancers (CRC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Oncology; Cohort; Stage (stratigraphy); Proportional hazards model; Natural history; Cancer; Gastroenterology","score_opus":0.03902261487461094,"score_gpt":0.3799765414398598,"score_spread":0.34095392656524887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591325514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391145,0.0030007607,0.000007331455,0.001377562,0.00085704296,0.00029364435,0.0000021367027,0.0000037253253,0.00054638035],"genre_scores_gemma":[0.9957696,0.00035999308,0.0017061398,0.0019305154,0.00013276546,0.0000067394044,0.0000041387825,0.000009319869,0.00008074951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780774,0.00019372535,0.001508062,0.0001515632,0.00018814311,0.0001507711],"domain_scores_gemma":[0.9970305,0.0015499333,0.00094850216,0.00008906448,0.00017035884,0.00021163335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009499497,0.0001123504,0.0015054232,0.00015898784,0.000014399704,0.0000029296593,0.000062535735,0.00020397831,0.00027522448],"category_scores_gemma":[0.0010656592,0.000081697246,0.00018179652,0.00004524731,0.00025723086,0.00013309985,0.000020065103,0.0006055344,9.1236626e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010371045,0.00019660946,0.95560575,0.000050176106,0.00023304095,0.0000678475,0.000080180886,0.000027846198,0.00021911804,0.000008171794,0.00061082526,0.041863356],"study_design_scores_gemma":[0.006464266,0.0034751028,0.98559445,0.000038270588,0.00018832392,0.000078161764,0.00004532215,0.001439999,0.000012646223,0.000023430055,0.0025661672,0.000073859825],"about_ca_topic_score_codex":0.002045909,"about_ca_topic_score_gemma":0.00078789116,"teacher_disagreement_score":0.0417895,"about_ca_system_score_codex":0.0010873493,"about_ca_system_score_gemma":0.0026270174,"threshold_uncertainty_score":0.46602163},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2591372505","doi":"10.1200/jco.2011.29.15_suppl.6082","title":"Cost-effectiveness of a survivorship care plan for breast cancer survivors.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Survivorship curve; Economic evaluation; Cost effectiveness; Health care; Cost–benefit analysis; Family medicine; Physical therapy; Cancer; Surgery; Internal medicine","score_opus":0.3705697753469716,"score_gpt":0.49916763132004505,"score_spread":0.12859785597307344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591372505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989602,0.0009186509,0.0005057151,0.00042216823,0.0028586816,0.0007077101,0.00018787773,0.0000076695915,0.004789473],"genre_scores_gemma":[0.9965671,0.00048871746,0.0013754759,0.0006725098,0.000784011,0.000026392037,0.000008287656,0.000021188347,0.000056318037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970802,0.00063234975,0.001655934,0.00017743629,0.00022437083,0.00022971912],"domain_scores_gemma":[0.9936227,0.0034732588,0.0013375077,0.00017889109,0.0010560419,0.00033156175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036517011,0.00013637569,0.0017757701,0.00011343004,0.000027315013,0.0000022208399,0.00018734067,0.00036524853,0.0005004311],"category_scores_gemma":[0.0009227772,0.000098211654,0.00063710415,0.00009758734,0.00021523162,0.00010069337,0.000029320976,0.000574567,0.0000021842568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049533684,0.000892289,0.68511564,0.00076716277,0.00069997687,0.00012866352,0.00095360656,0.0000098054325,0.00030913114,0.00013802518,0.00047892888,0.26097307],"study_design_scores_gemma":[0.011661931,0.008303567,0.95848817,0.00028234892,0.00046272567,0.00021128241,0.00062473735,0.000022654294,0.00080584065,0.00014294797,0.018880807,0.00011297338],"about_ca_topic_score_codex":0.0010971976,"about_ca_topic_score_gemma":0.001954153,"teacher_disagreement_score":0.27337253,"about_ca_system_score_codex":0.00022392806,"about_ca_system_score_gemma":0.0028293994,"threshold_uncertainty_score":0.547937},"labels":[],"label_agreement":null},{"id":"W2592525030","doi":"10.1158/1538-7445.sabcs16-p6-17-02","title":"Abstract P6-17-02: Evaluation of the impact of oncotype DX test results on systemic therapy in breast cancer patients at the BC cancer agency (BCCA)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Concordance; Breast cancer; Internal medicine; Cancer; Gynecology; Oncology; Hormone therapy","score_opus":0.17179414089313771,"score_gpt":0.4837780664100055,"score_spread":0.31198392551686777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592525030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842712,0.0028860548,2.4735474e-8,0.0023525653,0.00034614504,0.0020587144,0.001766446,0.0000063053226,0.0063125235],"genre_scores_gemma":[0.9922582,0.0057612276,5.0769063e-7,0.00008686006,0.0002637313,0.0004868313,0.000031061045,0.000035302834,0.0010763167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962229,0.00033084356,0.00057705335,0.00044334115,0.0019181744,0.00050765305],"domain_scores_gemma":[0.99602115,0.00038134694,0.0005361863,0.0014029386,0.0015338759,0.00012447422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025329867,0.00021841707,0.00043314326,0.000167748,0.00038354122,0.00003688917,0.00072297844,0.00014349444,0.0025935299],"category_scores_gemma":[0.0005281857,0.000116217896,0.0002065321,0.0003434871,0.00048482014,0.00015284854,0.00015260007,0.0006830576,0.000011526073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005184086,0.00033718042,0.80833155,0.00020901878,0.00020005218,0.0000026452008,0.0017162539,0.0018032858,0.067751974,0.0000019907675,0.014685659,0.099776335],"study_design_scores_gemma":[0.006087299,0.0004061325,0.97963506,0.001527116,0.000036097717,0.0000016940111,0.000062963074,0.00031259094,0.011515991,0.000013985843,0.0002878039,0.000113291906],"about_ca_topic_score_codex":0.07497452,"about_ca_topic_score_gemma":0.007377942,"teacher_disagreement_score":0.17130351,"about_ca_system_score_codex":0.0039198236,"about_ca_system_score_gemma":0.004288849,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W2593487892","doi":"10.1182/blood.v128.22.5975.5975","title":"Characterization and Management of Synchronous Dual Hematological Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Concomitant; Multiple myeloma; Internal medicine; Malignancy; Lymphoma; Lymphoproliferative disorders; Monoclonal gammopathy of undetermined significance; Hematology; Asymptomatic; Pediatrics; Immunology; Monoclonal","score_opus":0.014183194939847037,"score_gpt":0.23338348081457963,"score_spread":0.2192002858747326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593487892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975372,0.0001734913,0.00045715438,0.0003540371,0.000028743618,0.00014345963,0.0000118347025,0.000018526518,0.001275542],"genre_scores_gemma":[0.99798506,0.0007657908,0.0005348092,0.000121933714,0.000023681496,0.000009673736,0.000010750008,0.000004398665,0.0005439218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.0000071307454,0.00011245139,0.0001039717,0.00007102547,0.00007972554],"domain_scores_gemma":[0.9998091,0.000011837007,0.00003594797,0.00009114469,0.00001617589,0.000035819838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035748584,0.000050093306,0.00013122836,0.000021892216,0.000013742573,0.0000021818064,0.000016902311,0.000028393888,0.00015745741],"category_scores_gemma":[0.0000046977875,0.000030307,0.000019777844,0.000027051537,0.000048232465,0.000037908787,0.00002394166,0.000015002288,0.000005895635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013885343,0.000341213,0.06538732,0.0007542969,0.00021713143,0.00022740188,0.00013047102,2.2070546e-8,0.88081485,0.0028502285,0.00006811686,0.049070068],"study_design_scores_gemma":[0.0062804385,0.00040429248,0.7796464,0.00042876744,0.00023154954,0.00029423382,0.00006166237,0.0000038786775,0.20722523,0.00003499295,0.005266909,0.0001216518],"about_ca_topic_score_codex":0.0000010190184,"about_ca_topic_score_gemma":3.337997e-7,"teacher_disagreement_score":0.7142591,"about_ca_system_score_codex":0.000007649407,"about_ca_system_score_gemma":0.0000136037115,"threshold_uncertainty_score":0.17240481},"labels":[],"label_agreement":null},{"id":"W2594709205","doi":"10.1016/j.breast.2017.02.012","title":"Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Population; Environmental health","score_opus":0.019062989860445953,"score_gpt":0.29621751348345543,"score_spread":0.27715452362300946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594709205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801165,0.0022399132,0.00006261976,0.013943366,0.00044573724,0.00043898646,0.001427324,0.00008502549,0.00124053],"genre_scores_gemma":[0.99518764,0.0001962382,0.00008030889,0.0024581174,0.00047175688,0.00066846894,0.00011844842,0.000037430687,0.0007815691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983452,0.000060331833,0.00032897375,0.000412065,0.0004064804,0.00044693574],"domain_scores_gemma":[0.99824494,0.000088655695,0.00029392663,0.0010662645,0.00011077858,0.0001954441],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025471736,0.00027459284,0.00057858304,0.00021572872,0.0008464703,0.00015107638,0.00041841695,0.00008816184,0.004295151],"category_scores_gemma":[0.000030246167,0.00019127961,0.0005837521,0.0003846327,0.00010948421,0.0002756472,0.00007755413,0.00027432805,0.000019082798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023751214,0.0000588374,0.9411222,0.000060478338,0.0013950315,0.000039363036,0.0001401559,0.00039485813,0.00018538126,0.000009193426,0.0015548657,0.05480212],"study_design_scores_gemma":[0.001749633,0.000021714286,0.9918722,0.00021354742,0.0026792386,0.000070522496,0.00007806503,0.0017996379,0.000082696264,0.0000145855565,0.0011934316,0.00022475245],"about_ca_topic_score_codex":0.024106814,"about_ca_topic_score_gemma":0.005151284,"teacher_disagreement_score":0.05457737,"about_ca_system_score_codex":0.00036510165,"about_ca_system_score_gemma":0.0006537677,"threshold_uncertainty_score":0.99661505},"labels":[],"label_agreement":null},{"id":"W2598272769","doi":"10.1200/jco.2013.31.15_suppl.9536","title":"The role of social exposure to smoking on smoking cessation in adult cancer survivors.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; Public Health Ontario; Centre for Addiction and Mental Health; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Smoking cessation; Lung cancer; Logistic regression; Odds ratio; Cancer; Multivariate analysis; Breast cancer; Genitourinary system; Demography; Internal medicine; Pathology","score_opus":0.06328345347547781,"score_gpt":0.424789194692041,"score_spread":0.3615057412165632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598272769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97975916,0.00024159164,0.000008500086,0.012755209,0.001076835,0.00017819816,0.0000019887373,0.0000029175837,0.0059756185],"genre_scores_gemma":[0.99383056,0.00041261842,0.00011179143,0.0044221166,0.0011048869,0.000011112919,8.9246896e-7,0.00001001793,0.00009600892],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997361,0.00032791818,0.0016642585,0.00011585874,0.00034291027,0.00018806936],"domain_scores_gemma":[0.9966135,0.0015754731,0.0010843304,0.000103909486,0.0004842889,0.00013849177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001998918,0.00008613255,0.0007674879,0.000102129394,0.000054757038,0.000008683944,0.00015442146,0.000250938,0.00029991433],"category_scores_gemma":[0.0016163744,0.000054077336,0.00022505742,0.00013519975,0.000088697416,0.00010020896,0.000029161218,0.00082803454,0.000003651562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015644433,0.00022145064,0.43355545,0.000012849219,0.00012752411,0.0000144034875,0.0008002224,0.00010668994,0.0004332993,0.00022137322,0.0017613013,0.561181],"study_design_scores_gemma":[0.003822258,0.0035894495,0.9385166,0.000100658974,0.00006729244,0.000009546297,0.0010761332,0.000115891766,0.0003037374,0.00034575086,0.051988184,0.00006450528],"about_ca_topic_score_codex":0.0010234412,"about_ca_topic_score_gemma":0.0022696797,"teacher_disagreement_score":0.5611165,"about_ca_system_score_codex":0.00025968166,"about_ca_system_score_gemma":0.00091059535,"threshold_uncertainty_score":0.3597444},"labels":[],"label_agreement":null},{"id":"W2599912442","doi":"10.1200/jco.2012.30.15_suppl.1583","title":"Factors associated with referral to medical oncology (MO) and subsequent use of adjuvant chemotherapy (ACT) among patients with resected non-small cell lung cancer (NSCLC): A population-based study.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Referral; Cancer registry; Lung cancer; Population; Internal medicine; Stage (stratigraphy); Cancer; Comorbidity; Logistic regression; Multivariate analysis; Surgery; Family medicine; Environmental health","score_opus":0.1252188058244334,"score_gpt":0.419122485886459,"score_spread":0.2939036800620256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599912442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976226,0.000091883296,0.000059997532,0.00078488805,0.00045386437,0.0008498521,0.000018168843,0.000009715446,0.00010903128],"genre_scores_gemma":[0.99636286,0.00004251839,0.00055585854,0.0026531199,0.0002519724,0.000015381405,0.00003073714,0.00003774468,0.000049790462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958195,0.0006770081,0.0020355298,0.00026093467,0.0007921771,0.00041481925],"domain_scores_gemma":[0.9931774,0.0025220914,0.0021668873,0.00018812151,0.0007488051,0.0011966615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020206922,0.00024754152,0.001928111,0.00021346885,0.000047421374,0.000008131574,0.00015535772,0.0005123247,0.00046075694],"category_scores_gemma":[0.0023626122,0.00014763177,0.00018081733,0.00024343796,0.00017239308,0.00020255847,0.000038799706,0.0011007215,2.9461657e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011704543,0.004567444,0.9723417,0.00003691086,0.00074201805,0.00005729823,0.0008326507,0.000062324485,0.00003560153,4.0274693e-7,0.0005372109,0.009081889],"study_design_scores_gemma":[0.026291117,0.023823382,0.947659,0.00027981156,0.000576528,0.0000034627192,0.00017133179,0.00023825372,0.0000638264,3.4377254e-7,0.0007349823,0.0001579351],"about_ca_topic_score_codex":0.0007431437,"about_ca_topic_score_gemma":0.0034769862,"teacher_disagreement_score":0.024682682,"about_ca_system_score_codex":0.0008099903,"about_ca_system_score_gemma":0.0039248154,"threshold_uncertainty_score":0.6962454},"labels":[],"label_agreement":null},{"id":"W2600317547","doi":"10.1200/jco.2012.30.15_suppl.6026","title":"Is care coordination associated with improved care quality for comorbid conditions in cancer survivors?","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Comorbidity; Logistic regression; Survivorship curve; Cancer; Colorectal cancer; Quality of life (healthcare); Cancer registry; Prostate cancer; Internal medicine; Nursing","score_opus":0.20215787967630178,"score_gpt":0.5344449377528168,"score_spread":0.332287058076515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600317547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916479,0.0012463417,0.000067167544,0.003931193,0.0011995075,0.0004008139,0.00014176156,0.0000070278315,0.0013582786],"genre_scores_gemma":[0.99447805,0.00014428902,0.0004566583,0.0039659743,0.00067351555,0.000027007569,0.00008419286,0.000014576258,0.00015572231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767375,0.00034578567,0.0014039131,0.00012547834,0.00019917262,0.00025191877],"domain_scores_gemma":[0.9953169,0.001931109,0.0012956352,0.0001131527,0.0010807062,0.0002624613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017326826,0.00010835958,0.0011061702,0.00009554814,0.00004806488,0.0000046690166,0.00008127174,0.0003319777,0.00025953562],"category_scores_gemma":[0.0018664042,0.00007956387,0.0002867434,0.00012337125,0.000118446966,0.00018553043,0.000014249928,0.0006265562,0.0000012447591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031058395,0.00070837565,0.96231973,0.00012544215,0.00035400662,0.000014334955,0.0029040526,0.000011534608,0.0002749072,0.000048055506,0.0024830217,0.02765071],"study_design_scores_gemma":[0.014892531,0.0046250327,0.9350953,0.00011400287,0.00031317392,0.000012004942,0.004320229,0.00005527383,0.00016898058,0.000020782834,0.040271625,0.000111023415],"about_ca_topic_score_codex":0.00052859396,"about_ca_topic_score_gemma":0.0068528973,"teacher_disagreement_score":0.037788603,"about_ca_system_score_codex":0.00088238774,"about_ca_system_score_gemma":0.0021202483,"threshold_uncertainty_score":0.38240775},"labels":[],"label_agreement":null},{"id":"W2601243611","doi":"10.1200/jco.2017.35.5_suppl.179","title":"Awareness among patients with cancer of the harms of continued smoking.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Survivorship curve; Smoking cessation; Logistic regression; Internal medicine; Cancer survivorship; Radiation therapy; Head and neck cancer; Pathology","score_opus":0.11237551080340627,"score_gpt":0.4602248704921552,"score_spread":0.34784935968874897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601243611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417925,0.000109720124,0.0000138642545,0.0016333401,0.0016503346,0.00015159087,0.000013565129,0.000001238618,0.0022470793],"genre_scores_gemma":[0.99838066,0.00016677302,0.0001691792,0.00072726805,0.0003235157,0.0000016981277,8.4055597e-7,0.000008994342,0.00022107341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789625,0.00014205357,0.0014023817,0.00009979321,0.00033898067,0.00012052463],"domain_scores_gemma":[0.9937009,0.00051247573,0.004549606,0.00035441865,0.0007519173,0.00013068628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010452489,0.000082689156,0.0011820998,0.00003596476,0.000060090657,0.0000043687046,0.00035122837,0.0001829395,0.00021319173],"category_scores_gemma":[0.0017335762,0.00004144201,0.00032555923,0.000034456658,0.0007028328,0.00011895899,0.00006721097,0.00054940506,2.527948e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031763823,0.00041097813,0.9423321,0.000041481537,0.00035924843,0.00001734673,0.00007950136,0.000012948997,0.000055121076,0.000005833008,0.0012965627,0.05221248],"study_design_scores_gemma":[0.01176279,0.0027946979,0.97203964,0.00028296758,0.0003487972,0.0000049142805,0.000029952656,0.000026415104,0.0005559576,0.000017383458,0.01209251,0.0000439804],"about_ca_topic_score_codex":0.0002940424,"about_ca_topic_score_gemma":0.00025897508,"teacher_disagreement_score":0.0521685,"about_ca_system_score_codex":0.00006916509,"about_ca_system_score_gemma":0.0019953032,"threshold_uncertainty_score":0.35395822},"labels":[],"label_agreement":null},{"id":"W2602244356","doi":"10.1200/jco.2009.27.15_suppl.e17559","title":"Effect of geographic distance from a cancer centre on choice of systemic therapy in metastatic colorectal cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Juravinski Cancer Centre; McMaster University; BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Institutional review board; Statistical significance; Internal medicine; Cancer registry; Odds ratio; Oncology; Surgery","score_opus":0.0625923300848927,"score_gpt":0.45909779775988274,"score_spread":0.39650546767499006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602244356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883148,0.008479659,0.00000849504,0.0016365937,0.0008452714,0.00039018277,0.000046621586,0.0000037131942,0.00027466594],"genre_scores_gemma":[0.98685783,0.011282272,0.00011043228,0.0013247688,0.0003775821,0.000007100732,0.0000034561451,0.0000109750445,0.000025604719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961404,0.000859446,0.0022225354,0.00019804938,0.00036875674,0.0002108044],"domain_scores_gemma":[0.9930759,0.0042416407,0.002106814,0.0001555112,0.00023357393,0.00018655328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017153812,0.00016811377,0.0024248585,0.00017730422,0.000012582497,0.000002265985,0.00017776218,0.0002057185,0.0003008484],"category_scores_gemma":[0.0009686396,0.00010948241,0.0005387304,0.00021625134,0.00016696607,0.00007209905,0.000009575041,0.0007915998,8.853428e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028378785,0.0008251239,0.6446405,0.00011610113,0.0005585758,0.00012921229,0.0002028238,0.00019324421,0.0068252436,0.000008581894,0.00028498055,0.31783682],"study_design_scores_gemma":[0.026008312,0.03356405,0.93071556,0.0015176928,0.0004493955,0.000020486334,0.00006276333,0.00024519852,0.0042720456,0.000047520898,0.0029807608,0.00011619111],"about_ca_topic_score_codex":0.000952212,"about_ca_topic_score_gemma":0.00088055537,"teacher_disagreement_score":0.31772065,"about_ca_system_score_codex":0.00025156682,"about_ca_system_score_gemma":0.001318339,"threshold_uncertainty_score":0.4464563},"labels":[],"label_agreement":null},{"id":"W2602342955","doi":"10.1200/jco.2017.35.4_suppl.545","title":"Topographical incidence and survival analysis of gastrointestinal tract cancer in adolescent and young adults compared with older adults in the United States.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Young adult; Epidemiology; Colorectal cancer; Cancer; Internal medicine; Disease; Oncology","score_opus":0.07477609506736685,"score_gpt":0.42776841362506407,"score_spread":0.3529923185576972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602342955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594915,0.00026968715,0.000037802736,0.003376605,0.000104863226,0.0001756977,0.000012543865,0.0000013721574,0.00007225679],"genre_scores_gemma":[0.9969012,0.00183879,0.0003921665,0.00076166796,0.00008882045,0.0000027536375,0.000006200668,0.0000052952437,0.0000031037416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758136,0.00038235713,0.0013511892,0.00019033044,0.0003110435,0.00018370275],"domain_scores_gemma":[0.9968596,0.0011590496,0.0013018318,0.00020582524,0.00028689578,0.00018677027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023014287,0.00011825276,0.0012900105,0.00035917724,0.000040509774,0.000014736663,0.00019255865,0.000103651044,0.000035733956],"category_scores_gemma":[0.0009330815,0.000068737616,0.00014491884,0.00029163103,0.00057249534,0.000115078896,0.000039061393,0.0009952893,5.566944e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013477251,0.00078187184,0.96754366,0.000058880687,0.00016791624,0.000718485,0.0008124704,0.000110915644,0.0000064328797,0.0000044774924,0.000037637452,0.016280014],"study_design_scores_gemma":[0.012489672,0.0030621614,0.9743356,0.0008993399,0.00051404955,0.00028430007,0.0014186234,0.0068024495,0.000001296336,0.0000051463726,0.00012249289,0.00006487261],"about_ca_topic_score_codex":0.0035211504,"about_ca_topic_score_gemma":0.025358044,"teacher_disagreement_score":0.021836892,"about_ca_system_score_codex":0.00006565064,"about_ca_system_score_gemma":0.00055705395,"threshold_uncertainty_score":0.99242663},"labels":[],"label_agreement":null},{"id":"W2603540638","doi":"10.1200/jco.2013.31.15_suppl.10537","title":"Does a diagnosis of GIST predict a second primary cancer?","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Pediatric Oncology Group","funders":"","keywords":"GiST; Medicine; Incidence (geometry); Malignancy; Population; Confidence interval; Relative risk; Internal medicine; Cancer; Cohort; Retrospective cohort study; Stage (stratigraphy); Gastroenterology; Oncology","score_opus":0.07992411018448055,"score_gpt":0.432830839727377,"score_spread":0.3529067295428965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603540638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682724,0.0011904353,0.000020524622,0.012303249,0.00235795,0.00031916107,0.000026413798,0.000008229591,0.015501643],"genre_scores_gemma":[0.975826,0.005153961,0.002878947,0.011667748,0.0022247809,0.00004285686,0.000004608659,0.000021614027,0.0021794308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963167,0.00024750456,0.0026793114,0.00017854384,0.00035153708,0.00022640337],"domain_scores_gemma":[0.9942946,0.0024184028,0.0020384581,0.00022327823,0.0005735456,0.00045173516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014668818,0.0001359656,0.001905132,0.00012160489,0.00002467897,0.000006663416,0.00020691703,0.00034432267,0.009617566],"category_scores_gemma":[0.0014932075,0.00007248386,0.0006415056,0.00010826984,0.00035647588,0.00022192416,0.000057922014,0.0009024388,0.000017140668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018677858,0.001020411,0.5245886,0.00023860931,0.00067963067,0.00015945647,0.000122368,0.000004566705,0.0006660233,0.000014502542,0.08406352,0.3865745],"study_design_scores_gemma":[0.0062881648,0.006383102,0.66037804,0.0001568785,0.00028944752,0.00007319698,0.00008396745,0.000037449954,0.00044463022,0.00014485113,0.32564142,0.00007886839],"about_ca_topic_score_codex":0.00016841764,"about_ca_topic_score_gemma":0.0001451757,"teacher_disagreement_score":0.38649565,"about_ca_system_score_codex":0.00024238128,"about_ca_system_score_gemma":0.0033674352,"threshold_uncertainty_score":0.99128777},"labels":[],"label_agreement":null},{"id":"W2604232753","doi":"10.1016/j.juro.2017.02.2195","title":"PD52-07 MEDICATION USE AND KIDNEY CANCER RISK: A POPULATION-BASED STUDY","year":2017,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Medical prescription; Kidney cancer; Population; Epidemiology; Comorbidity; Demography; Gerontology; Internal medicine; Environmental health; Pharmacology","score_opus":0.0343252308905325,"score_gpt":0.32779415991904265,"score_spread":0.29346892902851013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604232753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98704714,0.00040481117,0.00014983161,0.011840115,0.0003172209,0.00016705238,0.0000073991805,0.0000036721763,0.00006276158],"genre_scores_gemma":[0.9959693,0.0004332671,0.000084641026,0.0031901565,0.00024187032,0.0000024480005,0.0000023348364,0.0000073687634,0.00006863165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992558,0.00017002928,0.00024706085,0.000067907014,0.00016061545,0.00009861355],"domain_scores_gemma":[0.99869925,0.00019241168,0.0005792919,0.00029380733,0.00010461806,0.00013060281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071509654,0.00006668112,0.00021099034,0.0000623528,0.00023150966,0.000017608536,0.00014127717,0.00004605444,0.00029696274],"category_scores_gemma":[0.00080271665,0.000039685005,0.000035294477,0.000016358683,0.00007865298,0.00013282376,0.00002196283,0.0002867689,0.0000021417973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010443303,0.000065359556,0.9918586,0.0000073966266,0.00012836435,0.000016364285,0.00045154666,0.00007237632,0.00025806276,0.0000036375416,0.0014436806,0.0046502785],"study_design_scores_gemma":[0.0030112315,0.00070558925,0.99023134,0.000010693872,0.0004668158,0.000057945657,0.000050232793,0.0008895117,0.000020509706,0.00003841331,0.00448152,0.000036176098],"about_ca_topic_score_codex":0.0015995194,"about_ca_topic_score_gemma":0.00031322797,"teacher_disagreement_score":0.008922146,"about_ca_system_score_codex":0.000043622673,"about_ca_system_score_gemma":0.00028249537,"threshold_uncertainty_score":0.32515338},"labels":[],"label_agreement":null},{"id":"W2604376325","doi":"10.1200/jco.2017.35.8_suppl.53","title":"Developing and evaluating new models of care in hematology.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Survivorship curve; Specialty; Health care; Family medicine; Cancer survivorship; Cohort; Cancer; Internal medicine","score_opus":0.39848522917504603,"score_gpt":0.5706012786670833,"score_spread":0.1721160494920373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604376325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857715,0.0024793502,0.00032796327,0.0059823277,0.0004924964,0.00009717773,5.864844e-7,0.0000014953922,0.0048471224],"genre_scores_gemma":[0.9653475,0.0009777125,0.032253962,0.0010887639,0.0002756358,4.9296955e-7,4.6820332e-7,0.000005841487,0.00004959673],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979184,0.00014064329,0.0015558826,0.00010766051,0.00015821027,0.00011916898],"domain_scores_gemma":[0.9969187,0.0008458767,0.0016560081,0.00016502914,0.0002510645,0.00016332245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019233874,0.00006665254,0.0012177959,0.000078702855,0.000037363756,0.000004921799,0.00013915772,0.00023017773,0.000034923683],"category_scores_gemma":[0.0038260794,0.000050473867,0.00014164082,0.000021945023,0.00015935641,0.00015655391,0.00006950174,0.00052594056,6.532437e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003266985,0.00008398849,0.19727343,0.0001493681,0.00011901338,0.00029168013,0.00079808506,0.00006934578,0.00010863152,0.00088108855,0.00039113293,0.79656726],"study_design_scores_gemma":[0.035508208,0.01630582,0.9190749,0.0011903719,0.0003413641,0.0009976319,0.0018226247,0.0037802402,0.00046615698,0.0090245,0.011291576,0.00019658884],"about_ca_topic_score_codex":0.00006737777,"about_ca_topic_score_gemma":0.00025139624,"teacher_disagreement_score":0.7963707,"about_ca_system_score_codex":0.000108095825,"about_ca_system_score_gemma":0.004556825,"threshold_uncertainty_score":0.8083612},"labels":[],"label_agreement":null},{"id":"W2608082715","doi":"10.1200/jco.2012.30.15_suppl.6002","title":"An international study of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cancer; Lung cancer; Oncology; Hazard ratio; Colorectal cancer; Proportional hazards model; Quality of life (healthcare); Nausea; Breast cancer; Confidence interval","score_opus":0.5061346646789477,"score_gpt":0.5786047145399951,"score_spread":0.07247004986104733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608082715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973627,0.0001575329,0.000023706429,0.00034942818,0.0015661126,0.0004341965,0.00006236043,0.000002135602,0.000041824864],"genre_scores_gemma":[0.99789697,0.00008277174,0.0004973526,0.00023717078,0.0012376176,0.0000047131107,0.000030041265,0.00000864901,0.000004713906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962805,0.0005720629,0.0025016984,0.00016121713,0.0003365539,0.0001479759],"domain_scores_gemma":[0.9914323,0.0057795662,0.001964262,0.00020606954,0.0002655782,0.00035219605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0039217486,0.00010383803,0.0013945653,0.00010117887,0.000014471821,0.0000037860552,0.00024471953,0.00015624896,0.00007032811],"category_scores_gemma":[0.019136354,0.00006977314,0.000112149406,0.00005188997,0.00015238141,0.00028361232,0.00009979453,0.0004199586,8.716011e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003995674,0.0034323826,0.974204,0.00007047554,0.00040289946,0.0000021994686,0.0010309707,0.000013158659,0.0007516498,0.000017684542,0.000035220226,0.016043669],"study_design_scores_gemma":[0.016947247,0.008337182,0.97216094,0.0000512698,0.00017282083,0.0000023015534,0.0013168629,0.00062930444,0.00003814196,0.000017085014,0.00026714618,0.000059711154],"about_ca_topic_score_codex":0.00045863038,"about_ca_topic_score_gemma":0.0007777952,"teacher_disagreement_score":0.015983956,"about_ca_system_score_codex":0.000086659486,"about_ca_system_score_gemma":0.0010166584,"threshold_uncertainty_score":0.98912585},"labels":[],"label_agreement":null},{"id":"W2623364824","doi":"10.1097/cej.0000000000000372","title":"Survival of solid cancer patients in France, 1989–2013: a population-based study","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Cancer; Lung cancer; Mesothelioma; Internal medicine; Population; Thyroid cancer; Prostate cancer; Cancer registry; Oncology; Pathology; Environmental health","score_opus":0.027752820595839823,"score_gpt":0.3410724843827274,"score_spread":0.3133196637868876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623364824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970454,0.00049002544,0.000112459216,0.00019051631,0.0010511467,0.0003715813,0.000025652722,0.000004526254,0.0007086887],"genre_scores_gemma":[0.99880296,0.00020471984,0.00010427713,0.00007930254,0.00030670717,0.000005827488,0.0000086188975,0.000026254256,0.0004613487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981687,0.00029605613,0.0007828272,0.00015442805,0.00044529015,0.00015269784],"domain_scores_gemma":[0.99801224,0.000020416497,0.0012821924,0.000282774,0.00031059227,0.000091806294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205455,0.0001284696,0.00043242687,0.00018351176,0.000087212,0.000019830413,0.0002270671,0.000021883523,0.0003553814],"category_scores_gemma":[0.000081009326,0.00011162409,0.0001680457,0.00007970011,0.000031534935,0.00027786088,0.000031238902,0.00023371528,0.0000023758278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004609274,0.00053524465,0.95856094,0.00007938098,0.000108182794,0.000030360447,0.0002501426,0.00077231025,0.0003332499,7.7488414e-7,0.00018511695,0.038683355],"study_design_scores_gemma":[0.008905508,0.00093083206,0.9876322,0.00066764967,0.00012243721,7.9791164e-7,0.00004602196,0.00012575422,0.00021191553,0.000007062757,0.0012532601,0.0000965555],"about_ca_topic_score_codex":0.00071769353,"about_ca_topic_score_gemma":0.0009878677,"teacher_disagreement_score":0.0385868,"about_ca_system_score_codex":0.0001695076,"about_ca_system_score_gemma":0.00028528803,"threshold_uncertainty_score":0.45518982},"labels":[],"label_agreement":null},{"id":"W2624634583","doi":"10.1002/hon.2438_64","title":"FREQUENCY OF PERFORATION &amp; IMPACT OF BOWEL REST IN AGGRESSIVE NON‐HODGKIN LYMPHOMA WITH GASTROINTESTINAL INVOLVEMENT: AN INTERNATIONAL, MULTI‐CENTER RETROSPECTIVE STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Perforation; Retrospective cohort study; Chemotherapy; Lymphoma; Internal medicine; Univariate analysis; Surgery; Peritonitis; Bowel obstruction; Gastrointestinal perforation; Multivariate analysis; Gastroenterology","score_opus":0.06494795422468139,"score_gpt":0.39566113440297185,"score_spread":0.33071318017829043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624634583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614316,0.000019064384,0.00017174854,0.00014976213,0.00007564662,0.00074093376,0.00003426336,0.00001269659,0.0026527073],"genre_scores_gemma":[0.99337375,0.000021173251,0.006326674,0.00006494591,0.00003967785,0.00005442925,0.00007462816,0.0000120607065,0.00003265334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984442,0.00012441263,0.0005551334,0.00038853684,0.00024878324,0.00023895755],"domain_scores_gemma":[0.99799895,0.00006394746,0.00096763676,0.0005089194,0.0003432307,0.00011728715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866726,0.00019185117,0.000737457,0.00015838555,0.000075192285,0.000013313524,0.00029423417,0.00011230945,0.00032719615],"category_scores_gemma":[0.0005462417,0.00012964968,0.00010128786,0.0000694111,0.0003918798,0.00026972068,0.00009574742,0.00021558457,0.0000047214517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022143896,0.0051112706,0.9851622,0.000039028044,0.00011506399,0.0006475938,0.0009973401,0.000015266407,0.004862369,0.000109356566,0.000028865543,0.0006972302],"study_design_scores_gemma":[0.012135351,0.009858567,0.97557247,0.00022419117,0.000037941685,0.0005592846,0.0005862091,0.0005095302,0.00034747308,0.000051676263,0.0000101059995,0.00010723153],"about_ca_topic_score_codex":0.0010352021,"about_ca_topic_score_gemma":0.0033301518,"teacher_disagreement_score":0.009920962,"about_ca_system_score_codex":0.0006398574,"about_ca_system_score_gemma":0.00043003648,"threshold_uncertainty_score":0.528696},"labels":[],"label_agreement":null},{"id":"W2642497087","doi":"10.1200/jco.2013.31.15_suppl.1597","title":"Androgen deprivation therapy and survival in patients with lung cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Lung cancer; Androgen deprivation therapy; Internal medicine; Cancer; Oncology; Cancer registry; Proportional hazards model; Population; Finasteride; Hazard ratio; Epidemiology; Prostate cancer; Gynecology; Prostate; Confidence interval","score_opus":0.07602882824092337,"score_gpt":0.41845361118827545,"score_spread":0.34242478294735207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2642497087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952852,0.0005621363,0.000017986538,0.0027959668,0.0003480843,0.00023475003,0.0000010199087,0.0000023245823,0.00075250084],"genre_scores_gemma":[0.99479485,0.001568877,0.0007983699,0.0025190834,0.00026654487,0.0000047296317,0.0000021716012,0.000007593534,0.000037757218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862874,0.00013678595,0.0008448528,0.000098971606,0.00017782276,0.00011284707],"domain_scores_gemma":[0.9985573,0.00043139627,0.0005294327,0.0000713524,0.0002496096,0.00016089957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068945845,0.00006786371,0.00064224645,0.000065333945,0.000014206778,0.0000054462566,0.00004992343,0.00013678378,0.00032579107],"category_scores_gemma":[0.0002442522,0.000041551826,0.00006392018,0.000066743414,0.000076174576,0.00016271608,0.000012431406,0.0004025057,0.0000012939797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021790983,0.00023819777,0.74316776,0.0000073151896,0.000091134076,0.000012735242,0.000044887816,0.000004509729,0.000013691728,0.0000046796913,0.00054232485,0.25369367],"study_design_scores_gemma":[0.016360987,0.004467194,0.97232145,0.000036877038,0.00003417678,0.0000073423266,0.000023581175,0.00013159572,0.000011177971,0.00002719437,0.006532373,0.00004606959],"about_ca_topic_score_codex":0.00010351196,"about_ca_topic_score_gemma":0.00007609182,"teacher_disagreement_score":0.2536476,"about_ca_system_score_codex":0.000105003375,"about_ca_system_score_gemma":0.0007277568,"threshold_uncertainty_score":0.35671836},"labels":[],"label_agreement":null},{"id":"W2728580199","doi":"10.1200/jco.2013.31.15_suppl.3593","title":"Natural history and outcomes of synchronous and metachronous colorectal cancers (CRC): A population-based analysis.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Rectum; Proportional hazards model; Oncology; Natural history; Cancer; Population; Chemotherapy; Gastroenterology","score_opus":0.04481300208295771,"score_gpt":0.3899589335891298,"score_spread":0.3451459315061721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728580199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301964,0.0039856243,0.000050605293,0.0015976483,0.0007147561,0.00018359954,0.0000033538618,0.000005177276,0.00043958097],"genre_scores_gemma":[0.99377745,0.00029605036,0.0031795977,0.0024514846,0.0001634042,0.000003821657,0.000008233468,0.000008832254,0.00011112195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764645,0.00021477751,0.0015900884,0.00017046512,0.00022369045,0.00015450045],"domain_scores_gemma":[0.99625325,0.0016835342,0.001377712,0.000118815224,0.00027976642,0.00028694133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008785031,0.00012743003,0.001994103,0.00025297358,0.000024471085,0.0000043584764,0.00007399856,0.00020402278,0.00047904882],"category_scores_gemma":[0.0009709962,0.00008920218,0.00044959705,0.00010521142,0.00029122614,0.00013750102,0.000022174698,0.00052635267,0.0000010138515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010267925,0.0001993208,0.937835,0.000047410882,0.0023630902,0.000048559545,0.00010204438,0.00011823524,0.00021522514,0.000012864784,0.0010836851,0.056947783],"study_design_scores_gemma":[0.004777276,0.003275448,0.9823062,0.0000140840575,0.0019645768,0.000044173914,0.00005708782,0.003830323,0.000012122559,0.000019363664,0.0036175826,0.000081806764],"about_ca_topic_score_codex":0.0014251934,"about_ca_topic_score_gemma":0.00060719455,"teacher_disagreement_score":0.056865975,"about_ca_system_score_codex":0.00078624353,"about_ca_system_score_gemma":0.0022944696,"threshold_uncertainty_score":0.52452487},"labels":[],"label_agreement":null},{"id":"W2729284305","doi":"10.1016/s1470-2045(17)30445-x","title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":503,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Consumers, Health, Agriculture and Food Executive Agency; Queen's University; Queen's University Belfast; European Commission","keywords":"Relative survival; Medicine; Incidence (geometry); European union; Cancer registry; Population; Demography; Cancer; Referral; Pediatrics; Internal medicine; Family medicine; Environmental health","score_opus":0.0724263099790792,"score_gpt":0.3657372715329165,"score_spread":0.2933109615538373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729284305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990731,0.00015036427,5.4822e-7,0.0043634535,0.000090864865,0.00059751817,0.00007495455,0.0000072649705,0.0039840126],"genre_scores_gemma":[0.9992575,0.00009045323,0.000105596526,0.00014363696,0.00017341736,0.000015575066,0.000054964607,0.000007560568,0.00015129353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999133,0.00018918648,0.0002878957,0.00015448323,0.00009068408,0.00014476784],"domain_scores_gemma":[0.99892735,0.00017632548,0.00026485577,0.0005307378,0.00006310459,0.000037596445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030641595,0.00008738053,0.00054779183,0.00004656929,0.000051057174,0.0000051008665,0.00014495359,0.000042147734,0.000031078984],"category_scores_gemma":[0.00020009701,0.00005579195,0.000027646041,0.00004894125,0.00008077618,0.00002958531,0.000031282507,0.000078208934,7.1803663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005510237,0.00025201277,0.9682473,0.00005506144,0.0000639691,0.00007478969,0.002971326,0.00018168143,0.0009735845,0.000019577747,0.00024837142,0.021402096],"study_design_scores_gemma":[0.018921698,0.001943299,0.9737187,0.000044531847,0.000073479474,0.0000032758655,0.00035916053,0.00024246938,0.00057892286,0.000010184494,0.004056111,0.000048148595],"about_ca_topic_score_codex":0.0040942705,"about_ca_topic_score_gemma":0.0020510366,"teacher_disagreement_score":0.021353947,"about_ca_system_score_codex":0.00011798234,"about_ca_system_score_gemma":0.00024540775,"threshold_uncertainty_score":0.618934},"labels":[],"label_agreement":null},{"id":"W2736456990","doi":"10.1088/2057-1739/aa7dec","title":"Predictive modeling of therapy induced secondary thyroid malignancies in childhood cancer survivors","year":2017,"lang":"en","type":"article","venue":"Convergent Science Physical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fields Institute for Research in Mathematical Sciences; Princess Margaret Cancer Centre; University of Toronto; University of Waterloo","funders":"","keywords":"Medicine; Thyroid cancer; Oncology; Chemotherapy; Radiation therapy; Malignancy; Cancer; Internal medicine; Relative risk","score_opus":0.048652501276606946,"score_gpt":0.3537129639222846,"score_spread":0.30506046264567765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736456990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913361,0.00023140683,0.000053344127,0.00094242615,0.0007749425,0.00046481713,0.000019830055,0.0000187408,0.006158357],"genre_scores_gemma":[0.99864036,0.00046532412,0.00005294929,0.0005245233,0.00018598906,0.000065383305,0.0000039384813,0.000012474544,0.0000490835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.000047352303,0.000324166,0.00049284403,0.00039240447,0.00043491935],"domain_scores_gemma":[0.99876016,0.00006304356,0.00024388346,0.00053479336,0.00020213114,0.0001959679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041870028,0.00017399807,0.00059427257,0.00016568342,0.00025348843,0.000018516888,0.000539704,0.00008861625,0.0001794131],"category_scores_gemma":[0.00013444567,0.00014245276,0.00012103298,0.00022302096,0.00093408255,0.00047444343,0.00017311788,0.0003508622,0.0000076022498],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011643756,0.0016721311,0.08495755,0.00007482774,0.00012197311,0.000053221975,0.01175389,0.0019182231,0.80577594,0.000641454,0.000075169446,0.09179121],"study_design_scores_gemma":[0.006528353,0.0027298916,0.7303953,0.00012561817,0.000045038276,0.000010442293,0.00097206514,0.12698086,0.13028334,0.00091117213,0.00065932545,0.00035858963],"about_ca_topic_score_codex":0.0016505208,"about_ca_topic_score_gemma":0.000327521,"teacher_disagreement_score":0.67549264,"about_ca_system_score_codex":0.00039325154,"about_ca_system_score_gemma":0.0030832046,"threshold_uncertainty_score":0.5809055},"labels":[],"label_agreement":null},{"id":"W2761393054","doi":"10.1093/annonc/mdx375.009","title":"Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Jewish General Hospital; Sunnybrook Health Science Centre; University of Toronto; Hôpital Notre-Dame; Queen's University; McMaster University; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; KRAS; Internal medicine; Lung cancer; Oncology; Placebo; Cancer; Pathology","score_opus":0.05790885297384296,"score_gpt":0.37695647449262687,"score_spread":0.3190476215187839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761393054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614072,0.00011702409,0.0000035931018,0.00077327,0.00017587845,0.0006052453,0.000038531656,0.000020725607,0.036858566],"genre_scores_gemma":[0.9987525,0.00023903356,0.00029010934,0.00040497078,0.000026757227,0.000026353493,0.00008359802,0.000024316367,0.0001523818],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987415,0.000089959525,0.00040904572,0.00026366912,0.00019086343,0.00030496268],"domain_scores_gemma":[0.9982164,0.00026949655,0.00050986855,0.00047999763,0.00041121422,0.00011303069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017386193,0.00015892248,0.0006629979,0.00014941537,0.000054146425,0.000004349228,0.00020375928,0.00016862895,0.00015806046],"category_scores_gemma":[0.00046346697,0.00013619525,0.00006479525,0.00011802213,0.00026471072,0.00014782646,0.000045940258,0.00021288298,0.0000065936542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16927734,0.0026357379,0.3754861,0.00026638506,0.00067833473,0.00017518616,0.0011650327,0.000103756145,0.00884544,0.00014409685,0.0066961762,0.4345264],"study_design_scores_gemma":[0.09634224,0.030027183,0.8234025,0.0004700037,0.00011749337,0.000010213574,0.00018173763,0.00023711882,0.031241018,0.000018213355,0.017657593,0.00029465716],"about_ca_topic_score_codex":0.00041164208,"about_ca_topic_score_gemma":0.0011345119,"teacher_disagreement_score":0.44791642,"about_ca_system_score_codex":0.000126329,"about_ca_system_score_gemma":0.0005262309,"threshold_uncertainty_score":0.5553881},"labels":[],"label_agreement":null},{"id":"W276409341","doi":"","title":"Urologic oncology: extraordinary opportunities for discovery: highlights from the 2nd annual winter meeting of the society of urologic oncology december 1-2, 2001, bethesda, MD.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Prostate cancer; Oncology; Session (web analytics); Renal cell carcinoma; Family medicine; Cancer","score_opus":0.07920373054853164,"score_gpt":0.28606441596785176,"score_spread":0.20686068541932012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W276409341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9345961,0.0029825554,0.00011802155,0.022880236,0.00093728735,0.00222799,0.00049341714,0.000036191042,0.035728164],"genre_scores_gemma":[0.9816663,0.0009784976,0.0014979396,0.011524171,0.00027885646,0.0008728505,0.000058525995,0.000032506305,0.003090345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775594,0.0004757968,0.00059762556,0.00036459445,0.00024046731,0.0005655828],"domain_scores_gemma":[0.99704176,0.0017286283,0.00047568302,0.0004921563,0.0001446707,0.000117084106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013007885,0.00024336344,0.0006945186,0.00003611889,0.0001609168,0.00001004634,0.00035741675,0.0003216384,0.00017884672],"category_scores_gemma":[0.00035404123,0.0001312491,0.0005736466,0.00012449326,0.0007585609,0.00016437778,0.00012479366,0.0003504689,7.665434e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046334676,0.0013547565,0.08766629,0.00029222682,0.0025785451,0.00006146937,0.0076591466,0.00010755496,0.0032763148,0.0024842,0.79929423,0.090591766],"study_design_scores_gemma":[0.0031200678,0.0007891737,0.05368675,0.000023260112,0.0005636546,0.00004082315,0.005342441,0.00003689241,0.0043062884,0.0010395944,0.9308631,0.00018800002],"about_ca_topic_score_codex":0.00014104975,"about_ca_topic_score_gemma":0.00019236795,"teacher_disagreement_score":0.13156879,"about_ca_system_score_codex":0.00022069017,"about_ca_system_score_gemma":0.00055135955,"threshold_uncertainty_score":0.5352183},"labels":[],"label_agreement":null},{"id":"W2778648146","doi":"10.1186/s12885-017-3902-4","title":"Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies","year":2017,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Meta-analysis; Surgical oncology; Randomized controlled trial; Oncology; Internal medicine; Cisplatin; Cancer; Chemotherapy","score_opus":0.15280708395746462,"score_gpt":0.40702508362278383,"score_spread":0.2542179996653192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778648146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035411894,0.98672146,9.605292e-7,0.000012301843,0.000050472197,0.009641621,0.0028366267,0.000010106655,0.0003723432],"genre_scores_gemma":[0.00012116263,0.99042696,0.00007740226,0.00020854434,0.000018640694,0.0069503277,0.00021149123,0.00006227213,0.001923194],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944362,0.0010248218,0.0029261925,0.0007338589,0.0005702237,0.00030869356],"domain_scores_gemma":[0.9910359,0.0011626635,0.00603363,0.0010598169,0.0005808084,0.00012719895],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014736727,0.0007926428,0.03736544,0.0007515701,0.00005897023,0.000012452895,0.0002619315,0.00020893228,0.00096711935],"category_scores_gemma":[0.0005646121,0.00042671376,0.0034665798,0.0008391834,0.0004603849,0.000119264456,0.00008487684,0.00037532224,6.105129e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013898314,0.000036087717,0.0008093769,0.65849566,0.336275,0.0000032592038,0.00014100666,0.0000062950685,3.2507124e-8,5.518383e-7,0.00012706194,0.0027158346],"study_design_scores_gemma":[0.017974522,0.000087260974,0.00023710866,0.14136273,0.83689773,0.0000020012121,0.000015365855,0.0000086316595,6.734912e-7,4.373086e-7,0.003088767,0.00032476507],"about_ca_topic_score_codex":0.0044343853,"about_ca_topic_score_gemma":0.015334964,"teacher_disagreement_score":0.51713294,"about_ca_system_score_codex":0.0011187978,"about_ca_system_score_gemma":0.0020848853,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W2786057372","doi":"","title":"Richtlijnen behandeling multipel myeloom anno 2008","year":2008,"lang":"nl","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"History","score_opus":0.0407615383661242,"score_gpt":0.2676962752059756,"score_spread":0.2269347368398514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786057372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95150906,0.030855605,0.0015692718,0.0004827724,0.001563147,0.00082084286,0.0038116386,0.00025653635,0.009131099],"genre_scores_gemma":[0.92410535,0.04643169,0.0032601918,0.0032025005,0.003768171,0.000025573621,0.013635777,0.00018045482,0.005390269],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9948301,0.0003364199,0.0010505555,0.001722962,0.0006736711,0.0013863409],"domain_scores_gemma":[0.9956136,0.00060623104,0.00038689427,0.0024718414,0.00009407287,0.000827394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083193067,0.0008246896,0.0011187736,0.0002490379,0.0012665276,0.00013595363,0.0016916014,0.00028561425,0.0005354971],"category_scores_gemma":[0.000040373605,0.0007657312,0.00015829584,0.0004896769,0.00045815497,0.0009066272,0.0015970068,0.0011049494,0.00028953346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037999349,0.0010623375,0.6419373,0.005474611,0.0028080537,0.0028233104,0.056944698,0.005052308,0.005414005,0.000029765622,0.11473387,0.15991978],"study_design_scores_gemma":[0.0047566346,0.00034250147,0.1874875,0.0019825858,0.0008046481,0.0006036936,0.003398047,0.62227046,0.00005626653,0.000025788002,0.17706351,0.0012083715],"about_ca_topic_score_codex":0.0044170865,"about_ca_topic_score_gemma":0.0020608925,"teacher_disagreement_score":0.61721814,"about_ca_system_score_codex":0.00010132112,"about_ca_system_score_gemma":0.00037266055,"threshold_uncertainty_score":0.99947935},"labels":[],"label_agreement":null},{"id":"W2787868303","doi":"10.1016/j.sjopt.2018.02.005","title":"Cognitive biases in orbital mass lesions – Lessons learned","year":2018,"lang":"en","type":"article","venue":"Saudi Journal of Ophthalmology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Differential diagnosis; Context (archaeology); Orbit (dynamics); Prostate cancer; Metastasis; Cancer; Medical history; Presentation (obstetrics); Radiology; Dermatology; Pathology; Internal medicine","score_opus":0.14729115984313604,"score_gpt":0.4126114775221703,"score_spread":0.2653203176790343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787868303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217727,0.0007337691,0.000057126275,0.0026426574,0.0005225568,0.00011323112,0.000017990318,0.0000056244007,0.023729749],"genre_scores_gemma":[0.99749833,0.000103345104,0.0007752577,0.0002966476,0.00045135565,0.0000025674235,0.000009719244,0.000018130477,0.00084466144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867827,0.00013735643,0.000495555,0.00017327174,0.00018690305,0.0003286285],"domain_scores_gemma":[0.99860924,0.00048568714,0.0002724565,0.00012497471,0.00032375837,0.0001838933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041417594,0.00013494364,0.0004974406,0.00035078166,0.00006353157,0.000007931597,0.00011509709,0.00013230016,0.0031000846],"category_scores_gemma":[0.001246945,0.000111298985,0.00014620743,0.00023083283,0.0003292227,0.0001302895,0.00003515061,0.00046537188,0.000060093204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020762842,0.002018593,0.6172645,0.00023642051,0.0014232534,0.15453073,0.0037579793,0.0000796062,0.13338214,0.0003793196,0.009462419,0.056702193],"study_design_scores_gemma":[0.01413663,0.011003881,0.74856776,0.0015555411,0.0003212662,0.20054772,0.0030172332,0.00013771618,0.01588785,0.0021649406,0.0022055695,0.00045385523],"about_ca_topic_score_codex":0.00003328285,"about_ca_topic_score_gemma":0.000005509055,"teacher_disagreement_score":0.13130328,"about_ca_system_score_codex":0.00011885928,"about_ca_system_score_gemma":0.00055889133,"threshold_uncertainty_score":0.9978112},"labels":[],"label_agreement":null},{"id":"W2788835969","doi":"10.7202/1043360ar","title":"Droit à l’oubli pour les malades de cancers : un risque relatif pour les assurances","year":2018,"lang":"fr","type":"article","venue":"Assurances et gestion des risques","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Political science; Humanities; Philosophy","score_opus":0.041821157443321696,"score_gpt":0.3088799787524866,"score_spread":0.26705882130916486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788835969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6097257,0.0949219,0.008967395,0.045066148,0.0040029753,0.0010442487,0.00050545856,0.0006618462,0.23510431],"genre_scores_gemma":[0.91756415,0.037578396,0.014483574,0.0011765212,0.004118133,0.00013406106,0.000104230545,0.00015246966,0.024688458],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940588,0.0012062067,0.0011638823,0.001190184,0.0008015889,0.0015793442],"domain_scores_gemma":[0.9957582,0.0014378189,0.00062482955,0.0007410567,0.0008284724,0.0006096593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018658646,0.0009014119,0.0011596879,0.0004124885,0.0009699423,0.0002636033,0.0005853736,0.0009265899,0.0075302967],"category_scores_gemma":[0.0011589392,0.00091444224,0.0004493706,0.00076377497,0.002320344,0.0015904608,0.00010064445,0.0013566946,0.00041411494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010017657,0.00031398144,0.20571728,0.0012363418,0.0011240831,0.00024926758,0.0034419124,0.008936955,0.0037197997,0.0050416514,0.06161543,0.70760155],"study_design_scores_gemma":[0.006429163,0.0018816801,0.6234294,0.006815921,0.0013498641,0.00077135535,0.00705055,0.06285589,0.032361243,0.010561921,0.24425375,0.0022392592],"about_ca_topic_score_codex":0.015538572,"about_ca_topic_score_gemma":0.0073530218,"teacher_disagreement_score":0.70536226,"about_ca_system_score_codex":0.0026410776,"about_ca_system_score_gemma":0.0020079874,"threshold_uncertainty_score":0.99933064},"labels":[],"label_agreement":null},{"id":"W2791567841","doi":"10.5858/2002-126-384a-pfic","title":"Prognostic Factors in Cancer","year":2002,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Compendium; Cancer; Disease; Relevance (law); Medicine; Pathology; History; Internal medicine; Political science","score_opus":0.032332557468075694,"score_gpt":0.2958710224801955,"score_spread":0.2635384650121198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791567841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832341,0.0061458442,0.000024036086,0.0019526674,0.00027964247,0.00032673212,0.000046440633,0.00003556667,0.007954989],"genre_scores_gemma":[0.99608356,0.001598083,0.00029493964,0.001427561,0.0001477426,0.000035116675,0.000028701488,0.000022090431,0.0003622156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865794,0.00012192576,0.00043558772,0.00030976912,0.00017454592,0.00030024798],"domain_scores_gemma":[0.9989999,0.00035598953,0.00012984473,0.00031060498,0.000048734262,0.00015493495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012973628,0.00018405722,0.0005967842,0.00035598886,0.000029408417,9.704314e-7,0.000119181284,0.00008344103,0.0018530226],"category_scores_gemma":[0.00034906788,0.00013930499,0.00005183968,0.00034147533,0.00078321894,0.000058017857,0.00003116242,0.00032302478,0.000008043772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001271693,0.00019941025,0.8758211,0.000206441,0.00004952327,0.00070098235,0.007028141,0.0000073595343,0.10569314,0.00014160709,0.0012273324,0.008797762],"study_design_scores_gemma":[0.0041039228,0.0010365625,0.97995687,0.0004553617,0.00012008621,0.000042059026,0.00081806147,0.00028102053,0.004549924,0.00009691068,0.008367847,0.0001713647],"about_ca_topic_score_codex":0.00007508256,"about_ca_topic_score_gemma":0.00009359168,"teacher_disagreement_score":0.104135744,"about_ca_system_score_codex":0.00004157532,"about_ca_system_score_gemma":0.00013426767,"threshold_uncertainty_score":0.99905944},"labels":[],"label_agreement":null},{"id":"W2792656163","doi":"10.1093/jcag/gwy008.063","title":"A62 POST COLONOSCOPY COLORECTAL CANCERS IN ALBERTA. A PROCESS FOR IDENTIFYING TRUE CASES","year":2018,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colonoscopy; Colorectal cancer; Population; Psychological intervention; Ambulatory; Cancer; Intensive care medicine; Surgery; Internal medicine; Environmental health; Nursing","score_opus":0.018516027513761094,"score_gpt":0.29922655333755277,"score_spread":0.2807105258237917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792656163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630154,0.00001145201,0.00001175198,0.012339572,0.0008286638,0.00028244336,0.00006525718,0.0000012418261,0.00015808758],"genre_scores_gemma":[0.9954113,0.0000064252945,0.00009705445,0.0039943457,0.00023002936,0.000008559527,0.000006288368,0.00001080514,0.00023524465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988502,0.00010050011,0.00046560317,0.00009435554,0.00017434626,0.00031496285],"domain_scores_gemma":[0.9981893,0.00015015039,0.0007973351,0.00007918331,0.0006182707,0.00016576464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004991782,0.00008663364,0.0003711652,0.0002658011,0.000088816545,0.000010047634,0.00015790755,0.00013562114,0.00008311753],"category_scores_gemma":[0.0009802155,0.0000715818,0.00015089057,0.00012046003,0.00010314507,0.00009867979,0.000009554385,0.00027317405,9.892822e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004409434,0.000028595074,0.98790014,0.00005223897,0.00022017719,0.000016935695,0.0011330935,0.00005619011,0.0014562454,0.0000113733,0.0046378006,0.0000777811],"study_design_scores_gemma":[0.009780447,0.008905421,0.97221124,0.00025832557,0.0002621438,0.00049358385,0.0006651724,0.00039425868,0.0026753673,0.00008513677,0.004167332,0.00010159935],"about_ca_topic_score_codex":0.038316555,"about_ca_topic_score_gemma":0.9499738,"teacher_disagreement_score":0.9116572,"about_ca_system_score_codex":0.003469463,"about_ca_system_score_gemma":0.0023342955,"threshold_uncertainty_score":0.9680874},"labels":[],"label_agreement":null},{"id":"W2793080367","doi":"10.1093/jcag/gwy009.229","title":"A229 QUALITY ASSESSMENT OF SURVEILLANCE PATTERNS OF PATIENTS WITH BRANCH DUCT TYPE INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (BD-IPMN)","year":2018,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Radiology; Intraductal papillary mucinous neoplasm; Demographics; Malignancy; Endoscopic ultrasound; Cyst; Pancreatic duct; General surgery; Internal medicine; Pancreas","score_opus":0.011003262234214741,"score_gpt":0.2576444958889752,"score_spread":0.24664123365476046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793080367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996282,0.000011344818,0.000040081635,0.002439566,0.0006957139,0.00016626462,0.00020433507,0.0000017171136,0.00015897176],"genre_scores_gemma":[0.9985377,0.00002460411,0.00021430588,0.0009819893,0.00014706707,5.7469543e-7,0.000022218743,0.000011880255,0.00005962925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998001,0.0003606318,0.00077925465,0.00011287996,0.00047987822,0.0002663469],"domain_scores_gemma":[0.9961432,0.000087525616,0.0020475404,0.0002283254,0.0013242363,0.00016916958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081888546,0.00011721415,0.00062742585,0.00016962229,0.000048730148,0.000004382743,0.00019587135,0.00009730839,0.00016826247],"category_scores_gemma":[0.0002406077,0.000085216794,0.00014612645,0.00012171519,0.00011439471,0.00007639253,0.000022041459,0.0002674173,4.272616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010285518,0.00009819981,0.9960647,0.000066260734,0.00041679933,0.000002740982,0.00020305287,0.000024383879,0.0006586446,0.000010115753,0.0011694037,0.00025710915],"study_design_scores_gemma":[0.0032931808,0.003379786,0.9923835,0.0000617152,0.00007436245,0.000021165371,0.00003564865,0.000014510294,0.00027082296,0.000009776732,0.00041217575,0.000043398526],"about_ca_topic_score_codex":0.0061018104,"about_ca_topic_score_gemma":0.1900944,"teacher_disagreement_score":0.1839926,"about_ca_system_score_codex":0.00090732344,"about_ca_system_score_gemma":0.0010904867,"threshold_uncertainty_score":0.92241526},"labels":[],"label_agreement":null},{"id":"W2793583610","doi":"10.1200/jco.2012.30.15_suppl.e18098","title":"Prognostication in non-small cell lung cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Performance status; Cohort; Proportional hazards model; Hazard ratio; Lung cancer; Oncology; Stage (stratigraphy); Cancer; Confidence interval","score_opus":0.10929904621740563,"score_gpt":0.4721509446286103,"score_spread":0.3628518984112047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793583610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772118,0.0023417345,0.00019350539,0.0040095313,0.0018669559,0.00023529862,0.000001337408,0.0000037157818,0.014136151],"genre_scores_gemma":[0.98846644,0.0016250656,0.0037407237,0.003647682,0.002171599,0.000008281428,0.000001928455,0.000010254245,0.00032802662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978334,0.0001661596,0.0015116356,0.00009271476,0.00015637676,0.00023975805],"domain_scores_gemma":[0.9974186,0.0010517886,0.0008895334,0.00010849214,0.00017424677,0.0003573687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024233572,0.000079960846,0.00079593307,0.00009995087,0.000014261927,0.0000028265495,0.00009717266,0.00025525966,0.0003472869],"category_scores_gemma":[0.0010315139,0.00005949071,0.00020843043,0.00010297654,0.000063384214,0.0001384984,0.000023012562,0.0008373491,0.00001244198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010350976,0.0010014577,0.8651864,0.00006995117,0.00005723932,0.00006772073,0.00024273797,0.000012527772,0.00042562347,0.000013711681,0.0053551137,0.12653244],"study_design_scores_gemma":[0.0060882433,0.0019699312,0.9225825,0.000088010274,0.00020731281,0.00006525989,0.00008643431,0.00039580968,0.00026003597,0.000011970026,0.06817865,0.00006581853],"about_ca_topic_score_codex":0.000037364418,"about_ca_topic_score_gemma":0.000043634733,"teacher_disagreement_score":0.12646662,"about_ca_system_score_codex":0.0002768507,"about_ca_system_score_gemma":0.0018836682,"threshold_uncertainty_score":0.3802548},"labels":[],"label_agreement":null},{"id":"W2796562992","doi":"10.1016/s1556-0864(18)30320-4","title":"40P Comparison of clinical characteristics and survival of lung cancer patients in a Canadian province and in the United States according to insurance status","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medicaid; Demography; Hazard ratio; Percentile; Population; Proportional hazards model; Lung cancer; Cancer; Health care; Survival analysis; Environmental health; Internal medicine; Confidence interval; Statistics","score_opus":0.051042875707591494,"score_gpt":0.4710203688380194,"score_spread":0.4199774931304279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796562992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982078,0.00020504059,0.000007143927,0.00085428427,0.0003378493,0.00023414599,0.00006283578,7.106424e-7,0.00009015498],"genre_scores_gemma":[0.9984376,0.0004697472,0.0003210287,0.0006553785,0.00009566969,0.0000020474956,0.000008050938,0.000005930609,0.0000045826405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833643,0.00029018265,0.00091514084,0.000099424884,0.00014690946,0.00021188],"domain_scores_gemma":[0.99846417,0.00041206175,0.00056790217,0.00008112993,0.00028216382,0.00019255988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011645819,0.00007775249,0.00067874865,0.00032594372,0.000022116106,0.00000522272,0.00008925028,0.00008586782,0.000011387171],"category_scores_gemma":[0.00048205582,0.000055588123,0.000026611815,0.00023312983,0.00016280623,0.000067321824,0.000027289088,0.00035171214,8.801696e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027855157,0.00015379598,0.933658,0.00012376455,0.00003163645,0.000025781801,0.002747172,0.00000914405,0.000082390805,0.0000023370765,0.00012769287,0.060252775],"study_design_scores_gemma":[0.0012263559,0.0018523324,0.9896238,0.00023674809,0.00003988724,0.000008370672,0.0012225754,0.001075173,0.000058882186,0.000004030842,0.0046033175,0.00004855919],"about_ca_topic_score_codex":0.04299426,"about_ca_topic_score_gemma":0.24493718,"teacher_disagreement_score":0.20194292,"about_ca_system_score_codex":0.0002515955,"about_ca_system_score_gemma":0.0014272721,"threshold_uncertainty_score":0.96337855},"labels":[],"label_agreement":null},{"id":"W2805506778","doi":"10.1080/10245332.2018.1466428","title":"Synchronous dual hematological malignancies: new or underreported entity?","year":2018,"lang":"en","type":"article","venue":"Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"","keywords":"Malignancy; Medicine; Hematological malignancy; Hematologic malignancy; Internal medicine; Retrospective cohort study; Hematological disorders; Cancer; Hematologic Neoplasms; Oncology","score_opus":0.05035532375406432,"score_gpt":0.3212731621708292,"score_spread":0.27091783841676487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805506778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95349234,0.0009313061,0.0048329453,0.0036685872,0.0011582286,0.0005915499,0.0000068800973,0.00039015483,0.034928024],"genre_scores_gemma":[0.9850162,0.00005704936,0.0034696916,0.0043736137,0.0004043163,0.000019085364,0.00003774081,0.000028111579,0.006594148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982843,0.000045421122,0.0004969028,0.0004690776,0.00020026056,0.0005040806],"domain_scores_gemma":[0.99884665,0.00011644545,0.00014128459,0.00047575025,0.00010867542,0.00031118197],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000116428426,0.00021829923,0.0007072446,0.00011277232,0.00011590522,0.000014510828,0.00010529226,0.00027203304,0.013335803],"category_scores_gemma":[0.00026897233,0.0001602374,0.00012329269,0.00021626016,0.00040049286,0.00008825176,0.00008351316,0.00020572328,0.00081797875],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005904709,0.001364477,0.120333955,0.001397312,0.001317521,0.027613053,0.0029000929,0.0000019113133,0.013989628,0.07030902,0.73866403,0.016204275],"study_design_scores_gemma":[0.018425258,0.007031208,0.0388354,0.00057391194,0.0007724805,0.21443011,0.002027394,0.000933407,0.07030732,0.0056423605,0.6392668,0.0017543939],"about_ca_topic_score_codex":0.00010442401,"about_ca_topic_score_gemma":0.00024023255,"teacher_disagreement_score":0.18681705,"about_ca_system_score_codex":0.00010373202,"about_ca_system_score_gemma":0.0010141504,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W2806959531","doi":"10.1200/jco.2018.36.7_suppl.39","title":"The impact of a well breast cancer patient transition model of care on oncologists’ practice.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Juravinski Cancer Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Family medicine; Breast cancer; Workload; Cancer; Thematic analysis; Nonprobability sampling; Nursing; Qualitative research; Population; Internal medicine","score_opus":0.10695712038728433,"score_gpt":0.5008333214586185,"score_spread":0.39387620107133414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806959531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421604,0.00049907196,0.00012333457,0.00914987,0.0007522013,0.00023206051,0.000058816502,0.0000031802833,0.014965416],"genre_scores_gemma":[0.99419546,0.0018770132,0.00081488374,0.0023345766,0.0007318541,0.0000029097282,0.0000019162994,0.000010309433,0.00003107907],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99711645,0.0003859631,0.0018523849,0.00012365355,0.00035068215,0.00017088767],"domain_scores_gemma":[0.99351144,0.0020799562,0.0024457297,0.00019987483,0.0015652333,0.00019773819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013950609,0.000111160414,0.0010234951,0.00006804182,0.000047103684,0.000002935036,0.00013506615,0.00026407928,0.00023408805],"category_scores_gemma":[0.001033349,0.000058631078,0.0006857783,0.0000877208,0.000514451,0.00010774457,0.000018291246,0.00068076525,0.0000032803307],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1379004,0.0036474026,0.007477903,0.00010723459,0.0016590906,0.00012827969,0.0048346454,0.008868237,0.0023945034,0.00008968098,0.020730391,0.8121622],"study_design_scores_gemma":[0.044285845,0.45224133,0.37898135,0.0010845145,0.0029008763,0.0012687274,0.008402342,0.024522666,0.0030786074,0.00051480037,0.08225207,0.0004668656],"about_ca_topic_score_codex":0.00020554008,"about_ca_topic_score_gemma":0.000107874264,"teacher_disagreement_score":0.8116954,"about_ca_system_score_codex":0.0005331875,"about_ca_system_score_gemma":0.005202474,"threshold_uncertainty_score":0.92289656},"labels":[],"label_agreement":null},{"id":"W2824622994","doi":"10.5114/ms.2018.76880","title":"Non-Hodgkin’s lymphoma in the course of asthma – incidence or predisposition?","year":2018,"lang":"en","type":"article","venue":"Medical Studies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Lymphoma; Medicine; Asthma; Internal medicine; Physics","score_opus":0.032215749641755574,"score_gpt":0.37146246532734206,"score_spread":0.3392467156855865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2824622994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692805,0.0020269288,0.000061952735,0.007661307,0.00030436655,0.00028907458,0.000007443942,0.000015209493,0.0027056476],"genre_scores_gemma":[0.9933319,0.00083590264,0.00011970323,0.004935535,0.00045013943,0.000045039833,0.0000050197823,0.0000065655504,0.0002702075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986916,0.000051469535,0.0003013928,0.00017373216,0.000584964,0.00019683264],"domain_scores_gemma":[0.99919885,0.00030838698,0.00006220922,0.00021495907,0.00013159592,0.00008397914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006331726,0.00010809004,0.0003426204,0.00003898181,0.00007985359,0.0000036824879,0.00017887262,0.00006775249,0.0006293277],"category_scores_gemma":[0.00054518896,0.00005376704,0.000052164298,0.0002040897,0.00065591885,0.000050427097,0.0000825091,0.00011290349,0.000019721763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004046727,0.0017577839,0.29720873,0.0009660876,0.0010028973,0.0014167401,0.05546999,0.0000011325635,0.00066062703,0.0003939604,0.1571314,0.47994393],"study_design_scores_gemma":[0.004692886,0.002174906,0.93981344,0.00079032907,0.00007985026,0.00020257753,0.0093718525,0.00044205086,0.0011235736,0.000117525924,0.041038647,0.00015234832],"about_ca_topic_score_codex":0.00010220144,"about_ca_topic_score_gemma":0.0007361904,"teacher_disagreement_score":0.6426047,"about_ca_system_score_codex":0.0000783326,"about_ca_system_score_gemma":0.00035749123,"threshold_uncertainty_score":0.68906975},"labels":[],"label_agreement":null},{"id":"W2884352828","doi":"10.4236/abcr.2018.73014","title":"Role of Radiotherapy-Induced Malignancies in Patients with Both Breast and Lung Cancer Diagnoses","year":2018,"lang":"en","type":"article","venue":"Advances in Breast Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Juravinski Cancer Centre","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Breast cancer; Radiation therapy; Lung cancer; Malignancy; Retrospective cohort study; Cancer; Cohort; Internal medicine; Medical diagnosis; Oncology; Radiology","score_opus":0.014018237904148755,"score_gpt":0.3558449095807176,"score_spread":0.3418266716765689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884352828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97834235,0.019145718,0.0000027253589,0.00067116105,0.00008588125,0.00075010303,0.0001866826,0.000013639509,0.000801718],"genre_scores_gemma":[0.9888125,0.010231216,0.00014981932,0.0001896908,0.00020512308,0.00030017836,0.000009286332,0.000038696475,0.00006346447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997777,0.00011680658,0.0003255428,0.00048692184,0.0006774181,0.0006163132],"domain_scores_gemma":[0.99891937,0.00014075721,0.00008919247,0.00031481963,0.00038522115,0.00015064004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035910707,0.00019956823,0.0004621811,0.00042650496,0.00008115021,0.000018258883,0.0001801535,0.00008205572,0.00060151034],"category_scores_gemma":[0.000019640396,0.00015718423,0.000029824094,0.00080748805,0.000602088,0.0005219194,0.000070901166,0.00037658584,9.0498526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034947472,0.00017380757,0.8475739,0.0002333111,0.00004375572,0.000007816066,0.0008681407,0.000022301087,0.0042611035,0.00003314632,0.00006470999,0.14322326],"study_design_scores_gemma":[0.0051799016,0.00041005693,0.988662,0.0011588212,0.000012758028,0.000015936617,0.00032106438,0.00018715799,0.0022833913,0.00003216046,0.0015558272,0.00018092472],"about_ca_topic_score_codex":0.005964681,"about_ca_topic_score_gemma":0.007190074,"teacher_disagreement_score":0.14304233,"about_ca_system_score_codex":0.00061635993,"about_ca_system_score_gemma":0.0006239457,"threshold_uncertainty_score":0.90168536},"labels":[],"label_agreement":null},{"id":"W2891093729","doi":"10.1200/jco.2017.35.15_suppl.6591","title":"Estimating the optimal rate of adjuvant chemotherapy utilization in stage III colon cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cancer registry; Colorectal cancer; Cancer; Population; Stage (stratigraphy); Adjuvant chemotherapy; Internal medicine; Benchmarking; Medical record; Oncology; Environmental health","score_opus":0.23347155479766216,"score_gpt":0.5293438185457285,"score_spread":0.2958722637480664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891093729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541194,0.00035589118,0.0005013491,0.010374457,0.0012313249,0.00019730457,0.0000043098453,0.0000025299128,0.0019208709],"genre_scores_gemma":[0.99126226,0.0011337094,0.0036168236,0.0028671403,0.0006535884,0.0000034199334,0.0000013578998,0.00001043594,0.0004512545],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976473,0.00024150584,0.0016802094,0.00011552079,0.000166127,0.00014933881],"domain_scores_gemma":[0.9955226,0.0009101907,0.002953525,0.00025553346,0.0002474345,0.00011069302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038534603,0.000087337336,0.0010712164,0.000053113996,0.00007880562,0.000010278946,0.0002660983,0.00019124454,0.00031999784],"category_scores_gemma":[0.0022888922,0.00005343016,0.00021505638,0.000045522796,0.00030983175,0.00014740859,0.000040250063,0.0006804765,0.0000010021431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012518596,0.0007213778,0.21660376,0.000094531664,0.00030365004,0.00027514208,0.0006731031,0.0043448517,0.002150314,0.000101479956,0.0021605378,0.7600527],"study_design_scores_gemma":[0.02137966,0.0055614365,0.9029467,0.00027757537,0.0001484439,0.000044135424,0.00018978317,0.040661443,0.0010411746,0.00008271747,0.027574053,0.00009288664],"about_ca_topic_score_codex":0.00020857579,"about_ca_topic_score_gemma":0.0002628946,"teacher_disagreement_score":0.75995976,"about_ca_system_score_codex":0.00013427618,"about_ca_system_score_gemma":0.0020177553,"threshold_uncertainty_score":0.35794112},"labels":[],"label_agreement":null},{"id":"W2891641109","doi":"10.22494/cot.v6i1.80","title":"Review of international and national principles of law in the field of tissue and cell transplantation and the approaches of improving the regulatory framework of hematopoietic stem cells transplantation in Ukraine","year":2018,"lang":"en","type":"article","venue":"Cell and Organ Transplantology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Legislation; Harmonization; Transplantation; Political science; Haematopoiesis; European union; Stem cell; Hematopoietic stem cell transplantation; Public administration; Law; Medicine; Business; Biology; International trade; Cell biology; Surgery","score_opus":0.02145517254047387,"score_gpt":0.25874723877536854,"score_spread":0.23729206623489468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891641109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820275,0.01556144,0.00037703814,0.0005959512,0.000029283125,0.00040493082,0.00006219314,0.0000012928073,0.00094039197],"genre_scores_gemma":[0.9644687,0.0349623,0.00024928333,0.00027630187,0.000011715544,0.000005596589,0.000016143245,0.0000041177236,0.0000058384944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910843,0.000121232115,0.00045004964,0.00012418383,0.00013015013,0.00006594144],"domain_scores_gemma":[0.998893,0.00075857947,0.00019506468,0.00008919221,0.000049773204,0.000014355452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005596561,0.000082600505,0.00032881112,0.0000605793,0.000019478925,0.0000016371096,0.00007893589,0.00008140279,0.000015661268],"category_scores_gemma":[0.000008143049,0.00004779173,0.00002356842,0.000071956085,0.00062492257,0.000037113987,0.0000059427125,0.00011422199,2.1124645e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008017964,0.00054652774,0.05866591,0.20980626,0.00023511704,0.00002495382,0.21508694,0.00002577293,0.43876606,0.056979995,0.000025218304,0.011819271],"study_design_scores_gemma":[0.006400306,0.0006360854,0.05135646,0.004098223,0.00044916573,0.00019520445,0.0022083544,0.00041940334,0.93342686,0.0005073267,0.00016704116,0.0001355572],"about_ca_topic_score_codex":0.00013400862,"about_ca_topic_score_gemma":0.00017305858,"teacher_disagreement_score":0.4946608,"about_ca_system_score_codex":0.0000037943205,"about_ca_system_score_gemma":0.000042645603,"threshold_uncertainty_score":0.23025532},"labels":[],"label_agreement":null},{"id":"W2894519075","doi":"10.1200/jco.2018.36.30_suppl.148","title":"Improving support for smoking cessation in medical oncology patients: A quality improvement initiative.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University; Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Smoking cessation; Referral; Family medicine; Psychological intervention; Intervention (counseling); Nursing","score_opus":0.1813620592666873,"score_gpt":0.5181388366743152,"score_spread":0.33677677740762785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894519075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98039484,0.00003532947,0.0026510954,0.0067400336,0.003123097,0.00047748885,0.000011057754,0.00000857144,0.0065584667],"genre_scores_gemma":[0.97169775,0.00011335656,0.0033669563,0.022322034,0.0023931686,0.000017205759,0.000020423593,0.000015484418,0.000053596257],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945643,0.00050039496,0.003808134,0.0002515652,0.00055811525,0.0003175101],"domain_scores_gemma":[0.9922205,0.0033741763,0.002717589,0.00015689184,0.0011002887,0.0004305396],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010384553,0.00013405987,0.0014433481,0.00018676241,0.00005013791,0.0000064757432,0.00018616083,0.0006380315,0.0008784515],"category_scores_gemma":[0.015203053,0.000102872196,0.00035514755,0.0001224563,0.00032406702,0.0002207725,0.000073780044,0.0010177505,0.0000046785317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008404742,0.002184687,0.13090426,0.00007516446,0.00017244836,0.00009726753,0.00038554997,4.782543e-7,0.00013614894,0.000079112404,0.0023970571,0.8551631],"study_design_scores_gemma":[0.06650885,0.09670893,0.5678741,0.00013331725,0.00026007107,0.000066455614,0.0006473376,0.0007352424,0.00046873753,0.0005152109,0.26586762,0.00021416918],"about_ca_topic_score_codex":0.00006399885,"about_ca_topic_score_gemma":0.00040170283,"teacher_disagreement_score":0.85494894,"about_ca_system_score_codex":0.000906927,"about_ca_system_score_gemma":0.0074897935,"threshold_uncertainty_score":0.9981368},"labels":[],"label_agreement":null},{"id":"W2895053718","doi":"10.1016/j.hpb.2018.06.2875","title":"Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review","year":2018,"lang":"en","type":"review","venue":"HPB","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University; McMaster University; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Critical appraisal; Data extraction; Systematic review; Population; Predictive modelling; Medical physics; MEDLINE; Machine learning; Computer science; Pathology","score_opus":0.1342247578405983,"score_gpt":0.4237340135741637,"score_spread":0.28950925573356534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895053718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014311862,0.99343115,0.00023813352,0.000045378823,0.00060436624,0.0039030125,0.00022016246,0.00002023279,0.0015232594],"genre_scores_gemma":[0.000018762708,0.9979823,0.0002723475,0.00029081685,0.00035205594,0.00062773406,0.00007808757,0.000032304186,0.00034555956],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99710685,0.00054443424,0.0012439986,0.00036072457,0.00052541436,0.00021855396],"domain_scores_gemma":[0.99566585,0.002389038,0.0004458131,0.00090934546,0.00045084592,0.00013912928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072499766,0.00030585783,0.0036025094,0.00009254036,0.000048079193,0.000014757019,0.0003219778,0.00019974598,0.00039252907],"category_scores_gemma":[0.005491454,0.00016542878,0.00060530764,0.00038137904,0.00023086237,0.00007712742,0.000110688314,0.00036934178,0.00005881986],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033051983,0.0000666435,0.0000016631559,0.9784935,0.00036025795,0.000009356903,0.00011347061,3.991397e-8,0.0000013904229,0.000054781238,0.011179062,0.009686801],"study_design_scores_gemma":[0.00021401444,0.0006125676,0.000029338775,0.748749,0.005867466,0.00011720557,0.000047165187,0.000013855725,0.0000049536657,3.7946543e-7,0.24420944,0.00013462116],"about_ca_topic_score_codex":0.000013019063,"about_ca_topic_score_gemma":0.0000052930504,"teacher_disagreement_score":0.23303038,"about_ca_system_score_codex":0.00014750386,"about_ca_system_score_gemma":0.0005935987,"threshold_uncertainty_score":0.674599},"labels":[],"label_agreement":null},{"id":"W2898188409","doi":"10.1016/j.jtho.2018.08.959","title":"P1.15-27 Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Stage (stratigraphy); Chemotherapy; Radiation therapy; Internal medicine; Cancer; Oncology; Surgery","score_opus":0.029739129605074143,"score_gpt":0.3528996003894662,"score_spread":0.3231604707843921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898188409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495125,0.000113707974,0.00012641084,0.0009565766,0.0019325193,0.00034084532,0.00007425441,0.0000028669185,0.0015015656],"genre_scores_gemma":[0.99577475,0.000097443626,0.00048445672,0.0008935095,0.00040761082,0.0000091362745,0.000027247585,0.000015116198,0.00229073],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868023,0.00008640115,0.0005853243,0.00016578037,0.00018378893,0.00029846668],"domain_scores_gemma":[0.99886894,0.00018819145,0.00039316175,0.00013725976,0.00019560274,0.00021685529],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031272456,0.0001502422,0.0006773657,0.00012512876,0.000056141398,0.000011465692,0.00006971985,0.000098432756,0.00092421385],"category_scores_gemma":[0.000055112017,0.00011653496,0.0000724862,0.000045710764,0.00005791163,0.00008240681,0.000027840551,0.00024608904,8.028963e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022212317,0.0010683927,0.48143178,0.00021931711,0.00058987446,0.0020408826,0.0050994116,0.000008343429,0.00249006,0.00001985545,0.008675131,0.47614464],"study_design_scores_gemma":[0.0065075103,0.016818829,0.4185949,0.00018758165,0.00023958679,0.00036637395,0.0014787299,0.0001320333,0.0030142164,0.00001836844,0.5524214,0.00022048641],"about_ca_topic_score_codex":0.65672743,"about_ca_topic_score_gemma":0.98717844,"teacher_disagreement_score":0.54374623,"about_ca_system_score_codex":0.0033711365,"about_ca_system_score_gemma":0.0047556395,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2898275725","doi":"10.1016/j.jtho.2018.08.1450","title":"P2.15-09 The Impact of Treatment Evolution in NSCLC (iTEN) Model: Survival and Cost of Treating Patients with Advanced NSCLC in 2017","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Oncology; Overall survival; Internal medicine","score_opus":0.027736596457365623,"score_gpt":0.4031379666839387,"score_spread":0.37540137022657305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898275725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626064,0.0003378484,0.00018427959,0.00015841011,0.00009309495,0.00036939053,0.000017412838,0.0000018238381,0.0025771228],"genre_scores_gemma":[0.99863756,0.00014250504,0.0010687481,0.000022118447,0.000065605826,0.000004861969,0.000005162092,0.00001042153,0.000043015232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987818,0.00016979827,0.00057651056,0.00011886947,0.00016644831,0.00018659105],"domain_scores_gemma":[0.9986321,0.00018390665,0.00070043677,0.00015413722,0.0002498126,0.00007961722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045957332,0.00013162124,0.000654125,0.00023649834,0.0000298237,0.0000029132086,0.000077775134,0.00009009129,0.00003014482],"category_scores_gemma":[0.00009105361,0.00007189308,0.00009297936,0.0001691902,0.00018919671,0.00015542902,0.000019347137,0.00019542438,3.678739e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025677504,0.0009238837,0.6717691,0.000049748254,0.00021627938,0.00003665865,0.0026898757,0.005409033,0.004092925,0.000009193813,0.000060553237,0.28906527],"study_design_scores_gemma":[0.009291444,0.020274192,0.9595434,0.0003423106,0.0001360659,0.00007266245,0.00077465666,0.008951749,0.00039726283,0.00006009771,0.00006868074,0.00008749296],"about_ca_topic_score_codex":0.0003554197,"about_ca_topic_score_gemma":0.00075267087,"teacher_disagreement_score":0.28897777,"about_ca_system_score_codex":0.0013476732,"about_ca_system_score_gemma":0.0009630893,"threshold_uncertainty_score":0.35241187},"labels":[],"label_agreement":null},{"id":"W2898323173","doi":"10.1016/j.jtho.2018.08.467","title":"MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Lung cancer; Clinical trial; Cohort; Surgery; Cancer; Chemotherapy; Internal medicine; Oncology; General surgery","score_opus":0.02523285328223142,"score_gpt":0.37759438176632903,"score_spread":0.35236152848409763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898323173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976612,0.00026124605,0.0000015542249,0.012618667,0.001174189,0.00024046257,0.00000773204,0.000002713228,0.009081445],"genre_scores_gemma":[0.9898019,0.00010770409,0.00006927186,0.0064992844,0.0006361295,0.000019333638,0.0000028627128,0.000009977317,0.0028535335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985829,0.00022748283,0.00038042845,0.00013924159,0.00038733293,0.0002826267],"domain_scores_gemma":[0.99872804,0.00018677097,0.00049335713,0.00022421725,0.00025891195,0.00010867706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039523822,0.00013389892,0.00039501808,0.000103960134,0.00012546501,0.00001981518,0.00032750441,0.00007055199,0.00081931305],"category_scores_gemma":[0.000063894215,0.000068591595,0.00008018333,0.00025160404,0.00016549895,0.00012364173,0.000032895605,0.0006101332,0.0000010188587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013405718,0.00012157203,0.89316326,0.000019714498,0.000078938065,0.00039676728,0.008401407,0.000004866673,0.000077617085,0.0000027455633,0.069131345,0.027261175],"study_design_scores_gemma":[0.000813529,0.00061917637,0.7838058,0.000097591175,0.000112471025,0.000086196975,0.0026939493,0.000036910747,0.00026895414,0.000004476711,0.21138428,0.0000767092],"about_ca_topic_score_codex":0.652014,"about_ca_topic_score_gemma":0.9931063,"teacher_disagreement_score":0.34109232,"about_ca_system_score_codex":0.0031746184,"about_ca_system_score_gemma":0.0030470698,"threshold_uncertainty_score":0.8970903},"labels":[],"label_agreement":null},{"id":"W2901559050","doi":"10.2188/jea.je20180140","title":"Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980–2010","year":2018,"lang":"en","type":"article","venue":"Journal of Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"University of Occupational and Environmental Health; Alberta Health Services","keywords":"Medicine; Population; Kidney; Internal medicine; Demography; Environmental health","score_opus":0.05184164958637681,"score_gpt":0.3416288887184226,"score_spread":0.2897872391320458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901559050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818856,0.0007512801,0.00007451489,0.015509377,0.0006622527,0.00015364224,0.000010619975,0.0000021149447,0.0009505721],"genre_scores_gemma":[0.9763285,0.00014469423,0.0018441941,0.020924091,0.00043522997,0.0000018416898,0.0000012056324,0.0000074849386,0.00031277348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850786,0.00028829917,0.0007699204,0.00012741917,0.00009979639,0.00020673666],"domain_scores_gemma":[0.99851316,0.00042364272,0.00044177508,0.00024669818,0.000173431,0.00020130066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020522508,0.00009719599,0.0007149545,0.00010137248,0.00002665958,0.0000014975376,0.00013120873,0.00014486609,0.00018469228],"category_scores_gemma":[0.005401099,0.00005496113,0.00011686108,0.0001257131,0.0002868942,0.000058234615,0.000058593025,0.00036183925,0.0000021703386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049662095,0.00005490402,0.9115514,0.0001165105,0.0001602082,0.000027282578,0.0010550278,0.0000120096665,0.016518356,0.00062620325,0.06753114,0.001850335],"study_design_scores_gemma":[0.0008185923,0.00050127116,0.97503096,0.00019851368,0.000063444204,0.0004883134,0.00010536017,0.000046972156,0.001391985,0.00093834754,0.020363318,0.000052903677],"about_ca_topic_score_codex":0.00012069341,"about_ca_topic_score_gemma":0.00016788182,"teacher_disagreement_score":0.06347958,"about_ca_system_score_codex":0.00004713742,"about_ca_system_score_gemma":0.00027941942,"threshold_uncertainty_score":0.646601},"labels":[],"label_agreement":null},{"id":"W2909995331","doi":"10.14740/jmc.v10i1.3172","title":"Metachronous and Synchronous Multiple Primary Carcinomas in an Elderly","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Epiglottis; Population; Carcinoma; Primary tumor; Internal medicine; Oncology; Larynx; Surgery; Metastasis","score_opus":0.022256303201662973,"score_gpt":0.29021307016436704,"score_spread":0.26795676696270404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909995331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913335,0.006293799,0.00003391364,0.0012667006,0.00031477946,0.00018625094,0.0000043215805,0.000008780602,0.0005579611],"genre_scores_gemma":[0.99657625,0.000604098,0.0005949862,0.0017597416,0.00035844612,0.0000019153115,0.00000833602,0.00001703402,0.000079199075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981112,0.00009193923,0.0005576095,0.00017854056,0.0008240667,0.00023666189],"domain_scores_gemma":[0.9986266,0.00038574002,0.00017802735,0.0001848349,0.00008764478,0.0005371545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007100282,0.00014014376,0.0006188067,0.000204685,0.000024560439,0.000019394402,0.00014335681,0.00015539645,0.0011539937],"category_scores_gemma":[0.00038197867,0.00010399326,0.000104417755,0.000097567565,0.00009897996,0.00028013636,0.00004188042,0.0005958382,0.00000881699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019252028,0.000680124,0.7462333,0.0006243502,0.00014792617,0.014369161,0.0009373563,0.000019656452,0.0049877656,0.000022934788,0.0014074093,0.22864482],"study_design_scores_gemma":[0.01968835,0.011396952,0.9191212,0.00073008426,0.00024559873,0.025530439,0.0014088828,0.0021486734,0.0008262438,0.000027937329,0.018510133,0.0003654784],"about_ca_topic_score_codex":0.00018494547,"about_ca_topic_score_gemma":0.0001594333,"teacher_disagreement_score":0.22827934,"about_ca_system_score_codex":0.00020751351,"about_ca_system_score_gemma":0.0010428824,"threshold_uncertainty_score":0.9997591},"labels":[],"label_agreement":null},{"id":"W2911680870","doi":"10.1093/ecco-jcc/jjy222.274","title":"P150 High adherence to surveillance guidelines in IBD results in low CRC and dysplasia rates, while rates of dysplasia and cancer are low before the suggested start of surveillance. Results from a tertiary IBD centre","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Dysplasia; Ulcerative colitis; Internal medicine; Incidence (geometry); Colonoscopy; Gastroenterology; Colorectal cancer; Cohort; Inflammatory bowel disease; Cancer; Disease","score_opus":0.01775415527071603,"score_gpt":0.2798482527093322,"score_spread":0.26209409743861617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911680870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886394,0.0044096434,0.0000013767733,0.004419879,0.00022119608,0.00050420314,0.0017298511,0.000003840393,0.000070607566],"genre_scores_gemma":[0.99439025,0.0045453757,0.00015142812,0.0004454315,0.00013177423,0.0000059386784,0.0000459123,0.000017744309,0.00026613058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974642,0.00016897774,0.0013870026,0.00033882502,0.00033612244,0.00030491228],"domain_scores_gemma":[0.9977631,0.0004078609,0.00078604964,0.00027247492,0.00058466353,0.00018585812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007891129,0.00023512993,0.0009361241,0.00017464043,0.000035763802,0.000034817163,0.00014188266,0.00012540593,0.000079224475],"category_scores_gemma":[0.000387361,0.0001646908,0.000057589037,0.0002729401,0.00016698199,0.00018099729,0.00007151083,0.00030145698,5.917482e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019434866,0.0000812582,0.95906806,0.0003990815,0.00010871996,0.00019311995,0.0027069512,0.00017035584,0.00089874887,0.0000056584063,0.004568441,0.012364715],"study_design_scores_gemma":[0.009139211,0.00059351034,0.9832172,0.00238368,0.000019048754,0.000049942842,0.0011847167,0.0004366177,0.0013197819,0.00004008607,0.0014699363,0.00014630938],"about_ca_topic_score_codex":0.009612478,"about_ca_topic_score_gemma":0.043644164,"teacher_disagreement_score":0.034031685,"about_ca_system_score_codex":0.00008847375,"about_ca_system_score_gemma":0.00034975313,"threshold_uncertainty_score":0.9969826},"labels":[],"label_agreement":null},{"id":"W2922032827","doi":"10.1093/jcag/gwz006.213","title":"A214 ADHERENCE TO COLONOSCOPY SURVEILLANCE GUIDELINES: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2019,"lang":"en","type":"review","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Guideline; Colonoscopy; CINAHL; Colorectal cancer; MEDLINE; Population; Confidence interval; Internal medicine; Meta-analysis; Family medicine; Cancer; Psychological intervention; Pathology; Environmental health","score_opus":0.1041054035909484,"score_gpt":0.3717909932812686,"score_spread":0.2676855896903202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922032827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024137362,0.98931754,0.000012890584,0.008442382,0.00022765114,0.0015839721,0.00034682872,0.0000017735371,0.000042844767],"genre_scores_gemma":[0.00015379836,0.98369735,0.0002383854,0.0139254285,0.00004825228,0.000034492637,0.000018150937,0.000019750498,0.0018643765],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99575883,0.0011307437,0.0022151591,0.00020036126,0.0004015924,0.00029331795],"domain_scores_gemma":[0.99286723,0.00027542858,0.0050156745,0.00045982524,0.0010467718,0.0003350427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028749625,0.00027057246,0.0090128025,0.00055000896,0.000043665445,0.000017496188,0.0004144524,0.0002032706,0.00024435713],"category_scores_gemma":[0.0021671064,0.0001591568,0.0027067284,0.00046590494,0.000028792116,0.00004288624,0.000042761352,0.00044447955,0.000009002883],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008125985,0.00002440477,0.0049627507,0.6249294,0.325488,0.000018498993,0.000051400035,0.00001642368,2.2668324e-7,0.000005094112,0.044131335,0.00029115897],"study_design_scores_gemma":[0.000385393,0.0009943368,0.0002607968,0.016903142,0.87052387,0.00018741672,0.000006946917,0.0000032465193,4.105988e-8,0.0000012174505,0.11063393,0.00009964246],"about_ca_topic_score_codex":0.0017653761,"about_ca_topic_score_gemma":0.14454831,"teacher_disagreement_score":0.6080263,"about_ca_system_score_codex":0.0017018323,"about_ca_system_score_gemma":0.0017789169,"threshold_uncertainty_score":0.87106144},"labels":[],"label_agreement":null},{"id":"W2946842905","doi":"10.1111/bju.14841","title":"Long‐term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large‐scale population‐based analysis","year":2019,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Brachytherapy; Prostate cancer; Prostatectomy; Incidence (geometry); Hazard ratio; Bladder cancer; Propensity score matching; Confounding; Cumulative incidence; Urology; Internal medicine; Proportional hazards model; Population; Epidemiology; Surgery; Cancer; Confidence interval; Radiation therapy; Cohort","score_opus":0.005614532374422019,"score_gpt":0.25831147800455284,"score_spread":0.25269694563013084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946842905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546534,0.003308156,0.00012624876,0.00021192504,0.00006969103,0.0005255774,0.00027123265,0.0000045660463,0.000017269527],"genre_scores_gemma":[0.99786854,0.0008407184,0.00024334858,0.0008079772,0.000032913333,0.00002372863,0.000094267634,0.000019045889,0.00006947381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875915,0.00008572215,0.0005289015,0.0002119645,0.00018492797,0.00022935894],"domain_scores_gemma":[0.9989476,0.0000707547,0.00046243865,0.000100872196,0.00032049138,0.00009779773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020696182,0.000120835364,0.0007155385,0.00030517994,0.000030209438,0.00001163909,0.00006572553,0.00009637308,0.00060322357],"category_scores_gemma":[0.00002006672,0.00011347873,0.00012162856,0.00032652763,0.000060070754,0.00016522968,0.000010864838,0.00023368462,1.5662201e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075927563,0.00015872126,0.9553109,0.00010464484,0.0005993645,0.000067736626,0.00019180098,0.0010430551,0.00016706066,2.2154202e-7,0.00004592252,0.03471786],"study_design_scores_gemma":[0.01851834,0.0019934268,0.9767641,0.00014301762,0.00053170125,0.00011410131,0.000017665334,0.0015446417,0.00014546336,0.0000050584335,0.00011340437,0.00010908722],"about_ca_topic_score_codex":0.0012362184,"about_ca_topic_score_gemma":0.00784209,"teacher_disagreement_score":0.034608774,"about_ca_system_score_codex":0.000108927954,"about_ca_system_score_gemma":0.0003588111,"threshold_uncertainty_score":0.66048753},"labels":[],"label_agreement":null},{"id":"W2946917538","doi":"10.1200/jco.2019.37.15_suppl.e20676","title":"Effect of body mass index and age on survival in patients with advanced lung cancer treated with anti-PD-1 immune checkpoint inhibitors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Body mass index; Internal medicine; Hazard ratio; Proportional hazards model; Lung cancer; Oncology; Cancer; Confidence interval; Overweight; Retrospective cohort study; Univariate analysis; Multivariate analysis","score_opus":0.015824066699492417,"score_gpt":0.3729389510020911,"score_spread":0.3571148843025987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946917538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973913,0.00020755784,0.000004236426,0.00026281585,0.0004676079,0.00055703364,0.0000057845577,0.000004320732,0.0010993601],"genre_scores_gemma":[0.99914557,0.00027590565,0.00011821951,0.00022106527,0.00013287608,0.000004882218,0.000006717712,0.000021662665,0.00007309782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973136,0.00038889394,0.0014959372,0.00021922932,0.0003682218,0.0002140771],"domain_scores_gemma":[0.9969398,0.0011418642,0.0013565657,0.00017747954,0.00019644012,0.00018784907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015078598,0.00018518537,0.0020545316,0.00016189004,0.000013704208,0.0000039815827,0.00008436374,0.00024011522,0.00010325724],"category_scores_gemma":[0.00031058316,0.00010435859,0.00016189345,0.0001548264,0.00016549349,0.00012323115,0.000023296543,0.00090371806,0.0000010156475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06652714,0.000531153,0.9050258,0.00016557235,0.00033125,0.00021497087,0.00003715037,0.00015745609,0.0012673505,0.0000013577467,0.00002429812,0.025716495],"study_design_scores_gemma":[0.05257887,0.05712483,0.887312,0.0006022853,0.00019301186,0.000008996183,0.000020383033,0.00011817518,0.0015105262,0.0000010047455,0.00042793134,0.000102007616],"about_ca_topic_score_codex":0.00008811761,"about_ca_topic_score_gemma":0.000048546848,"teacher_disagreement_score":0.05659368,"about_ca_system_score_codex":0.00023571373,"about_ca_system_score_gemma":0.0006748959,"threshold_uncertainty_score":0.425562},"labels":[],"label_agreement":null},{"id":"W2947022664","doi":"10.1200/jco.2019.37.15_suppl.6509","title":"The impact of routine ESAS use on overall survival: Results of a population-based retrospective matched cohort analysis.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; McMaster University; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Retrospective cohort study; Propensity score matching; Proportional hazards model; Cancer; Cohort; Internal medicine; Comorbidity; Cohort study; Population; Survival analysis","score_opus":0.08710106740873273,"score_gpt":0.4617616227388621,"score_spread":0.3746605553301294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947022664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553406,0.000037737733,0.000027062635,0.0014722726,0.0005193953,0.000266782,0.000045799625,0.00000403244,0.0020928676],"genre_scores_gemma":[0.99838716,0.00013763666,0.00037522928,0.00046207383,0.00022777254,7.9646327e-7,0.000032354,0.0000118532635,0.00036511404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954702,0.0006017696,0.0030205268,0.00019284768,0.0005338154,0.00018082107],"domain_scores_gemma":[0.98769206,0.0070598666,0.0038272347,0.0004462606,0.00078243564,0.00019213966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005141414,0.00013604733,0.0023801725,0.00019592786,0.00002413155,0.0000064633696,0.0001686641,0.00026203756,0.0002108283],"category_scores_gemma":[0.006660866,0.00007474284,0.0015476615,0.00031598454,0.000121925135,0.00008865843,0.000021946056,0.0007436129,0.0000035207966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032587636,0.0006331635,0.9562439,0.000010428234,0.0033088943,0.000023273786,0.000041515395,0.0046373545,0.00016549863,0.000058162623,0.0009576009,0.0013326069],"study_design_scores_gemma":[0.012162228,0.012763765,0.97071475,0.000044120774,0.0009603156,0.0000050361314,0.000024149007,0.002625909,0.000045552053,0.00007652507,0.0005153385,0.00006229991],"about_ca_topic_score_codex":0.0017371601,"about_ca_topic_score_gemma":0.0002670981,"teacher_disagreement_score":0.020425407,"about_ca_system_score_codex":0.00051024667,"about_ca_system_score_gemma":0.0015852295,"threshold_uncertainty_score":0.79741603},"labels":[],"label_agreement":null},{"id":"W2947804662","doi":"10.1200/jco.2019.37.15_suppl.e16058","title":"Impact of cisplatin-related adverse health outcomes (AHOs) on employment outcomes and self-reported health (SRH) among testicular cancer survivors (TCS).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Behavioral Risk Factor Surveillance System; Renal function; Internal medicine; Physical therapy; Medical record; Population; Environmental health","score_opus":0.08652499422483131,"score_gpt":0.4938337333037047,"score_spread":0.40730873907887344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947804662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870295,0.00063090475,0.000008303974,0.00772379,0.0015634494,0.0007079821,0.000022281361,0.000022643158,0.0006176885],"genre_scores_gemma":[0.9904229,0.0022501878,0.00071456435,0.0059826532,0.0001178338,0.000003821118,0.000010197774,0.000033401106,0.00046442638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99338484,0.00063024944,0.0045934697,0.00033896317,0.0006046985,0.0004477564],"domain_scores_gemma":[0.9903913,0.0024941629,0.0054725544,0.00037017037,0.00034807986,0.0009236955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004233228,0.00029530263,0.0036084026,0.00025475156,0.000055178978,0.0000052294845,0.00014457083,0.00034782072,0.0008510195],"category_scores_gemma":[0.0014703016,0.00018660272,0.0009635131,0.00018270526,0.00018100553,0.00014291631,0.000054087872,0.0012008869,0.0000095262085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013306384,0.0015885794,0.9653158,0.00011206335,0.0028651406,0.00015329139,0.00036443432,0.00039920074,0.000011787971,0.000013406897,0.001121015,0.026724646],"study_design_scores_gemma":[0.0131925745,0.023118181,0.9596904,0.0002315784,0.00030762405,0.000093523835,0.00009885915,0.0003169618,0.0000024779185,0.000019259092,0.0027886224,0.0001399546],"about_ca_topic_score_codex":0.004716596,"about_ca_topic_score_gemma":0.000866786,"teacher_disagreement_score":0.026584692,"about_ca_system_score_codex":0.0010137599,"about_ca_system_score_gemma":0.007157206,"threshold_uncertainty_score":0.9984713},"labels":[],"label_agreement":null},{"id":"W2947849849","doi":"10.1200/jco.2019.37.15_suppl.e15597","title":"The impact of geography and center volume on access to care and outcomes in advanced hepatocellular carcinoma (HCC): A retrospective population based study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Population; Liver disease; Sorafenib; Liver cancer; Hepatitis B; Gastroenterology; Cancer; Hepatitis C; Surgery","score_opus":0.045606782079829426,"score_gpt":0.4379082440342711,"score_spread":0.39230146195444165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947849849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977069,0.00020246109,0.0000028381273,0.0008709908,0.0003007973,0.0006861351,0.00000953205,0.0000018391232,0.00021850115],"genre_scores_gemma":[0.9991706,0.000059626353,0.00011128733,0.0005652325,0.000063156374,0.0000036922547,0.000002510735,0.000008217921,0.000015670468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823856,0.00024567597,0.0010020247,0.00016889497,0.0002078971,0.00013693297],"domain_scores_gemma":[0.99811417,0.0007319574,0.00061862456,0.00016268119,0.00020735794,0.0001652211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087842013,0.00010553752,0.001054863,0.00017177552,0.00002749917,0.000010607754,0.000098328645,0.000110071276,0.000021874757],"category_scores_gemma":[0.00059494853,0.000059806163,0.00025387495,0.00010006085,0.000043952285,0.000107879256,0.000042570882,0.0004460639,9.371459e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006614474,0.00042444534,0.97174454,0.000016351156,0.00011984885,0.000046590245,0.00018511525,0.000055743294,0.000024949692,0.0000013081125,0.00003831598,0.02072831],"study_design_scores_gemma":[0.010840857,0.026742592,0.9614356,0.00004562868,0.000050549756,0.0000062841164,0.00032163752,0.0002852309,0.000005031711,0.000016050513,0.00019733218,0.00005316917],"about_ca_topic_score_codex":0.00036812722,"about_ca_topic_score_gemma":0.00023630074,"teacher_disagreement_score":0.026318146,"about_ca_system_score_codex":0.00023645512,"about_ca_system_score_gemma":0.00032269824,"threshold_uncertainty_score":0.24388245},"labels":[],"label_agreement":null},{"id":"W2954554512","doi":"10.3747/co.26.4289","title":"Screening for New Primary Cancers in Patients with Metastatic Breast Cancer: A Provincial Analysis of the Choosing Wisely Canada Recommendations","year":2019,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Cancer; Internal medicine; Sigmoidoscopy; Mammography; Oncology; Disease; Cancer screening; Colorectal cancer; Colonoscopy; Gynecology","score_opus":0.0476292123572345,"score_gpt":0.34293621015416553,"score_spread":0.29530699779693104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954554512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937614,0.00026777707,0.00032114956,0.002490763,0.00076985307,0.0014609899,0.0006785964,0.0000060456637,0.00024341012],"genre_scores_gemma":[0.99672073,0.000041787724,0.0012526625,0.0010807244,0.00008526406,0.00011158663,0.00052636507,0.000019543242,0.00016135354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890625,0.000059834438,0.000340392,0.00024271476,0.00021003064,0.00024074479],"domain_scores_gemma":[0.99916226,0.00011947051,0.0002753834,0.0002017033,0.00014719165,0.00009401947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010984871,0.00012688707,0.00055277045,0.00017647752,0.000049242557,0.0000043057653,0.00011655731,0.0000312909,0.00027667716],"category_scores_gemma":[0.000022990867,0.00008964288,0.00010012825,0.00062676345,0.00004134828,0.00007638116,0.00003342518,0.00018665496,1.7163445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009384711,0.0001088289,0.79237807,0.00012981777,0.0005555648,3.709225e-7,0.00022616905,0.00085005106,0.000019683539,0.000006277573,0.0035461301,0.20124055],"study_design_scores_gemma":[0.0065578697,0.00024602973,0.9597043,0.00017268317,0.0013803358,0.0000010320505,0.00011744254,0.002370935,0.00001581217,0.0000022771185,0.029315583,0.000115725474],"about_ca_topic_score_codex":0.20666254,"about_ca_topic_score_gemma":0.683617,"teacher_disagreement_score":0.4769545,"about_ca_system_score_codex":0.0026226586,"about_ca_system_score_gemma":0.009363257,"threshold_uncertainty_score":0.9962527},"labels":[],"label_agreement":null},{"id":"W2964600451","doi":"10.1200/jco.2007.25.18_suppl.2522","title":"Evaluation of Cockcroft-Gault (CG) and abbreviated modified diet in renal disease (MDRD) formulae in dosing of cancer drugs other than carboplatin","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Dosing; Renal function; Concordance; Carboplatin; Urology; Cancer; Creatinine; Internal medicine; Population; Chemotherapy; Cisplatin","score_opus":0.16108371904726282,"score_gpt":0.5006183896202324,"score_spread":0.3395346705729696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964600451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445456,0.0026726408,0.000052070605,0.0007948771,0.0002982328,0.00031164422,0.000011932075,0.000001920275,0.0014021217],"genre_scores_gemma":[0.99811864,0.00064966106,0.0003734241,0.000596791,0.00021930099,0.000003352373,0.00000338721,0.000011637629,0.000023809678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959854,0.00048003913,0.0025982596,0.0001566701,0.00058348646,0.0001961567],"domain_scores_gemma":[0.99625504,0.0012542193,0.0016055658,0.00012817016,0.0005217619,0.00023522544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010588019,0.0001133518,0.0011866685,0.00026092926,0.000011557915,0.000002160591,0.00008033883,0.00023570596,0.00013563177],"category_scores_gemma":[0.0022234647,0.0000869942,0.00019210025,0.00019050369,0.0001679691,0.000106836866,0.000025957943,0.0005791311,2.285652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030995768,0.000953292,0.66113937,0.00015666644,0.0002592906,0.000107337226,0.0010189732,0.0013999538,0.004521156,0.000028696953,0.000109094166,0.29931042],"study_design_scores_gemma":[0.020680727,0.002250526,0.9653017,0.00055466086,0.0004591847,0.0000071271297,0.00018107034,0.00908934,0.00053073314,0.00030475185,0.0005585025,0.00008170976],"about_ca_topic_score_codex":0.00074177375,"about_ca_topic_score_gemma":0.002723526,"teacher_disagreement_score":0.30416232,"about_ca_system_score_codex":0.0003732053,"about_ca_system_score_gemma":0.0024289954,"threshold_uncertainty_score":0.43089333},"labels":[],"label_agreement":null},{"id":"W2966549507","doi":"10.1200/jco.2007.25.18_suppl.19649","title":"Quality of life and survival in patients receiving chemotherapy for advanced non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Chemotherapy; Lung cancer; Internal medicine; Clinical endpoint; Cancer; Clinical trial; Surgery","score_opus":0.08999110794584979,"score_gpt":0.46830363874297365,"score_spread":0.37831253079712385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966549507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941757,0.0006199724,0.00085202866,0.0009701615,0.0011270114,0.00035611587,0.0000059524,0.00000225308,0.0018908267],"genre_scores_gemma":[0.9891772,0.0013744789,0.006004376,0.002862432,0.00047498473,0.0000029662167,0.0000020916582,0.000014726073,0.00008670354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967456,0.0001579849,0.0025121567,0.00016302975,0.00020089158,0.00022034338],"domain_scores_gemma":[0.9943062,0.0031654236,0.00174009,0.00011230583,0.0003945372,0.00028143867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055292547,0.00010614543,0.0014443038,0.0001000546,0.000017230723,0.0000021766539,0.00009432315,0.0002610265,0.000057818903],"category_scores_gemma":[0.0019620545,0.0000843064,0.00025585815,0.00008373819,0.00009143942,0.000079596204,0.000020819607,0.00051736395,1.6088855e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015669798,0.0006254547,0.772722,0.00016922678,0.00008675497,0.0000051963343,0.00019915318,0.000011505425,0.0006720636,0.0000029727973,0.00029926433,0.20953658],"study_design_scores_gemma":[0.036519703,0.003882711,0.9543672,0.000096880685,0.000043318243,9.689378e-7,0.00013861866,0.00007531181,0.00027943985,0.000017751638,0.004499127,0.00007892926],"about_ca_topic_score_codex":0.000056896442,"about_ca_topic_score_gemma":0.0004041121,"teacher_disagreement_score":0.20945765,"about_ca_system_score_codex":0.00018217092,"about_ca_system_score_gemma":0.0015547468,"threshold_uncertainty_score":0.3437915},"labels":[],"label_agreement":null},{"id":"W2970643758","doi":"10.1186/s12885-019-6074-6","title":"Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Malignancy; Internal medicine; Colorectal cancer; Oncology; Cancer; Surgical oncology; Stage (stratigraphy); Clinical trial","score_opus":0.12040691322005269,"score_gpt":0.4945583027634433,"score_spread":0.3741513895433906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970643758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464136,0.00068643887,0.0000053935864,0.00008322818,0.0011980991,0.0012433792,0.00026416153,0.000023679857,0.0018542397],"genre_scores_gemma":[0.99804384,0.00027105934,0.0003252555,0.00023316419,0.00062492595,0.00005688556,0.000013029523,0.00002467678,0.0004071887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976054,0.00012828606,0.0011721466,0.0004182495,0.00039373458,0.00028219353],"domain_scores_gemma":[0.99827415,0.00038883678,0.0005465531,0.00043848905,0.00021825341,0.00013372974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079530483,0.0002040377,0.0011450927,0.00008050557,0.00002546659,0.000007795306,0.00013677527,0.00014972853,0.0038675023],"category_scores_gemma":[0.00047570045,0.00015532164,0.00066411094,0.00016162502,0.00013365428,0.00008320921,0.00004987719,0.00024074852,0.000010040857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0640971,0.00014304848,0.9055593,0.0006431095,0.00015226704,0.0000019443926,0.00012513113,0.000043214503,0.015802143,0.000011940722,0.00062565994,0.012795135],"study_design_scores_gemma":[0.032626595,0.0026874256,0.95714873,0.0004894721,0.00013599609,0.0000021939004,0.000045554818,0.00027772,0.0057921666,0.0000059707277,0.00061695644,0.00017120407],"about_ca_topic_score_codex":0.0013699069,"about_ca_topic_score_gemma":0.0001350112,"teacher_disagreement_score":0.051589437,"about_ca_system_score_codex":0.00044404995,"about_ca_system_score_gemma":0.0016156363,"threshold_uncertainty_score":0.9970431},"labels":[],"label_agreement":null},{"id":"W2971880201","doi":"10.1200/jco.2019.37.15_suppl.11540","title":"Prognostic factors among older adults with advanced non-small cell lung cancer (NSCLC): A multisite cohort study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Cohort; Oncology; Population; Quality of life (healthcare); non-small cell lung cancer (NSCLC); Performance status; Proportional hazards model; Cancer","score_opus":0.02517728441168255,"score_gpt":0.3799202275765152,"score_spread":0.3547429431648327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971880201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234474,0.00048246092,0.00008092052,0.00025101166,0.0016775646,0.0027407093,0.000006747862,0.000017099966,0.0023987682],"genre_scores_gemma":[0.99587697,0.00041152618,0.0011691968,0.0010274661,0.00052088406,0.000040999636,0.000006498188,0.00004608231,0.00090037205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627066,0.00026817937,0.0020711021,0.00044784148,0.0005303719,0.00041187525],"domain_scores_gemma":[0.99484813,0.0016301374,0.0019630804,0.00034315174,0.00062779017,0.00058771094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013096081,0.0002897284,0.0021520979,0.00015291029,0.000046106998,0.00001307559,0.00024434188,0.00034486194,0.00080849195],"category_scores_gemma":[0.00047257726,0.00018401018,0.00042137297,0.00017842076,0.0001362085,0.0002364211,0.00006135541,0.0015535217,0.000016072505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063386275,0.002126016,0.9684227,0.00017751276,0.0007141996,0.00059338036,0.0010974854,0.00014133229,0.0000717019,2.0832644e-7,0.00051884825,0.019797962],"study_design_scores_gemma":[0.03016201,0.016292034,0.94836724,0.000645455,0.00096839457,0.000039282855,0.0013074981,0.0006191281,0.000064915024,3.9182814e-7,0.0013225953,0.00021103783],"about_ca_topic_score_codex":0.00019385235,"about_ca_topic_score_gemma":0.00056279846,"teacher_disagreement_score":0.023823382,"about_ca_system_score_codex":0.00032407587,"about_ca_system_score_gemma":0.0023218743,"threshold_uncertainty_score":0.885242},"labels":[],"label_agreement":null},{"id":"W2972996301","doi":"10.1200/jco.2019.37.15_suppl.11559","title":"Tobacco retail availability and tobacco cessation in lung and head and neck (HN) cancer survivors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Centre for Addiction and Mental Health; Ontario Institute for Cancer Research; Toronto General Hospital; University Health Network; Health Sciences North; Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Smoking cessation; Logistic regression; Christian ministry; Vendor; Demography; Cancer; Physical therapy; Internal medicine; Pathology","score_opus":0.08799793800231909,"score_gpt":0.431932958562066,"score_spread":0.3439350205597469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972996301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609614,0.003792957,0.0000031410416,0.006959834,0.0007059196,0.0002320635,0.0000038099427,0.0000039113916,0.0022022428],"genre_scores_gemma":[0.98819596,0.007612673,0.000517398,0.0030271816,0.00033009212,0.0000024186268,0.0000017153643,0.000008872259,0.00030368395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780416,0.00027581025,0.0013493111,0.00024339833,0.00015626871,0.00017102799],"domain_scores_gemma":[0.9974965,0.0013171993,0.00062670885,0.00013684145,0.00016129346,0.00026145994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002596561,0.000113188915,0.0011259379,0.00009293051,0.000022849083,0.000012980788,0.00005580102,0.0003043282,0.0004912328],"category_scores_gemma":[0.0009982144,0.000085813655,0.00008780434,0.00008449511,0.00018171103,0.00026138156,0.00005628073,0.0007559223,0.0000023236414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020242669,0.00012721757,0.82609385,0.00007254216,0.000056899196,0.000036471974,0.00016143233,0.0000033110784,0.00009166729,0.000019724574,0.0004481771,0.17086442],"study_design_scores_gemma":[0.007864025,0.0022318382,0.95453763,0.00011751739,0.00007925997,0.00007342499,0.00014504576,0.0002757875,0.000010957651,0.00008633156,0.034495894,0.000082290724],"about_ca_topic_score_codex":0.0006637695,"about_ca_topic_score_gemma":0.004843582,"teacher_disagreement_score":0.17078213,"about_ca_system_score_codex":0.00016909915,"about_ca_system_score_gemma":0.00084979687,"threshold_uncertainty_score":0.53786546},"labels":[],"label_agreement":null},{"id":"W2994671572","doi":"","title":"Mortalité - Taux ajusté de mortalité par tumeurs (poumon), Montréal : indice comparatif de mortalité par cancer du poumon, CLSC de Montréal, 1994-1998","year":2005,"lang":"fr","type":"article","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.00935458884116347,"score_gpt":0.20991131256279277,"score_spread":0.2005567237216293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994671572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77914655,0.20189983,0.0006359762,0.003968459,0.0019027833,0.0011424054,0.00076659035,0.00034111037,0.010196306],"genre_scores_gemma":[0.9488464,0.023005527,0.0019449402,0.00481023,0.003312658,0.00023363295,0.0005121903,0.00019543027,0.01713901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99092156,0.0007215509,0.0017714995,0.0018214298,0.0017623416,0.0030016212],"domain_scores_gemma":[0.99409974,0.00033699922,0.0010688651,0.001499821,0.00028922062,0.0027053417],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0011097896,0.0015712732,0.001820734,0.0006407901,0.0063640885,0.00021141209,0.0011931733,0.0011975577,0.00070655503],"category_scores_gemma":[0.00009430843,0.0018479358,0.0011405143,0.00093279773,0.0014673173,0.0015498409,0.0005113382,0.0018803823,0.00023102025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003205091,0.0017977356,0.73786896,0.00079538254,0.003963784,0.02307821,0.041876458,0.08914362,0.021192247,0.0054432848,0.055413455,0.016221758],"study_design_scores_gemma":[0.009161213,0.00051379297,0.44351813,0.0010896219,0.0041560917,0.0078918915,0.01792692,0.06388683,0.010345429,0.00025116993,0.43884823,0.002410687],"about_ca_topic_score_codex":0.5010892,"about_ca_topic_score_gemma":0.12299885,"teacher_disagreement_score":0.38343477,"about_ca_system_score_codex":0.025667492,"about_ca_system_score_gemma":0.009592928,"threshold_uncertainty_score":0.9997035},"labels":[],"label_agreement":null},{"id":"W2997322954","doi":"10.1002/9780471420194.tnmm04","title":"Principles of Cancer Staging","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"TNM staging system; Medicine; Cancer; Staging system; Oncology; Distant metastasis; Stage (stratigraphy); Lymph node; Cancer staging; Lymph node metastasis; Disease; Internal medicine; AJCC staging system; Metastasis; Biology","score_opus":0.061390568895057084,"score_gpt":0.37570265940701464,"score_spread":0.3143120905119576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997322954","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009002275,0.0066347998,0.0000103989,0.00037272435,0.00041928588,0.00032445422,0.006502353,0.00009725901,0.98473847],"genre_scores_gemma":[0.00022753626,0.0036744745,0.0017781127,0.00038518014,0.0010553009,0.000013064872,0.0013111754,0.00024204553,0.9913131],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992212,0.0000088210145,0.00018757631,0.00022540637,0.00018950664,0.00016748063],"domain_scores_gemma":[0.9988927,0.000014625859,0.00036514102,0.00060591835,0.000037637223,0.00008396254],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004339789,0.00018186725,0.0005417215,0.00014526332,0.000021811555,0.000004536589,0.0001587995,0.00016047512,0.033172835],"category_scores_gemma":[0.00004248964,0.00015229078,0.00010495499,0.000029076251,0.00010118181,0.000017380618,0.000055938242,0.00021262738,0.000018349805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009786977,0.00012400621,0.005743518,0.0013744946,0.00044522286,0.00005433013,0.00007155105,0.0000019920562,0.0005628483,0.000048632435,0.89134806,0.10012748],"study_design_scores_gemma":[0.00088516326,0.000044438646,0.0039078533,0.0016303945,0.00013281804,0.0000022953716,0.000010089913,0.000060658018,0.00017436696,0.0000010149525,0.9930136,0.0001373122],"about_ca_topic_score_codex":0.0015266864,"about_ca_topic_score_gemma":0.0021091392,"teacher_disagreement_score":0.10166554,"about_ca_system_score_codex":0.000070613845,"about_ca_system_score_gemma":0.0005258856,"threshold_uncertainty_score":0.967711},"labels":[],"label_agreement":null},{"id":"W3004691185","doi":"10.1200/jco.2020.38.4_suppl.34","title":"Outcomes of elderly patients with resectable liver metastases from colorectal cancer (CRLM): Single center experience.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Colorectal cancer; Single Center; Internal medicine; Chemotherapy; Overall survival; Cancer; Surgery; Gastroenterology","score_opus":0.13731152393570564,"score_gpt":0.4206249374435166,"score_spread":0.2833134135078109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004691185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949632,0.0004543834,0.000045178356,0.0025930826,0.0006575034,0.00019003688,0.00010072613,0.0000064085493,0.000989426],"genre_scores_gemma":[0.9911686,0.0002583842,0.0027356404,0.005316048,0.00044001816,0.0000043585273,0.000015268264,0.00001599096,0.000045681707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732405,0.00023104773,0.0015786776,0.00021053273,0.00045059217,0.00020510364],"domain_scores_gemma":[0.9964927,0.0011457385,0.0013411212,0.00011627453,0.00048717187,0.00041699648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031954612,0.0001443716,0.0016094039,0.00005439337,0.000026980431,0.0000065548247,0.00017738839,0.00017259382,0.0021153989],"category_scores_gemma":[0.0012418596,0.00008899599,0.000344351,0.00011565579,0.0002545859,0.00021259423,0.000053331547,0.0005663856,0.0000053637323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148903355,0.0015674083,0.93272454,0.000023777753,0.00077761285,0.00019819876,0.00078676903,0.000011543466,0.0006312675,0.0000022548465,0.004556867,0.043829408],"study_design_scores_gemma":[0.018888328,0.030494021,0.8869169,0.000079602,0.00041951062,0.000012096882,0.0003709035,0.00004493131,0.0016729475,0.000006861024,0.060972404,0.00012149042],"about_ca_topic_score_codex":0.00022226498,"about_ca_topic_score_gemma":0.00018426812,"teacher_disagreement_score":0.056415536,"about_ca_system_score_codex":0.00012475358,"about_ca_system_score_gemma":0.0010885851,"threshold_uncertainty_score":0.9987968},"labels":[],"label_agreement":null},{"id":"W3004915050","doi":"10.1200/jco.2020.38.4_suppl.489","title":"Impact of population center (PC) size on access to care in advanced hepatocellular carcinoma (HCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Population; Gastroenterology; Hepatitis B","score_opus":0.1432439840675946,"score_gpt":0.4894312652430605,"score_spread":0.34618728117546593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004915050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218684,0.00019525981,0.0000142291365,0.005404037,0.00047753804,0.00031087076,0.000012793153,0.0000039862384,0.0013944135],"genre_scores_gemma":[0.9908401,0.00011020708,0.00062501023,0.0078136595,0.0005737498,0.0000019730824,0.000010027831,0.000014096832,0.000011175067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973491,0.00022749827,0.0017935298,0.00018577526,0.0002655243,0.00017856406],"domain_scores_gemma":[0.99745566,0.0008000188,0.00087933143,0.00014591074,0.00025498343,0.000464108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885969,0.000120954435,0.0013588263,0.00010579098,0.000012604149,0.000004872053,0.00018661912,0.00020907081,0.00031304758],"category_scores_gemma":[0.0026805247,0.00008805073,0.00052262604,0.00018129226,0.000033581073,0.00014894517,0.00005183404,0.000684785,0.0000061460646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017056758,0.00034637554,0.88273275,0.0000566675,0.00007275858,0.0003560559,0.00034692878,0.00045438128,0.0004914202,0.0000025072766,0.0010795675,0.09700386],"study_design_scores_gemma":[0.010325791,0.024034197,0.9574527,0.00009198973,0.000055057488,0.000021493639,0.00009541237,0.00028022024,0.00016031617,0.000014872685,0.007394838,0.00007311653],"about_ca_topic_score_codex":0.00009575038,"about_ca_topic_score_gemma":0.000056417317,"teacher_disagreement_score":0.09693074,"about_ca_system_score_codex":0.0003985371,"about_ca_system_score_gemma":0.0009994062,"threshold_uncertainty_score":0.35906044},"labels":[],"label_agreement":null},{"id":"W3004969922","doi":"10.1200/jco.2020.38.4_suppl.284","title":"Access to care and outcomes for noncurative esophagogastric cancer: A population-based geographic study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; University of Manitoba; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Poisson regression; Cancer registry; Population; Residence; Cancer; Socioeconomic status; Internal medicine; Demography; Family medicine; Environmental health","score_opus":0.181791988006145,"score_gpt":0.5220059450616065,"score_spread":0.3402139570554615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004969922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975093,0.0005595991,0.0003275697,0.022375217,0.0006152297,0.0009000523,0.00002729175,0.000008105395,0.00009392669],"genre_scores_gemma":[0.9713142,0.000098437624,0.002340495,0.0254717,0.00071786443,0.000030201603,0.0000056104227,0.000012265136,0.000009227334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798876,0.00012697767,0.0013036566,0.00020783626,0.00022177119,0.00015102737],"domain_scores_gemma":[0.99641293,0.0017708488,0.00075934164,0.00008748684,0.0004330511,0.00053636485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005274286,0.000121293386,0.0012949699,0.00013827684,0.000055824385,0.000014964946,0.0001483584,0.00013230085,0.00010504012],"category_scores_gemma":[0.0022318983,0.00008535266,0.0003360558,0.0001938504,0.00004248796,0.00012215765,0.00004149034,0.00041540133,8.5650845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038644029,0.00023535447,0.8636811,0.000055114488,0.0002531892,0.000069879134,0.0005272488,0.00016986537,0.0000040683917,0.000003669429,0.00076782785,0.1303683],"study_design_scores_gemma":[0.012694551,0.021865115,0.95531285,0.000026844158,0.00041589508,0.000005099281,0.0007267003,0.0002541824,0.0000060583,0.000014340857,0.008603836,0.000074550146],"about_ca_topic_score_codex":0.00012131645,"about_ca_topic_score_gemma":0.00031779526,"teacher_disagreement_score":0.13029377,"about_ca_system_score_codex":0.00011667266,"about_ca_system_score_gemma":0.0014975828,"threshold_uncertainty_score":0.34805804},"labels":[],"label_agreement":null},{"id":"W3005126119","doi":"10.1200/jco.2020.38.4_suppl.506","title":"Determination of quality of care for patients with hepatocellular carcinoma in Nova Scotia.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre; Dalhousie University; Université Laval","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Referral; Malignancy; Cancer; Internal medicine; Sorafenib; Liver cancer; Retrospective cohort study; Family medicine","score_opus":0.15456249670780797,"score_gpt":0.4494805019600084,"score_spread":0.2949180052522004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005126119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974387,0.00015565283,0.00042431368,0.0010931009,0.00022372449,0.0003166059,0.000016744756,0.0000011310135,0.00033002434],"genre_scores_gemma":[0.992753,0.000017521066,0.0060103545,0.0010337589,0.00016247264,8.312135e-7,0.000011246566,0.0000074061136,0.0000033775632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973596,0.0001803774,0.0020187094,0.00010908018,0.0002388103,0.00009344124],"domain_scores_gemma":[0.9962823,0.0009688505,0.0017261736,0.000088659865,0.0007903561,0.00014367969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085798395,0.00006963423,0.0012658427,0.00006556842,0.0000057151187,8.3438863e-7,0.000088422465,0.00016321764,0.000054899454],"category_scores_gemma":[0.0020101508,0.00005017483,0.00024995417,0.00009184228,0.00010743788,0.0000674809,0.000017027223,0.00029939285,4.4945585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0133518055,0.00048525207,0.93868154,0.00047735425,0.000043406344,0.000024348865,0.00052434707,0.0000070507162,0.00019855038,0.000011930221,0.00007109832,0.04612329],"study_design_scores_gemma":[0.018549584,0.026532004,0.9516774,0.00008445827,0.000118191,0.0000028692232,0.0002816841,0.00044332625,0.0006632061,0.000015604644,0.0015803163,0.000051390172],"about_ca_topic_score_codex":0.00006453414,"about_ca_topic_score_gemma":0.00016384311,"teacher_disagreement_score":0.0460719,"about_ca_system_score_codex":0.00009389455,"about_ca_system_score_gemma":0.0012464662,"threshold_uncertainty_score":0.24064836},"labels":[],"label_agreement":null},{"id":"W3007448899","doi":"10.1200/jco.2020.38.6_suppl.317","title":"Risk of secondary sarcoma after abdominopelvic cancer treatment: Results from a contemporary cohort.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sarcoma; Hazard ratio; Cohort; Internal medicine; Cancer; Population; Perioperative; Retrospective cohort study; Radical surgery; Surgery; Oncology; Pathology; Confidence interval","score_opus":0.13325043050915222,"score_gpt":0.42336786243798596,"score_spread":0.29011743192883377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007448899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692374,0.0063849483,0.000023026412,0.011744606,0.0009872201,0.00032391722,0.00069950055,0.000009878338,0.010589486],"genre_scores_gemma":[0.9799599,0.005785607,0.0014499997,0.010390107,0.0021329639,0.000008716281,0.000029041474,0.000022980857,0.00022069666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949704,0.00060569454,0.0035848357,0.00031917795,0.000321596,0.00019830762],"domain_scores_gemma":[0.9926296,0.0030159547,0.0030943698,0.00026624688,0.0003203172,0.0006735074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012241103,0.00020483046,0.0025110191,0.000076808974,0.000024974865,0.000005697178,0.000174891,0.00039098435,0.0015953472],"category_scores_gemma":[0.0021101504,0.00013978695,0.0008840332,0.00011459296,0.00027711998,0.00016156666,0.000049382325,0.001084413,0.000022627273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10297663,0.0009564089,0.57807994,0.000039446855,0.0030901986,0.0019739782,0.00094366947,0.000012016513,0.00042261113,0.0000019282456,0.022778882,0.2887243],"study_design_scores_gemma":[0.036849525,0.014595358,0.6769392,0.000090728216,0.0009965905,0.00003467386,0.00014039295,0.00016872727,0.00043332172,0.000046785506,0.2695891,0.00011561762],"about_ca_topic_score_codex":0.0009033083,"about_ca_topic_score_gemma":0.00017746285,"teacher_disagreement_score":0.2886087,"about_ca_system_score_codex":0.00022737037,"about_ca_system_score_gemma":0.0058187214,"threshold_uncertainty_score":0.9998174},"labels":[],"label_agreement":null},{"id":"W3010849044","doi":"10.1200/jco.2013.31.15_suppl.9593","title":"Utility of standardized letters in assisting primary care providers (PCPs) with the care of cancer survivors (CS).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Family medicine; Logistic regression; Survivorship curve; Graduation (instrument); Primary care; Cancer; Internal medicine","score_opus":0.06666981473719337,"score_gpt":0.41312553797226714,"score_spread":0.3464557232350738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010849044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868319,0.0023011493,0.000060131148,0.0059661935,0.00042899675,0.0005033206,0.000021325382,0.0000039506513,0.0038830054],"genre_scores_gemma":[0.9953067,0.00031594696,0.0015692305,0.0025281585,0.00022510077,0.000010176506,0.0000049571554,0.000015163156,0.00002461149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964356,0.00057164184,0.0020685236,0.00018775884,0.0005069757,0.00022953512],"domain_scores_gemma":[0.99462324,0.0018733668,0.0020754985,0.0002543473,0.0010050315,0.00016852382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016228362,0.00014619798,0.0017112292,0.00010502154,0.000032018732,0.0000055046244,0.00021760513,0.00020346725,0.0002789719],"category_scores_gemma":[0.0007984094,0.000081203456,0.00037138554,0.00017352223,0.00057003536,0.00015149647,0.00004828772,0.0009762372,5.4495104e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005969202,0.000174433,0.75264215,0.0005673721,0.00032703677,0.000067620764,0.0020597214,0.000094843264,0.0012305871,0.0000021145947,0.0014317934,0.23543312],"study_design_scores_gemma":[0.009528135,0.0029507065,0.96765286,0.0003573827,0.00029454456,0.000018010322,0.0064120153,0.00004004508,0.0004180864,0.000004110689,0.012233224,0.00009088633],"about_ca_topic_score_codex":0.0027149788,"about_ca_topic_score_gemma":0.0056797583,"teacher_disagreement_score":0.23534222,"about_ca_system_score_codex":0.0003359453,"about_ca_system_score_gemma":0.0047334936,"threshold_uncertainty_score":0.8397015},"labels":[],"label_agreement":null},{"id":"W3010959823","doi":"10.1200/jco.2012.30.15_suppl.9078","title":"Effect of aprepitant on adherence to high-dose cisplatin-based chemotherapy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Aprepitant; Medicine; Nausea; Vomiting; Cisplatin; Chemotherapy-induced nausea and vomiting; Oncology; Chemotherapy; Internal medicine; Antiemetic","score_opus":0.09986393440077473,"score_gpt":0.4832723019448377,"score_spread":0.383408367544063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010959823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169147,0.00017664535,0.00013710487,0.0025893496,0.0017310283,0.0002838521,0.0000038027774,0.000006218821,0.0033805477],"genre_scores_gemma":[0.98591506,0.00006808298,0.002855139,0.009813553,0.0011657515,0.0000040932464,0.0000015183359,0.00001554919,0.0001612465],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970573,0.00050526665,0.0017053438,0.00013249338,0.00035106103,0.000248515],"domain_scores_gemma":[0.9927192,0.005126551,0.0011771927,0.00023876544,0.00017967886,0.00055866654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004696511,0.00013804347,0.0015522239,0.00011870944,0.000017810431,0.000002261448,0.00015117765,0.0002637242,0.0008814096],"category_scores_gemma":[0.003227276,0.00008824543,0.00046063756,0.0001142682,0.00010658518,0.00006623072,0.000018208255,0.0006907789,0.000044473407],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049701568,0.00157445,0.08729838,0.00012454385,0.00027779792,0.000107771484,0.00013849465,0.000077453005,0.00560657,0.000048954935,0.0071302312,0.8479138],"study_design_scores_gemma":[0.042771325,0.27159423,0.5588315,0.00042848632,0.00053681503,0.0001170627,0.000031429634,0.00019139849,0.032892767,0.00003459587,0.09234219,0.00022817939],"about_ca_topic_score_codex":0.000017288081,"about_ca_topic_score_gemma":0.0000035161004,"teacher_disagreement_score":0.8476856,"about_ca_system_score_codex":0.00015552132,"about_ca_system_score_gemma":0.00093656126,"threshold_uncertainty_score":0.96508175},"labels":[],"label_agreement":null},{"id":"W3018872551","doi":"10.1093/jjco/hyaa057","title":"Age-specific cancer incidence rate in the world","year":2020,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer incidence; Cancer; Incidence (geometry); Oncology; Internal medicine","score_opus":0.21877365168866897,"score_gpt":0.47589474800537873,"score_spread":0.25712109631670976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018872551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9119439,0.000430504,0.0000152335815,0.08050783,0.0005038238,0.00015810753,7.5515374e-7,0.000005690322,0.006434118],"genre_scores_gemma":[0.9317558,0.0008911051,0.00045759854,0.06515464,0.001539171,0.00000629703,7.716392e-7,0.0000078880785,0.00018676923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970968,0.00068193494,0.0015698157,0.00017016506,0.0002745945,0.0002067173],"domain_scores_gemma":[0.9959454,0.0028634695,0.00059022236,0.00015592607,0.00015190397,0.0002930751],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031406893,0.00010394676,0.000877434,0.000082504965,0.00003285483,0.0000108976565,0.00031812713,0.000105756124,0.0010126004],"category_scores_gemma":[0.0014228459,0.000059155864,0.00027475812,0.00040191622,0.00020940801,0.00014334923,0.000036906527,0.0012315812,0.000033402674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024350783,0.0014034811,0.55921835,0.00009662831,0.0003190962,0.0175551,0.014750191,0.00070547115,0.013935049,0.00033603978,0.061102208,0.3062276],"study_design_scores_gemma":[0.0058998126,0.0023315244,0.59119046,0.00004421954,0.000052581614,0.00019308973,0.000992945,0.00020913228,0.00008159535,0.00007792194,0.39884955,0.000077169934],"about_ca_topic_score_codex":0.000026233023,"about_ca_topic_score_gemma":0.00035482136,"teacher_disagreement_score":0.33774734,"about_ca_system_score_codex":0.0001173411,"about_ca_system_score_gemma":0.00075102027,"threshold_uncertainty_score":0.99990064},"labels":[],"label_agreement":null},{"id":"W3021379838","doi":"","title":"[Hepatocellular carcinoma : updated management guidelines].","year":2018,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Gynecology; Context (archaeology); Liver cancer; Internal medicine","score_opus":0.05803738328846745,"score_gpt":0.2700661434503321,"score_spread":0.21202876016186464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021379838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82891893,0.0003115474,0.00026403353,0.0023915519,0.0005801008,0.0013002673,0.000008786716,0.00013930636,0.16608545],"genre_scores_gemma":[0.97512144,0.000037333124,0.0011743656,0.005783251,0.0006195409,0.00048825797,0.00008178967,0.000024716603,0.016669292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987758,0.000017098615,0.00028832414,0.00029555583,0.00023011185,0.00039314615],"domain_scores_gemma":[0.9991354,0.0000057373536,0.000049303453,0.00042482783,0.00016732984,0.0002173982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002371832,0.00013351893,0.00020125114,0.00011199393,0.000065021784,0.000015551668,0.000115621886,0.000056317636,0.0008860293],"category_scores_gemma":[0.000023537148,0.00011603469,0.000078205856,0.00019947802,0.00008015219,0.00006718977,0.0000672538,0.000085495994,0.00018097345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044588352,0.000081694525,0.16759975,0.000103374754,0.00023477507,0.00034875388,0.00009266197,5.416116e-7,0.00023618106,0.0003805146,0.27555925,0.5549166],"study_design_scores_gemma":[0.0016121835,0.000041043426,0.4574001,0.0000056895583,0.000088651315,0.000024799441,0.000036028312,0.0006482276,0.0026602114,0.000038260587,0.5373235,0.00012132677],"about_ca_topic_score_codex":0.000044352433,"about_ca_topic_score_gemma":0.0000038816866,"teacher_disagreement_score":0.5547953,"about_ca_system_score_codex":0.00012962695,"about_ca_system_score_gemma":0.000037921047,"threshold_uncertainty_score":0.9701399},"labels":[],"label_agreement":null},{"id":"W3025043271","doi":"","title":"The Impact of Multiple Primary Rules on Cancer Statistics in Canada, 1992 to 2012.","year":2018,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; International agency; Breast cancer; Medicine; Demography; Stage (stratigraphy); Lung cancer; Incidence (geometry); Cancer registry; Confidence interval; Standardized rate; Oncology; Internal medicine; Mathematics; Biology","score_opus":0.02168525808767383,"score_gpt":0.2711131191955253,"score_spread":0.24942786110785145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025043271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094266,0.0003880912,0.000029695968,0.00084315304,0.00028176594,0.00092841656,0.0008243454,0.000008107661,0.0057537444],"genre_scores_gemma":[0.9969418,0.000120062614,0.00017226241,0.0013689237,0.00017903083,0.00039852582,0.000036157453,0.000016974136,0.000766271],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99889594,0.000031534437,0.00025287256,0.00016594573,0.00024947664,0.00040421772],"domain_scores_gemma":[0.99913955,0.00024566188,0.00007093447,0.0002758155,0.000074565905,0.00019344801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018104845,0.000117016105,0.00024463917,0.000064336775,0.000050885123,0.000007671955,0.0001193795,0.000029271307,0.00011775349],"category_scores_gemma":[0.0001704579,0.000075111966,0.00004047915,0.00012268769,0.00007027583,0.00003959204,0.000030218778,0.00012511606,0.0000058713913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015322845,0.000054027783,0.24964343,0.000044131084,0.00011320565,0.000018380491,0.00021701612,0.00011081657,0.0002386002,0.000026828595,0.1882332,0.5597681],"study_design_scores_gemma":[0.0009954827,0.00010631876,0.97971004,0.000018767976,0.000012155901,0.0000015628519,0.000028991017,0.00020068936,0.00058561726,0.000015488507,0.018240543,0.000084347004],"about_ca_topic_score_codex":0.89557225,"about_ca_topic_score_gemma":0.9520459,"teacher_disagreement_score":0.7300666,"about_ca_system_score_codex":0.0018478483,"about_ca_system_score_gemma":0.0018612524,"threshold_uncertainty_score":0.4832059},"labels":[],"label_agreement":null},{"id":"W3025847027","doi":"10.1016/j.canep.2020.101721","title":"Rare cancers in Canada, 2006–2016: A population-based surveillance report and comparison of different methods for classifying rare cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Social Sciences and Humanities Research Council of Canada; Brain Tumour Foundation of Canada","keywords":"Medicine; Concordance; Cancer registry; Cancer; Confidence interval; Incidence (geometry); Population; Internal medicine; Demography; Environmental health","score_opus":0.13555911871595233,"score_gpt":0.43007648824504485,"score_spread":0.2945173695290925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025847027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92422974,0.03153957,0.015942419,0.023829589,0.0015422449,0.0019130938,0.00073899503,0.000053617285,0.00021075679],"genre_scores_gemma":[0.98304725,0.00041286994,0.0071279206,0.008352038,0.00022603812,0.00034146925,0.00040154273,0.00003718634,0.000053672036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968792,0.0004716662,0.0012904466,0.000688671,0.0001243157,0.00054566836],"domain_scores_gemma":[0.99631464,0.0021908374,0.00070602994,0.00031067035,0.000133151,0.00034468388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006478362,0.00029740902,0.0019054319,0.00009363915,0.000068016416,0.0000028249676,0.00012926821,0.00016501508,0.00017041616],"category_scores_gemma":[0.0015671471,0.0002653763,0.00013517108,0.00019408941,0.000113735725,0.000047341793,0.000034343622,0.00034932292,1.4921635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000899994,0.000008066382,0.95492035,0.0007780032,0.00009643079,0.00001966924,0.00016590442,0.009619572,0.0004958613,0.00002139979,0.010238453,0.022736307],"study_design_scores_gemma":[0.003400164,0.00024689623,0.8512993,0.00026023653,0.00008364537,0.000009964881,0.00030601333,0.12387838,0.0006867649,0.000053410582,0.019436507,0.00033870578],"about_ca_topic_score_codex":0.7966209,"about_ca_topic_score_gemma":0.8503066,"teacher_disagreement_score":0.11425881,"about_ca_system_score_codex":0.0038815034,"about_ca_system_score_gemma":0.006142657,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W3030975652","doi":"10.1200/jco.2020.38.15_suppl.e21092","title":"Role of the total mutation burden (TMB) and tumor-infiltrating lymphocytes (TILs) on the development of second primary cancer after complete resection of non-small cell lung cancer (NSCLC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Lung cancer; Oncology; Internal medicine; Tumor-infiltrating lymphocytes; Stage (stratigraphy); non-small cell lung cancer (NSCLC); Proportional hazards model; Cancer; Confidence interval; Immunotherapy","score_opus":0.057446507698336244,"score_gpt":0.36440029034867566,"score_spread":0.3069537826503394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030975652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936819,0.0013495822,0.000031368443,0.001961373,0.00033183664,0.0003306957,0.00002195597,0.0000019650533,0.0022892966],"genre_scores_gemma":[0.9960102,0.0001728228,0.0011848096,0.0020811893,0.00046936815,0.000014392006,0.0000016488356,0.000012439166,0.00005313614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99725205,0.00025355394,0.0018760838,0.00015725284,0.00032039292,0.00014065558],"domain_scores_gemma":[0.99608546,0.0012753862,0.00205021,0.00012202548,0.0003412687,0.00012562545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010778676,0.00012440272,0.00088999677,0.000050608876,0.000046797766,0.0000042152956,0.0001410289,0.00012818447,0.00040084895],"category_scores_gemma":[0.00036970302,0.000072198985,0.00023169052,0.000117641124,0.00019706681,0.00006807077,0.000069965114,0.0005373027,4.211808e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029025957,0.0006394101,0.21455911,0.0022395423,0.001476004,0.00005936521,0.018664587,0.002148866,0.5553478,0.000016602116,0.0015973862,0.17422539],"study_design_scores_gemma":[0.007312553,0.004052978,0.9234913,0.0007050344,0.00036006822,0.000045556986,0.0015986577,0.0039602844,0.05546598,0.000016296883,0.0028687457,0.0001225675],"about_ca_topic_score_codex":0.000094829215,"about_ca_topic_score_gemma":0.00022923957,"teacher_disagreement_score":0.70893216,"about_ca_system_score_codex":0.0002493875,"about_ca_system_score_gemma":0.0037956873,"threshold_uncertainty_score":0.67333865},"labels":[],"label_agreement":null},{"id":"W3031874598","doi":"10.1200/jco.2020.38.15_suppl.10551","title":"Lung cancer as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lung cancer; Cumulative incidence; Cancer; Proportional hazards model; Internal medicine; Hazard ratio; Incidence (geometry); Univariate analysis; Epidemiology; Radiation therapy; Confidence interval; Multivariate analysis; Cohort","score_opus":0.14471593337249153,"score_gpt":0.4897102574731136,"score_spread":0.34499432410062203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031874598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87686557,0.008027239,0.000023049122,0.10952811,0.0029998308,0.0006253097,0.000027622269,0.000016257029,0.0018870356],"genre_scores_gemma":[0.9098663,0.004652029,0.00019100044,0.07845955,0.006400328,0.000034902147,0.0000066080397,0.000031457326,0.00035782598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950937,0.00066355366,0.0029110692,0.0003821977,0.0006532877,0.0002962176],"domain_scores_gemma":[0.9940771,0.0022514942,0.0022023586,0.00033746634,0.00043195442,0.0006996428],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022082627,0.0002139948,0.0018444597,0.00003791815,0.000083510386,0.000019167259,0.00036239973,0.00027479813,0.0033608575],"category_scores_gemma":[0.0035671587,0.00012519993,0.0006364615,0.00020371922,0.00015789997,0.0001518864,0.00010785004,0.0018988957,0.000019196563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053031566,0.0016627802,0.8040518,0.00002002772,0.00278108,0.0078058355,0.0028426552,0.00009511767,0.000108542896,0.0000037871987,0.105351776,0.06997343],"study_design_scores_gemma":[0.009910149,0.00458041,0.63248783,0.00007069384,0.0012352933,0.00034835376,0.000767835,0.0001856432,0.000027420043,0.000014344334,0.35024896,0.00012302524],"about_ca_topic_score_codex":0.0036295338,"about_ca_topic_score_gemma":0.0027794,"teacher_disagreement_score":0.2448972,"about_ca_system_score_codex":0.0003478629,"about_ca_system_score_gemma":0.009017632,"threshold_uncertainty_score":0.9975502},"labels":[],"label_agreement":null},{"id":"W3032259300","doi":"10.1093/sleep/zsaa056.1049","title":"1053 Sleep Duration And Timing Associated With History Of Breast Prostate And Skin Cancer: Data From A Nationally-representative Sample","year":2020,"lang":"en","type":"article","venue":"SLEEP","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Bedtime; Medicine; Prostate cancer; Breast cancer; Cancer; Population; Internal medicine; Family history; Oncology; Demography; Gynecology","score_opus":0.047977001942416296,"score_gpt":0.28056107009415693,"score_spread":0.23258406815174062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032259300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088997,0.001624253,0.00051720097,0.002972023,0.00007031751,0.00044572057,0.0026282126,0.000031038166,0.0008212927],"genre_scores_gemma":[0.9950492,0.00014145268,0.0009916958,0.0010321356,0.00008544135,0.000016527954,0.0025179742,0.000014115798,0.00015150638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991641,0.000036763042,0.00019731603,0.00030323613,0.00020220135,0.000096397634],"domain_scores_gemma":[0.99937314,0.00012782787,0.00016016698,0.00014551418,0.00009571614,0.00009763093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079464284,0.00009543617,0.00021237144,0.000032821034,0.000031453343,0.000007910442,0.000058963175,0.000031349544,0.00029853667],"category_scores_gemma":[0.000139052,0.00008411124,0.000012440654,0.00007236969,0.00010236676,0.00022799478,0.00006901176,0.000099758014,8.3461117e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069961757,0.00034015815,0.67220074,0.0006080474,0.002621968,0.00009861133,0.060664076,0.0003021727,0.03805793,0.00011647483,0.037314765,0.18067889],"study_design_scores_gemma":[0.008275451,0.00038325612,0.86148596,0.0001848222,0.00052579405,0.000013339026,0.0011080949,0.11776571,0.0010134735,0.00005245882,0.008868908,0.00032271876],"about_ca_topic_score_codex":0.0021455507,"about_ca_topic_score_gemma":0.00079099287,"teacher_disagreement_score":0.18928523,"about_ca_system_score_codex":0.0001941446,"about_ca_system_score_gemma":0.00020598831,"threshold_uncertainty_score":0.3429957},"labels":[],"label_agreement":null},{"id":"W3034379023","doi":"","title":"PREVALENCE AND INCIDENCE OF HORMONAL-RELATED CANCERS (HRCs) IN RURAL SASKATCHEWAN: THE SASKATCHEWAN RURAL HEALTH STUDY","year":2020,"lang":"en","type":"dissertation","venue":"University Library (University of Saskatchewan)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Geography; Medicine; Socioeconomics; Demography; Environmental health; Sociology; Physics","score_opus":0.007200144022946621,"score_gpt":0.20824866436573983,"score_spread":0.20104852034279322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034379023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232256,0.0017021861,0.0000073898127,0.001983932,0.00021057623,0.001845562,0.00034514416,0.00010344774,0.0014792136],"genre_scores_gemma":[0.97473216,0.001707282,0.00045646407,0.00026729752,0.00003793871,5.475015e-7,0.0006815895,0.000052673004,0.02206407],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9970279,0.00038310772,0.00059825036,0.000732903,0.00072749174,0.00053037447],"domain_scores_gemma":[0.9975583,0.00020258475,0.0009940492,0.0006646547,0.00013566375,0.00044476753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027391256,0.000576758,0.0014660773,0.00059016503,0.00034574815,0.000021125721,0.0009735821,0.00043000784,0.0007277231],"category_scores_gemma":[0.000015622,0.000636158,0.00037165816,0.0011965119,0.0006008996,0.0012486923,0.00038008764,0.0012461818,0.000008224823],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008309731,0.0005315738,0.27185857,0.003548244,0.0011075413,0.00066910754,0.6975163,0.00006227047,0.0008561886,0.000024511322,0.0018470652,0.013668866],"study_design_scores_gemma":[0.003621902,0.0010483238,0.26079562,0.0009088641,0.00041741767,0.000012239868,0.73202956,0.00015273686,0.00013540678,0.000029741335,0.00045550632,0.00039263946],"about_ca_topic_score_codex":0.044151396,"about_ca_topic_score_gemma":0.06491588,"teacher_disagreement_score":0.034513246,"about_ca_system_score_codex":0.00057028094,"about_ca_system_score_gemma":0.007074607,"threshold_uncertainty_score":0.999609},"labels":[],"label_agreement":null},{"id":"W3035865887","doi":"10.1016/j.canep.2020.101760","title":"Epidemiology of liver metastases","year":2020,"lang":"es","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Penn State Hershey Cancer Institute; International Association for the Study of Lung Cancer; National Institutes of Health; American Cancer Society","keywords":"Medicine; Metastasis; Epidemiology; Internal medicine; Oncology; Incidence (geometry); Prostate; Cancer; Gastroenterology; Population; Breast cancer","score_opus":0.19877578710040247,"score_gpt":0.4049519550317286,"score_spread":0.20617616793132612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035865887","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09749539,0.77614,0.00506988,0.11212452,0.002908265,0.0013490809,0.0020702716,0.00015331943,0.0026892954],"genre_scores_gemma":[0.78910285,0.06808261,0.0044062557,0.13401309,0.0034400637,0.00013099445,0.0002866599,0.00009296074,0.00044450388],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.991866,0.0032300595,0.0023962567,0.0011763258,0.00013207595,0.0011992936],"domain_scores_gemma":[0.98729235,0.009580677,0.0013261468,0.0006844719,0.00022528059,0.00089109706],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027186868,0.00057438377,0.004186155,0.00014959427,0.000084466265,0.0000011287912,0.00047749357,0.00061993516,0.009529464],"category_scores_gemma":[0.012484555,0.0004991987,0.0007274374,0.00033309628,0.0013072233,0.00012561325,0.00023882517,0.00091082527,0.00037786266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001559252,0.000086043496,0.83549273,0.0028622968,0.0014284527,0.000079628364,0.00048925076,0.00089212874,0.0009628322,0.014391563,0.108908206,0.03284762],"study_design_scores_gemma":[0.003441418,0.0020939137,0.41811743,0.0005483007,0.0016051996,0.00003361947,0.00017743795,0.010009974,0.0012543873,0.0007777233,0.5612551,0.00068549055],"about_ca_topic_score_codex":0.0019736765,"about_ca_topic_score_gemma":0.000038296726,"teacher_disagreement_score":0.70805734,"about_ca_system_score_codex":0.00024586573,"about_ca_system_score_gemma":0.00097315124,"threshold_uncertainty_score":0.99974597},"labels":[],"label_agreement":null},{"id":"W3049075803","doi":"10.1200/jco.2009.27.15_suppl.e20646","title":"A systematic review of the impact of comorbidity on chemotherapy utilization and outcomes in solid tumors","year":2009,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Comorbidity; Medicine; Internal medicine; Checklist; MEDLINE; Retrospective cohort study; Tolerability; Cancer; Oncology; Adverse effect","score_opus":0.25744584290701306,"score_gpt":0.5728542867962853,"score_spread":0.3154084438892722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049075803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002161172,0.99541366,0.0000018245079,0.00045512748,0.00022211314,0.001288659,0.000011319404,0.0000014027834,0.00044473162],"genre_scores_gemma":[0.001033689,0.9970429,0.000049955783,0.0017099589,0.000101669015,0.0000043100044,0.0000034157015,0.000013712618,0.00004042004],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917686,0.00143399,0.0062195696,0.00013644231,0.00032011443,0.000121305646],"domain_scores_gemma":[0.9877348,0.002855011,0.008718691,0.0003368734,0.00022953271,0.00012507419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047005285,0.00022376736,0.01176405,0.00015681428,0.000009728121,0.0000019103202,0.0002347922,0.00037448524,0.000075905744],"category_scores_gemma":[0.0065321946,0.00009850223,0.002270769,0.00020498184,0.0001494744,0.000036569287,0.000024217868,0.001029032,7.601614e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023857057,0.0007683297,0.0011890021,0.5484458,0.0007897839,0.00003727367,0.000023182389,7.01549e-7,1.8136222e-7,0.0000063777597,0.00062332203,0.44787744],"study_design_scores_gemma":[0.0031383045,0.00806311,0.025685824,0.93732643,0.0028777174,0.00036943526,0.000008177621,0.000011275044,6.292227e-7,0.00002724652,0.022383634,0.000108200125],"about_ca_topic_score_codex":0.000014037269,"about_ca_topic_score_gemma":0.000006136294,"teacher_disagreement_score":0.44776925,"about_ca_system_score_codex":0.00032242658,"about_ca_system_score_gemma":0.0036565496,"threshold_uncertainty_score":0.804167},"labels":[],"label_agreement":null},{"id":"W3083023269","doi":"10.1158/1538-7445.am2020-2298","title":"Abstract 2298: Is smoking a risk factor for second primary lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Prostate cancer; Cancer; Cohort; Prospective cohort study; Risk factor","score_opus":0.13318791249727896,"score_gpt":0.431848614623794,"score_spread":0.298660702126515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083023269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96688884,0.012507495,0.00008294663,0.007624002,0.00035572262,0.0018613966,0.0034487161,0.00008862977,0.0071422434],"genre_scores_gemma":[0.9826706,0.0027267372,0.00015247721,0.009233885,0.0017527654,0.00082956086,0.000053303993,0.00009616623,0.0024845148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720824,0.00006403748,0.00036861282,0.0007174267,0.0007880873,0.0008535714],"domain_scores_gemma":[0.99815947,0.0003311952,0.000108847584,0.00037761443,0.00043213446,0.0005907196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044209926,0.00023552445,0.00049440545,0.00016100123,0.00031207464,0.00007460038,0.0002951899,0.00017419769,0.036093067],"category_scores_gemma":[0.00013487427,0.00021300693,0.00022229581,0.00041902246,0.00015916613,0.00022090702,0.00011939906,0.001175184,0.000027644186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004225024,0.000099189274,0.11361348,0.006571442,0.0011136362,0.00008724832,0.008873508,0.000044729502,0.19682007,0.000024405654,0.3966741,0.27185318],"study_design_scores_gemma":[0.0072003403,0.0004681742,0.20321903,0.00045522835,0.00015769871,0.0000043448035,0.00041087106,0.0011103849,0.11191416,0.000032686872,0.6744735,0.00055356545],"about_ca_topic_score_codex":0.0007487529,"about_ca_topic_score_gemma":0.00019635275,"teacher_disagreement_score":0.27779943,"about_ca_system_score_codex":0.001131021,"about_ca_system_score_gemma":0.0022753866,"threshold_uncertainty_score":0.9647881},"labels":[],"label_agreement":null},{"id":"W3092318819","doi":"10.1016/j.hpb.2020.04.446","title":"Corrected age-adjusted Charlson Comorbidity Index (CaCCI) for patients undergoing ALPPS: A tool for preoperative patients selection.","year":2020,"lang":"en","type":"article","venue":"HPB","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Comorbidity; Hepatectomy; Logistic regression; Receiver operating characteristic; Charlson comorbidity index; Retrospective cohort study; Surgery; Internal medicine; Liver disease; Resection","score_opus":0.03957556960742798,"score_gpt":0.2776721001766082,"score_spread":0.23809653056918023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092318819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989035,0.000030148723,0.014384521,0.00028954408,0.0005845139,0.004033316,0.00029606454,0.00015749475,0.0003340723],"genre_scores_gemma":[0.9890146,0.000025918123,0.0030433729,0.0047387285,0.00031874143,0.0004353692,0.0017206752,0.000054858316,0.00064769544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864584,0.00004235026,0.00034537876,0.00042208587,0.00022064311,0.00032372357],"domain_scores_gemma":[0.99887586,0.0002121621,0.00013895446,0.00013609597,0.00046420968,0.00017274976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006318869,0.00021715769,0.00038561624,0.00006157854,0.00019235257,0.00003282399,0.000087906665,0.00012549634,0.00024599655],"category_scores_gemma":[0.000710165,0.00020404582,0.00014100606,0.00021605942,0.000028766795,0.00019448082,0.00003600757,0.000184138,0.000014361477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067804763,0.00085063087,0.8006202,0.0010500032,0.0003935536,0.000003880766,0.0036255454,0.000117922136,0.0007143295,0.000023101533,0.12504397,0.060776353],"study_design_scores_gemma":[0.0395331,0.007865786,0.7750208,0.00020190784,0.00033063124,0.0000020981615,0.00033475482,0.107187964,0.002072218,0.000014225947,0.06675554,0.000681021],"about_ca_topic_score_codex":0.00003575132,"about_ca_topic_score_gemma":0.00009800455,"teacher_disagreement_score":0.10707004,"about_ca_system_score_codex":0.00027066472,"about_ca_system_score_gemma":0.00028756517,"threshold_uncertainty_score":0.8320747},"labels":[],"label_agreement":null},{"id":"W3096356475","doi":"","title":"GENDER IN SMALL-CELL LUNG CANCER (SCLC): AN ANALYSIS OF CHEMOTHERAPY TRIALS FROM THE MANCHESTER LUNG CANCER GROUP (MLCG) AND THE UK MEDICAL RESEARCH COUNCIL CLINICAL TRIALS UNIT (MRC CTU)","year":2008,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Medicine; Lung cancer; Clinical trial; Oncology; Chemotherapy; Internal medicine; Cancer; Family medicine","score_opus":0.5200107346484711,"score_gpt":0.4692954128159116,"score_spread":0.05071532183255956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096356475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784035,0.009756791,0.0001649658,0.008904876,0.00012874583,0.0022469654,0.000118375865,0.000015710844,0.0002600301],"genre_scores_gemma":[0.93569946,0.06235248,0.00012218714,0.000994952,0.00048353508,0.00004843818,0.000049903854,0.00003844679,0.00021061514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9794236,0.013855044,0.0014919402,0.0008556873,0.0035700398,0.00080367894],"domain_scores_gemma":[0.97628254,0.019774351,0.00055797194,0.0015003481,0.0014214185,0.00046334416],"candidate_categories":["metaresearch","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.07988184,0.0003106239,0.0023413473,0.00048555588,0.00057657727,0.000040817224,0.0014120779,0.00041504612,0.004427433],"category_scores_gemma":[0.0037740439,0.00017841446,0.0007480877,0.0015836153,0.0041349796,0.00022729418,0.00051407376,0.0021151402,0.000005071349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02831283,0.00076226186,0.69557536,0.00049478136,0.008229107,0.00025226024,0.23111582,0.00014574784,0.0011709954,0.00018225671,0.020872423,0.012886166],"study_design_scores_gemma":[0.044250093,0.0004923105,0.84957737,0.0006685122,0.0031776088,0.000008934182,0.054612,0.027053002,0.0005227253,0.00024099307,0.018916124,0.0004803282],"about_ca_topic_score_codex":0.008370053,"about_ca_topic_score_gemma":0.004079389,"teacher_disagreement_score":0.17650382,"about_ca_system_score_codex":0.0009578253,"about_ca_system_score_gemma":0.00361847,"threshold_uncertainty_score":0.9985752},"labels":[],"label_agreement":null},{"id":"W3107142083","doi":"10.1016/j.ctarc.2020.100246","title":"The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Cancer Care Ontario; McMaster University; University Health Network; University of Toronto","funders":"Government of Ontario; Cancer Care Ontario","keywords":"Stage (stratigraphy); Lung cancer; Oncology; Medicine; Internal medicine; Cancer; Overall survival; Biology","score_opus":0.07345195613966087,"score_gpt":0.3851385666671447,"score_spread":0.3116866105274838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107142083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863706,0.007201628,0.0000020412037,0.002219977,0.000015419695,0.0010725885,0.00017151498,0.00000852533,0.0029376806],"genre_scores_gemma":[0.97560203,0.023135452,0.000044142962,0.000036420544,0.00002126241,0.0004026946,0.000044490942,0.000016927199,0.0006965863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989682,0.00014818281,0.00017726899,0.00018563369,0.0002227773,0.0002979785],"domain_scores_gemma":[0.99855953,0.00032287263,0.00006196808,0.0006673957,0.00023013467,0.00015812018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015893648,0.0001302398,0.00024462852,0.00007511355,0.000330635,0.00003219866,0.00025869516,0.000038476403,0.00007743406],"category_scores_gemma":[0.000018392737,0.00007122035,0.000057476285,0.00032463798,0.00030751267,0.000066819666,0.00010036547,0.00027371378,0.0000017474717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010684654,0.00039103068,0.98508286,0.00007877898,0.00024330529,0.000002077848,0.0029737984,0.00021327291,0.0002972479,0.00003431847,0.00031356225,0.009301299],"study_design_scores_gemma":[0.0052005574,0.0027114998,0.9875017,0.00019474029,0.000048743295,8.75748e-8,0.00047476043,0.0014354726,0.0005718613,0.0000022862725,0.0017611439,0.00009717844],"about_ca_topic_score_codex":0.014698123,"about_ca_topic_score_gemma":0.001932442,"teacher_disagreement_score":0.015933823,"about_ca_system_score_codex":0.0007406729,"about_ca_system_score_gemma":0.0010952915,"threshold_uncertainty_score":0.9918631},"labels":[],"label_agreement":null},{"id":"W3108289200","doi":"10.1007/s00261-020-02862-3","title":"SAR Prostate Cancer Disease-Focused Panel report","year":2020,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Hepatology; Prostate cancer; Internal medicine; Prostate; Disease; Cancer; Oncology; Prostatic disease; Prostate disease","score_opus":0.04813461781180547,"score_gpt":0.2944567889100748,"score_spread":0.24632217109826934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108289200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95892125,0.002916989,0.000116988405,0.031970546,0.00041773214,0.00057481945,0.00005213439,0.00010736126,0.0049221963],"genre_scores_gemma":[0.980141,0.0005759133,0.0007332361,0.01603926,0.0008256019,0.0000517292,0.00011663375,0.000032692282,0.0014839328],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986333,0.000058079462,0.00035244314,0.00046311942,0.00014700826,0.0003460429],"domain_scores_gemma":[0.9989493,0.000066549925,0.00011906292,0.00027965146,0.00006258615,0.000522852],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011055112,0.00017791567,0.0004707723,0.00004288383,0.000059670223,0.0000068066506,0.00010262113,0.00008200666,0.0015276993],"category_scores_gemma":[0.00020889711,0.0001502187,0.00013749604,0.00012271208,0.00016614217,0.00006342032,0.00003741145,0.00024511074,0.00008942683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028710809,0.00021462605,0.5023264,0.0009182737,0.00097022526,0.04116396,0.004356761,0.00029296393,0.06588659,0.00040144115,0.16732012,0.1874378],"study_design_scores_gemma":[0.008672475,0.0012758737,0.33522213,0.00008136591,0.0006165517,0.002609478,0.00032412587,0.0029778017,0.0028624644,0.00014430576,0.6445996,0.0006138568],"about_ca_topic_score_codex":0.000108823246,"about_ca_topic_score_gemma":0.0000066375974,"teacher_disagreement_score":0.47727948,"about_ca_system_score_codex":0.00011300941,"about_ca_system_score_gemma":0.00060348585,"threshold_uncertainty_score":0.99938506},"labels":[],"label_agreement":null},{"id":"W3111539826","doi":"10.1097/md.0000000000023440","title":"Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer","year":2020,"lang":"en","type":"article","venue":"Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"Chang Gung Memorial Hospital, Linkou","keywords":"Medicine; Lung cancer; Internal medicine; Cancer; Malignancy; Gastroenterology; Gastrointestinal cancer; Stage (stratigraphy); Lung; Survival rate; Oncology; Colorectal cancer","score_opus":0.02365591209733271,"score_gpt":0.30054103532235804,"score_spread":0.27688512322502534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111539826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823574,0.002369248,0.00008347758,0.0071556694,0.00027961482,0.0010231615,0.00017647594,0.00009944472,0.0064555113],"genre_scores_gemma":[0.9733036,0.0006485305,0.0012471351,0.022051591,0.00094392785,0.00017014322,0.0006097592,0.00009779575,0.00092749984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966498,0.00012651431,0.0009203257,0.00086520764,0.00080018485,0.0006379765],"domain_scores_gemma":[0.99817693,0.00014741167,0.0003484292,0.0003985905,0.00041583486,0.0005127973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045740049,0.00046263423,0.0013019695,0.00014317578,0.000080773956,0.000014639422,0.00025092904,0.000092541675,0.0059436606],"category_scores_gemma":[0.00018688808,0.00034773676,0.00007343534,0.0007813277,0.00041140438,0.0002722224,0.00010212474,0.0007454193,0.00001314147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020405736,0.00011312304,0.9643845,0.00115515,0.00014602517,0.00016207203,0.0006499349,0.0000055106175,0.0018834723,6.984505e-7,0.022917306,0.006541623],"study_design_scores_gemma":[0.010140475,0.0008195321,0.98266095,0.0013113507,0.00011868148,0.000012592999,0.00009116975,0.00022632084,0.00026757972,0.0000013685184,0.0039900434,0.00035995457],"about_ca_topic_score_codex":0.00097035704,"about_ca_topic_score_gemma":0.0009373956,"teacher_disagreement_score":0.018927263,"about_ca_system_score_codex":0.00076942856,"about_ca_system_score_gemma":0.001707088,"threshold_uncertainty_score":0.9998975},"labels":[],"label_agreement":null},{"id":"W3112512222","doi":"","title":"Screeningul tumorilor digestive în perioada pandemiei de COVID-19","year":2020,"lang":"ro","type":"article","venue":"Medic ro","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Incidence (geometry); Cancer; 2019-20 coronavirus outbreak; Quarter (Canadian coin); Disease; Virology; Internal medicine; Outbreak; Geography; Infectious disease (medical specialty)","score_opus":0.06616139228662815,"score_gpt":0.32604031752716733,"score_spread":0.2598789252405392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112512222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38885525,0.068523504,0.043639995,0.36827978,0.008344958,0.0047735493,0.0011224486,0.0013939872,0.11506651],"genre_scores_gemma":[0.85716724,0.0017002773,0.00082327274,0.12878607,0.0055811605,0.000062621235,0.00024583857,0.000100871606,0.005532638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588513,0.00027590542,0.0007762312,0.00096861017,0.0009819795,0.0011121313],"domain_scores_gemma":[0.9948543,0.0006552464,0.0002794881,0.0005280881,0.00010430945,0.0035785844],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008117394,0.00055802334,0.0010725788,0.00012125161,0.00036069623,0.000057723835,0.000497682,0.0003398223,0.015812052],"category_scores_gemma":[0.0052377474,0.00051460013,0.00029282557,0.0004947294,0.0005978915,0.00017803871,0.0002104061,0.0012646841,0.00052899827],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047145644,0.0002755281,0.24237317,0.002791218,0.0011143223,0.0083790235,0.07483043,0.00042628366,0.003879606,0.00020227078,0.5460332,0.11498039],"study_design_scores_gemma":[0.009523598,0.001635663,0.019211499,0.00035743398,0.00063497695,0.00022156349,0.009513759,0.0099363765,0.0005385813,0.000046486562,0.9476484,0.00073167606],"about_ca_topic_score_codex":0.0015659938,"about_ca_topic_score_gemma":0.000067340225,"teacher_disagreement_score":0.468312,"about_ca_system_score_codex":0.0012216754,"about_ca_system_score_gemma":0.006178577,"threshold_uncertainty_score":0.9997306},"labels":[],"label_agreement":null},{"id":"W3114984412","doi":"10.1136/ijgc-2020-001946","title":"Risk of second malignancy in patients with ovarian clear cell carcinoma","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Clear cell carcinoma; Ovarian carcinoma; Carcinoma; Malignancy; Oncology; Ovarian cancer; Internal medicine; Radiation therapy; Incidence (geometry); Cancer","score_opus":0.01358094029146053,"score_gpt":0.24746597567322795,"score_spread":0.23388503538176741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114984412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574596,0.00023429438,0.000033752327,0.001213042,0.00028485927,0.00013676309,0.00007979668,0.000003434082,0.0022680764],"genre_scores_gemma":[0.9967515,0.00008603348,0.0006285102,0.0022653814,0.00019003269,0.0000031683187,0.000007165876,0.000009687509,0.000058537247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987454,0.000050734132,0.00049163896,0.00013842026,0.00044638908,0.0001274375],"domain_scores_gemma":[0.9987367,0.0001036711,0.00047422101,0.000061012448,0.00047890499,0.00014549466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118853204,0.00010418836,0.0003408377,0.00009422421,0.000012416481,0.000008470304,0.00020578063,0.000070983195,0.0063075307],"category_scores_gemma":[0.00013726814,0.00007067769,0.00011296151,0.00010328791,0.00005587684,0.00012517592,0.00003837002,0.000356053,0.0000042504057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049278466,0.0002443944,0.9863511,0.00003052147,0.0001226184,0.0001786852,0.00025249587,0.00015855447,0.00036601129,0.0000145420745,0.00075825787,0.0065950216],"study_design_scores_gemma":[0.007743005,0.0024382249,0.9843922,0.0000406119,0.000051607323,0.000006322883,0.000057493497,0.000060652044,0.0014287615,0.00002468159,0.0036791347,0.000077272045],"about_ca_topic_score_codex":0.00004016408,"about_ca_topic_score_gemma":0.00004878864,"teacher_disagreement_score":0.0065177493,"about_ca_system_score_codex":0.00022692143,"about_ca_system_score_gemma":0.00029453434,"threshold_uncertainty_score":0.99460083},"labels":[],"label_agreement":null},{"id":"W3116667756","doi":"10.3747/co.27.5951","title":"The Cost of Failed First-Line Cancer Treatment Related to Continued Smoking in Canada","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Canada Research Chairs; Canadian Partnership Against Cancer","funders":"","keywords":"Medicine; Lung cancer; Cancer; Breast cancer; Prostate cancer; Colorectal cancer; Disease; Smoking cessation; Cancer treatment; Environmental health; Internal medicine; Pathology","score_opus":0.10702281155164714,"score_gpt":0.38588267171023377,"score_spread":0.27885986015858666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116667756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96895283,0.0037255941,0.0000147083,0.024090806,0.0011100885,0.00091834186,0.000061153245,0.0000119047845,0.0011145484],"genre_scores_gemma":[0.9969799,0.0015649385,0.000011060093,0.00108193,0.000082477614,0.00014652273,0.00003362585,0.000010303372,0.000089227986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990077,0.000054299286,0.00038050316,0.00019970961,0.00012071723,0.00023706332],"domain_scores_gemma":[0.9993059,0.00021088419,0.00010834591,0.00013862294,0.0000622228,0.00017399628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007525433,0.00011378727,0.00041256307,0.00003055025,0.000043930548,0.000002643092,0.00008946223,0.000044905642,0.00032379545],"category_scores_gemma":[0.00010705859,0.000078253135,0.00004752599,0.0001989223,0.000038068967,0.000016266786,0.00003168636,0.00018104003,0.0000032538615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011976742,0.00012277902,0.4004971,0.00007827006,0.0001438091,0.000072849485,0.0022980256,0.00074018823,0.000323908,0.00004480699,0.01106454,0.58341604],"study_design_scores_gemma":[0.005906168,0.0007203864,0.0965166,0.00008043203,0.00007027764,0.0000025834768,0.00041735583,0.002044875,0.0007117405,0.000005079981,0.89343053,0.00009399485],"about_ca_topic_score_codex":0.25443307,"about_ca_topic_score_gemma":0.89616567,"teacher_disagreement_score":0.88236594,"about_ca_system_score_codex":0.002745084,"about_ca_system_score_gemma":0.0029357248,"threshold_uncertainty_score":0.75053173},"labels":[],"label_agreement":null},{"id":"W3117572444","doi":"10.1093/jjco/hyaa253","title":"Age-specific prostate cancer incidence rate in the world","year":2020,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Incidence (geometry); Oncology; Cancer; Prostate; Internal medicine","score_opus":0.17030637135514176,"score_gpt":0.4597530143942606,"score_spread":0.2894466430391188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117572444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91286594,0.00045091263,0.0000068344157,0.08182365,0.00045217262,0.00023783054,0.000001191262,0.000006479162,0.0041549737],"genre_scores_gemma":[0.9439898,0.0012356152,0.00043631153,0.052868,0.0011763227,0.000010335757,0.0000011246171,0.000009398613,0.00027306477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693465,0.0006992144,0.001658405,0.00018772302,0.00028750798,0.0002324791],"domain_scores_gemma":[0.9963768,0.0023239693,0.00066189206,0.00015786591,0.00017724348,0.000302198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032801933,0.00011443785,0.0008904018,0.0000857503,0.00003643562,0.000013509008,0.00029855836,0.00009743388,0.00065809727],"category_scores_gemma":[0.0012770452,0.00006484774,0.00025544877,0.000426601,0.00022980782,0.00016708154,0.000039736373,0.0012559547,0.000030244679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028671606,0.0011846162,0.6051336,0.00011059361,0.0002648576,0.01563334,0.020928206,0.0007103941,0.011769589,0.00018491727,0.038418557,0.27698973],"study_design_scores_gemma":[0.007160197,0.0029345518,0.6044721,0.00005832001,0.000054952998,0.00019903763,0.0012994226,0.00021631598,0.00010097503,0.00009119845,0.3833221,0.0000908527],"about_ca_topic_score_codex":0.000025875062,"about_ca_topic_score_gemma":0.00031835097,"teacher_disagreement_score":0.34490353,"about_ca_system_score_codex":0.00012094919,"about_ca_system_score_gemma":0.0008451495,"threshold_uncertainty_score":0.7205704},"labels":[],"label_agreement":null},{"id":"W3129100388","doi":"10.1007/s13304-020-00939-8","title":"Full robotic multivisceral resections: the Modena experience and literature review","year":2021,"lang":"en","type":"review","venue":"Updates in Surgery","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"","keywords":"Medicine; Surgery; Robotic surgery; Endometriosis; Perioperative; Laparoscopy; General surgery; Colorectal surgery; Abdominal surgery","score_opus":0.0712275759009649,"score_gpt":0.3743702178089023,"score_spread":0.3031426419079374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129100388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024127346,0.9975812,0.00000685852,0.0005297106,0.00057851063,0.0008670625,0.00002830536,0.0000289568,0.00035525835],"genre_scores_gemma":[0.000011225469,0.99562085,0.00011610971,0.0020822596,0.00025279308,0.00036816098,0.00067281537,0.000045835495,0.0008299793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975918,0.00040995228,0.00081549305,0.0005969526,0.00024639117,0.00033940817],"domain_scores_gemma":[0.997805,0.001018619,0.0002160565,0.00076084107,0.00008677939,0.000112707174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061556476,0.0004018694,0.0023788195,0.00022893495,0.00009404678,0.000077652156,0.00014979244,0.00023785688,0.00036778397],"category_scores_gemma":[0.00067428785,0.00024582713,0.0005259867,0.00090018014,0.00015015826,0.00016588466,0.00013472752,0.0009801647,0.000013274502],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020946163,0.00005030543,0.00010877625,0.07971814,0.00013116458,0.0008729945,0.0003146936,0.0000014792803,3.8982859e-7,0.00002025978,0.03733361,0.8814272],"study_design_scores_gemma":[0.00007841456,0.000011729306,0.000016253322,0.1978811,0.00024550696,0.0011523445,0.000032572865,0.000024844805,3.020869e-7,0.0000031653005,0.8003466,0.00020716325],"about_ca_topic_score_codex":0.000016013792,"about_ca_topic_score_gemma":0.000013456005,"teacher_disagreement_score":0.8812201,"about_ca_system_score_codex":0.00016548329,"about_ca_system_score_gemma":0.00057813176,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W3133034676","doi":"10.1158/1538-7445.sabcs20-ps4-26","title":"Abstract PS4-26: Impact of TAILORx data on chemotherapy prescribing in British Columbia","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cohort; Internal medicine; Retrospective cohort study; Cancer; Oncology","score_opus":0.16549578978122634,"score_gpt":0.4498005009759668,"score_spread":0.28430471119474043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133034676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924209,0.0024734135,0.000001148198,0.00095236924,0.00008478086,0.00040595434,0.00031494605,0.000019595165,0.0033269078],"genre_scores_gemma":[0.99389815,0.0033774711,0.00006836351,0.0005108891,0.00024146355,0.000037358146,0.00015299431,0.000045015076,0.0016682972],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979939,0.00008937068,0.00029365992,0.0005154006,0.0006247341,0.00048296087],"domain_scores_gemma":[0.9984023,0.00015772856,0.000045646702,0.00094343105,0.00027836705,0.00017253481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007753955,0.00008342745,0.00034957528,0.00009341908,0.000066638575,0.00011157089,0.0003333769,0.00009555975,0.00887562],"category_scores_gemma":[0.00025126088,0.00011450692,0.00008675901,0.0005247328,0.00015898953,0.00017741222,0.00014794573,0.00069912954,0.000013198363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007875938,0.0005042526,0.26412156,0.00056023145,0.00024990042,0.0008572643,0.00037508883,0.00007357323,0.15892273,0.0000017693213,0.32764286,0.24590318],"study_design_scores_gemma":[0.004369494,0.00036324523,0.9649567,0.0010787968,0.000009929988,0.000027109998,0.0002678656,0.00021741052,0.009212184,0.00003735681,0.019295715,0.00016419268],"about_ca_topic_score_codex":0.10937484,"about_ca_topic_score_gemma":0.08380659,"teacher_disagreement_score":0.70083517,"about_ca_system_score_codex":0.00069151743,"about_ca_system_score_gemma":0.0021972146,"threshold_uncertainty_score":0.9920304},"labels":[],"label_agreement":null},{"id":"W3133096119","doi":"10.1158/1538-7445.sabcs20-ps7-47","title":"Abstract PS7-47: Real-world treatment patterns in older patients with stage I-III breast cancer: A population-based study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Interquartile range; Breast cancer; Cancer registry; Stage (stratigraphy); Internal medicine; Proportional hazards model; Radiation therapy; Cancer; Comorbidity; Population; Logistic regression; Hazard ratio; Confidence interval","score_opus":0.06104834497759498,"score_gpt":0.4074367634052676,"score_spread":0.3463884184276726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133096119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953348,0.00017316967,0.0000016497542,0.00096098054,0.00012150505,0.0018389231,0.0006599816,0.000033840985,0.0008751533],"genre_scores_gemma":[0.99462336,0.00026612997,0.000016100435,0.0002637355,0.00017816824,0.0009926573,0.0004443046,0.000056828965,0.00315871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970772,0.0001670948,0.00038416722,0.00069511717,0.0010198657,0.00065650675],"domain_scores_gemma":[0.9983936,0.00013603792,0.000079869285,0.0006072726,0.0004966592,0.00028653842],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027072933,0.00024824834,0.00048367167,0.00041134632,0.0001545971,0.000058003152,0.00012769423,0.00006411608,0.0069846264],"category_scores_gemma":[0.000012478564,0.00019416836,0.00007432756,0.0008487798,0.00004771179,0.0001386381,0.000045237943,0.0004650343,0.000012220542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017586562,0.0017516066,0.9750935,0.00019731591,0.00015083521,0.00036858814,0.0007313917,0.00037443574,0.00012364348,0.0000023875364,0.00023421267,0.019213414],"study_design_scores_gemma":[0.014245396,0.000438638,0.9827118,0.00040131444,0.00003937569,7.4620016e-7,0.0006763124,0.000065229986,0.0004626771,9.737489e-7,0.0007613892,0.00019615496],"about_ca_topic_score_codex":0.17829026,"about_ca_topic_score_gemma":0.29522866,"teacher_disagreement_score":0.11693841,"about_ca_system_score_codex":0.0037127165,"about_ca_system_score_gemma":0.0026105845,"threshold_uncertainty_score":0.9939231},"labels":[],"label_agreement":null},{"id":"W3135809705","doi":"10.1200/jco.2021.39.6_suppl.42","title":"Symptom burden, functional status, and clinical outcomes of hospitalized patients with advanced genitourinary cancers.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Conquer Cancer Foundation","keywords":"Medicine; Cancer; Prostate cancer; Internal medicine; Genitourinary system; Bladder cancer; Kidney cancer; Univariate analysis; Performance status; Oncology; Multivariate analysis","score_opus":0.05310652804474687,"score_gpt":0.41406597832809355,"score_spread":0.3609594502833467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135809705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939597,0.0008255587,0.000037302612,0.002012246,0.0018594835,0.00016704101,0.00001951171,0.0000060824163,0.0011130383],"genre_scores_gemma":[0.986159,0.0035523607,0.006514307,0.0026363966,0.0007406471,0.0000016563681,0.000023584444,0.000020041101,0.00035195056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960886,0.00034232312,0.0025780967,0.0002653616,0.00048489784,0.00024067593],"domain_scores_gemma":[0.99423087,0.002145484,0.0017482075,0.00021552618,0.0011460066,0.00051391224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009869523,0.00016071965,0.0019798062,0.00007935892,0.00003612867,0.0000053155145,0.00007509628,0.0002986958,0.00051618216],"category_scores_gemma":[0.0023727145,0.00010835026,0.00050125725,0.0001139389,0.00039233192,0.00016724781,0.000069884685,0.0008840322,0.0000023191374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009870335,0.0009317141,0.9004766,0.000037279147,0.0012370236,0.00029155932,0.000040499835,0.000026431684,0.000016517353,0.00001374161,0.0009868415,0.08607149],"study_design_scores_gemma":[0.02830175,0.014582743,0.92063576,0.0000728858,0.0005443879,0.000057597103,0.00012873,0.000017321297,0.000008736766,0.000036269696,0.035509385,0.00010444014],"about_ca_topic_score_codex":0.000028437862,"about_ca_topic_score_gemma":0.00003313447,"teacher_disagreement_score":0.08596705,"about_ca_system_score_codex":0.00020837481,"about_ca_system_score_gemma":0.0054287133,"threshold_uncertainty_score":0.96303046},"labels":[],"label_agreement":null},{"id":"W3136330176","doi":"10.1016/j.jtho.2021.02.024","title":"Tobacco Smoking and Risk of Second Primary Lung Cancer","year":2021,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Pharmacyclics; Centers for Disease Control and Prevention; Clovis Oncology; National Institutes of Health; Helsinn; ACEA Biosciences; Pfizer; Daiichi Sankyo Europe; World Health Organization; Exelixis; Centre International de Recherche sur le Cancer; Celgene; Myriad Genetics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lung cancer; Primary (astronomy); Environmental health; Oncology; Primary cancer; Internal medicine; Cancer","score_opus":0.043188087231221556,"score_gpt":0.4503426521901326,"score_spread":0.407154564958911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136330176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007546848,0.98739165,0.0000144176,0.000109971515,0.0013638869,0.000338194,0.00010510208,0.0000050151516,0.0031248992],"genre_scores_gemma":[0.00005533047,0.99636066,0.0014503485,0.00032705546,0.0009356198,0.000011345588,0.00002753646,0.00004604192,0.00078606233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705696,0.0005639415,0.0015661289,0.00027369676,0.00027543225,0.00026383527],"domain_scores_gemma":[0.9953997,0.00063573173,0.0030891255,0.00028820132,0.0003547152,0.00023248348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011908553,0.00032952332,0.00448307,0.00040972527,0.000050728562,0.000013961546,0.0001945232,0.00059264427,0.0016705068],"category_scores_gemma":[0.00018389591,0.00024507468,0.0008269787,0.0002491622,0.00013304023,0.00012817945,0.00012931215,0.0016879836,7.611102e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019613175,0.000085068204,0.0017535955,0.022325652,0.0028608837,0.0006269406,0.00012925333,0.0000010098246,0.0000084550065,0.0000028036643,0.005414223,0.966596],"study_design_scores_gemma":[0.00061184296,0.000510986,0.00086080696,0.016659595,0.011890551,0.0032746946,0.00006421992,0.0000023395726,0.000010236508,0.000004606853,0.96592563,0.0001844592],"about_ca_topic_score_codex":0.000025934685,"about_ca_topic_score_gemma":0.00005934047,"teacher_disagreement_score":0.96641153,"about_ca_system_score_codex":0.0012134223,"about_ca_system_score_gemma":0.0060473494,"threshold_uncertainty_score":0.9995874},"labels":[],"label_agreement":null},{"id":"W3163240042","doi":"10.1016/j.annonc.2021.03.061","title":"47P The impact of endocrine therapy and chemotherapy on quality of life 5 years after a breast cancer diagnosis: VICAN5 survey","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Cancer; Chemotherapy; Adjuvant chemotherapy; Pediatrics; Database; Internal medicine","score_opus":0.14495511747565393,"score_gpt":0.451559960320621,"score_spread":0.3066048428449671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163240042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98736256,0.00418314,5.797888e-7,0.0072065582,0.000053864147,0.00019176523,0.0005375887,0.000003933503,0.00046002763],"genre_scores_gemma":[0.9730374,0.020048287,0.000017511726,0.00669512,0.00006564357,0.000059394384,0.000017248285,0.000012790167,0.000046584217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874705,0.000339361,0.00040363433,0.00018027281,0.00015636648,0.0001733165],"domain_scores_gemma":[0.99833417,0.00070620904,0.00025052106,0.00029883088,0.00031851625,0.00009178312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005013714,0.00011543088,0.0006680544,0.000051883955,0.0000120165905,0.0000022877425,0.000077959885,0.00007358164,0.002053699],"category_scores_gemma":[0.00015668313,0.000075615455,0.00018060324,0.00015918732,0.00023178168,0.000032559306,0.000025301557,0.00013137785,6.516572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007883926,0.0006519781,0.8468906,0.0000647998,0.0006832422,0.000013828193,0.0007457342,0.00000874112,0.0030850668,0.00001182815,0.0064687566,0.1334915],"study_design_scores_gemma":[0.0031108793,0.0015595262,0.9865617,0.000043177213,0.000012998442,0.000011096268,0.00007435549,0.000005443165,0.0049527115,0.00001920895,0.0035849584,0.000063919],"about_ca_topic_score_codex":0.008109457,"about_ca_topic_score_gemma":0.00093737565,"teacher_disagreement_score":0.13967112,"about_ca_system_score_codex":0.00003727493,"about_ca_system_score_gemma":0.00093771727,"threshold_uncertainty_score":0.9988586},"labels":[],"label_agreement":null},{"id":"W3165986417","doi":"10.1200/jco.2021.39.15_suppl.567","title":"Clinicopathologic features of breast cancers diagnosed in females treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Lymphoma; Radiation therapy; Internal medicine; Population; Malignancy; Epidemiology; Cancer; Cohort; Chemotherapy; Hodgkin lymphoma; Gynecology","score_opus":0.07719767955081487,"score_gpt":0.4173071556359994,"score_spread":0.34010947608518455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165986417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417037,0.0013277947,0.000051885017,0.0031470729,0.00039563046,0.00049800164,0.000218259,0.000007911045,0.00018307948],"genre_scores_gemma":[0.9900665,0.0018337861,0.004839942,0.0023482218,0.0005140706,0.000019671936,0.00031629324,0.000018201448,0.000043302174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996223,0.0005840726,0.0024247512,0.00030574173,0.000272939,0.00018954309],"domain_scores_gemma":[0.9897753,0.0069945743,0.0022956799,0.00022975076,0.00053004746,0.0001746279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019482172,0.00015870138,0.001675187,0.00014272236,0.00003098567,0.0000074297436,0.00010826713,0.0004017932,0.000074215364],"category_scores_gemma":[0.0035244029,0.00010861389,0.00039635279,0.00022132954,0.00012270991,0.000087547975,0.000009132824,0.00035938708,4.414728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045219425,0.0009105465,0.69617957,0.000016864282,0.00021244232,0.00050785724,0.000072672556,0.00035305944,0.00018128319,0.0000031354716,0.0003664595,0.25597665],"study_design_scores_gemma":[0.061102152,0.0067536687,0.9287842,0.0001680857,0.0002188682,0.0000869338,0.00009403918,0.00027291488,0.00038742856,0.00003300084,0.0019980897,0.00010065029],"about_ca_topic_score_codex":0.0010320095,"about_ca_topic_score_gemma":0.0018962923,"teacher_disagreement_score":0.255876,"about_ca_system_score_codex":0.0005004772,"about_ca_system_score_gemma":0.0057611912,"threshold_uncertainty_score":0.99987525},"labels":[],"label_agreement":null},{"id":"W3167868994","doi":"10.1002/cnr2.1406","title":"Bladder and upper urinary tract cancers as first and second primary cancers","year":2021,"lang":"en","type":"article","venue":"Cancer Reports","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"China Scholarship Council; Biomedicum Helsinki-säätiö; European Commission; Vetenskapsrådet; Finska Läkaresällskapet","keywords":"Medicine; Renal pelvis; Bladder cancer; Urology; Cancer; Ureter; Urinary system; Endometrial cancer; Urothelial cancer; Urothelium; Oncology; Urinary bladder; Internal medicine; Population; Gynecology","score_opus":0.01424547717559799,"score_gpt":0.27298972003881666,"score_spread":0.2587442428632187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167868994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91315037,0.04338682,0.0000036237361,0.0021671664,0.00086351956,0.0003961053,0.000047230653,0.00006616235,0.039919026],"genre_scores_gemma":[0.95872474,0.012111078,0.00026254155,0.011302355,0.00048714795,0.00016810674,0.00010415049,0.000073392235,0.016766485],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784726,0.000027870592,0.00048765133,0.00086765375,0.00032127052,0.00044831104],"domain_scores_gemma":[0.9986108,0.000060438644,0.00020694916,0.0005222359,0.00014071677,0.00045887422],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015254143,0.00031783967,0.0005965586,0.00009222476,0.00019845799,0.00005352481,0.00004460051,0.00016607187,0.0062907105],"category_scores_gemma":[0.000049222705,0.0003094204,0.00011370866,0.0001857239,0.00023467845,0.0002798683,0.00009310221,0.00036560165,0.000004020029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011036157,0.00033698563,0.717791,0.0034463375,0.0015926168,0.05336878,0.004450761,0.000162965,0.0170186,0.000058515332,0.10290659,0.09776321],"study_design_scores_gemma":[0.0017361594,0.00029082943,0.3364016,0.00030418084,0.00027665557,0.017453663,0.00043088093,0.000051719613,0.003969316,0.00007692298,0.63853437,0.0004737269],"about_ca_topic_score_codex":0.0013245455,"about_ca_topic_score_gemma":0.00064875267,"teacher_disagreement_score":0.5356278,"about_ca_system_score_codex":0.0012338713,"about_ca_system_score_gemma":0.0038707221,"threshold_uncertainty_score":0.9999358},"labels":[],"label_agreement":null},{"id":"W3168085238","doi":"10.1200/jco.2021.39.15_suppl.e18621","title":"Health-related quality of life in the treatment and survivorship phases of breast cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"","keywords":"Medicine; Survivorship curve; Breast cancer; Quality of life (healthcare); Cancer; Cancer survivorship; Gerontology; Family medicine; Demography; Oncology; Internal medicine; Nursing","score_opus":0.29198196866330306,"score_gpt":0.5311552330096143,"score_spread":0.23917326434631125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168085238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95581317,0.0072258688,0.0000031884506,0.035839237,0.00036225416,0.00010434782,0.00003077535,0.0000010974894,0.00062006793],"genre_scores_gemma":[0.9842171,0.012057865,0.00015151431,0.0033108944,0.00019319773,0.0000015920382,0.0000032835042,0.0000041427893,0.000060400027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533033,0.0013931282,0.002866628,0.00010622354,0.00018433202,0.000119352946],"domain_scores_gemma":[0.99367064,0.0038872235,0.0018735488,0.00013938673,0.00024396292,0.00018525546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039285594,0.000075386895,0.0017642211,0.000050986142,0.000014968807,0.0000016527696,0.000069943344,0.00014877532,0.00027700874],"category_scores_gemma":[0.0013726905,0.000043466087,0.00027043113,0.00013659336,0.00020519097,0.000039783623,0.000011661483,0.00039061648,2.1920408e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070890086,0.0032700219,0.77037317,0.00014098441,0.00045286864,0.00012471665,0.0010105368,0.000015031248,0.00023924983,0.00009374812,0.0007297665,0.21646091],"study_design_scores_gemma":[0.011934417,0.006487424,0.9757454,0.00010994193,0.00010041297,0.0001975377,0.00070424407,0.000015203436,0.00005174243,0.0000864537,0.004531197,0.0000360545],"about_ca_topic_score_codex":0.0031751152,"about_ca_topic_score_gemma":0.005315525,"teacher_disagreement_score":0.21642487,"about_ca_system_score_codex":0.0001407877,"about_ca_system_score_gemma":0.004997063,"threshold_uncertainty_score":0.8864575},"labels":[],"label_agreement":null},{"id":"W3169739440","doi":"10.1200/jco.2021.39.15_suppl.12063","title":"Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Cisplatin; Interquartile range; Renal function; Internal medicine; Oncology; Cumulative dose; Kidney disease; Cohort; Urology; Chemotherapy","score_opus":0.11447322152867585,"score_gpt":0.39557839741050715,"score_spread":0.2811051758818313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169739440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870057,0.00033055403,0.009662951,0.0013765437,0.00042069503,0.00031258812,0.00022922676,0.0000026737496,0.0006590332],"genre_scores_gemma":[0.9923564,0.0003185585,0.0063475836,0.00048325968,0.00027239096,0.0000028925222,0.000015353546,0.0000089280375,0.00019462942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977542,0.00025283828,0.0015709207,0.00011932165,0.00021681009,0.000085867076],"domain_scores_gemma":[0.99356127,0.0029955634,0.0023449976,0.00012952398,0.0008391729,0.00012945515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016912118,0.00008708904,0.0008779393,0.000070909824,0.000032338405,0.0000023656912,0.000049516137,0.00020240371,0.00024231093],"category_scores_gemma":[0.0043513807,0.000050117073,0.00020626858,0.00013407093,0.00020965285,0.00011939887,0.000020354186,0.00041390472,1.9632292e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066502534,0.0017158082,0.33581066,0.00057948,0.004613933,0.00002977559,0.002026768,0.0012336456,0.07142491,0.00059999136,0.0060162195,0.50944626],"study_design_scores_gemma":[0.014443686,0.020958984,0.93993086,0.0004329949,0.0018353331,0.000114095674,0.00053520524,0.014746689,0.003482935,0.0006921471,0.0027698854,0.0000572026],"about_ca_topic_score_codex":0.000023446177,"about_ca_topic_score_gemma":0.000028741495,"teacher_disagreement_score":0.6041202,"about_ca_system_score_codex":0.000051517716,"about_ca_system_score_gemma":0.002579689,"threshold_uncertainty_score":0.5209323},"labels":[],"label_agreement":null},{"id":"W3183089822","doi":"10.1093/jnci/djab138","title":"Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Brock University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Brier score; Quartile; Internal medicine; Confidence interval; Receiver operating characteristic; Oncology; Lung cancer; Population; Proportional hazards model; Cohort; Statistics","score_opus":0.05132450612951987,"score_gpt":0.32935613216184606,"score_spread":0.2780316260323262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183089822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995745,0.0026100671,0.0040396727,0.00083645433,0.001238257,0.0002374301,0.00051653327,0.0000040173313,0.00056008686],"genre_scores_gemma":[0.97916424,0.0011528141,0.015912449,0.0016490704,0.0009081851,0.0000537487,0.00005761655,0.000015901916,0.0010859631],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988046,0.000019620235,0.00047495007,0.0001115788,0.00050145143,0.00008775446],"domain_scores_gemma":[0.998263,0.000050554325,0.00048593545,0.000059310816,0.0010815522,0.000059655296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003452293,0.00008549225,0.00022228736,0.000084051346,0.00011423599,0.000011213632,0.00006952289,0.00005520571,0.00007848952],"category_scores_gemma":[0.0001570904,0.00006327275,0.00010850645,0.0001202894,0.000050663337,0.00029661471,0.000029179331,0.00017880957,6.890044e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060494663,0.0006502097,0.15660967,0.004456424,0.0048424355,0.000018808478,0.013032512,0.4107654,0.20928758,0.0017828331,0.07528132,0.11722334],"study_design_scores_gemma":[0.017253745,0.00013844982,0.28015822,0.0018269467,0.0015759474,0.00039271807,0.00017123004,0.13967116,0.36531144,0.0014189294,0.19162962,0.00045159526],"about_ca_topic_score_codex":0.000010885913,"about_ca_topic_score_gemma":0.00012889992,"teacher_disagreement_score":0.27109426,"about_ca_system_score_codex":0.00078661,"about_ca_system_score_gemma":0.0045898873,"threshold_uncertainty_score":0.8142263},"labels":[],"label_agreement":null},{"id":"W3193781013","doi":"10.3390/curroncol28010035","title":"The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Oncology; Internal medicine; Surveillance, Epidemiology, and End Results; Epidemiology; Cancer; Population; Adenocarcinoma; Incidence (geometry); Breast cancer; Cancer registry","score_opus":0.10209331590990368,"score_gpt":0.4433463188099095,"score_spread":0.3412530029000058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193781013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961735,0.031520482,0.00000517879,0.0041756607,0.0006290095,0.000875206,0.00007554945,0.000006160066,0.0009777723],"genre_scores_gemma":[0.9859715,0.012417638,0.0000067149094,0.00088384957,0.00019055136,0.00031431782,0.000007169347,0.000013352251,0.0001949071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981007,0.00055545615,0.00048560332,0.00025935823,0.000318246,0.00028066733],"domain_scores_gemma":[0.99762356,0.0011862215,0.00030803648,0.0006267434,0.00021578827,0.000039652386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008287599,0.0001791005,0.0005203148,0.000053237916,0.00011086969,0.000013121422,0.00035548315,0.00007264873,0.0008495492],"category_scores_gemma":[0.00021699588,0.00007980981,0.00019262441,0.0003985677,0.00043205317,0.000050825514,0.000054254022,0.0005389372,0.000001395762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022269965,0.0017105985,0.7133137,0.00017979242,0.0006520841,0.000091356414,0.022696586,0.00022387251,0.004883901,0.0002781523,0.037510745,0.21623221],"study_design_scores_gemma":[0.003704808,0.002473386,0.87031436,0.000267804,0.000112947375,0.000036111098,0.0076864115,0.00017218653,0.0014897716,0.00007815819,0.113524936,0.0001391453],"about_ca_topic_score_codex":0.0011754053,"about_ca_topic_score_gemma":0.0027281,"teacher_disagreement_score":0.21609306,"about_ca_system_score_codex":0.00059415225,"about_ca_system_score_gemma":0.0033277362,"threshold_uncertainty_score":0.9301968},"labels":[],"label_agreement":null},{"id":"W3194546266","doi":"10.1002/pros.24209","title":"The effect of primary urological cancers on survival in men with secondary prostate cancer","year":2021,"lang":"en","type":"article","venue":"The Prostate","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Urology; Prostate; Cancer; Internal medicine; Prostatectomy; Bladder cancer; Proportional hazards model; Oncology; Gynecology; Gastroenterology","score_opus":0.010287403424976348,"score_gpt":0.2559697296781598,"score_spread":0.24568232625318343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194546266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96165437,0.0026250267,0.0000011141981,0.005529856,0.00016446626,0.0011657759,0.00008064515,0.000037331472,0.028741414],"genre_scores_gemma":[0.99195766,0.0020849288,0.000021173631,0.001506124,0.00007426732,0.000298571,0.000050243103,0.00003389891,0.0039731353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982409,0.00034391857,0.00030713688,0.0003294099,0.00036772876,0.00041089402],"domain_scores_gemma":[0.99869835,0.0005558497,0.0001300222,0.00045426996,0.00007765714,0.00008386613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075396686,0.0002169827,0.00047549076,0.000037270212,0.00014131989,0.000022397215,0.00015798255,0.000055046738,0.00015830039],"category_scores_gemma":[0.000055601235,0.00009722869,0.00008164279,0.00028697026,0.00033609933,0.000061672166,0.00007564198,0.00057091407,0.000005960235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0834057,0.000197041,0.45130053,0.0014199404,0.0010896947,0.0010821514,0.007393756,0.003853104,0.022881161,0.0002465565,0.008468411,0.41866192],"study_design_scores_gemma":[0.02544603,0.008578453,0.81760037,0.0006460364,0.0003734415,0.00012861201,0.0009472885,0.0010199645,0.0796132,0.00026232656,0.06473663,0.0006476682],"about_ca_topic_score_codex":0.00049871777,"about_ca_topic_score_gemma":0.0006642513,"teacher_disagreement_score":0.41801426,"about_ca_system_score_codex":0.0003547391,"about_ca_system_score_gemma":0.0011516622,"threshold_uncertainty_score":0.3964871},"labels":[],"label_agreement":null},{"id":"W3194827107","doi":"10.2139/ssrn.3572896","title":"Nationwide Incidence of Sarcomas and Tumors of Intermediate Malignancy in France","year":2020,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Incidence (geometry); Malignancy; Medicine; Sarcoma; Demography; Internal medicine; Pathology; Sociology","score_opus":0.008214719907890015,"score_gpt":0.24423932461688286,"score_spread":0.23602460470899284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194827107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906995,0.007428108,0.0005516292,0.000938432,0.00003184749,0.00010109337,0.0000026637863,0.0000043877094,0.00024233348],"genre_scores_gemma":[0.99487233,0.0044378634,0.000102061094,0.00042214338,0.0000605311,0.0000015867461,0.0000017664032,0.000008821089,0.00009287195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988053,0.00003406421,0.00038650705,0.00011659001,0.00018097955,0.0004765621],"domain_scores_gemma":[0.9995901,0.000037085283,0.00016500421,0.000067470464,0.00006455506,0.0000757621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003971923,0.00007985988,0.00028258018,0.00009790756,0.0000164129,0.0000029420069,0.00009319954,0.00003415084,0.000037249614],"category_scores_gemma":[0.0001444017,0.00007158134,0.000050812265,0.00017509889,0.0000729304,0.00011869663,0.000024309611,0.0007249037,0.0000010932212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005466596,0.00007712647,0.8959954,0.00031448013,0.00012627323,0.00005456947,0.0022647164,0.000060606915,0.044581402,0.0070813457,0.00003236002,0.04886507],"study_design_scores_gemma":[0.007937715,0.0028214403,0.95232254,0.0008083083,0.00007626686,0.00071063003,0.00256061,0.0023279649,0.017761985,0.01197406,0.00041987124,0.00027858283],"about_ca_topic_score_codex":0.00006314416,"about_ca_topic_score_gemma":0.00016730907,"teacher_disagreement_score":0.056327175,"about_ca_system_score_codex":0.00013106385,"about_ca_system_score_gemma":0.0014792373,"threshold_uncertainty_score":0.3149386},"labels":[],"label_agreement":null},{"id":"W3199433115","doi":"10.1093/jjco/hyab151","title":"Age-specific lymphoma incidence rate in the world","year":2021,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Lymphoma; MEDLINE; Oncology; Internal medicine","score_opus":0.13229591577078115,"score_gpt":0.4459558411035854,"score_spread":0.31365992533280423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199433115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629728,0.0004871541,0.00001427974,0.017582605,0.00080114993,0.000098036944,4.392049e-7,0.0000046345335,0.018038863],"genre_scores_gemma":[0.9738695,0.0007023601,0.0011165782,0.022395134,0.00091744866,0.0000035105188,0.000001994042,0.000008056338,0.0009854072],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99643207,0.0011259967,0.0017316096,0.00018205024,0.00030077738,0.00022750847],"domain_scores_gemma":[0.9937673,0.004914283,0.0005480068,0.00028694444,0.0002801493,0.0002032738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050420514,0.00010476314,0.00089681643,0.00012139886,0.000041592175,0.000016044556,0.00025819373,0.00013096559,0.0008003276],"category_scores_gemma":[0.0022318962,0.00006279025,0.0003450433,0.00045705636,0.00021966915,0.00014612,0.000046976093,0.0007082088,0.000039871386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111144325,0.003993271,0.28620675,0.00006020253,0.00030128937,0.086187184,0.0050943727,0.0001336237,0.01354174,0.00085167197,0.023368005,0.56914747],"study_design_scores_gemma":[0.0067791035,0.0011008851,0.68902403,0.000046431076,0.00003974823,0.0021038062,0.0012204756,0.00004361986,0.00019595987,0.00025247753,0.2991291,0.000064328626],"about_ca_topic_score_codex":0.000009713582,"about_ca_topic_score_gemma":0.00039230363,"teacher_disagreement_score":0.5690831,"about_ca_system_score_codex":0.00017303239,"about_ca_system_score_gemma":0.0013631315,"threshold_uncertainty_score":0.87630254},"labels":[],"label_agreement":null},{"id":"W3200159260","doi":"10.1200/jco.2020.39.28_suppl.93","title":"Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Systemic therapy; Tolerability; Performance status; Comorbidity; Oncology; Log-rank test; Cancer; Survival analysis; Adverse effect","score_opus":0.08946220534220825,"score_gpt":0.44009138552760724,"score_spread":0.350629180185399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200159260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665201,0.019954296,0.000011805699,0.0012144314,0.0038327063,0.0001429157,0.000011341371,0.0000040216873,0.008308406],"genre_scores_gemma":[0.97746474,0.019722762,0.00079860806,0.00091371697,0.0007754164,0.0000031524403,0.000010029291,0.000014450113,0.00029714016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965371,0.00036581024,0.002327873,0.00020891883,0.00035080366,0.00020948144],"domain_scores_gemma":[0.9958643,0.0019647721,0.0012551714,0.00019776532,0.00049703685,0.00022095743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001105939,0.00013490889,0.0017304252,0.00010432786,0.000013791592,0.0000032718108,0.000114050345,0.00030171726,0.00042997292],"category_scores_gemma":[0.0016376021,0.0001014653,0.00046838616,0.00013514418,0.00009611193,0.00026785483,0.000036110814,0.0006115145,0.0000072041203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051734444,0.0035702304,0.21149056,0.00034875426,0.0010776032,0.0021840418,0.00048730956,0.00022674185,0.0003230221,0.00032026888,0.0008521109,0.7273849],"study_design_scores_gemma":[0.09692819,0.013265629,0.85237235,0.0016313766,0.0006642453,0.0006269998,0.001165173,0.000066103166,0.0002809879,0.0000402089,0.032766096,0.00019263],"about_ca_topic_score_codex":0.000028867078,"about_ca_topic_score_gemma":0.00016848299,"teacher_disagreement_score":0.7271923,"about_ca_system_score_codex":0.0003154386,"about_ca_system_score_gemma":0.0021441537,"threshold_uncertainty_score":0.47079018},"labels":[],"label_agreement":null},{"id":"W3201711148","doi":"10.1016/j.annonc.2021.08.1515","title":"1406P Survival outcomes in older adults with metastatic gastric and esophageal carcinoma receiving palliative chemotherapy","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Palliative chemotherapy; Chemotherapy; Oncology; Internal medicine; Carcinoma; Gastric carcinoma; Palliative care; Chemotherapy regimen; Cancer; Nursing","score_opus":0.051994736549696996,"score_gpt":0.35630927910549975,"score_spread":0.30431454255580276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201711148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912206,0.0013729171,0.000039396386,0.0047038235,0.00006632922,0.00025765746,0.000014905775,0.000008738283,0.002315642],"genre_scores_gemma":[0.99352664,0.0008937209,0.001951246,0.0031832021,0.000028926703,0.000017493105,0.000025222362,0.000016183783,0.00035739498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988829,0.00013593322,0.0003024615,0.0002757747,0.00015062676,0.00025230082],"domain_scores_gemma":[0.9990906,0.00034223477,0.00013066328,0.00016406541,0.00017312125,0.000099321944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022478779,0.00014271656,0.0007184747,0.00012274554,0.000021704604,0.0000044496646,0.000048099722,0.0000657522,0.00031589728],"category_scores_gemma":[0.00009926837,0.00011328705,0.000059651855,0.0002267879,0.000100763005,0.000069504276,0.000026164327,0.00018315438,0.0000015985684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013843244,0.0004362875,0.91996,0.00022289631,0.00022531183,0.0007889901,0.0034976392,0.000005419917,0.000375124,0.000037527218,0.0002736176,0.072792865],"study_design_scores_gemma":[0.008731295,0.0016676948,0.984983,0.00009046744,0.000040011495,0.00005981286,0.0014266144,0.0000806095,0.0022199836,0.000025690457,0.0005769175,0.000097883516],"about_ca_topic_score_codex":0.00016070258,"about_ca_topic_score_gemma":0.0005203481,"teacher_disagreement_score":0.07269498,"about_ca_system_score_codex":0.000052459985,"about_ca_system_score_gemma":0.00052975473,"threshold_uncertainty_score":0.4619712},"labels":[],"label_agreement":null},{"id":"W3203911529","doi":"10.3389/fonc.2021.754996","title":"The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cancer; Prostate cancer; Prostate; Stomach; Pancreatic cancer; Oncology","score_opus":0.008137122396595507,"score_gpt":0.28102777605458545,"score_spread":0.2728906536579899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203911529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90365636,0.004353497,0.0000067491756,0.0036527761,0.0009787914,0.0008640494,0.000050881652,0.000018528839,0.08641834],"genre_scores_gemma":[0.9893584,0.0023167632,0.00058757735,0.0029445116,0.0001528347,0.00044283897,0.00016386664,0.00004720876,0.0039859684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979423,0.00055765366,0.00041903256,0.000397675,0.00024388089,0.00043944834],"domain_scores_gemma":[0.99879825,0.00056643324,0.00015127192,0.0003297814,0.000057476558,0.00009677602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061870663,0.0002152102,0.0009331266,0.00012263542,0.000063677224,0.00000731149,0.0001624723,0.00020703787,0.00024316958],"category_scores_gemma":[0.00008111124,0.00013694225,0.0000672783,0.00038686275,0.00039760084,0.000053118463,0.00006303806,0.00074784766,0.0000020919672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02884426,0.00013736005,0.711719,0.00022864739,0.0001866345,0.001161101,0.0005754525,0.0010492296,0.0008594386,0.000020522039,0.046893243,0.20832513],"study_design_scores_gemma":[0.031614445,0.016111689,0.66573447,0.00026728856,0.00017585428,0.00008462855,0.0012673133,0.001602737,0.008161781,0.0001003232,0.2744108,0.00046865633],"about_ca_topic_score_codex":0.00062378345,"about_ca_topic_score_gemma":0.003394368,"teacher_disagreement_score":0.22751756,"about_ca_system_score_codex":0.0019359221,"about_ca_system_score_gemma":0.0022681307,"threshold_uncertainty_score":0.5584343},"labels":[],"label_agreement":null},{"id":"W3204126457","doi":"10.3390/curroncol28050330","title":"The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Canto; Breast cancer; Cohort; Cancer; Work (physics); Internal medicine; Linguistics","score_opus":0.0416991644271028,"score_gpt":0.35253097458749116,"score_spread":0.31083181016038836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204126457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91654325,0.053030245,0.00002345141,0.02099833,0.0015024018,0.00060780416,0.00010691728,0.000012085406,0.007175507],"genre_scores_gemma":[0.9936898,0.005006828,0.000026596294,0.00059154694,0.00029923106,0.00016683018,0.00001964824,0.000010405087,0.00018913075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99895585,0.000111621026,0.0003313296,0.00019898522,0.00020712276,0.00019510133],"domain_scores_gemma":[0.998866,0.00017310624,0.0001260508,0.00038546842,0.00036474178,0.000084637424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026204798,0.0000996548,0.0003195108,0.000030190005,0.00005973937,0.0000039223196,0.00013362283,0.00006623024,0.00038415132],"category_scores_gemma":[0.00005496331,0.000059366026,0.00009022339,0.00021457401,0.00015128432,0.000023379343,0.00007866179,0.00021079059,0.0000060700145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010491746,0.00028657966,0.26942378,0.00010525754,0.00018930844,0.000011485795,0.0039476524,0.000011288964,0.0018865697,0.00021439229,0.0072000166,0.71567446],"study_design_scores_gemma":[0.00071177376,0.00015764132,0.5239118,0.000107576125,0.00014398686,0.000013383133,0.0011899931,0.000048205646,0.00073542376,0.00012566714,0.472781,0.00007361108],"about_ca_topic_score_codex":0.00014587936,"about_ca_topic_score_gemma":0.0011080814,"teacher_disagreement_score":0.71560085,"about_ca_system_score_codex":0.00023275167,"about_ca_system_score_gemma":0.0009863294,"threshold_uncertainty_score":0.42061877},"labels":[],"label_agreement":null},{"id":"W3208350871","doi":"10.30683/1929-2279.2021.10.03","title":"Intensity Modulated Radiotherapy of Two Simultaneous Neoplasms - Cervical Carcinoma and Breast Carcinoma: A Case Report with a Review of the Literature","year":2021,"lang":"en","type":"review","venue":"Journal of cancer research updates","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Concomitant; Breast cancer; Carcinoma; Dissection (medical); Stage (stratigraphy); Radiology; Pelvis; Cancer; Internal medicine","score_opus":0.044408946329425866,"score_gpt":0.40587379006915536,"score_spread":0.3614648437397295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208350871","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035632174,0.9617632,0.0000019611268,0.0010387867,0.00015351406,0.0010784316,0.00028168896,0.0000037149787,0.000046526813],"genre_scores_gemma":[0.023823267,0.97500527,0.00023571312,0.0002690931,0.00035423978,0.000020557924,0.000058687503,0.00006289412,0.00017029764],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.995363,0.0007554807,0.0016867974,0.00043823384,0.0013407584,0.0004157561],"domain_scores_gemma":[0.9924284,0.0005811641,0.0015838364,0.00086230977,0.004186266,0.00035799848],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017004195,0.00042519072,0.003822298,0.00038836861,0.00009955664,0.00004445324,0.00036590788,0.00023914056,0.00028448645],"category_scores_gemma":[0.00044969842,0.00022073554,0.0007557756,0.0014005434,0.0005242968,0.00012877444,0.00017624878,0.0023427214,1.6872546e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019513592,0.00030058034,0.0033252696,0.32242298,0.0033649316,0.26746175,0.0007694561,0.000016142365,0.00013255698,0.000007909139,0.004286248,0.3959608],"study_design_scores_gemma":[0.0018381998,0.0006371731,0.00019366897,0.23571265,0.001660242,0.56830406,0.00007780377,0.000053923886,0.00007594635,0.0000045831257,0.19123133,0.00021039876],"about_ca_topic_score_codex":0.00092249474,"about_ca_topic_score_gemma":0.00012159941,"teacher_disagreement_score":0.3957504,"about_ca_system_score_codex":0.00058485055,"about_ca_system_score_gemma":0.005947668,"threshold_uncertainty_score":0.99995893},"labels":[],"label_agreement":null},{"id":"W3212929447","doi":"10.1503/cmaj.202731-f","title":"Cancer de l’endomètre","year":2021,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System; Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Gynecology; Endometrial cancer; Cancer; Internal medicine","score_opus":0.010065942347329788,"score_gpt":0.27032627781394014,"score_spread":0.26026033546661037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212929447","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050615888,0.16738574,0.0001731246,0.6724709,0.025832184,0.00015437372,0.00040286465,0.000024298512,0.08294063],"genre_scores_gemma":[0.11506672,0.1088324,0.000841438,0.4170734,0.06936279,0.000029810168,0.00012818795,0.00013062725,0.2885346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959097,0.00046369416,0.00057963905,0.00024255422,0.0014635677,0.001340857],"domain_scores_gemma":[0.9927499,0.00030577785,0.00021726005,0.00015058744,0.00081142824,0.005765045],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018072685,0.00019393275,0.00043214665,0.00014254569,0.0003495346,0.0001373163,0.00018568452,0.00090387487,0.23760623],"category_scores_gemma":[0.0036579466,0.00021418749,0.0002649829,0.00037787884,0.00007845812,0.00018840827,0.000021095795,0.0024877153,0.00063169794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000112750195,0.00003763119,0.081720576,0.000058803198,0.0004760452,0.011753606,0.00049687084,0.000018727516,0.000049244623,0.00037331588,0.58870846,0.31629544],"study_design_scores_gemma":[0.0025102382,0.00003921455,0.030058991,0.00066253636,0.00020319833,0.0037761985,0.00094803644,0.0008331057,0.0001243423,0.00011396147,0.96052796,0.00020220997],"about_ca_topic_score_codex":0.020211086,"about_ca_topic_score_gemma":0.19587295,"teacher_disagreement_score":0.37181953,"about_ca_system_score_codex":0.012979534,"about_ca_system_score_gemma":0.08253598,"threshold_uncertainty_score":0.99981356},"labels":[],"label_agreement":null},{"id":"W37581420","doi":"10.1007/978-3-540-72314-1_16","title":"Radiation-Related Second Primary Cancers: Clinical Perspectives","year":2013,"lang":"en","type":"book-chapter","venue":"Medical radiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Primary (astronomy); Medicine; Astronomy; Physics","score_opus":0.02340821913775881,"score_gpt":0.3097379131662831,"score_spread":0.28632969402852426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W37581420","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004774497,0.026212793,0.000024223651,0.0046373615,0.0025695518,0.00091542886,0.00007518469,0.00016426566,0.9606267],"genre_scores_gemma":[0.0069420813,0.025846334,0.00031986902,0.018900206,0.004665368,0.00007600308,0.0012451173,0.00017725876,0.9418278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961773,0.00015100258,0.0013936377,0.0010545426,0.0006719758,0.0005515147],"domain_scores_gemma":[0.99678355,0.0008818894,0.00043779257,0.00069848663,0.00017525867,0.0010230455],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0007755576,0.0005442783,0.0019754153,0.00025054836,0.00008780371,0.00001167358,0.00035260915,0.0025936835,0.24971724],"category_scores_gemma":[0.0007154089,0.0004611311,0.0006283912,0.000046614576,0.0015331968,0.00008481499,0.000109855515,0.0028918937,0.0018339447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005054842,0.00010646579,0.0011651185,0.00034066834,0.0027356842,0.0011907882,0.00072695175,0.0000011273353,0.000025082667,0.03686581,0.69740164,0.25893515],"study_design_scores_gemma":[0.004420688,0.0009345034,0.007754224,0.00023067801,0.0003176464,0.0009680855,0.000074050244,0.00012016968,0.0000021261499,0.0017847632,0.98289394,0.00049911113],"about_ca_topic_score_codex":0.00005828412,"about_ca_topic_score_gemma":0.00003904561,"teacher_disagreement_score":0.2854923,"about_ca_system_score_codex":0.0012785699,"about_ca_system_score_gemma":0.004502455,"threshold_uncertainty_score":0.99978405},"labels":[],"label_agreement":null},{"id":"W4200333351","doi":"10.1016/s1470-2045(25)00522-4","title":"Correction to Lancet Oncol 2024; 25: 1038–52","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grail; Program for Creating STart-ups from Advanced Research and Technology; UCLH Biomedical Research Centre; Novartis; Merck Sharp and Dohme; American Association for Cancer Research; Servier; Basilea Pharmaceutica; Medical Research Council; Celgene; Johnson and Johnson; AstraZeneca; Genentech; Ipsen; Vifor Pharma; PharmaMar; Deutsche Krebshilfe; Bayer; Astellas Pharma; MedImmune; Daiichi-Sankyo; National Institutes of Health; CRUK Lung Cancer Centre of Excellence; Rosetrees Trust; Cancer Research UK; Janssen Pharmaceuticals; Breast Cancer Research Foundation; Canadian Cancer Society; Center for Cancer Research; National Institute for Health and Care Research; Clovis Oncology; Astex Pharmaceuticals; Harvard University; Entertainment Industry Foundation; AbbVie; National Cancer Institute; Gilead Sciences; Pfizer; Baxter International; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; American Society of Clinical Oncology; Bristol-Myers Squibb; Deutsche Forschungsgemeinschaft; Roche; Astellas Pharma US","keywords":"Medicine; Family medicine","score_opus":0.04504243712373093,"score_gpt":0.37463845798410506,"score_spread":0.3295960208603741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200333351","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.097711444,0.00045573962,0.000573508,0.08724792,0.009600664,0.0009058187,0.000020884858,0.00016866619,0.80331534],"genre_scores_gemma":[0.6328479,0.0006698735,0.0016677621,0.16622074,0.00582255,0.00034225368,0.000056921002,0.000034101988,0.19233792],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988215,0.00015304796,0.0002402693,0.00027027552,0.00012465258,0.00039026322],"domain_scores_gemma":[0.9988797,0.0003651802,0.000063996646,0.00052414264,0.000073314586,0.00009369838],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005477937,0.00013730017,0.0006392261,0.00010845869,0.00012174661,0.000014177096,0.00023853107,0.00011462147,0.0012483184],"category_scores_gemma":[0.00025082304,0.00009718769,0.00008214218,0.000356709,0.00008492253,0.0000406414,0.00009819751,0.0005344594,0.0003303398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013701107,0.00006520853,0.00727114,0.000051993607,0.00009039057,0.000030185656,0.00037537655,0.000039874445,0.0023202805,0.0007172677,0.90379757,0.08387059],"study_design_scores_gemma":[0.0029205063,0.0005702613,0.05314692,0.00006960134,0.00008082839,0.000049796177,0.00021290511,0.00040331882,0.0005980162,0.00017293969,0.94168216,0.0000927509],"about_ca_topic_score_codex":0.0002321809,"about_ca_topic_score_gemma":0.0007646471,"teacher_disagreement_score":0.6109774,"about_ca_system_score_codex":0.0006186663,"about_ca_system_score_gemma":0.0006465872,"threshold_uncertainty_score":0.99966466},"labels":[],"label_agreement":null},{"id":"W4205906208","doi":"10.1016/j.jval.2021.11.015","title":"P16 Recent Estimates of Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in the US (2010-2020)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Nivolumab; Stage (stratigraphy); Lung cancer; Internal medicine; Oncology; Ipilimumab; Cancer; Disease; Database; Immunotherapy","score_opus":0.020252863955841333,"score_gpt":0.2807579044830403,"score_spread":0.2605050405271989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205906208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940863,0.0020928446,0.000008461793,0.0013271221,0.00040574768,0.001449292,0.00006709467,0.000008617656,0.00055446575],"genre_scores_gemma":[0.9960366,0.0012592884,0.00073543505,0.0016065226,0.00002834472,0.00019765348,0.00007576092,0.000025555531,0.000034872002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811167,0.0002642676,0.00053004624,0.00030023334,0.00039591044,0.0003978877],"domain_scores_gemma":[0.9991866,0.00018577416,0.00019974414,0.0003057663,0.000042905802,0.00007925776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079969695,0.0001489268,0.00044152763,0.00016675059,0.000059073867,0.0000040081736,0.00017503911,0.00003339869,0.00023583781],"category_scores_gemma":[0.00003329335,0.00011302421,0.000030501285,0.0005961066,0.00003195157,0.000050894345,0.000056561086,0.0005024835,7.0492945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010261441,0.00041748007,0.94215167,0.00061535655,0.000008071092,0.000022036817,0.0039025007,0.042979322,0.000031542782,0.000005824607,0.00025263111,0.008587424],"study_design_scores_gemma":[0.00760413,0.0009569569,0.98030126,0.00031864096,0.0000104880555,0.0000016818142,0.00075486006,0.008187705,0.00006304821,0.0000110244155,0.0016574048,0.00013278861],"about_ca_topic_score_codex":0.018222876,"about_ca_topic_score_gemma":0.0020231407,"teacher_disagreement_score":0.038149603,"about_ca_system_score_codex":0.0009714575,"about_ca_system_score_gemma":0.0014263573,"threshold_uncertainty_score":0.98831487},"labels":[],"label_agreement":null},{"id":"W4206500036","doi":"10.1007/s13187-020-01940-w","title":"2020 International Cancer Education Conference Program and Abstracts","year":2020,"lang":"en","type":"article","venue":"Journal of Cancer Education","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Medical education; Family medicine; Medical physics","score_opus":0.028738348516717308,"score_gpt":0.41854978371845314,"score_spread":0.38981143520173583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206500036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91680384,0.007905426,0.000025909254,0.0666259,0.003018716,0.00031898927,0.0000122556285,0.000014756777,0.0052741854],"genre_scores_gemma":[0.98051864,0.007298326,0.0016422359,0.006854603,0.0030647248,0.000056161272,0.000022752882,0.000012191697,0.0005303461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914044,0.000015510443,0.0003650917,0.00013348756,0.00025020397,0.00009528075],"domain_scores_gemma":[0.99864566,0.00001538908,0.0003936041,0.00006284833,0.0006250813,0.00025743165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007331391,0.00009466799,0.00018925358,0.00006808966,0.000029914003,0.000050602135,0.00008904286,0.000049132235,0.0011866447],"category_scores_gemma":[0.000069566435,0.000083130195,0.00005399249,0.00010449234,0.000038058748,0.00031384052,0.000012134178,0.00023634513,0.0000033404374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040931898,0.00025245865,0.067268915,0.00014151288,0.000112323185,0.0000022168595,0.0013073409,0.000025443382,0.0031312,0.000049810344,0.052609544,0.87468994],"study_design_scores_gemma":[0.0010957015,0.00036760958,0.4210258,0.00039010684,0.00018244391,0.000084415915,0.0011533492,0.00031175063,0.0014722229,0.000085634194,0.5736955,0.00013546724],"about_ca_topic_score_codex":0.00018469903,"about_ca_topic_score_gemma":0.00004697674,"teacher_disagreement_score":0.87455446,"about_ca_system_score_codex":0.000255308,"about_ca_system_score_gemma":0.0057237525,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W4212896580","doi":"10.3747/co.v16i0.446","title":"Preface","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.13654540550791802,"score_gpt":0.4464307940814162,"score_spread":0.30988538857349823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212896580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7808217,0.0059530456,0.00037288058,0.008873198,0.0020203034,0.00045977664,0.0000063467555,0.00014711983,0.20134562],"genre_scores_gemma":[0.99395066,0.0005244879,0.0005688893,0.0032087388,0.0004758189,0.00000922233,0.00004149569,0.000006528733,0.0012141357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994473,0.00002218095,0.00013030622,0.00015272011,0.000077052835,0.00017042868],"domain_scores_gemma":[0.9996446,0.000023183275,0.00003392753,0.00015169462,0.000035911205,0.00011071835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000665036,0.00007135509,0.00019549199,0.000044924775,0.0000273193,0.0000029397986,0.000050498078,0.000058091653,0.0007320136],"category_scores_gemma":[0.000030052335,0.00006042353,0.000056077257,0.000063755346,0.00003285411,0.000036608657,0.000010539867,0.0001894624,0.00013212653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017888399,0.0002950378,0.0049217716,0.000022766122,0.000011148043,0.000023881108,0.00020303635,0.0000014152919,0.0020554848,0.0004081773,0.047906518,0.9439719],"study_design_scores_gemma":[0.001538552,0.00085937587,0.057237394,0.000015329024,0.000028360477,0.000048467376,0.000024426094,0.000113839116,0.0004532761,0.0001569594,0.9394611,0.000062908344],"about_ca_topic_score_codex":0.000001124569,"about_ca_topic_score_gemma":0.0000017260761,"teacher_disagreement_score":0.943909,"about_ca_system_score_codex":0.00018670145,"about_ca_system_score_gemma":0.00023029307,"threshold_uncertainty_score":0.80150354},"labels":[],"label_agreement":null},{"id":"W4214884454","doi":"10.1200/po.21.00286","title":"Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"St. Baldrick's Foundation; Hospital for Sick Children; Bristol-Myers Squibb","keywords":"Somatic hypermutation; Immune checkpoint; Immune system; Medicine; Oncology; Immunology; Immunotherapy; Antibody; B cell","score_opus":0.04808232243282154,"score_gpt":0.35595393747601456,"score_spread":0.30787161504319305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214884454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886605,0.000643334,0.00039152353,0.0011330124,0.0009038496,0.0028014844,0.00003508466,0.00010970634,0.0053214747],"genre_scores_gemma":[0.99377245,0.00006127782,0.0014684779,0.0021215472,0.00038365787,0.0012368147,0.00031131122,0.000050920265,0.00059352495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977201,0.0003222155,0.00065645773,0.0005712612,0.00038580896,0.0003441091],"domain_scores_gemma":[0.9986372,0.0003621049,0.00029295118,0.0003887916,0.00017132267,0.00014764295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010014276,0.00020462839,0.00053562305,0.00020557822,0.00052494876,0.000024548115,0.00013120438,0.00010326128,0.00279135],"category_scores_gemma":[0.00014173894,0.00019929053,0.00016451676,0.00022921413,0.000062172316,0.0001954785,0.000109361696,0.00035891656,0.000016782713],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008494086,0.0029969371,0.0007527857,0.000033163735,0.00014675717,0.00021179966,0.00855598,0.0013304874,0.27028608,0.000043627188,0.0012519967,0.7058963],"study_design_scores_gemma":[0.07830066,0.2003094,0.032570213,0.0001182913,0.00039818964,0.0017759851,0.06999581,0.009634104,0.085646085,0.0017209445,0.51808727,0.0014430244],"about_ca_topic_score_codex":0.00039026022,"about_ca_topic_score_gemma":0.00011927133,"teacher_disagreement_score":0.7044533,"about_ca_system_score_codex":0.0028803288,"about_ca_system_score_gemma":0.0012563777,"threshold_uncertainty_score":0.99812025},"labels":[],"label_agreement":null},{"id":"W4225353296","doi":"10.1007/s13187-022-02141-3","title":"2021 International Cancer Education Conference Program and Abstracts","year":2021,"lang":"en","type":"article","venue":"Journal of Cancer Education","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre","funders":"","keywords":"Medicine; Family medicine; Cancer; Medical education; Internal medicine","score_opus":0.022832302926771873,"score_gpt":0.42560166524585646,"score_spread":0.4027693623190846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225353296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94846576,0.016905535,0.000023028835,0.018258153,0.0055619925,0.00018805546,0.000010671102,0.00000631546,0.010580511],"genre_scores_gemma":[0.9710017,0.017085873,0.0027395582,0.0021221775,0.002572087,0.00006844286,0.000046341327,0.000012564702,0.0043512485],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99911714,0.000022201077,0.00036185313,0.00013772598,0.00025823773,0.00010283269],"domain_scores_gemma":[0.99805236,0.000020684054,0.00035007097,0.000101621634,0.0013154352,0.00015985315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011234524,0.00009004576,0.00018692554,0.00011011954,0.00003570185,0.00006565106,0.0000632718,0.000055498564,0.0026353502],"category_scores_gemma":[0.0000736669,0.000082192426,0.00006055014,0.00011363683,0.00003651238,0.00030280655,0.000013124482,0.00021960297,0.0000026822743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014012243,0.00045879677,0.060129102,0.00008823465,0.00012137341,0.0000050423755,0.00049761747,0.000014390889,0.0050385115,0.00009338264,0.015508791,0.9179046],"study_design_scores_gemma":[0.00094107335,0.00012817506,0.501175,0.00068057614,0.00018612288,0.00027048207,0.001451748,0.00007179378,0.0053892797,0.00019978148,0.48938158,0.00012438608],"about_ca_topic_score_codex":0.00022964462,"about_ca_topic_score_gemma":0.0001978947,"teacher_disagreement_score":0.9177802,"about_ca_system_score_codex":0.00039443874,"about_ca_system_score_gemma":0.011806798,"threshold_uncertainty_score":0.99827635},"labels":[],"label_agreement":null},{"id":"W4231752673","doi":"10.1093/annonc/mdn217","title":"session 6 – extranodal lymphoma","year":2008,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Session (web analytics); Lymphoma; Medical physics; Internal medicine; World Wide Web","score_opus":0.1252000018567793,"score_gpt":0.38811413738070877,"score_spread":0.2629141355239295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231752673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.886431,0.0006067867,0.00003430867,0.0035711324,0.00018287222,0.000102233265,0.00000546129,0.000022254038,0.10904395],"genre_scores_gemma":[0.98973674,0.0012045061,0.00061566697,0.0065055303,0.00013693151,0.0000054739644,0.000017295122,0.000009346511,0.0017685338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993067,0.00003740347,0.00022073252,0.00013721308,0.000121044024,0.00017692267],"domain_scores_gemma":[0.999478,0.000067035224,0.00007749944,0.00016572067,0.00010566024,0.000106097206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010860291,0.0000750573,0.00031791805,0.00007450545,0.000044354056,6.48416e-7,0.000058584697,0.000116722375,0.0008488548],"category_scores_gemma":[0.000041006126,0.00006320147,0.00010180566,0.00008155975,0.00014744281,0.000055762353,0.000020191492,0.00006344574,0.00003966343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001997807,0.0008286258,0.023745254,0.00010009597,0.00012810975,0.0008868066,0.0010626564,0.000006134334,0.03986168,0.0002495254,0.13842188,0.79271144],"study_design_scores_gemma":[0.0034628913,0.0028290423,0.17648834,0.000026190815,0.000019778243,0.00072378526,0.00007457621,0.000056024062,0.029819341,0.0000704943,0.7863368,0.000092782095],"about_ca_topic_score_codex":0.00004819804,"about_ca_topic_score_gemma":0.0000057424286,"teacher_disagreement_score":0.79261863,"about_ca_system_score_codex":0.0000333509,"about_ca_system_score_gemma":0.0005800888,"threshold_uncertainty_score":0.92943645},"labels":[],"label_agreement":null},{"id":"W4233452951","doi":"10.1007/978-3-030-32482-7_26","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hodgkin lymphoma; Medicine; Malignancy; Lymphoma; Oncology; Internal medicine","score_opus":0.02560708882478763,"score_gpt":0.23870812350478146,"score_spread":0.21310103467999383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233452951","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051340662,0.04366722,0.00004462043,0.00046752614,0.0005500999,0.0019231259,0.0020551055,0.00027019964,0.89968145],"genre_scores_gemma":[0.3766647,0.013727988,0.00232439,0.0018596599,0.0004413483,0.00032315622,0.00051903975,0.00023724807,0.60390246],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726385,0.000038516122,0.0009908477,0.00085196097,0.00042139157,0.00043345694],"domain_scores_gemma":[0.9978385,0.00014350335,0.00074189797,0.00084268796,0.0001550845,0.0002783369],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007972428,0.0008213217,0.0022266437,0.00020946783,0.000070732734,0.000017424258,0.0001615862,0.00064894155,0.015204717],"category_scores_gemma":[0.000041891184,0.0006362433,0.0008394125,0.000060737413,0.00034584574,0.00006658741,0.0000885922,0.00018087718,0.00037404455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022146104,0.0035341855,0.076947294,0.041197643,0.017758323,0.06616707,0.013815235,0.000008532846,0.009878968,0.3712642,0.16617623,0.21110623],"study_design_scores_gemma":[0.0050690887,0.0033401514,0.004853304,0.0013579392,0.0014806543,0.0011261714,0.000120009965,0.000018111494,0.012263624,0.006172257,0.96307796,0.0011207412],"about_ca_topic_score_codex":0.000023115195,"about_ca_topic_score_gemma":0.000041948388,"teacher_disagreement_score":0.7969017,"about_ca_system_score_codex":0.00032130413,"about_ca_system_score_gemma":0.000547285,"threshold_uncertainty_score":0.9996089},"labels":[],"label_agreement":null},{"id":"W4233497917","doi":"10.5539/cco.v8n1p43","title":"Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 8, No. 1","year":2019,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clinical Oncology; Medicine; Library science; Cancer; Family medicine; Oncology; Gerontology; Internal medicine","score_opus":0.11755437892017392,"score_gpt":0.4946695536484514,"score_spread":0.3771151747282775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233497917","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8134947,0.04408101,0.000051935043,0.0076301643,0.10180073,0.0042931316,0.00021023506,0.000089146175,0.02834896],"genre_scores_gemma":[0.047040876,0.5896665,0.0044932007,0.15213826,0.05882044,0.001692969,0.0002129494,0.00019731138,0.14573748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970126,0.00019947514,0.0013730732,0.000833657,0.00013561934,0.000445579],"domain_scores_gemma":[0.99307597,0.0018049013,0.00039066357,0.0003588096,0.0038107561,0.0005588866],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017569154,0.0002528122,0.001770898,0.000048615762,0.000082714396,0.000011454242,0.00013949655,0.00070706615,0.0050419206],"category_scores_gemma":[0.0086628385,0.00019736672,0.00035685697,0.000086975,0.0005578552,0.00010216594,0.00015465125,0.00073599396,0.00028317826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012053484,0.00026590013,0.21870235,0.00023588628,0.0003361097,0.0000040390582,0.00002325251,1.5353427e-7,0.00000834364,0.000009016839,0.30548814,0.47372144],"study_design_scores_gemma":[0.01280246,0.0053731385,0.13956276,0.000164165,0.0006651243,0.0000016957074,0.000042753407,0.00030010138,0.000006015298,0.00004339492,0.8408399,0.0001984697],"about_ca_topic_score_codex":0.00007710526,"about_ca_topic_score_gemma":0.00072293886,"teacher_disagreement_score":0.7664538,"about_ca_system_score_codex":0.00040152203,"about_ca_system_score_gemma":0.002105177,"threshold_uncertainty_score":0.9996876},"labels":[],"label_agreement":null},{"id":"W4238498628","doi":"10.1097/01.cot.0000475720.67235.a2","title":"Merit Award Presented at the Breast Cancer Symposium","year":2015,"lang":"en","type":"article","venue":"Oncology Times","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Internal medicine","score_opus":0.028656322761467713,"score_gpt":0.3266875490605343,"score_spread":0.2980312262990666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238498628","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13109753,0.0032025087,0.000008160063,0.30303445,0.0017841172,0.0006323995,0.00012212398,0.00012414074,0.5599946],"genre_scores_gemma":[0.14506274,0.0008210971,0.00017546074,0.017060045,0.001446681,0.00023732253,0.00009362635,0.00005273331,0.8350503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910015,0.00008706623,0.00016504082,0.0002164367,0.00017756537,0.00025376776],"domain_scores_gemma":[0.9992403,0.0000869017,0.0000680725,0.0002934742,0.000112863425,0.00019839063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018015847,0.000121169054,0.0002813833,0.000035847836,0.000088263194,0.0000069786906,0.00012138783,0.00011767655,0.006602896],"category_scores_gemma":[0.000021525446,0.00007578847,0.000074813994,0.000093005074,0.00023134665,0.000059937705,0.00010222439,0.00018437055,0.00031915313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008237302,0.00007307409,0.01879965,0.000015720223,0.00015880424,0.0000733648,0.0005038751,0.000026614616,0.0026396362,0.000029006835,0.9703207,0.0065358067],"study_design_scores_gemma":[0.0021785686,0.00025965617,0.010820466,0.000014121989,0.00013375634,0.00059827045,0.00021301661,0.00038588693,0.0009766518,0.00001645667,0.9843128,0.00009036748],"about_ca_topic_score_codex":0.0005386856,"about_ca_topic_score_gemma":0.000282114,"teacher_disagreement_score":0.2859744,"about_ca_system_score_codex":0.00065955933,"about_ca_system_score_gemma":0.0008937161,"threshold_uncertainty_score":0.9943052},"labels":[],"label_agreement":null},{"id":"W4240203605","doi":"10.1200/jco.2011.29.4_suppl.511","title":"Associations between county-level surgeon density and colorectal cancer (CRC) mortality.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Demography; Incidence (geometry); Socioeconomic status; Mortality rate; Population; Cancer; Gerontology; Demographics; Internal medicine; Environmental health","score_opus":0.3425276109720428,"score_gpt":0.4770876392922603,"score_spread":0.13456002832021746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240203605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991919,0.0002558268,0.000058835667,0.0014489407,0.0010976397,0.00012353217,0.000085921434,0.000008115312,0.005002178],"genre_scores_gemma":[0.9942378,0.001082492,0.0011184082,0.0022511624,0.0011272529,0.0000018035842,0.000010679496,0.000011129523,0.0001592845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738944,0.00027827403,0.0016803656,0.00016100987,0.00028716945,0.00020377443],"domain_scores_gemma":[0.9961435,0.0014760451,0.0013920069,0.000100591,0.00048244256,0.0004054186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002959635,0.00011031684,0.001419465,0.00007487602,0.000061391656,0.0000054475295,0.00009075837,0.00038823253,0.00041181635],"category_scores_gemma":[0.0018213362,0.00008577899,0.0003013058,0.00008317235,0.00022352408,0.00013478476,0.000041626667,0.0008725362,0.000004947925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007311787,0.00027133216,0.95538175,0.000010393209,0.0007002252,0.00016986796,0.0001810373,3.151662e-7,0.00007592581,0.000040856907,0.0037013076,0.03873579],"study_design_scores_gemma":[0.003441462,0.002182412,0.9808143,0.000024460636,0.00068675674,0.000056501678,0.00004300128,0.000013735696,0.00018488613,0.00023251242,0.012236333,0.000083670835],"about_ca_topic_score_codex":0.00073257857,"about_ca_topic_score_gemma":0.0010130313,"teacher_disagreement_score":0.03865212,"about_ca_system_score_codex":0.0002692492,"about_ca_system_score_gemma":0.0024686805,"threshold_uncertainty_score":0.45091},"labels":[],"label_agreement":null},{"id":"W4240924366","doi":"10.1200/jco.2014.32.3_suppl.568","title":"Causes of urban-rural disparities in adjuvant chemotherapy (AC) for rectal cancer (RC).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Logistic regression; Quartile; Demography; Internal medicine; Cancer; Colorectal cancer; Confidence interval","score_opus":0.10933204418235218,"score_gpt":0.47580950033287683,"score_spread":0.3664774561505246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240924366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846159,0.0017213046,0.00017380502,0.010388691,0.0016379086,0.00021847259,0.000012856221,0.000004595432,0.0012264617],"genre_scores_gemma":[0.9866302,0.002969837,0.0017274378,0.006418812,0.0017004772,0.000010742609,0.0000032400105,0.000017428267,0.0005218227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973688,0.00018689202,0.001916261,0.00012016148,0.00019273438,0.00021515474],"domain_scores_gemma":[0.99634725,0.0019480526,0.0011200326,0.00012769585,0.00027342237,0.00018355963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018948131,0.00011333098,0.0016718024,0.000109185545,0.000016769047,0.0000031956472,0.00013071808,0.00026654548,0.00026212705],"category_scores_gemma":[0.001830291,0.00008095851,0.00044029186,0.00006994606,0.00022186854,0.00009772855,0.000017180259,0.0005478664,0.0000010591857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014340744,0.0008839042,0.6149031,0.00019215925,0.00037463996,0.00003821493,0.000323474,0.000038432565,0.0013176574,0.0002115767,0.03589209,0.33148402],"study_design_scores_gemma":[0.02139228,0.012082575,0.69505745,0.00028189507,0.0001971614,0.0000663116,0.000179123,0.00045011405,0.0012402836,0.00039624076,0.2685246,0.00013197484],"about_ca_topic_score_codex":0.00019113734,"about_ca_topic_score_gemma":0.00042322942,"teacher_disagreement_score":0.33135203,"about_ca_system_score_codex":0.00016968886,"about_ca_system_score_gemma":0.0014550909,"threshold_uncertainty_score":0.33013922},"labels":[],"label_agreement":null},{"id":"W4240946306","doi":"10.1016/s0360-3016(01)02787-0","title":"Second malignancies after prostate radiation: results from a linked tumour - radiation registry in a stable population base","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Incidence (geometry); Radiation therapy; Malignancy; Urology; Population; Cancer registry; Cancer; Oncology; Internal medicine","score_opus":0.022534617750085282,"score_gpt":0.29231578521737434,"score_spread":0.26978116746728903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240946306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988524,0.0019132249,0.0005826752,0.0045704073,0.002086839,0.0004503798,0.00073211745,0.000043856322,0.0010964794],"genre_scores_gemma":[0.99064326,0.0012741439,0.0019212143,0.0021835011,0.0022552696,0.00003427266,0.0011837333,0.000037122983,0.00046748412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713135,0.0002915187,0.0014535864,0.0004047959,0.00039944684,0.00031927598],"domain_scores_gemma":[0.99705637,0.00042792075,0.0015898392,0.00024994774,0.0004954287,0.00018051719],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006402651,0.00027577506,0.0006374396,0.00034665418,0.00006872393,0.000058904927,0.00026736828,0.00033549208,0.00097032945],"category_scores_gemma":[0.00055074,0.00026908203,0.00022850599,0.00027815564,0.000103230595,0.00083714287,0.000042065967,0.0006548628,0.000057912468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063179005,0.0010982035,0.6799052,0.000046585057,0.00069295306,0.0005068603,0.0047975564,0.0024933484,0.01066112,0.0007165124,0.011784291,0.28097948],"study_design_scores_gemma":[0.037300367,0.0013607069,0.8184289,0.00027249625,0.0002057178,0.00024011836,0.00024827427,0.026467144,0.0036400761,0.004552829,0.10669299,0.0005904036],"about_ca_topic_score_codex":0.00016970116,"about_ca_topic_score_gemma":0.000087516506,"teacher_disagreement_score":0.28038907,"about_ca_system_score_codex":0.0017400864,"about_ca_system_score_gemma":0.00045362787,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4242471800","doi":"10.5539/cco.v7n1p63","title":"Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 7, No. 1","year":2018,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chapel; Clinical Oncology; Library science; Medicine; University hospital; Gerontology; Family medicine; Cancer; History; Internal medicine; Art history","score_opus":0.14884600930352618,"score_gpt":0.5142612446355055,"score_spread":0.3654152353319793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242471800","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68616307,0.06052723,0.0002868905,0.016874978,0.1791319,0.005419195,0.00038722195,0.00018298627,0.051026534],"genre_scores_gemma":[0.042345446,0.5083,0.008145179,0.19217336,0.16404164,0.0018449535,0.00016212069,0.0001988436,0.08278848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969819,0.00021043769,0.0013934025,0.0008182541,0.00012918515,0.00046682873],"domain_scores_gemma":[0.9910198,0.0015023071,0.00038985536,0.00034210776,0.00610345,0.000642467],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018854076,0.0002516698,0.0015737802,0.000049727565,0.00015861074,0.000012266536,0.00014334514,0.0006997162,0.0040490343],"category_scores_gemma":[0.013996732,0.00019591837,0.00030887302,0.00010012347,0.0015100101,0.00009512982,0.00016303762,0.0006217575,0.00017664595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012922578,0.0002594937,0.08566566,0.0001214172,0.00031393545,0.000004304929,0.000033520162,1.9027686e-8,0.000006277389,0.0000076205188,0.40934604,0.5029495],"study_design_scores_gemma":[0.010708449,0.008286468,0.1047327,0.00014876323,0.0008179048,0.000002180429,0.000037510268,0.00024572454,0.000012968516,0.00006849129,0.8747398,0.00019903155],"about_ca_topic_score_codex":0.00009079533,"about_ca_topic_score_gemma":0.0018443242,"teacher_disagreement_score":0.6438176,"about_ca_system_score_codex":0.00038108838,"about_ca_system_score_gemma":0.0021762445,"threshold_uncertainty_score":0.9968614},"labels":[],"label_agreement":null},{"id":"W4243678380","doi":"10.1158/1538-7445.sabcs19-p2-08-08","title":"Abstract P2-08-08: A population-based study examining the epidemiology, treatment patterns and resource utilization by stage in Ontario patients with triple negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Triple-negative breast cancer; Stage (stratigraphy); Breast cancer; Population; Incidence (geometry); Health care; Cancer registry; Epidemiology; Cancer; Disease; Internal medicine; Oncology; Environmental health","score_opus":0.20374761579835007,"score_gpt":0.4044712027633965,"score_spread":0.2007235869650464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243678380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482656,0.0002590747,0.000012170721,0.0021653618,0.000028491186,0.0021738852,0.00040839714,0.000017233444,0.00010882826],"genre_scores_gemma":[0.99759245,0.0000633819,0.000013509648,0.0010361368,0.000060851395,0.00059652585,0.00028632052,0.000028363442,0.00032246712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791133,0.00041414116,0.00034300913,0.00053937366,0.00036999013,0.0004221506],"domain_scores_gemma":[0.998718,0.000559764,0.00011538879,0.0002495358,0.00014164411,0.00021562594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005647734,0.00019174888,0.00040025907,0.000106807995,0.00019687215,0.000026341178,0.00011089821,0.00006718391,0.0014334923],"category_scores_gemma":[0.0001204621,0.0001221009,0.000027702165,0.00030926272,0.00009739255,0.00010450876,0.000041116124,0.000529101,0.0000021749686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024736507,0.00022114835,0.97680366,0.00005660335,0.00009207089,0.0000099071885,0.005103594,0.0005013344,0.000037491645,7.6249165e-7,0.0004159232,0.014283831],"study_design_scores_gemma":[0.007727408,0.0011094806,0.9867329,0.00012610089,0.00003154533,2.8400635e-7,0.0021808571,0.0004429844,0.000054261836,0.0000011930506,0.0014753052,0.000117679556],"about_ca_topic_score_codex":0.43252978,"about_ca_topic_score_gemma":0.45248124,"teacher_disagreement_score":0.019951453,"about_ca_system_score_codex":0.0019220941,"about_ca_system_score_gemma":0.00090465345,"threshold_uncertainty_score":0.99947935},"labels":[],"label_agreement":null},{"id":"W4245285343","doi":"10.5489/cuaj.1267","title":"Podium Session 3: All Oncology","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medical physics; Medicine; Oncology; Internal medicine; Computer science; World Wide Web","score_opus":0.019322602466742785,"score_gpt":0.26345758590136364,"score_spread":0.24413498343462087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245285343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78752935,0.00021232005,0.000038219307,0.16124897,0.00079734524,0.00026789957,0.000011937705,0.000034721837,0.04985926],"genre_scores_gemma":[0.9302834,0.00010188273,0.00042275435,0.0653802,0.00065610034,0.000010768124,0.00003099351,0.000009369577,0.0031045256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987209,0.00013705301,0.00028243003,0.00014426431,0.00023703216,0.0004783409],"domain_scores_gemma":[0.99830353,0.00011525539,0.00017565265,0.00008272373,0.00024081669,0.0010820354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039731813,0.00010137105,0.00024478673,0.00013562321,0.00016802517,0.000060398877,0.000091130125,0.00031565994,0.013034718],"category_scores_gemma":[0.00039668358,0.00007696138,0.00011347121,0.00009505987,0.000022998891,0.00014813236,0.000011245448,0.0007087579,0.0006259712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054668086,0.00006307373,0.44649333,0.0000047141953,0.00015210285,0.00021306344,0.00019788805,0.000015939575,0.0017217414,0.000106074585,0.48596776,0.06500963],"study_design_scores_gemma":[0.0007763972,0.00028945453,0.42113614,0.000003136548,0.000027196915,0.00024246782,0.0000535701,0.0001417838,0.000017717837,0.0003469042,0.576896,0.00006919239],"about_ca_topic_score_codex":0.0021875931,"about_ca_topic_score_gemma":0.0005099535,"teacher_disagreement_score":0.14275408,"about_ca_system_score_codex":0.0026279078,"about_ca_system_score_gemma":0.001174627,"threshold_uncertainty_score":0.9878675},"labels":[],"label_agreement":null},{"id":"W4247734966","doi":"10.1159/isbn.978-3-8055-8498-2","title":"The Prevention of Second Primary Cancers","year":2008,"lang":"en","type":"book","venue":"Progress in tumor research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Primary (astronomy); Primary prevention; Medicine; Internal medicine; Physics; Disease","score_opus":0.07558569888072093,"score_gpt":0.3952110527923283,"score_spread":0.3196253539116074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247734966","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026439965,0.08784971,6.07728e-7,0.00040759728,0.00035636505,0.003323076,0.000076839126,0.000036952446,0.8815089],"genre_scores_gemma":[0.011312537,0.010671648,0.00021642988,0.000115294715,0.00049151684,0.00065456046,0.00027164753,0.00010886086,0.9761575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963326,0.00026236623,0.00067998574,0.00050711667,0.0015214894,0.0006964692],"domain_scores_gemma":[0.99793684,0.0004523334,0.00024458944,0.0007720708,0.00043799033,0.00015615532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017894303,0.00024926235,0.00067306106,0.0004892533,0.0002047137,0.000028351267,0.00049731944,0.00020194447,0.0005374818],"category_scores_gemma":[0.00010681919,0.00018597985,0.00021109018,0.00031559146,0.0016104993,0.00008175939,0.00024538697,0.0020206412,0.000030089574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051597115,0.00039980115,0.018647553,0.009701484,0.00060008734,0.0021842509,0.0012996375,0.0000030246872,0.0001490415,0.0019491407,0.38846344,0.57144284],"study_design_scores_gemma":[0.002495469,0.0010486237,0.014143243,0.0019279312,0.000033931778,0.00015979593,0.00010003881,0.000048238886,0.00058834587,0.0012230469,0.9779539,0.0002774335],"about_ca_topic_score_codex":0.000042313877,"about_ca_topic_score_gemma":0.00036491113,"teacher_disagreement_score":0.5894905,"about_ca_system_score_codex":0.002704761,"about_ca_system_score_gemma":0.010332457,"threshold_uncertainty_score":0.99527806},"labels":[],"label_agreement":null},{"id":"W4248902005","doi":"10.9778/cmajo.20180186","title":"Correction: Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort study Correction","year":2018,"lang":"en","type":"erratum","venue":"CMAJ Open","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Retrospective cohort study; Oncology; Cohort; Primary cancer; Internal medicine; Medical physics; Information retrieval; Computer science","score_opus":0.044993770463032885,"score_gpt":0.34223041709740804,"score_spread":0.29723664663437516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248902005","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12392861,0.0054658516,0.0051506055,0.001202941,0.3639652,0.12146155,0.002475692,0.000626311,0.3757232],"genre_scores_gemma":[0.014572803,0.0004123421,0.0029491354,0.0019133661,0.007297224,0.0077584386,0.004235897,0.00043763014,0.9604232],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99663216,0.00012004183,0.0007201972,0.0012539519,0.0007204907,0.0005531512],"domain_scores_gemma":[0.99760514,0.000114152754,0.000749554,0.00059639255,0.0006946694,0.00024009003],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059002993,0.0005839472,0.0017450971,0.00032613936,0.00029846805,0.00016909228,0.00039771982,0.00023289796,0.0013172005],"category_scores_gemma":[0.0002475063,0.0005112113,0.00013320996,0.0006389427,0.00008920592,0.00043458384,0.00023057549,0.0011528588,0.0000059152467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027546028,0.00018578219,0.47130564,0.00012213096,0.0006542506,0.000009441683,0.00066371605,0.000026280835,4.767375e-7,1.5907752e-7,0.49857056,0.02570694],"study_design_scores_gemma":[0.010647633,0.002926872,0.8730439,0.0025639385,0.0011938169,0.0000060581483,0.00045937637,0.0008486074,0.0000046267587,0.0000034453171,0.10774524,0.00055646163],"about_ca_topic_score_codex":0.06349684,"about_ca_topic_score_gemma":0.05442557,"teacher_disagreement_score":0.5846999,"about_ca_system_score_codex":0.0037240812,"about_ca_system_score_gemma":0.0041857646,"threshold_uncertainty_score":0.9997339},"labels":[],"label_agreement":null},{"id":"W4250491542","doi":"10.1200/jco.2004.22.90140.6588","title":"Long-term follow up of limited stage primary testicular lymphoma: Outcome and patterns of relapse after combined-modality treatment","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Chemotherapy; Surgery; Lymphoma; Internal medicine; CHOP; Gastroenterology","score_opus":0.09729579567684771,"score_gpt":0.41592034318740273,"score_spread":0.318624547510555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250491542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557966,0.0007818925,0.00016875919,0.0020853158,0.00073649234,0.00028957915,0.000042169144,0.000006173601,0.0003099754],"genre_scores_gemma":[0.9951169,0.0010252757,0.0015540188,0.0017165641,0.00019121887,0.0000048042816,0.0000137102725,0.000017806295,0.0003597159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607277,0.00023922767,0.0029206243,0.00021643445,0.0003426516,0.00020826406],"domain_scores_gemma":[0.9960097,0.0011610675,0.0018279743,0.00031177636,0.000317479,0.00037196916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012003097,0.0001943323,0.0022220283,0.00013070516,0.000018891984,0.0000039459846,0.00011469442,0.0003436966,0.00014638511],"category_scores_gemma":[0.00088288647,0.00013387171,0.0006503253,0.000080011916,0.00026549725,0.000115596864,0.000058445625,0.00033648606,0.000001765269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012319042,0.0032346917,0.94074816,0.00029449654,0.0006717764,0.0016843533,0.00015581542,0.00001154279,0.00036891602,0.000029061883,0.000023266875,0.040458858],"study_design_scores_gemma":[0.048787724,0.02099877,0.92783725,0.00018231198,0.0007604482,0.00021530488,0.00003849996,0.0000064544834,0.00030507508,0.00006586428,0.00070315896,0.00009910356],"about_ca_topic_score_codex":0.000077706114,"about_ca_topic_score_gemma":0.00008036081,"teacher_disagreement_score":0.040359754,"about_ca_system_score_codex":0.0005077273,"about_ca_system_score_gemma":0.002042546,"threshold_uncertainty_score":0.545913},"labels":[],"label_agreement":null},{"id":"W4254912924","doi":"10.5114/wo.2015.48671","title":"Editorial","year":2015,"lang":"pl","type":"editorial","venue":"Współczesna Onkologia","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Computer science","score_opus":0.023786924518887757,"score_gpt":0.3041604650052729,"score_spread":0.28037354048638513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254912924","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006189377,0.005363383,0.000022000424,0.0004685673,0.93460876,0.0014140271,0.0014370889,0.00042573837,0.05564151],"genre_scores_gemma":[0.00062743423,0.0017809218,0.00037459255,0.0007020875,0.9585378,0.0001361818,0.005759624,0.00029006676,0.03179125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889609,0.0005412792,0.0018873882,0.0023031193,0.0041502146,0.0021571028],"domain_scores_gemma":[0.99137,0.0014707169,0.0010434085,0.0022966922,0.002240434,0.0015787131],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0025245722,0.001794613,0.0031906667,0.0005571863,0.0003637132,0.00022912472,0.0015029975,0.006828736,0.0069170087],"category_scores_gemma":[0.0064501744,0.0016532354,0.0008758553,0.0006405312,0.0008396136,0.00040114237,0.00064935983,0.0062638437,0.0074560274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035300192,0.00035815712,0.00028451905,0.00062999857,0.0008441969,0.00032821274,0.00052142073,0.000014368129,0.00028207965,0.000058372334,0.9879216,0.0052270764],"study_design_scores_gemma":[0.010479622,0.00287669,0.00009663565,0.00046313464,0.0012012802,0.000023035203,0.00026602985,0.00006214512,0.000062744526,0.00021633253,0.9826657,0.0015866448],"about_ca_topic_score_codex":0.0008795301,"about_ca_topic_score_gemma":0.000099177676,"teacher_disagreement_score":0.023929095,"about_ca_system_score_codex":0.0032091844,"about_ca_system_score_gemma":0.0136129195,"threshold_uncertainty_score":0.9994799},"labels":[],"label_agreement":null},{"id":"W4256418718","doi":"10.1093/ajcp/138.suppl2.317","title":"Synchronous Occurrence of Papillary Urothelial Carcinoma, Cystic Clear Cell Carcinoma, Multiple Papillary Renal Cell Carcinomas of Unknown Malignant Potential and Multiple Cortical Cysts in Same Kidney: A Rare Case Report","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Pathology; Papillary renal cell carcinomas; Medicine; Papillary carcinoma; Kidney; Carcinoma; Clear cell; Internal medicine; Thyroid carcinoma; Thyroid","score_opus":0.02249548357750456,"score_gpt":0.30181229990505165,"score_spread":0.27931681632754707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256418718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519885,0.0025177798,0.00031498444,0.00016939262,0.000906739,0.00047881267,0.00024929826,0.000011395302,0.00015276096],"genre_scores_gemma":[0.9947838,0.00033799376,0.0035682584,0.0006136591,0.00057051925,0.000005647187,0.000045632754,0.000049100603,0.000025351164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927536,0.0013488608,0.0039247563,0.00060021074,0.00055116176,0.0008213971],"domain_scores_gemma":[0.99299544,0.0018564,0.0027929316,0.00067779125,0.00044799058,0.0012294446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025376535,0.00044629714,0.002655395,0.00038094417,0.000079575504,0.000008090994,0.00027068605,0.00032973842,0.00010374721],"category_scores_gemma":[0.002788924,0.00037621384,0.0006295313,0.0003354885,0.0019555916,0.00019885284,0.00021106818,0.0014106004,0.0000042982356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060898587,0.0011845115,0.8452402,0.00041070182,0.00007281379,0.11040838,0.0010028665,0.000046745936,0.029341621,0.0000024568944,0.00025660123,0.0059432904],"study_design_scores_gemma":[0.013264705,0.012281911,0.8120777,0.00022479761,0.00077295414,0.15135752,0.0017986407,0.0010454404,0.006092316,0.000008595334,0.0005491467,0.00052629143],"about_ca_topic_score_codex":0.000675154,"about_ca_topic_score_gemma":0.000031652944,"teacher_disagreement_score":0.04094913,"about_ca_system_score_codex":0.00012260492,"about_ca_system_score_gemma":0.0017735484,"threshold_uncertainty_score":0.999869},"labels":[],"label_agreement":null},{"id":"W4285395215","doi":"10.3390/curroncol29070393","title":"A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Colorectal cancer; Breast cancer; Internal medicine; Incidence (geometry); Adenocarcinoma; Cancer; Oncology","score_opus":0.036852909642035095,"score_gpt":0.3133591412081566,"score_spread":0.27650623156612153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285395215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997624,0.00039288812,0.000007383051,0.000025273333,0.00062307244,0.0009476824,0.00021414873,0.000008459071,0.00015711866],"genre_scores_gemma":[0.99959695,0.000029855893,0.000021484153,0.000112934904,0.000025457994,0.00013376736,0.00005012749,0.000013225368,0.000016194737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879366,0.00019001463,0.0002738049,0.00025815945,0.00030774876,0.0001766214],"domain_scores_gemma":[0.9992737,0.00006519614,0.00019458309,0.00025719724,0.00015502071,0.000054283606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007105038,0.00012722818,0.00037060276,0.0000562748,0.000096970885,0.0000024133672,0.00014708893,0.0000273469,0.00018002123],"category_scores_gemma":[0.00002719248,0.00008607115,0.000048498645,0.0000898417,0.00013007277,0.00004633154,0.00031749997,0.00021267628,3.6145093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067249604,0.0014812081,0.94525975,0.00020704196,0.00006762667,0.0000056018607,0.046821605,0.0000068803547,0.00027151447,0.0000014669175,0.00008066228,0.0051241177],"study_design_scores_gemma":[0.007057018,0.002456313,0.94389075,0.00006836607,0.00007313292,0.0000039274596,0.043387197,0.000014430009,0.00014786016,5.860559e-7,0.0028148273,0.00008559336],"about_ca_topic_score_codex":0.00010102259,"about_ca_topic_score_gemma":0.00012232196,"teacher_disagreement_score":0.006384522,"about_ca_system_score_codex":0.0003023758,"about_ca_system_score_gemma":0.00024519398,"threshold_uncertainty_score":0.35098797},"labels":[],"label_agreement":null},{"id":"W4286295817","doi":"10.1200/jco.2022.40.16_suppl.11536","title":"Second primary malignancies (SPM) in patients with gastrointestinal stromal tumors (GIST): 10-year experience from the Ottawa Hospital (TOH).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; GiST; Cancer; Internal medicine; Stromal tumor; Oncology; Cancer registry; Colorectal cancer; Cohort; Melanoma; Gastroenterology; Stromal cell; Cancer research","score_opus":0.03214689705471082,"score_gpt":0.33579312524414234,"score_spread":0.30364622818943154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286295817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933788,0.0001167107,0.000016713302,0.0024744465,0.00063434907,0.00028341758,0.00006202506,0.0000077396135,0.0030258042],"genre_scores_gemma":[0.99127865,0.000008785898,0.0035172582,0.004217929,0.0005426543,0.00001559431,0.00003174123,0.000020857718,0.0003665352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631405,0.0004909247,0.0018654874,0.000287123,0.00070624193,0.00033617803],"domain_scores_gemma":[0.9964399,0.001331227,0.0014457302,0.00027412956,0.00024399164,0.00026504247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014704647,0.00018057607,0.0010989839,0.00007913906,0.000113762464,0.000013602926,0.0004139662,0.00007670285,0.0055903657],"category_scores_gemma":[0.0010436048,0.00011493141,0.0002767554,0.00016503259,0.00041137243,0.0001920307,0.00017624376,0.0016072126,0.000008244439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009015986,0.0014587793,0.9716017,0.000010725662,0.000082229795,0.0010125219,0.0005491904,0.000037377933,0.000056324287,0.000017869284,0.010302351,0.0058549],"study_design_scores_gemma":[0.011532351,0.026813684,0.9243987,0.00007396079,0.000057695575,0.00018139482,0.0013914959,0.000014456703,0.000008262481,0.000023619628,0.035387512,0.000116820134],"about_ca_topic_score_codex":0.000057375077,"about_ca_topic_score_gemma":0.00006804245,"teacher_disagreement_score":0.047203,"about_ca_system_score_codex":0.0004902534,"about_ca_system_score_gemma":0.0025336395,"threshold_uncertainty_score":0.99531865},"labels":[],"label_agreement":null},{"id":"W4286487975","doi":"10.1093/jjco/hyac115","title":"International variations in hepatic tumours incidence in children and adolescents","year":2022,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Pediatrics; Internal medicine","score_opus":0.03774096934690959,"score_gpt":0.40203910483971333,"score_spread":0.36429813549280377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286487975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475646,0.000045716522,0.000012271632,0.0040420885,0.0004226835,0.00013757695,0.0000022916847,0.000002614833,0.0005782838],"genre_scores_gemma":[0.99638134,0.00014004273,0.0006079992,0.002650073,0.00017923846,0.000006107735,0.0000039893216,0.0000048771526,0.000026329093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797374,0.00036527356,0.0011558911,0.00012696515,0.0002571317,0.0001209823],"domain_scores_gemma":[0.9988211,0.00048100765,0.0004242902,0.00007529612,0.00007048556,0.00012782447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002195245,0.00006049986,0.00046950343,0.00024061196,0.000029524015,0.0000041476314,0.00015190446,0.00005538842,0.00035109243],"category_scores_gemma":[0.0012303095,0.000052594645,0.000085153304,0.00016642755,0.000068286055,0.00013013933,0.00009744306,0.00081126473,0.0000020165983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012908927,0.00064897723,0.98164815,0.0000035606652,0.000027603368,0.00021039485,0.0005178752,0.00018209028,0.000135981,0.000018417666,0.00006620046,0.015249867],"study_design_scores_gemma":[0.0074276575,0.0012316095,0.9879122,0.00002923917,0.000021695296,0.0011345601,0.00026838807,0.0012362286,0.0000027604217,0.000108430664,0.00058182416,0.000045415283],"about_ca_topic_score_codex":0.00011959485,"about_ca_topic_score_gemma":0.000093179,"teacher_disagreement_score":0.015204452,"about_ca_system_score_codex":0.00029732363,"about_ca_system_score_gemma":0.0005343284,"threshold_uncertainty_score":0.3844216},"labels":[],"label_agreement":null},{"id":"W4295819472","doi":"10.1016/j.annonc.2022.07.902","title":"776P Early mortality in patients with cancer treated with immunotherapy in routine practice","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Cancer; Lung cancer; Retrospective cohort study; Bladder cancer; Cohort; Logistic regression; Head and neck cancer; Radiation therapy; Surgery","score_opus":0.0481672227730674,"score_gpt":0.37488362760163546,"score_spread":0.32671640482856806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295819472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010426,0.00030390386,0.0000011168773,0.0023798076,0.00003950291,0.0004900939,0.000042384123,0.000009650623,0.006629311],"genre_scores_gemma":[0.9944266,0.0002018207,0.00010077996,0.0049014385,0.000015153811,0.00012750959,0.000057779274,0.000016780541,0.00015214154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988027,0.00020285389,0.0003007909,0.00021826656,0.00024320703,0.00023217779],"domain_scores_gemma":[0.99927557,0.00009751037,0.00022116453,0.00020917671,0.00014975149,0.00004683143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033982232,0.000112012036,0.00043333074,0.00014935204,0.000030128249,0.000002275954,0.000081474005,0.000049547965,0.00071067945],"category_scores_gemma":[0.000026022915,0.000087609784,0.000028826322,0.00037606986,0.00007595404,0.00013160985,0.000026569813,0.0003120022,8.710371e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015715603,0.0014896828,0.964225,0.000017649576,0.00018494883,0.00012789405,0.0010321666,0.0002394647,0.00009367032,0.000016729371,0.0002731738,0.016584001],"study_design_scores_gemma":[0.011515897,0.010421542,0.95449483,0.000024007426,0.000029431758,0.0000065241675,0.00026026217,0.000019339855,0.00018924811,0.000004075662,0.022939341,0.000095475174],"about_ca_topic_score_codex":0.012469656,"about_ca_topic_score_gemma":0.0018649684,"teacher_disagreement_score":0.022666167,"about_ca_system_score_codex":0.00025362626,"about_ca_system_score_gemma":0.0005897421,"threshold_uncertainty_score":0.9941064},"labels":[],"label_agreement":null},{"id":"W4302282155","doi":"10.1007/s13187-022-02218-z","title":"2022 International Cancer Education Conference Program and Abstract","year":2022,"lang":"en","type":"article","venue":"Journal of Cancer Education","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute; Jazz Pharmaceuticals; Amgen","keywords":"Medicine; Medical education; Family medicine","score_opus":0.023081040058053514,"score_gpt":0.42304954249311794,"score_spread":0.39996850243506443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302282155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636173,0.01112847,0.000008513656,0.013080222,0.006378682,0.000323934,0.000027507138,0.000010734246,0.0054246276],"genre_scores_gemma":[0.9880138,0.004528413,0.0005518974,0.0022447226,0.0013624617,0.00028595456,0.000044805915,0.000013116474,0.0029548523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990412,0.000024907278,0.00032453286,0.00012814144,0.00037898042,0.00010224648],"domain_scores_gemma":[0.998912,0.000018329374,0.00041389023,0.0000914554,0.00044174388,0.0001226105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019447433,0.00008607159,0.00016602184,0.00019276484,0.00009467609,0.000036852078,0.000111734465,0.000026400729,0.006868984],"category_scores_gemma":[0.000024824376,0.00008158194,0.000060121492,0.00012364535,0.000033818855,0.00024496755,0.000027490292,0.0003467706,9.4922257e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036608934,0.00054367736,0.07795273,0.000060489638,0.00010301392,0.0000018270547,0.00076013576,0.00003880816,0.0025587238,0.000111278074,0.038593847,0.87890935],"study_design_scores_gemma":[0.0008462371,0.00030679588,0.3560489,0.0001224676,0.000117219795,0.00017661709,0.0023376932,0.00013234734,0.00033241758,0.00017436704,0.639296,0.000108918815],"about_ca_topic_score_codex":0.00039164614,"about_ca_topic_score_gemma":0.00006989341,"teacher_disagreement_score":0.87880045,"about_ca_system_score_codex":0.000820902,"about_ca_system_score_gemma":0.007397968,"threshold_uncertainty_score":0.99822915},"labels":[],"label_agreement":null},{"id":"W4310913820","doi":"10.3390/curroncol29120762","title":"Descriptive Epidemiology of Hospitalization of Patients with a Rare Tumor in an Italian Region","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Medicine; Epidemiology; Confounding; Retrospective cohort study; Pediatrics; Emergency medicine; Health care; Public health; Internal medicine","score_opus":0.1152456858834259,"score_gpt":0.3733146070334446,"score_spread":0.25806892115001867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310913820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808955,0.00046758086,0.00015491834,0.00013337629,0.00036985596,0.0004980337,0.00004736238,0.000008257358,0.00023108072],"genre_scores_gemma":[0.99903095,0.00002082154,0.00019188867,0.00018234612,0.000022399865,0.00007082973,0.0004587279,0.000010069031,0.000011977553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998776,0.00034837652,0.0003975533,0.00021328163,0.000106119136,0.00015863303],"domain_scores_gemma":[0.9992242,0.000082561026,0.0003286009,0.00017131584,0.00013347075,0.00005987106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020836215,0.00008734506,0.00047670663,0.00017616169,0.000026596623,2.9999165e-7,0.00008074089,0.000035740508,0.0001733162],"category_scores_gemma":[0.00012321872,0.00007648878,0.000041785304,0.00021008059,0.00013025095,0.00007262225,0.000048826525,0.00018372748,3.6789018e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015732162,0.0009543734,0.98268974,0.000111618974,0.00001731974,0.000013605455,0.0018036951,0.00009059298,0.000026638923,0.00023451555,0.0004528384,0.012031876],"study_design_scores_gemma":[0.0043431306,0.007098245,0.9801061,0.00004684505,0.000040283114,0.000009479752,0.0012599471,0.00041739165,0.000040431434,0.00010071267,0.0064551285,0.00008227307],"about_ca_topic_score_codex":0.00004101073,"about_ca_topic_score_gemma":0.000055681237,"teacher_disagreement_score":0.0119496025,"about_ca_system_score_codex":0.0004321889,"about_ca_system_score_gemma":0.00031260157,"threshold_uncertainty_score":0.31191218},"labels":[],"label_agreement":null},{"id":"W4312185378","doi":"10.7759/cureus.32839","title":"A Single-Center Study of Patients With Synchronous Primary Malignancy: A Case Series","year":2022,"lang":"en","type":"article","venue":"Cureus","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Malignancy; Incidence (geometry); Rectum; Series (stratigraphy); Kidney; Pathology; Internal medicine","score_opus":0.015067112009226695,"score_gpt":0.22691348203868267,"score_spread":0.21184637002945597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312185378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956415,0.00025600818,0.0000049735927,0.000043597363,0.00016590576,0.0009524777,0.0001232065,0.000032142663,0.0027801876],"genre_scores_gemma":[0.9987379,0.000003782024,0.0002158847,0.00040552777,0.000032035885,0.00011160999,0.00010738965,0.000025781621,0.0003600925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990054,0.000054690652,0.00022325196,0.00023455232,0.00030549313,0.00017664794],"domain_scores_gemma":[0.9993885,0.000017152823,0.00010480628,0.00034047326,0.00007476641,0.00007425656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059577742,0.00012866869,0.00029196916,0.00005336853,0.00012703854,0.0000061607257,0.0000757612,0.000019369294,0.0010402576],"category_scores_gemma":[0.000007751687,0.000107506195,0.00004182496,0.00013481255,0.000044179473,0.000108767774,0.00011945262,0.00014012633,0.0000017574232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004352666,0.011883406,0.9556653,0.0002979845,0.0004892142,0.0064878855,0.010088154,0.000047485533,0.00045238485,0.00000865667,0.002226129,0.00800072],"study_design_scores_gemma":[0.094927534,0.12410022,0.61022675,0.00026030955,0.0015350463,0.016589012,0.038892657,0.00007318375,0.0006187027,0.000020126892,0.111116044,0.0016404035],"about_ca_topic_score_codex":0.000105130835,"about_ca_topic_score_gemma":0.00015333323,"teacher_disagreement_score":0.34543857,"about_ca_system_score_codex":0.0003463039,"about_ca_system_score_gemma":0.00017158763,"threshold_uncertainty_score":0.9998729},"labels":[],"label_agreement":null},{"id":"W4319968648","doi":"10.1186/s13058-023-01610-x","title":"Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Meta-analysis; Incidence (geometry); Internal medicine; Surgical oncology; Oncology; Demography; Gynecology; Cancer","score_opus":0.2595119031484425,"score_gpt":0.49229580545064866,"score_spread":0.23278390230220614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319968648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082582774,0.9800461,0.0000010990271,0.0011797955,0.00008700159,0.0068031987,0.0114914775,0.00004377822,0.00026499806],"genre_scores_gemma":[0.0004999174,0.9824381,0.0000135109285,0.00041670154,0.00013402224,0.012285284,0.00015347934,0.00018979186,0.0038692057],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99105644,0.0014209078,0.0026582952,0.0014886161,0.0019286595,0.0014471039],"domain_scores_gemma":[0.9952716,0.0008912252,0.0009194208,0.0016170905,0.00068153307,0.0006191172],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005654929,0.0009778906,0.017065534,0.0024546622,0.00018251264,0.000115251176,0.0007599944,0.00045965938,0.008587865],"category_scores_gemma":[0.000135249,0.0006803153,0.0033787494,0.006371147,0.00039119352,0.00026992662,0.0005326272,0.0018713447,0.000045624678],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011323298,0.000080093254,0.00010018176,0.8199891,0.15319517,0.0001387517,0.00024778693,0.0000019767617,0.0000011031751,0.0000037515229,0.0006147861,0.025514074],"study_design_scores_gemma":[0.0012415427,0.00007380017,0.002310761,0.25928417,0.7223554,0.00074495096,0.00031907755,0.000020025102,4.9574766e-7,0.000008890646,0.012719258,0.0009216013],"about_ca_topic_score_codex":0.007879471,"about_ca_topic_score_gemma":0.003183116,"teacher_disagreement_score":0.5691603,"about_ca_system_score_codex":0.0026945623,"about_ca_system_score_gemma":0.0051326137,"threshold_uncertainty_score":0.9995648},"labels":[],"label_agreement":null},{"id":"W4324132198","doi":"10.1016/s0960-9776(23)00177-7","title":"P058 Outcomes of Rural Men With Breast Cancer: A Multicenter Population Based Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Retrospective cohort study; Breast cancer; Oncology; Gynecology; Cohort study; Internal medicine; Demography; Cancer","score_opus":0.010276856039041393,"score_gpt":0.27553135792528544,"score_spread":0.26525450188624405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507165,0.000011049792,0.000006091809,0.002296721,0.000077451325,0.0012293162,0.0002841649,0.00008844641,0.0009350991],"genre_scores_gemma":[0.99866295,0.000007246417,0.000014653398,0.00026088097,0.00007833065,0.00010090098,0.00010732793,0.000026843341,0.000740889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888974,0.00006410713,0.000226342,0.00017738494,0.00042854072,0.00021385893],"domain_scores_gemma":[0.9992422,0.00004908902,0.00012106451,0.00038494568,0.00013324295,0.00006947919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002506389,0.00015677242,0.0004072723,0.00009079974,0.00008667303,0.000010468237,0.00010867284,0.0000315104,0.00044810053],"category_scores_gemma":[0.000009175675,0.00008840168,0.000076606804,0.00031104928,0.000059794205,0.00008539273,0.000033688288,0.00013971872,0.000016327365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013662509,0.00016215483,0.9948911,0.000026312906,0.00036492848,0.000009047326,0.00076371524,0.000101050515,0.00016445683,0.0000061233736,0.00039394514,0.0017509055],"study_design_scores_gemma":[0.0039795693,0.0001570339,0.99140906,0.000060079125,0.00027690816,0.000034575773,0.0018817439,0.0020580199,0.000028203298,0.000003514578,0.0000093417975,0.00010192069],"about_ca_topic_score_codex":0.00790673,"about_ca_topic_score_gemma":0.00059306086,"teacher_disagreement_score":0.007313669,"about_ca_system_score_codex":0.00027093716,"about_ca_system_score_gemma":0.00010670589,"threshold_uncertainty_score":0.9986997},"labels":[],"label_agreement":null},{"id":"W4362469831","doi":"10.6004/jnccn.2022.7199","title":"CLO23-056: Risk of Second Malignancy Among Non-Metastatic Seminoma Patients Treated With Radiation Therapy and Chemotherapy in Manitoba","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Malignancy; Radiation therapy; Chemotherapy; Seminoma; Oncology; Internal medicine; Cancer","score_opus":0.025859424793628853,"score_gpt":0.2705497157981843,"score_spread":0.24469029100455547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362469831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695635,0.0019454394,0.000003819957,0.00024836382,0.0002188105,0.00043689707,0.00004832982,0.0000050978315,0.00013686567],"genre_scores_gemma":[0.9945899,0.0037200705,0.00012412264,0.0011203856,0.0003029067,0.000013252063,0.000016796692,0.000021188771,0.00009137449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998658,0.00010368485,0.0004582995,0.000135548,0.00047760477,0.00016687156],"domain_scores_gemma":[0.9981557,0.00024579247,0.00072957785,0.00008767662,0.00071716576,0.000064082466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017677103,0.0001482133,0.00039280383,0.00017886204,0.00006824034,0.000011120688,0.00010253651,0.00004775919,0.00008723517],"category_scores_gemma":[0.000025565258,0.00009552691,0.000104147104,0.000579727,0.00009097823,0.00013665657,0.000017268922,0.00026543965,6.1583887e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014882443,0.00005893959,0.9716079,0.000053567317,0.00041800112,0.000007756258,0.00034147952,0.0071956157,0.0003287125,0.000003912305,0.007972912,0.010522945],"study_design_scores_gemma":[0.0073045786,0.0004057397,0.98766136,0.0003451644,0.000060899063,0.000013560293,0.00008831521,0.0015194167,0.00044732238,0.000121466255,0.0019395589,0.00009262875],"about_ca_topic_score_codex":0.00007290451,"about_ca_topic_score_gemma":0.00011870605,"teacher_disagreement_score":0.016053434,"about_ca_system_score_codex":0.0002414335,"about_ca_system_score_gemma":0.00023603458,"threshold_uncertainty_score":0.38954747},"labels":[],"label_agreement":null},{"id":"W4366351024","doi":"10.20452/pamw.16480","title":"&lt;i&gt;Polish Archives of Internal Medicine&lt;/i&gt;: a journal connecting generations","year":2023,"lang":"en","type":"article","venue":"Polskie Archiwum Medycyny Wewnętrznej","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"History","score_opus":0.0312795447923077,"score_gpt":0.3010555133733272,"score_spread":0.2697759685810195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366351024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67486465,0.0037653502,0.011264803,0.014223602,0.0034556678,0.0010968643,0.00019947902,0.00056248996,0.29056707],"genre_scores_gemma":[0.97909427,0.0017639195,0.0074492586,0.0023602918,0.003363944,0.000049812334,0.00021730339,0.00013458368,0.0055666286],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607015,0.00026451855,0.0012711794,0.0005606071,0.00089679175,0.00093678513],"domain_scores_gemma":[0.99690056,0.0010012748,0.00049654354,0.00066314044,0.00018528795,0.00075320853],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088547746,0.0004381103,0.000967353,0.0011667099,0.00045594198,0.00005573541,0.0005315384,0.00012976886,0.001280964],"category_scores_gemma":[0.0014061785,0.00037193537,0.00044324543,0.00071125565,0.000607343,0.0002522652,0.00024240967,0.0008350812,0.000106902764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008165155,0.00023006876,0.003055653,0.00040706887,0.0009122262,0.00048395427,0.016066255,0.00024859465,0.76900804,0.014690271,0.061614167,0.13246721],"study_design_scores_gemma":[0.012244087,0.0020007498,0.048386768,0.001959313,0.0006402879,0.002772426,0.0019752402,0.0111044515,0.017864408,0.011624052,0.8883757,0.0010525371],"about_ca_topic_score_codex":0.00009802065,"about_ca_topic_score_gemma":0.00021807647,"teacher_disagreement_score":0.8267615,"about_ca_system_score_codex":0.00012878499,"about_ca_system_score_gemma":0.00068354176,"threshold_uncertainty_score":0.9998733},"labels":[],"label_agreement":null},{"id":"W4379282258","doi":"10.1200/jco.2023.41.16_suppl.e16516","title":"Characteristics and outcomes of 795 patients with renal cell cancer following hospitalization for acute myocardial infarction.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Odds ratio; Cardiology; Conventional PCI; Population; Cancer; Surgery","score_opus":0.044379127709354906,"score_gpt":0.4195478630284488,"score_spread":0.3751687353190939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379282258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649084,0.000042572377,0.0002563116,0.0012960039,0.0015105401,0.00022075298,0.000039754977,0.0000057538164,0.00013749438],"genre_scores_gemma":[0.9958406,0.000835216,0.0012717197,0.0013535691,0.00044451212,0.000007437178,0.00003555245,0.000014525314,0.00019685684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984304,0.00005766432,0.0010685931,0.00010578586,0.0002149446,0.00012261195],"domain_scores_gemma":[0.9978124,0.00064047193,0.0009955048,0.0000715126,0.00034364386,0.0001364664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006331459,0.00008164578,0.00096467213,0.000095552066,0.000031051848,0.0000042311835,0.00004741403,0.00015018479,0.000022001863],"category_scores_gemma":[0.0005570166,0.000054677497,0.00026772034,0.000095193864,0.00006832173,0.00010690619,0.000020425457,0.00021852211,6.6548887e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024577728,0.00017267444,0.9610243,0.000032150678,0.00096476136,0.000022670294,0.000089327514,0.000010253243,0.000095914096,0.0000048695424,0.0017058881,0.033419427],"study_design_scores_gemma":[0.009806618,0.0061605936,0.9705302,0.000038619735,0.00097501057,0.000002703671,0.000024527024,0.00009870619,0.000029399347,0.000019560955,0.012257265,0.00005678991],"about_ca_topic_score_codex":0.000007433846,"about_ca_topic_score_gemma":0.00000524626,"teacher_disagreement_score":0.03336264,"about_ca_system_score_codex":0.00006905875,"about_ca_system_score_gemma":0.0007157265,"threshold_uncertainty_score":0.22296835},"labels":[],"label_agreement":null},{"id":"W4379345936","doi":"10.1200/jco.2023.41.16_suppl.10503","title":"Second primary breast cancer in young breast cancer survivors.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Cancer; Proportional hazards model; Internal medicine; Oncology; Genetic testing; Prospective cohort study; Cohort; Quartile; Cancer registry; Gynecology; Confidence interval","score_opus":0.07792445159145578,"score_gpt":0.442798516397978,"score_spread":0.36487406480652224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379345936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581054,0.00072858814,0.000004453194,0.02472407,0.004816329,0.00020562278,0.00023349066,0.000026061716,0.011156014],"genre_scores_gemma":[0.97600484,0.008659652,0.00014402941,0.008329024,0.0037155075,0.000019195899,0.000012937904,0.00004350635,0.0030712923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958912,0.0003649584,0.00251518,0.00030236496,0.00045905146,0.00046721217],"domain_scores_gemma":[0.9966148,0.0010730536,0.0011773218,0.00022609398,0.00040800354,0.0005006839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003218088,0.00020222712,0.0019439644,0.00034130635,0.00004187059,0.000011495509,0.00024998863,0.00046863095,0.007149633],"category_scores_gemma":[0.00025029472,0.00015477094,0.0005103469,0.00052150094,0.00022048909,0.0002645794,0.00009127168,0.0016614846,0.000052712207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046357415,0.00042937478,0.736311,0.00012398275,0.00032053704,0.0010967308,0.00017883212,0.00008308651,0.00051346404,0.000012428489,0.018261382,0.2380334],"study_design_scores_gemma":[0.007670975,0.00073211576,0.9384886,0.00019544031,0.00014365208,0.0013357366,0.00013999578,0.00019635368,0.000012282237,0.00004776509,0.050888795,0.0001483043],"about_ca_topic_score_codex":0.0009783852,"about_ca_topic_score_gemma":0.013629316,"teacher_disagreement_score":0.2378851,"about_ca_system_score_codex":0.00082813966,"about_ca_system_score_gemma":0.0058667837,"threshold_uncertainty_score":0.99976903},"labels":[],"label_agreement":null},{"id":"W4385580917","doi":"10.14740/wjon1658","title":"A Case of <i>BRCA2</i>-Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Endometrial cancer; Metastasis; Cancer; Radiation therapy; Pancreatic cancer; Oncology; Surgery; Internal medicine","score_opus":0.02949447622200169,"score_gpt":0.3280872616599005,"score_spread":0.2985927854378988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385580917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981525,0.01210661,0.00003397577,0.0039362027,0.0009922485,0.00038363,0.00026805306,0.000017193463,0.0007370807],"genre_scores_gemma":[0.9848598,0.011396452,0.00066534267,0.0008944364,0.0010860186,0.00006865386,0.000004479063,0.000040011928,0.0009847825],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9982055,0.00013796061,0.0007356615,0.00024597114,0.00028917403,0.00038572622],"domain_scores_gemma":[0.9980031,0.00040777543,0.00074820797,0.00018867374,0.00034589533,0.0003063382],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060408405,0.00022315557,0.0012225201,0.00077866734,0.0000815073,0.0000111092095,0.00011189207,0.00009366012,0.0015423477],"category_scores_gemma":[0.000052098945,0.00015670323,0.00017609102,0.001097828,0.00022556262,0.0001387945,0.000049211492,0.0004647676,0.000002193584],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02654352,0.0006464889,0.11538888,0.0009844112,0.007437867,0.078865804,0.0031266147,0.0015501507,0.041507423,0.00014590584,0.012224734,0.7115782],"study_design_scores_gemma":[0.11337079,0.013263724,0.29321167,0.0025878272,0.0173116,0.34837145,0.0021884742,0.0020311181,0.004330957,0.00013584485,0.20173635,0.0014602122],"about_ca_topic_score_codex":0.0029103647,"about_ca_topic_score_gemma":0.007982253,"teacher_disagreement_score":0.710118,"about_ca_system_score_codex":0.00071232463,"about_ca_system_score_gemma":0.0031518482,"threshold_uncertainty_score":0.9993704},"labels":[],"label_agreement":null},{"id":"W4386292655","doi":"10.1093/bjs/znad258.640","title":"1282 Comparing Overall Survival and Oncological Recurrence in Laparoscopic and Open Hepatectomy for Colorectal Cancer Metastases: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"British journal of surgery","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colorectal cancer; Hepatectomy; Overall survival; Quality of life (healthcare); Resection; Surgery; Cancer; General surgery; Internal medicine; Oncology","score_opus":0.22281141987659775,"score_gpt":0.41691495425579683,"score_spread":0.19410353437919908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386292655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004408145,0.99143547,0.0000022554998,0.000048439615,0.00052064075,0.003325272,0.00020670122,0.000009715397,0.000043384338],"genre_scores_gemma":[0.00015122016,0.9987933,0.000099549645,0.00017618439,0.00013387554,0.0004832201,0.00006863462,0.00004120085,0.00005281068],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996325,0.00058906537,0.0021055585,0.0003563528,0.00029723544,0.00032676215],"domain_scores_gemma":[0.9956532,0.0024950695,0.0013356335,0.000117502044,0.00016181605,0.00023676777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003855274,0.00031226897,0.008367394,0.00024346611,0.00006867941,0.00016371257,0.00023269249,0.00016278475,0.000048410053],"category_scores_gemma":[0.0016827893,0.00026531395,0.0004920824,0.00029588726,0.00008797425,0.00024156102,0.00017981502,0.0006577854,0.0000011518816],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089529814,0.00005552539,0.0007905252,0.8586708,0.00051435246,0.0013347556,0.000010987956,1.2666693e-7,1.9724835e-7,0.0000026376172,0.0028187314,0.13571188],"study_design_scores_gemma":[0.0012562415,0.00012719777,0.00084914,0.94817007,0.0028157067,0.005103771,0.000021383068,0.000008305196,2.1126928e-7,0.000008784544,0.041373547,0.00026566928],"about_ca_topic_score_codex":0.00036617363,"about_ca_topic_score_gemma":0.00037371338,"teacher_disagreement_score":0.1354462,"about_ca_system_score_codex":0.0003422947,"about_ca_system_score_gemma":0.0015039616,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W4386870428","doi":"10.5114/ppiel.2023.130707","title":"Nursing staff knowledge of parenteral nutrition –preliminary report","year":2023,"lang":"en","type":"article","venue":"Problemy Pielęgniarstwa","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nursing; Medicine; Nursing staff","score_opus":0.03398161647427109,"score_gpt":0.3350387934162793,"score_spread":0.3010571769420082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386870428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94395304,0.0018830306,0.0005185617,0.002103687,0.00080811343,0.001416826,0.000055036806,0.00046750862,0.04879418],"genre_scores_gemma":[0.9939908,0.00033587177,0.0012028854,0.00007542593,0.00023393813,0.000108230815,0.00045556767,0.000039285067,0.0035579884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984523,0.00003983489,0.0005619875,0.00036996958,0.00022092806,0.00035498614],"domain_scores_gemma":[0.9990945,0.000071129245,0.00016755452,0.00037630103,0.00014668837,0.00014384098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027945204,0.00017662389,0.00039719619,0.00028669284,0.00007459732,0.000011640815,0.000099856195,0.000109439316,0.0002787661],"category_scores_gemma":[0.00006421731,0.00017139608,0.00016949074,0.0004845748,0.00011407182,0.00014943969,0.000049933697,0.0002117704,0.000111900896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054716137,0.007854731,0.03883657,0.010228703,0.0007594931,0.0026093049,0.017365322,0.00012470451,0.11251496,0.0019321481,0.3119032,0.49039924],"study_design_scores_gemma":[0.052404214,0.017671,0.30853447,0.03163107,0.002290357,0.009567191,0.013947287,0.03295303,0.15002476,0.034377553,0.3424847,0.0041143578],"about_ca_topic_score_codex":0.000009699286,"about_ca_topic_score_gemma":0.0000029550747,"teacher_disagreement_score":0.4862849,"about_ca_system_score_codex":0.00015639672,"about_ca_system_score_gemma":0.0002344075,"threshold_uncertainty_score":0.69893295},"labels":[],"label_agreement":null},{"id":"W4387521763","doi":"10.1159/000533783","title":"Combination of Osimertinib with Concurrent Chemotherapy and Hormonal Therapy for Synchronous NSCLC, Hormone Receptor-Positive Breast Cancer, and Triple-Negative Breast Cancer: Case Report","year":2023,"lang":"en","type":"article","venue":"Case Reports in Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Triple-negative breast cancer; Lung cancer; Osimertinib; Carboplatin; Cancer; Hormonal therapy; Docetaxel; Adenocarcinoma; Chemotherapy; Epidermal growth factor receptor; Erlotinib","score_opus":0.018917183410635512,"score_gpt":0.32717061768116495,"score_spread":0.3082534342705294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078554,0.0032227917,0.000050116916,0.0026513066,0.00036145275,0.002125454,0.00058829406,0.000045373035,0.00016965937],"genre_scores_gemma":[0.9913534,0.006936501,0.00018032338,0.00034052142,0.00015122839,0.0006794697,0.00017549032,0.00004365008,0.0001394532],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9979731,0.00007801266,0.00078956026,0.0006259582,0.00018709865,0.00034625977],"domain_scores_gemma":[0.99805826,0.00036137388,0.0007399842,0.00023850438,0.0004077887,0.00019409419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059245934,0.0002780546,0.00084374426,0.00022796933,0.00012648391,0.000011166027,0.00002519683,0.00019979398,0.00008497999],"category_scores_gemma":[0.00005320813,0.00023238463,0.000071217306,0.0003419901,0.0004695601,0.00012996666,0.000030110612,0.00024988363,1.7178029e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075215977,0.00050080323,0.021935603,0.00019014922,0.0005939415,0.34931388,0.0030185997,0.00001729026,0.0038211031,0.000023605413,0.0023907684,0.61067265],"study_design_scores_gemma":[0.0153742535,0.0026827413,0.121369325,0.00019744688,0.0001595581,0.8546595,0.001216736,0.00076592795,0.0017684107,0.00003213825,0.0014697755,0.00030418253],"about_ca_topic_score_codex":0.0032811663,"about_ca_topic_score_gemma":0.000718295,"teacher_disagreement_score":0.6103685,"about_ca_system_score_codex":0.00069050916,"about_ca_system_score_gemma":0.0013904836,"threshold_uncertainty_score":0.947637},"labels":[],"label_agreement":null},{"id":"W4387930873","doi":"10.1002/cncr.35069","title":"Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model","year":2023,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Brock University","funders":"Stanford Cancer Institute; Pharmacyclics; National Cancer Institute; Natera; Calithera Biosciences; Daiichi Sankyo Europe; Exelixis; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Helsinn; Clovis Oncology; American College of Radiology Imaging Network; Gilead Sciences; Jounce Therapeutics; Celgene; AstraZeneca; Eli Lilly and Company; Regeneron Pharmaceuticals; International Association for the Study of Lung Cancer; Amgen","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Cohort; Receiver operating characteristic; Retrospective cohort study; Cancer; Population","score_opus":0.024881704437611594,"score_gpt":0.312851129294527,"score_spread":0.2879694248569154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387930873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9129331,0.0060056695,0.055752907,0.00061145314,0.0018666913,0.0044532707,0.012682793,0.0007487384,0.0049453606],"genre_scores_gemma":[0.8921255,0.042131923,0.00565093,0.0058953357,0.0014086954,0.017502414,0.0027506098,0.00049698015,0.032037638],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964456,0.00009081707,0.00073429657,0.0011274936,0.0006285737,0.00097322627],"domain_scores_gemma":[0.99809134,0.00011438184,0.00045084252,0.0007498083,0.0002935193,0.00030012304],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049143,0.00055848976,0.0007839317,0.00029858318,0.00045044775,0.000058418926,0.0002789963,0.00029648465,0.0013539331],"category_scores_gemma":[0.000025669895,0.0005339512,0.00038641389,0.00076779234,0.00015404285,0.0005315174,0.000112284135,0.000579196,0.000006090183],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012233893,0.00007941079,0.14995044,0.002555141,0.0014536065,0.000016638936,0.0015773214,0.7362115,0.0010511578,0.000023336697,0.09415083,0.011707233],"study_design_scores_gemma":[0.0058628125,0.000060118564,0.033296183,0.00056015496,0.0019491769,6.033539e-7,0.000099221346,0.9486244,0.002483977,0.000100929836,0.0064258166,0.0005366632],"about_ca_topic_score_codex":0.006117912,"about_ca_topic_score_gemma":0.0055351425,"teacher_disagreement_score":0.21241286,"about_ca_system_score_codex":0.0023392634,"about_ca_system_score_gemma":0.0012052516,"threshold_uncertainty_score":0.9997112},"labels":[],"label_agreement":null},{"id":"W4387962128","doi":"10.1200/op.2023.19.11_suppl.134","title":"Rates of surgery and adjuvant chemotherapy use in patients with stage IB to IIIA non-small cell lung cancer: A provincial population-based study.","year":2023,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Toronto Metropolitan University; McMaster University; Ontario Clinical Oncology Group; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Chemotherapy; Internal medicine; Population; Guideline; Logistic regression; Cancer; Comorbidity; Surgery; Pathology","score_opus":0.031711421245193376,"score_gpt":0.34087622135803974,"score_spread":0.30916480011284636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387962128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657834,0.000039137947,0.000012300719,0.0011077217,0.00015496096,0.0019023449,0.000037282596,0.000027875003,0.00014006294],"genre_scores_gemma":[0.9959288,0.000041213123,0.00070982426,0.0027284666,0.000047562935,0.00014933114,0.00008387922,0.00002926126,0.0002816162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986451,0.00018483025,0.00037798178,0.0003298607,0.00021426841,0.0002479066],"domain_scores_gemma":[0.99762297,0.0015521538,0.00031457446,0.0002132452,0.00018401997,0.00011304087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005546988,0.00015580359,0.0005339955,0.0002879441,0.00005285421,0.000012783253,0.000053434607,0.00009676302,0.000064734704],"category_scores_gemma":[0.0004001241,0.00013255946,0.00003222054,0.0004377826,0.000025792859,0.00025685946,0.000032658867,0.00022778615,0.0000030493575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080558425,0.0010431579,0.9823256,0.00015621379,0.00007748536,0.000095248535,0.0013627674,0.00027002522,0.00014501835,5.013839e-7,0.00070408446,0.0057640574],"study_design_scores_gemma":[0.00850208,0.00143194,0.98462486,0.00005786729,0.00012158469,7.1923944e-7,0.00060174085,0.0006578524,0.00015913737,2.1874152e-7,0.0037042205,0.00013779526],"about_ca_topic_score_codex":0.006667658,"about_ca_topic_score_gemma":0.0061639315,"teacher_disagreement_score":0.005626262,"about_ca_system_score_codex":0.00038978638,"about_ca_system_score_gemma":0.0012504758,"threshold_uncertainty_score":0.999947},"labels":[],"label_agreement":null},{"id":"W4389058558","doi":"10.1080/07853890.2023.2282652","title":"Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis","year":2023,"lang":"en","type":"article","venue":"Annals of Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Shandong First Medical University; Natural Science Foundation of Shandong Province; China Postdoctoral Science Foundation; Key Technology Research and Development Program of Shandong; National Natural Science Foundation of China","keywords":"Incidence (geometry); Lymphoma; Medicine; Oncology; Population; Internal medicine; Cancer incidence; Primary (astronomy); Cancer; Demography; Environmental health","score_opus":0.04791686897998556,"score_gpt":0.3378963714081172,"score_spread":0.28997950242813164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389058558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948636,0.0017462642,0.00003104282,0.0022323127,0.000055288565,0.00017825092,0.000070125076,0.000029186138,0.0007939154],"genre_scores_gemma":[0.99500406,0.00032357743,0.00009999695,0.0038879695,0.00006816525,0.000015823824,0.00025254345,0.00001049188,0.00033739005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851537,0.000045350804,0.0005517234,0.00024449313,0.00045375896,0.00018931807],"domain_scores_gemma":[0.9988666,0.0001975329,0.00021991777,0.0003652957,0.00021742671,0.00013318258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006545057,0.00013763853,0.00077156624,0.0005109552,0.00002462022,0.000002084452,0.00006995054,0.00007112858,0.00087793847],"category_scores_gemma":[0.0001984398,0.00010833291,0.00014003439,0.0010290968,0.0002699212,0.00008476449,0.00003413803,0.000054884582,0.0000021722105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039766144,0.000050050247,0.9858028,0.001015521,0.00058039953,0.00005987497,0.00041664267,0.000036024016,0.0044503496,0.000030494177,0.0020888047,0.0050713676],"study_design_scores_gemma":[0.0015360883,0.00026326027,0.99387854,0.00023311473,0.0005488387,0.0000033691763,0.00010318662,0.0005662924,0.0021802923,0.000120090284,0.0004803544,0.00008659848],"about_ca_topic_score_codex":0.0007695224,"about_ca_topic_score_gemma":0.00025842467,"teacher_disagreement_score":0.008075705,"about_ca_system_score_codex":0.000021012615,"about_ca_system_score_gemma":0.00015937675,"threshold_uncertainty_score":0.96128106},"labels":[],"label_agreement":null},{"id":"W4389555383","doi":"10.30683/1927-7229.2023.12.09","title":"Multiple Primary Malignant Tumours","year":2023,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Malignancy; Medicine; Etiology; Incidence (geometry); Epidemiology; Intensive care medicine; Cancer; Pathology; Internal medicine","score_opus":0.04204537465753948,"score_gpt":0.3405465523919292,"score_spread":0.2985011777343897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389555383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455442,0.00027824385,0.0002240544,0.016687276,0.000800091,0.00015079038,0.0000073525466,0.000043581047,0.03626444],"genre_scores_gemma":[0.987476,0.0005415109,0.0015913559,0.005584334,0.00088661024,0.000002133027,0.00001689173,0.000025244382,0.0038759366],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840236,0.00007558325,0.000678819,0.00014675547,0.00036300044,0.00033350204],"domain_scores_gemma":[0.9985121,0.0004738129,0.00025480113,0.00015776175,0.00022232861,0.00037923554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072639197,0.0001210803,0.0007279787,0.0003725586,0.00004234452,0.000008993114,0.00013690845,0.00014728612,0.0005826893],"category_scores_gemma":[0.00043092738,0.00008821683,0.00033849943,0.00040208994,0.00013684294,0.00010107956,0.000052122185,0.00048696858,0.00017163705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008133139,0.0014741004,0.23860084,0.0003863948,0.0013979331,0.027619727,0.0007598343,0.00048588048,0.030573267,0.0013969988,0.56492424,0.12424762],"study_design_scores_gemma":[0.008630177,0.005380089,0.4232274,0.00011954869,0.00062782393,0.0035535663,0.00047372942,0.0066415886,0.0007546472,0.0003298365,0.5500324,0.0002292111],"about_ca_topic_score_codex":0.0000066110642,"about_ca_topic_score_gemma":0.0000049853047,"teacher_disagreement_score":0.18462656,"about_ca_system_score_codex":0.00048373407,"about_ca_system_score_gemma":0.0011434847,"threshold_uncertainty_score":0.63800395},"labels":[],"label_agreement":null},{"id":"W4390902249","doi":"10.2139/ssrn.4691775","title":"Risks of Second Primary Cancers for Female and Male Breast Cancer Survivors in England: A Retrospective Cohort Study","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Cohort; Demography; Incidence (geometry); Proportional hazards model; Socioeconomic status; Retrospective cohort study; Cohort study; Cancer; Internal medicine; Population; Environmental health","score_opus":0.021338507393421625,"score_gpt":0.3157113584326092,"score_spread":0.2943728510391876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390902249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973947,0.020101968,0.000035869263,0.00031062408,0.0008470161,0.0026305385,0.0007285171,0.00002352136,0.0013749473],"genre_scores_gemma":[0.979198,0.01666767,0.0000428487,0.00010520312,0.0006772348,0.00035928597,0.000058771115,0.0000892233,0.0028017834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996194,0.00013125333,0.00079972687,0.0008023766,0.0004818675,0.0015907739],"domain_scores_gemma":[0.9986647,0.000090635665,0.0004413989,0.00036661586,0.00026852914,0.00016815982],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027025288,0.0004495962,0.0013848274,0.00047629877,0.00008751232,0.00004775084,0.00022728537,0.00029965024,0.00041127784],"category_scores_gemma":[0.00003509127,0.00041045708,0.00028671007,0.00022167168,0.00011751972,0.000083102845,0.0002660956,0.0054067215,0.0000011005017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0020283747,0.000191813,0.9780088,0.0011566089,0.0021346228,0.000051498137,0.0023972993,0.00012006917,0.00018533159,0.00014564053,0.00008425082,0.013495688],"study_design_scores_gemma":[0.0058614546,0.0011814925,0.9804061,0.00055782497,0.0009111587,0.00088991015,0.0026819385,0.00021607889,0.000032922835,0.0063208053,0.0005037728,0.00043653807],"about_ca_topic_score_codex":0.016453372,"about_ca_topic_score_gemma":0.23688424,"teacher_disagreement_score":0.22043087,"about_ca_system_score_codex":0.0104590235,"about_ca_system_score_gemma":0.016226685,"threshold_uncertainty_score":0.9998347},"labels":[],"label_agreement":null},{"id":"W4392629847","doi":"10.7759/cureus.55843","title":"A Rare Case of Synchronous Invasive Adenocarcinoma of the Colon and Marginal Zone Lymphoma of a Splenule Associated With Hemolytic Anemia","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Roswell Park Cancer Institute","keywords":"Medicine; Anemia; Concomitant; Pathology; Colonoscopy; Gastroenterology; Pancytopenia; Microcytic anemia; Red pulp; Splenic marginal zone lymphoma; Internal medicine; Hereditary spherocytosis; Spleen; Splenectomy; Bone marrow; Colorectal cancer; Cancer","score_opus":0.011372646880756907,"score_gpt":0.23609485279867962,"score_spread":0.22472220591792272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392629847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898582,0.0086569805,0.000007895312,0.00013272681,0.00007077033,0.00035001757,0.0001559643,0.000012890686,0.00075453037],"genre_scores_gemma":[0.9994498,0.00009126057,0.00007827955,0.000074815995,0.00002526805,0.000008874893,0.000017914159,0.000017157286,0.00023661795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992541,0.000039025923,0.00023533375,0.0001768591,0.00015903139,0.00013565835],"domain_scores_gemma":[0.99928117,0.00017866536,0.00013235024,0.0002454006,0.00010196458,0.000060423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009802306,0.0001162762,0.00035573274,0.000051697014,0.000028284407,0.000004794302,0.00006954953,0.000079110556,0.0001429252],"category_scores_gemma":[0.00009789112,0.000077910874,0.0000675138,0.00022102815,0.00024363169,0.000051883868,0.000047736456,0.00009219185,6.3693915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069979243,0.0017541191,0.6219618,0.023986284,0.0042239646,0.032960612,0.035000943,0.00007002449,0.23243108,0.0015185494,0.008582776,0.030511932],"study_design_scores_gemma":[0.017244797,0.007206333,0.78071487,0.0068778177,0.0030128572,0.02095728,0.0060754307,0.002588355,0.1540973,0.00012253642,0.00050340744,0.0005990094],"about_ca_topic_score_codex":0.0005318144,"about_ca_topic_score_gemma":0.0005099286,"teacher_disagreement_score":0.15875308,"about_ca_system_score_codex":0.00018483147,"about_ca_system_score_gemma":0.0008068346,"threshold_uncertainty_score":0.31771132},"labels":[],"label_agreement":null},{"id":"W4392728963","doi":"10.2196/48380","title":"Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Retrospective cohort study; Cancer; Cohort; Cohort study; Demography; Pediatrics; Internal medicine","score_opus":0.016596250250991377,"score_gpt":0.29647279129145704,"score_spread":0.27987654104046567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392728963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892579,0.0041522016,0.000012703418,0.0011353138,0.00049385295,0.002467342,0.00058306823,0.0001100732,0.001787578],"genre_scores_gemma":[0.9936273,0.0043967725,0.00002899162,0.00083371944,0.00013877681,0.00050380523,0.0001415361,0.000045838933,0.00028324118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664575,0.00045719836,0.00078439526,0.0008048434,0.00058567483,0.0007221533],"domain_scores_gemma":[0.99826276,0.00016313493,0.00024519005,0.00045334292,0.00023870009,0.00063688465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021393062,0.00030166228,0.0010511515,0.0003830117,0.000109512956,0.000053680582,0.00012977785,0.00012823794,0.0001396474],"category_scores_gemma":[0.00018159758,0.00025993655,0.0001083828,0.00092635356,0.00022902922,0.00020778629,0.000060366452,0.0006725498,0.000003396464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002785764,0.00012227504,0.9851486,0.0007895999,0.000206729,0.00003746887,0.0071030976,0.0000064401784,0.0000028536717,0.00003587159,0.00090847776,0.0053599845],"study_design_scores_gemma":[0.0017526839,0.0005691022,0.99229234,0.00010827894,0.0000069251787,0.0000058217015,0.0023498966,0.0004300769,0.0000012604572,0.0000076274173,0.002252418,0.0002235646],"about_ca_topic_score_codex":0.041440133,"about_ca_topic_score_gemma":0.06384712,"teacher_disagreement_score":0.022406986,"about_ca_system_score_codex":0.0020247207,"about_ca_system_score_gemma":0.0041456,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W4393094075","doi":"10.1158/1538-7445.am2024-4847","title":"Abstract 4847: Diverging global incidence trends of early-onset and later-onset cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Age of onset; Cancer; Pediatrics; Demography; Oncology; Internal medicine; Disease; Physics; Sociology","score_opus":0.07356735176665763,"score_gpt":0.4272938993333801,"score_spread":0.35372654756672245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393094075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802205,0.011304323,0.0000039144707,0.0011757363,0.0003070202,0.0001884771,0.00049197586,0.000051958137,0.0062561184],"genre_scores_gemma":[0.9955074,0.0026732297,0.000051333263,0.00014814307,0.00017925061,0.00005854101,0.000027858254,0.000022061888,0.0013321686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979902,0.000062661056,0.000270823,0.00046543358,0.00069099315,0.0005199027],"domain_scores_gemma":[0.9990635,0.00018249433,0.00003380617,0.00030369576,0.000141011,0.00027553018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006078056,0.00015570922,0.00030842217,0.00030315074,0.00011848654,0.000073072435,0.00017386793,0.00010247014,0.0017945255],"category_scores_gemma":[0.000056023306,0.00013593848,0.00008381604,0.0008490115,0.0004490758,0.00021835996,0.00015057666,0.0005470274,0.000022256467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018001802,0.000044806664,0.61769146,0.0020366758,0.00042442203,0.000818656,0.0025750822,0.00005478136,0.011761605,0.00012032112,0.039376475,0.32329553],"study_design_scores_gemma":[0.0011608856,0.00039514914,0.97167677,0.0012543969,0.000061207844,0.00008130505,0.00034593456,0.00037431414,0.005690065,0.00022239795,0.018503252,0.000234354],"about_ca_topic_score_codex":0.0102622425,"about_ca_topic_score_gemma":0.000993977,"teacher_disagreement_score":0.35398528,"about_ca_system_score_codex":0.0011088601,"about_ca_system_score_gemma":0.0018326258,"threshold_uncertainty_score":0.999118},"labels":[],"label_agreement":null},{"id":"W4393226968","doi":"10.5489/cuaj.8760","title":"Second primary cancers following radiotherapy for prostate cancer: How many are actually due to the radiotherapy?","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Radiation therapy; Prostate cancer; Medicine; Oncology; Primary treatment; Cancer; Prostate; Internal medicine","score_opus":0.01224050337477313,"score_gpt":0.2528180818756942,"score_spread":0.24057757850092107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393226968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49429172,0.026632925,0.002067733,0.46833366,0.0045488216,0.0021617739,0.0008065597,0.00012181087,0.0010349808],"genre_scores_gemma":[0.8343065,0.0023367184,0.0014344916,0.14333902,0.004595004,0.00038278682,0.00007699766,0.000106354164,0.013422166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979885,0.000129263,0.0003317573,0.000376528,0.00039757244,0.00077633606],"domain_scores_gemma":[0.99836904,0.00031377847,0.00017831975,0.00016817403,0.00015824918,0.0008124656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094343134,0.00024959087,0.00049781887,0.00023560447,0.00048411655,0.00043191327,0.00023539677,0.00023102242,0.0012633929],"category_scores_gemma":[0.00018394833,0.00017151507,0.0004198316,0.0003303228,0.000028679655,0.00021347465,0.000009356371,0.00075206195,0.000007612052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006645189,0.000025098512,0.05332287,0.00013234603,0.0026521115,0.0008034638,0.0042473143,0.0007869762,0.0026225594,0.00010228518,0.7582812,0.17635927],"study_design_scores_gemma":[0.001429808,0.00040312973,0.0757352,0.0000680291,0.00011371844,0.00016545736,0.00019419378,0.0012632725,0.000030892792,0.000057709804,0.9203159,0.00022268142],"about_ca_topic_score_codex":0.00061896053,"about_ca_topic_score_gemma":0.006086069,"teacher_disagreement_score":0.34001473,"about_ca_system_score_codex":0.009664242,"about_ca_system_score_gemma":0.0038691883,"threshold_uncertainty_score":0.9996496},"labels":[],"label_agreement":null},{"id":"W4394424621","doi":"10.6084/m9.figshare.20092802.v1","title":"ECS22-0325.xlsx","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04997190945575518,"score_gpt":0.3027456775593879,"score_spread":0.2527737681036327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394424621","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.3163625e-7,0.0012091652,4.8948356e-9,0.00013408142,0.0003058905,0.00045080108,0.99329937,0.0000658679,0.004534114],"genre_scores_gemma":[6.865289e-7,0.00008396501,0.000007413604,0.0054371767,0.0005715643,0.00044504454,0.9901068,0.00003871522,0.0033086177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985054,0.000036380283,0.00025653985,0.00045015005,0.00044044232,0.00031105446],"domain_scores_gemma":[0.9986617,0.000088665125,0.00014467805,0.0008554287,0.0000551605,0.00019438547],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00003517454,0.00029116045,0.0004789429,0.0001526405,0.00011441892,0.000027811795,0.00034276716,0.00024712636,0.99721617],"category_scores_gemma":[0.00041632462,0.00028473977,0.00023175059,0.00016056815,0.0000064020637,0.000056369892,0.00031832673,0.0009891888,0.007654783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005099295,0.000043270622,7.9607514e-7,0.0012049042,0.000083609804,0.0005403795,0.000008682565,0.0000015208597,0.0000013428622,6.668867e-8,0.996745,0.0013194277],"study_design_scores_gemma":[0.00068508845,0.0001665881,0.00008170479,0.00065395347,0.00007982862,0.0000939453,0.000012961221,0.000003571239,0.000010920743,8.6952963e-7,0.997927,0.0002835731],"about_ca_topic_score_codex":0.00005673945,"about_ca_topic_score_gemma":0.00002942283,"teacher_disagreement_score":0.9895614,"about_ca_system_score_codex":0.0003057277,"about_ca_system_score_gemma":0.00078871124,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W4394740367","doi":"","title":"The Burden of Rare Cancers in North America.","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services","funders":"","keywords":"Incidence (geometry); Medicine; Demography; Ethnic group; Cancer registry; Cancer; Population; Cancer incidence; Epidemiology; Pediatrics; Environmental health; Internal medicine","score_opus":0.024581585222179417,"score_gpt":0.2459490440536521,"score_spread":0.22136745883147269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394740367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849748,0.0004444232,0.000001153525,0.003487657,0.00020512742,0.0005691375,0.000019723568,0.000039776718,0.01025822],"genre_scores_gemma":[0.9949889,0.0006902563,0.000008200079,0.0003497246,0.00013078499,0.00056615577,0.000032067754,0.0000096774975,0.003224192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99929637,0.000018913897,0.00016279891,0.000112833695,0.00014711187,0.000261964],"domain_scores_gemma":[0.99957246,0.00009069151,0.000046086025,0.00019757236,0.000023675297,0.00006953145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001199664,0.000057855978,0.00015451528,0.000073478426,0.000030603675,0.00000451942,0.00009176422,0.000020791187,0.000035583205],"category_scores_gemma":[0.00009338577,0.00003988053,0.000045723868,0.0005490149,0.00008025582,0.00003116628,0.000027775064,0.00009936546,0.000014468354],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025055348,0.0000073210917,0.052904367,0.00006226843,0.00005861695,0.00004310299,0.0014851949,0.00092884834,0.000036790476,0.000007635662,0.020378977,0.92383635],"study_design_scores_gemma":[0.0007573479,0.000017501465,0.7783332,0.0000058793244,0.000010819799,0.0000013383154,0.00092310144,0.0004767526,0.000089664485,0.0000074939653,0.21932895,0.000047961556],"about_ca_topic_score_codex":0.0012404864,"about_ca_topic_score_gemma":0.00067910255,"teacher_disagreement_score":0.92378837,"about_ca_system_score_codex":0.000155067,"about_ca_system_score_gemma":0.00012922728,"threshold_uncertainty_score":0.18752527},"labels":[],"label_agreement":null},{"id":"W4394801025","doi":"10.1097/01.ju.0001008736.23117.7f.02","title":"PD29-02 ASSOCIATION OF PROTON PUMP INHIBITORS CUMULATIVE USE WITH PROSTATE CANCER RISK AND ADVERSE OUTCOMES: A POPULATION-BASED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Population; Internal medicine; Adverse effect; Logistic regression; Proton-pump inhibitor; Cumulative dose; Cancer; Epidemiology; Demography; Gynecology; Environmental health","score_opus":0.01196917928485372,"score_gpt":0.2850793515640131,"score_spread":0.27311017227915935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394801025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996584,0.00037700197,0.00021458972,0.0022739954,0.000089214336,0.00039435946,0.00004020976,0.000007541461,0.000019086609],"genre_scores_gemma":[0.9989536,0.00027288258,0.00010345143,0.00040710482,0.00005274688,0.000009043693,0.000008524948,0.000010681336,0.00018196095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890465,0.00022399746,0.00039991425,0.000094284456,0.00025657177,0.000120613346],"domain_scores_gemma":[0.9985145,0.0005411776,0.00058510806,0.000103294566,0.00020042634,0.000055546898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006964705,0.00010012352,0.00040596345,0.00030613327,0.000042738728,0.00000814631,0.00004006223,0.00006431228,0.000083126026],"category_scores_gemma":[0.00017156602,0.000053857522,0.0001239249,0.0003577743,0.000050215927,0.00015657906,0.000009541697,0.0003207935,5.41702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021888646,0.000028431068,0.9774827,0.000060888262,0.0019093608,0.000016753556,0.0014909914,0.015775388,0.00017874323,0.0000026868076,0.00005651094,0.0008087051],"study_design_scores_gemma":[0.0018160334,0.0008491327,0.9790517,0.000046136647,0.0045664725,0.000013673531,0.00011904119,0.012414617,0.0002455494,0.00003545698,0.00077990274,0.00006228271],"about_ca_topic_score_codex":0.000996674,"about_ca_topic_score_gemma":0.0005044002,"teacher_disagreement_score":0.0033607709,"about_ca_system_score_codex":0.00019642165,"about_ca_system_score_gemma":0.00025986152,"threshold_uncertainty_score":0.21962461},"labels":[],"label_agreement":null},{"id":"W4396586584","doi":"10.1158/1940-6207.capr-24-0115","title":"On the Hunt for the Missed Genetic Causes of Multiple Primary Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Prevention Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Jewish General Hospital","funders":"","keywords":"Primary (astronomy); Medicine; Biology; Oncology; Internal medicine","score_opus":0.1633746486936685,"score_gpt":0.432576505645325,"score_spread":0.26920185695165655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396586584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93791103,0.027898077,0.0017365841,0.022091206,0.00073148543,0.005238688,0.0001558685,0.00007353752,0.0041635167],"genre_scores_gemma":[0.98331356,0.0014478303,0.00014069819,0.0008201747,0.0003087387,0.0012673851,0.000024296194,0.000033797252,0.012643528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984949,0.00016255594,0.00025239892,0.00027026414,0.00053233263,0.00028755295],"domain_scores_gemma":[0.99712276,0.0021457693,0.00003608026,0.00040785826,0.00022086778,0.000066683635],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011153194,0.00009870411,0.00017460865,0.00012754221,0.00019744471,0.00003982147,0.00021025458,0.000049337974,0.0013041762],"category_scores_gemma":[0.00030094144,0.00005324782,0.00018287514,0.0003399366,0.00022363254,0.00004232263,0.000051290554,0.00036897685,0.000019325349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003495311,0.00044159984,0.0039519756,0.0062080985,0.0013302577,0.00005544263,0.0023612017,0.0009387273,0.13385028,0.0061200745,0.37143227,0.46981478],"study_design_scores_gemma":[0.005780019,0.0028381064,0.17681636,0.004378093,0.00041667544,0.000033230055,0.0019101443,0.031542618,0.111679785,0.006224806,0.65790284,0.00047734036],"about_ca_topic_score_codex":0.00018673974,"about_ca_topic_score_gemma":0.00007759194,"teacher_disagreement_score":0.46933743,"about_ca_system_score_codex":0.00026803807,"about_ca_system_score_gemma":0.0011240215,"threshold_uncertainty_score":0.99960876},"labels":[],"label_agreement":null},{"id":"W4396804647","doi":"10.3389/fonc.2024.1418512","title":"Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study","year":2024,"lang":"en","type":"erratum","venue":"Frontiers in Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; C17 Council; University of Toronto; Hospital for Sick Children; Public Health Ontario; University of Manitoba; Izaak Walton Killam Health Centre; Institute for Clinical Evaluative Sciences; Public Health Agency of Canada","funders":"","keywords":"Medicine; Retrospective cohort study; Oncology; Cohort; Internal medicine; Pediatric oncology; Population; Pediatrics; Cancer; Environmental health","score_opus":0.009957848375283386,"score_gpt":0.24311190692837437,"score_spread":0.233154058553091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396804647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88919556,0.0026679386,0.0000034068405,0.00032037345,0.09640767,0.004157592,0.0012054506,0.00003954943,0.0060024736],"genre_scores_gemma":[0.9456465,0.0038154842,0.0020396255,0.0054888288,0.0027675175,0.0043814844,0.019407295,0.00044780227,0.016005417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99427164,0.0005552143,0.0018359849,0.0016650188,0.00079722545,0.000874947],"domain_scores_gemma":[0.9979006,0.0003619624,0.00070289464,0.000645818,0.00011600598,0.00027269076],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006801059,0.00070033217,0.0031403813,0.0017906218,0.000056916695,0.000021002437,0.0004363701,0.0013569649,0.00079823995],"category_scores_gemma":[0.00030783864,0.00075480965,0.00017032723,0.0011813949,0.000087206914,0.00010727525,0.00017843519,0.003644892,0.000014974648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00054305873,0.0007300788,0.5486721,0.00018065002,0.00014416485,0.003059522,0.0009084125,0.0000843816,4.6928463e-8,3.7463752e-7,0.44458458,0.0010926767],"study_design_scores_gemma":[0.0072674467,0.0017032053,0.91657275,0.00025327416,0.00040224925,0.0000042031133,0.00075271755,0.0007440981,3.749272e-7,0.000052404397,0.07166328,0.0005840079],"about_ca_topic_score_codex":0.85395324,"about_ca_topic_score_gemma":0.9952871,"teacher_disagreement_score":0.3729213,"about_ca_system_score_codex":0.06649868,"about_ca_system_score_gemma":0.028037786,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W4399196316","doi":"10.5281/zenodo.10012083","title":"MEDICAL-ECONOMIC APPROACH TO MASS SCREENING FOR COLORECTAL CANCER IN THE WILAYA OF BEJAÏA","year":2023,"lang":"en","type":"article","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Olivieri Foods","funders":"","keywords":"Colorectal cancer; Geography; Cancer; Environmental science; Medicine; Internal medicine","score_opus":0.02563727509060216,"score_gpt":0.27816290197346405,"score_spread":0.2525256268828619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399196316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674405,0.00037464223,0.045848172,0.033270612,0.00015290383,0.0014055494,0.00015209705,0.0001051503,0.05125035],"genre_scores_gemma":[0.98419386,0.00022844506,0.012658983,0.0006040118,0.000032244516,0.0002980663,0.00021058971,0.000022884708,0.0017508956],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99823856,0.0006341709,0.00032472162,0.0002922809,0.00026774744,0.00024249047],"domain_scores_gemma":[0.99792343,0.0011050532,0.000108744054,0.00049415795,0.00024657493,0.00012201815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040659625,0.000108697684,0.00024498385,0.00015464835,0.00010342139,0.00002810736,0.00046026427,0.000082222694,0.00015612681],"category_scores_gemma":[0.0007027342,0.000091037036,0.00010084298,0.00040991054,0.00011029054,0.00006249252,0.00009736201,0.00017232409,0.000010385615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096588326,0.001236642,0.15165336,0.0010473512,0.0004586448,0.00002143902,0.07616686,0.0025336887,0.053857107,0.06552717,0.0372968,0.60923505],"study_design_scores_gemma":[0.008988449,0.000011150143,0.34249166,0.0024731394,0.00014634684,0.00003647852,0.003662768,0.43338633,0.10227183,0.00069312355,0.10504875,0.00078998593],"about_ca_topic_score_codex":0.00092818274,"about_ca_topic_score_gemma":0.0014433117,"teacher_disagreement_score":0.60844505,"about_ca_system_score_codex":0.00009146917,"about_ca_system_score_gemma":0.00033772783,"threshold_uncertainty_score":0.37123826},"labels":[],"label_agreement":null},{"id":"W4399281543","doi":"10.1200/jco.2024.42.16_suppl.10554","title":"Risk of subsequent primary cancers among adult cancer survivors.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine; Primary cancer","score_opus":0.07439936143624962,"score_gpt":0.4380478404294067,"score_spread":0.3636484789931571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399281543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711241,0.007889478,0.00011376474,0.0029407388,0.0056265835,0.00018803154,0.000044364446,0.000017290493,0.012055619],"genre_scores_gemma":[0.9625719,0.030478448,0.00092396233,0.0029357842,0.0021648759,0.0000074325408,0.000005748901,0.000030009636,0.0008818167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959258,0.0004051814,0.0026926997,0.00024151913,0.0004768983,0.00025789562],"domain_scores_gemma":[0.99535197,0.0019057925,0.0014903122,0.00021546078,0.00061514456,0.00042130318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028715811,0.00016346677,0.0017781007,0.00018659623,0.000027691562,0.000008775085,0.00018992001,0.0003853358,0.0008946054],"category_scores_gemma":[0.0010659926,0.00011386109,0.0008769517,0.00022375752,0.00043277637,0.00019176859,0.000043566997,0.0016229787,0.0000092977325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038634674,0.0003444683,0.60634667,0.00045584308,0.0019306918,0.0010536285,0.00034902833,0.0002487465,0.00044327741,0.00012836972,0.022371609,0.3624642],"study_design_scores_gemma":[0.005189308,0.0060214875,0.81635135,0.00068343093,0.0014529059,0.00019572572,0.00017508134,0.0008369035,0.00045471292,0.00015383429,0.16830844,0.00017680146],"about_ca_topic_score_codex":0.004571413,"about_ca_topic_score_gemma":0.0038875856,"teacher_disagreement_score":0.36228737,"about_ca_system_score_codex":0.0009810758,"about_ca_system_score_gemma":0.009132346,"threshold_uncertainty_score":0.99648494},"labels":[],"label_agreement":null},{"id":"W4399481017","doi":"10.1007/s10549-024-07400-z","title":"Second primary non-breast cancers in young breast cancer survivors","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Susan G. Komen; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Cumulative incidence; Internal medicine; Incidence (geometry); Population; Hazard ratio; Gynecology; Oncology; Proportional hazards model; Confidence interval; Obstetrics; Cancer; Cohort","score_opus":0.033906846359865156,"score_gpt":0.35156391040752355,"score_spread":0.31765706404765837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561425,0.016525844,0.0000033051685,0.00731811,0.00065313326,0.0015037819,0.0054578753,0.00011094023,0.01228451],"genre_scores_gemma":[0.9731999,0.01586064,0.000028535233,0.00026978258,0.000810152,0.0014248005,0.00017434219,0.00009613939,0.00813569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99630547,0.00011605981,0.0004414194,0.0011040168,0.00079609477,0.001236942],"domain_scores_gemma":[0.99840164,0.00013786071,0.00004615495,0.00047255313,0.00023162487,0.00071015],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043561318,0.0004864192,0.0007113791,0.0006810475,0.00023124125,0.00018722545,0.0001677854,0.00017768973,0.005282803],"category_scores_gemma":[0.0000030258245,0.0003766397,0.00016739171,0.0009606714,0.0004021304,0.00038585506,0.00011695452,0.00066009926,0.000054691915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005494212,0.0005794346,0.45477283,0.0014820986,0.001291694,0.0016352459,0.0019894643,0.000044509103,0.003615524,0.000105296764,0.0056199837,0.5233697],"study_design_scores_gemma":[0.0049932227,0.00047289513,0.9760759,0.0012582765,0.00011573645,0.0023847877,0.00047592292,0.0007159605,0.0003731025,0.00004720433,0.012643498,0.00044347942],"about_ca_topic_score_codex":0.13911642,"about_ca_topic_score_gemma":0.14853929,"teacher_disagreement_score":0.5229262,"about_ca_system_score_codex":0.0075115645,"about_ca_system_score_gemma":0.0044597583,"threshold_uncertainty_score":0.9998686},"labels":[],"label_agreement":null},{"id":"W4402266498","doi":"10.1158/1538-7445.pediatric24-a030","title":"Abstract A030 Secondary malignancies after radiotherapy treatment of pediatric cancer patients in Egypt over a six-year period","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Pediatric cancer; Period (music); Oncology; Internal medicine","score_opus":0.04425394060280891,"score_gpt":0.38398121148533654,"score_spread":0.33972727088252763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402266498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93613106,0.06051158,6.2082984e-7,0.0004884808,0.0004351241,0.0008252656,0.00040049845,0.00002995183,0.0011774302],"genre_scores_gemma":[0.9604556,0.035842173,0.000036223566,0.00014234186,0.00074784283,0.00082875375,0.000034822217,0.00006119819,0.0018510249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977249,0.00006987532,0.0003976869,0.00052154117,0.0006891766,0.00059682917],"domain_scores_gemma":[0.99914736,0.00011397272,0.00004113977,0.000328115,0.00018245161,0.00018698433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025713016,0.00022488783,0.00045071082,0.00061817275,0.00005143691,0.000050674953,0.00012685842,0.00013737408,0.013682482],"category_scores_gemma":[0.000017618257,0.00017947846,0.0001741156,0.0007133822,0.00016442729,0.00019199916,0.000034260553,0.00042709365,0.000029670404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034832524,0.00071386865,0.86770195,0.0025194131,0.00039152513,0.00053075724,0.00819199,0.00003269317,0.013451812,0.000029672867,0.012391628,0.09056142],"study_design_scores_gemma":[0.004691727,0.0009602216,0.9226619,0.0003749548,0.00005036449,0.0000025692048,0.0001985914,0.00006168648,0.0037906272,0.00001353457,0.06696797,0.0002258452],"about_ca_topic_score_codex":0.003336869,"about_ca_topic_score_gemma":0.001031794,"teacher_disagreement_score":0.09033557,"about_ca_system_score_codex":0.002022008,"about_ca_system_score_gemma":0.0024180245,"threshold_uncertainty_score":0.98721915},"labels":[],"label_agreement":null},{"id":"W4402560286","doi":"10.1016/j.annonc.2024.08.1559","title":"1494P Prognostic features in NSCLC patients with ECOG-PS 2-4: A prospective cohort study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Prospective cohort study; Oncology; Internal medicine","score_opus":0.024725848833969055,"score_gpt":0.35017321021668457,"score_spread":0.3254473613827155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768556,0.0006593937,0.000002523381,0.00095626636,0.00018649768,0.0023308762,0.000019814235,0.000039202034,0.018949823],"genre_scores_gemma":[0.9983329,0.000058373713,0.00008501853,0.0007871257,0.00006884672,0.00020554969,0.000035482735,0.000021074744,0.00040559235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998804,0.00007829586,0.00027926834,0.00036045376,0.00022768369,0.00025032394],"domain_scores_gemma":[0.9993034,0.00017088432,0.00006498169,0.00018670526,0.00019298635,0.00008103375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002710715,0.00014613842,0.00049653533,0.00021701465,0.000022263182,0.0000091472175,0.00007522412,0.00009612633,0.00017525423],"category_scores_gemma":[0.000115245944,0.000105682855,0.000057034853,0.00029386696,0.00009961139,0.00009579267,0.000035505505,0.00030825476,0.00001612447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014054271,0.00154101,0.9637259,0.00010990417,0.00035946743,0.00031115112,0.001657243,0.0000065620325,0.000020394935,0.000053381926,0.003782694,0.027026864],"study_design_scores_gemma":[0.0030512721,0.011807237,0.98008573,0.00013290255,0.00010829637,0.000014293021,0.00030722792,0.000021280059,0.00011198645,0.00005101483,0.0042030998,0.000105678584],"about_ca_topic_score_codex":0.00016303816,"about_ca_topic_score_gemma":0.00061471,"teacher_disagreement_score":0.026921187,"about_ca_system_score_codex":0.000121770994,"about_ca_system_score_gemma":0.0005823278,"threshold_uncertainty_score":0.43096218},"labels":[],"label_agreement":null},{"id":"W4402909072","doi":"10.1016/j.ijrobp.2024.07.1896","title":"Comprehensive Assessment of Pneumonitis, Pseudoprogression and Hyperprogression among Inoperable Stage III NSCLC Patients Treated with Trimodal Therapy","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Stage (stratigraphy); Medicine; Pneumonitis; Radiology; Oncology; Internal medicine; Lung","score_opus":0.01944472311928893,"score_gpt":0.34371622557598863,"score_spread":0.3242715024566997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402909072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953072,0.001939649,0.00064948935,0.00043247905,0.0006940793,0.00035790264,0.00008130477,0.000028450671,0.0005094525],"genre_scores_gemma":[0.99472,0.0030031253,0.0012895532,0.0002949265,0.0003991849,0.000013605012,0.00019727107,0.000026016594,0.000056340476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852085,0.00016054606,0.00059584645,0.00023410193,0.00032695816,0.00016168323],"domain_scores_gemma":[0.9982171,0.00022702091,0.0005866132,0.00010439092,0.0007486836,0.00011618969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019659176,0.00019430403,0.0005080877,0.00019755602,0.000060996437,0.00003296648,0.00014242485,0.00016269683,0.000078188255],"category_scores_gemma":[0.00002000938,0.00013299976,0.000121760364,0.0001497741,0.00024988994,0.00036360102,0.000037771533,0.00046821017,0.0000012132914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010713369,0.00035075907,0.7009957,0.00002873197,0.0005617996,0.0000656123,0.00024494276,0.00008705955,0.0077821454,0.00031141212,0.00013467208,0.28836584],"study_design_scores_gemma":[0.023297923,0.008277371,0.92709064,0.00080875756,0.00020104258,0.00017647838,0.00020141424,0.009799695,0.007925481,0.0002059547,0.021720942,0.00029432322],"about_ca_topic_score_codex":0.000047039837,"about_ca_topic_score_gemma":0.0000015886309,"teacher_disagreement_score":0.2880715,"about_ca_system_score_codex":0.00042807937,"about_ca_system_score_gemma":0.00071289,"threshold_uncertainty_score":0.54235727},"labels":[],"label_agreement":null},{"id":"W4403410089","doi":"10.1016/j.jtho.2024.09.322","title":"P1.06C.05 The Impact of Lymphovascular Invasion as Prognostic Factor on Long-Term Survival in More Than 3500 Resected NSCLC Patients","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Lymphovascular invasion; Oncology; Internal medicine; Term (time); Overall survival; Cancer; Metastasis","score_opus":0.03662981427040972,"score_gpt":0.4182928472195161,"score_spread":0.38166303294910636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403410089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955946,0.0011675986,0.000013890161,0.00085724733,0.0010706285,0.0005154994,0.00002370627,0.000013273444,0.00074352144],"genre_scores_gemma":[0.9989351,0.00033540276,0.00004629889,0.00020105383,0.00029980665,0.000006449721,0.000027058119,0.000031233012,0.00011756883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976598,0.0004587812,0.00076853496,0.0002229651,0.00058002566,0.00030986304],"domain_scores_gemma":[0.9982023,0.0006856133,0.0003764879,0.00029629256,0.00025661394,0.0001826759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076919596,0.00021741574,0.00074168656,0.00048174488,0.000042882355,0.000022944021,0.00025646258,0.00022312309,0.00040565286],"category_scores_gemma":[0.00063633715,0.000121975514,0.00049095723,0.00042890623,0.00012603575,0.00017095444,0.00006405389,0.000750312,0.000015251064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091698775,0.0011424072,0.7178114,0.00041932895,0.00096998503,0.002471262,0.0023449787,0.00013907686,0.0064797625,0.000005853868,0.0011780065,0.25786805],"study_design_scores_gemma":[0.002111007,0.007880761,0.9859286,0.0009702004,0.00021972483,0.00044932493,0.00016086562,0.00014778203,0.0016044361,0.000033489792,0.00037970167,0.00011409635],"about_ca_topic_score_codex":0.00016362025,"about_ca_topic_score_gemma":0.00009309672,"teacher_disagreement_score":0.26811722,"about_ca_system_score_codex":0.001274354,"about_ca_system_score_gemma":0.0020159106,"threshold_uncertainty_score":0.4974017},"labels":[],"label_agreement":null},{"id":"W4403540821","doi":"10.1158/1055-9965.epi-24-0636","title":"Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2024,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"Arnie Charbonneau Cancer Institute, University of Calgary","keywords":"Medicine; Cancer; Cancer registry; Incidence (geometry); Population; Lung cancer; Colorectal cancer; Breast cancer; Cervix; Demography; Gynecology; Internal medicine; Environmental health","score_opus":0.047413331702615226,"score_gpt":0.36670747027632944,"score_spread":0.3192941385737142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403540821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8599637,0.12327777,0.0041281027,0.006118807,0.003787818,0.0011884548,0.00029174017,0.00021888428,0.0010246881],"genre_scores_gemma":[0.8359452,0.14908066,0.0043043955,0.0035057943,0.001009626,0.002048879,0.00055171043,0.00015186015,0.0034018904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959506,0.0007846834,0.0013199393,0.0009714912,0.00025759824,0.00071572926],"domain_scores_gemma":[0.9977274,0.0006662535,0.0006038055,0.0004582769,0.00029767523,0.00024660863],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019659752,0.00043596193,0.001165552,0.0003726842,0.00013203235,0.000012305047,0.00021446722,0.00043052202,0.0012477994],"category_scores_gemma":[0.0002750471,0.0003781556,0.0005844167,0.0005925229,0.00051987224,0.00030828538,0.000092764174,0.0005378932,0.000013103418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068659533,0.000045360164,0.8457031,0.0018583469,0.003042587,0.000023571702,0.0003499039,0.00016517204,0.0028367883,0.0004445917,0.009659055,0.13518488],"study_design_scores_gemma":[0.0015890797,0.000181021,0.967771,0.004400096,0.0014651684,0.000019432542,0.00011232744,0.002890051,0.0032667085,0.0011954047,0.016558954,0.00055075716],"about_ca_topic_score_codex":0.038795438,"about_ca_topic_score_gemma":0.020175382,"teacher_disagreement_score":0.13463412,"about_ca_system_score_codex":0.0018659439,"about_ca_system_score_gemma":0.0020633936,"threshold_uncertainty_score":0.999867},"labels":[],"label_agreement":null},{"id":"W4403760352","doi":"10.1016/s0167-8140(24)03613-2","title":"126 Canadian Kidney Cancer Patients’ Treatment Preferences for Early-Stage Disease","year":2024,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Medicine; Disease; Cancer; Kidney cancer; Oncology; Internal medicine; Kidney disease; Biology","score_opus":0.029582962170261323,"score_gpt":0.32965142138778847,"score_spread":0.3000684592175271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403760352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972795,0.0143573545,0.000058133617,0.0070380373,0.0009911188,0.0010945436,0.0010053013,0.000054037067,0.0026064746],"genre_scores_gemma":[0.96309,0.014065801,0.00042830006,0.0102856895,0.0006556073,0.0005273692,0.0002454334,0.000037605612,0.010664207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992713,0.000025554762,0.00012874926,0.00026878304,0.000053981585,0.00025165698],"domain_scores_gemma":[0.9991364,0.000074045856,0.000019635796,0.00009841801,0.000025711464,0.0006457744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045652392,0.0001303998,0.00024597265,0.00010812121,0.00008435449,0.000024290246,0.000035674355,0.00008659319,0.0012642924],"category_scores_gemma":[0.000010488324,0.000096399504,0.000075591925,0.000055681397,0.000067796806,0.00006189517,0.0000028174506,0.00006688294,0.0000029341945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018406861,0.00020577916,0.30726713,0.00039475274,0.00066385075,0.00011493583,0.0033869427,0.0000070469773,0.00026011863,0.0005208907,0.025015188,0.66032267],"study_design_scores_gemma":[0.002561464,0.0020006876,0.08408714,0.00004258145,0.000095421936,0.000001975895,0.0000228246,0.0006657141,0.000053319218,0.00003821536,0.9103257,0.0001049227],"about_ca_topic_score_codex":0.027782254,"about_ca_topic_score_gemma":0.039299708,"teacher_disagreement_score":0.88531053,"about_ca_system_score_codex":0.001554058,"about_ca_system_score_gemma":0.002728906,"threshold_uncertainty_score":0.9996487},"labels":[],"label_agreement":null},{"id":"W4403852207","doi":"10.1093/jjco/hyae147","title":"Projection of the number of new lymphoma cases in the world","year":2024,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Projection (relational algebra); Algorithm","score_opus":0.1377087749573969,"score_gpt":0.49188770430723394,"score_spread":0.3541789293498371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403852207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895026,0.00020881328,0.0000035450655,0.008473725,0.0009342883,0.00015135253,9.3204443e-7,0.0000028973152,0.011274163],"genre_scores_gemma":[0.9959224,0.000104802595,0.00027093448,0.0018054901,0.0006109436,0.0000017737957,3.3724618e-7,0.000005762015,0.0012775564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978197,0.0003809423,0.0013503598,0.000089489346,0.0002564506,0.00010301901],"domain_scores_gemma":[0.9961334,0.0030632366,0.0004624119,0.00016081473,0.000112307804,0.00006783106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020999797,0.00006691542,0.00056942354,0.00009001006,0.000015179181,0.000003940103,0.00016768245,0.000096690725,0.0003427207],"category_scores_gemma":[0.0013102061,0.000030270341,0.00036723923,0.00040496615,0.00017917683,0.00008491368,0.00002533765,0.00040280024,0.0000048594975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006234241,0.0013561364,0.4871412,0.00020402804,0.00033702663,0.000881108,0.0051405556,0.000035528265,0.001743856,0.00053847634,0.014953994,0.48143384],"study_design_scores_gemma":[0.005044803,0.0022168632,0.84682477,0.00027054467,0.0002245662,0.005015151,0.0018892648,0.00021203671,0.00045454066,0.00034216413,0.1374495,0.00005581118],"about_ca_topic_score_codex":0.00019977846,"about_ca_topic_score_gemma":0.00042591858,"teacher_disagreement_score":0.48137802,"about_ca_system_score_codex":0.00009363574,"about_ca_system_score_gemma":0.0017596969,"threshold_uncertainty_score":0.37525514},"labels":[],"label_agreement":null},{"id":"W4404712311","doi":"10.3390/curroncol31120550","title":"Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre; University of British Columbia","funders":"Calgary Health Foundation","keywords":"Medicine; Malignancy; Clinical significance; Context (archaeology); Cancer; Positron emission tomography; Hematologic malignancy; Radiology; Abnormality; Internal medicine","score_opus":0.11106906453336156,"score_gpt":0.4308563650579363,"score_spread":0.3197873005245747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404712311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0112245865,0.97498,0.0000017258493,0.000013993651,0.00059118104,0.0123699345,0.00077005604,0.00002223152,0.00002627108],"genre_scores_gemma":[0.0019565513,0.99456763,0.00004051414,0.000055021985,0.000023386909,0.0029479617,0.0003222075,0.000047265923,0.000039433726],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961167,0.00045439118,0.002170362,0.000641451,0.00029219617,0.00032491685],"domain_scores_gemma":[0.9973483,0.0006086917,0.001276705,0.00039650657,0.0002747103,0.00009509473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008125677,0.0005009024,0.0056447205,0.00034325558,0.000019961835,0.0000046698447,0.00027665222,0.00009024665,0.00006995509],"category_scores_gemma":[0.00055533415,0.00033722637,0.0004699311,0.0005060521,0.00019171822,0.00005430384,0.00014409583,0.00047189315,0.0000037002926],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007064984,0.00023952813,0.002501858,0.947351,0.00029839182,0.000029757482,0.000051581952,4.045004e-8,0.0000024384976,0.0000052258097,0.00032736018,0.0491222],"study_design_scores_gemma":[0.0015994163,0.00086647336,0.0008411116,0.97182405,0.010516585,0.00020044847,0.000010609878,0.000030301313,0.000010269223,0.000011935277,0.013780263,0.00030852968],"about_ca_topic_score_codex":0.0000131325705,"about_ca_topic_score_gemma":0.000015692547,"teacher_disagreement_score":0.04881367,"about_ca_system_score_codex":0.0011290136,"about_ca_system_score_gemma":0.0021072538,"threshold_uncertainty_score":0.999908},"labels":[],"label_agreement":null},{"id":"W4405363773","doi":"10.1101/2024.02.21.24303162","title":"Risk of subsequent primary cancers among adult cancer survivors in Alberta","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Oncology; Primary (astronomy); Cancer; Medicine; Internal medicine; Gerontology; Demography; Sociology","score_opus":0.014948068327001492,"score_gpt":0.27185666758674476,"score_spread":0.25690859925974324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405363773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736931,0.0064075007,0.000005287146,0.0008855436,0.002547516,0.001084718,0.0004053841,0.00006223393,0.0149087235],"genre_scores_gemma":[0.9835498,0.011145066,0.00011393499,0.0005674356,0.0003454237,0.00040158545,0.00022716347,0.00011668902,0.0035329172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670935,0.00017170433,0.000996835,0.0010037601,0.00059408677,0.00052429555],"domain_scores_gemma":[0.9979161,0.00019686879,0.0004429707,0.0009868954,0.00020078682,0.00025637375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050862384,0.0005365077,0.0013078804,0.00048485424,0.00003071353,0.000022539112,0.0003702877,0.0004979284,0.00073159975],"category_scores_gemma":[0.00013935158,0.0004785211,0.00045354178,0.00040370107,0.00027897913,0.000056413908,0.0005681238,0.0020978998,0.000025226007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036381313,0.00006831686,0.9831578,0.004552777,0.0006395745,0.00016332508,0.0024243544,0.0019787883,0.0006354302,0.00005161669,0.0009903256,0.0049738777],"study_design_scores_gemma":[0.0015249941,0.00010472369,0.9845667,0.003389071,0.0007395039,0.000008614244,0.00014025909,0.002380139,0.003469215,0.00036170144,0.0026954825,0.00061959174],"about_ca_topic_score_codex":0.56331563,"about_ca_topic_score_gemma":0.47599348,"teacher_disagreement_score":0.08732218,"about_ca_system_score_codex":0.0020403306,"about_ca_system_score_gemma":0.0029034573,"threshold_uncertainty_score":0.99976665},"labels":[],"label_agreement":null},{"id":"W4405364934","doi":"10.1016/j.msard.2024.106114","title":"153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Placebo; Relapsing remitting; Internal medicine; Pathology; Immunology; Alternative medicine","score_opus":0.03891098586633257,"score_gpt":0.2788187953834719,"score_spread":0.2399078095171393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96930987,0.023054255,0.00001695668,0.0017060835,0.0012085158,0.0026391263,0.00058144826,0.00010187776,0.0013818658],"genre_scores_gemma":[0.9896395,0.009095225,0.0003193617,0.00013530649,0.00012618094,0.00009230773,0.00045075698,0.00006664058,0.00007468128],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996892,0.00020566337,0.0011346175,0.0009139643,0.00035628496,0.0004974694],"domain_scores_gemma":[0.99647063,0.0025386102,0.0002453809,0.00046782324,0.00005701794,0.00022055353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006507599,0.00044649284,0.0007485379,0.00020508564,0.00029371295,0.00011201963,0.00017232455,0.00040085037,0.00017147814],"category_scores_gemma":[0.0007248787,0.00032403134,0.00022708636,0.0005087633,0.0005980095,0.0002791408,0.00014313075,0.0009407832,0.000008784837],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.371079,0.0011183523,0.0026659225,0.000279444,0.0012486194,0.00004389282,0.013866543,0.00030241878,0.0147426175,0.000022995098,0.0018300661,0.59280014],"study_design_scores_gemma":[0.82134414,0.0025447235,0.11265946,0.0061765015,0.0007306149,0.000010508718,0.0063729393,0.042544387,0.0013360772,0.000049115693,0.0053987713,0.00083277584],"about_ca_topic_score_codex":0.0012714755,"about_ca_topic_score_gemma":0.0005587736,"teacher_disagreement_score":0.59196734,"about_ca_system_score_codex":0.000115468254,"about_ca_system_score_gemma":0.00026169154,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4406165596","doi":"10.1101/2025.01.07.25320152","title":"MULTIPLE PRIMARY CANCERS IN LUNG CANCER PATIENTS IN ATLANTIC CANADA AND IMPLICATIONS FOR SCREENING AND MANAGEMENT","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Dalhousie University","funders":"Research Nova Scotia; AstraZeneca; Dalhousie University; Bristol-Myers Squibb","keywords":"Medicine; Lung cancer; Cancer; Oncology; Primary (astronomy); Internal medicine; Intensive care medicine","score_opus":0.016912994037178167,"score_gpt":0.2832315159784172,"score_spread":0.26631852194123906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406165596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924349,0.0024661126,0.00014700637,0.001197589,0.00026721964,0.0024114915,0.00041875095,0.000014194247,0.00064270233],"genre_scores_gemma":[0.9881361,0.006351302,0.0015135697,0.0016134518,0.00004634429,0.0013934821,0.00054745516,0.000023417344,0.00037484604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857265,0.000027257143,0.0003923356,0.0005720612,0.00013303172,0.00030267864],"domain_scores_gemma":[0.9993231,0.00013192811,0.00010753237,0.00027302981,0.000054794556,0.000109602486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014217247,0.00022986226,0.00047863176,0.00025142732,0.000053423304,0.000016179341,0.00011005311,0.00011010726,0.000009233682],"category_scores_gemma":[0.000037619848,0.0002379156,0.000038606537,0.00014494112,0.000038978596,0.000038910617,0.00027448096,0.00031308128,2.4635973e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016193236,0.000023757939,0.97950035,0.0038147827,0.00010768299,0.000007719452,0.00014971547,0.00033806777,0.000015407344,0.000015153963,0.0011241917,0.014741252],"study_design_scores_gemma":[0.0033570721,0.000015954478,0.98675966,0.0012103602,0.00011163594,5.6850496e-7,0.00003122094,0.0040144,0.000009907196,0.000015465988,0.004275133,0.00019864115],"about_ca_topic_score_codex":0.6928201,"about_ca_topic_score_gemma":0.9195488,"teacher_disagreement_score":0.22672871,"about_ca_system_score_codex":0.0014413976,"about_ca_system_score_gemma":0.0011730915,"threshold_uncertainty_score":0.97019166},"labels":[],"label_agreement":null},{"id":"W4406226798","doi":"10.1158/1055-9965.28171812","title":"Table S1 from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Table (database); Cancer; Primary cancer; Medicine; Oncology; Demography; Environmental health; Internal medicine; Database; Computer science; Sociology","score_opus":0.02241229564945459,"score_gpt":0.29084579268912386,"score_spread":0.2684334970396693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406226798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94171065,0.008959886,0.0018210437,0.0010231966,0.0028196082,0.0016128785,0.0052078157,0.00017831866,0.036666594],"genre_scores_gemma":[0.6166219,0.23297842,0.036503363,0.019482253,0.0027821357,0.004262058,0.010299996,0.00039081933,0.076679036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656504,0.00013341941,0.001059982,0.0010860754,0.0006092758,0.0005461801],"domain_scores_gemma":[0.9971246,0.00021565564,0.0007008714,0.0010129673,0.0007215301,0.0002243909],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023480668,0.000611467,0.0016264874,0.00028992083,0.000096925345,0.00003346798,0.00043367498,0.00061273505,0.005434264],"category_scores_gemma":[0.00008216085,0.00053951185,0.00038098224,0.00034691347,0.00018521021,0.00011965104,0.00072829874,0.0012857068,0.000009974229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061101204,0.000095729505,0.9599551,0.0037734613,0.0027326567,0.00003058042,0.0012527192,0.0021749411,0.0007745244,0.00013293262,0.009400333,0.019066036],"study_design_scores_gemma":[0.005313121,0.00008701435,0.8990419,0.010759835,0.0029182902,0.0000024510264,0.00050058065,0.0038780598,0.045604143,0.00044019244,0.029698258,0.0017561691],"about_ca_topic_score_codex":0.70307547,"about_ca_topic_score_gemma":0.21503317,"teacher_disagreement_score":0.4880423,"about_ca_system_score_codex":0.0016514006,"about_ca_system_score_gemma":0.008104463,"threshold_uncertainty_score":0.9997056},"labels":[],"label_agreement":null},{"id":"W4406226824","doi":"10.1158/1055-9965.28171821","title":"Figure S1 from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary cancer; Cancer; Medicine; Cumulative incidence; Cancer incidence; Incidence (geometry); Demography; Cumulative risk; Primary prevention; Oncology; Gerontology; Internal medicine; Disease; Mathematics","score_opus":0.022287831337415676,"score_gpt":0.294391153931469,"score_spread":0.2721033225940533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406226824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477047,0.008611236,0.0011183218,0.0017054706,0.0026388606,0.0015782007,0.004504587,0.00017594454,0.031962715],"genre_scores_gemma":[0.69914305,0.17784059,0.02312325,0.020411666,0.0027936634,0.003364768,0.010898116,0.00032828958,0.062096577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965486,0.0001495954,0.0010612833,0.0011022341,0.0006332044,0.00050511333],"domain_scores_gemma":[0.99711376,0.00023206638,0.00071238854,0.0010276812,0.0006860388,0.0002280842],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020103231,0.00064918277,0.0016168384,0.0002988155,0.00009034072,0.000029724835,0.00044984446,0.00072976155,0.007314962],"category_scores_gemma":[0.000087282744,0.0005630149,0.000502517,0.00028570477,0.00018687276,0.00009930244,0.00063771394,0.0014867556,0.000014041048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006854363,0.00009426445,0.9425762,0.004497122,0.0031704567,0.000043678574,0.0018516777,0.001517033,0.00067884737,0.00012779933,0.013126181,0.031631283],"study_design_scores_gemma":[0.0042107445,0.00007498969,0.9304674,0.0106815435,0.0025252483,0.0000017059208,0.00042082465,0.0021178026,0.026867414,0.00035472182,0.020807147,0.0014704135],"about_ca_topic_score_codex":0.5272797,"about_ca_topic_score_gemma":0.13863999,"teacher_disagreement_score":0.3886397,"about_ca_system_score_codex":0.0019201987,"about_ca_system_score_gemma":0.0066974266,"threshold_uncertainty_score":0.9996821},"labels":[],"label_agreement":null},{"id":"W4406226825","doi":"10.1158/1055-9965.28171818","title":"Figure S2 from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Primary cancer; Medicine; Primary (astronomy); Oncology; Demography; Internal medicine; Sociology; Physics","score_opus":0.022287831337415676,"score_gpt":0.294391153931469,"score_spread":0.2721033225940533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406226825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94082373,0.010071998,0.0011122802,0.0016961794,0.0026127207,0.0015610119,0.0039853663,0.00017411883,0.037962567],"genre_scores_gemma":[0.75107783,0.14654598,0.019199722,0.017005479,0.0023235017,0.0028068463,0.006230372,0.00027274402,0.05453753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965452,0.00015441404,0.0010605735,0.0011018912,0.0006329565,0.00050494395],"domain_scores_gemma":[0.997119,0.00023462754,0.00071243587,0.0010189393,0.0006869712,0.0002280248],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023795474,0.00064880087,0.0016171142,0.00029839357,0.00009057659,0.00002973113,0.00045111173,0.0007288619,0.005157015],"category_scores_gemma":[0.0000872825,0.00056264043,0.0005022616,0.00028605468,0.00018879089,0.00009921731,0.00063898746,0.0014874729,0.000007634447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071059057,0.00009756782,0.9348889,0.0046752924,0.0032840057,0.000045203553,0.0019365473,0.00158538,0.00053523015,0.000120354176,0.009981238,0.042139716],"study_design_scores_gemma":[0.003017028,0.000054071046,0.95675343,0.007583047,0.0018078429,0.0000012246702,0.00030267364,0.0015368675,0.014787154,0.00025425208,0.012847842,0.0010545574],"about_ca_topic_score_codex":0.57354075,"about_ca_topic_score_gemma":0.15981434,"teacher_disagreement_score":0.4137264,"about_ca_system_score_codex":0.001919361,"about_ca_system_score_gemma":0.006733734,"threshold_uncertainty_score":0.9996825},"labels":[],"label_agreement":null},{"id":"W4406227060","doi":"10.1158/1055-9965.28171809","title":"Table S2 from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary cancer; Cancer; Medicine; Cancer registry; Incidence (geometry); Confidence interval; Oncology; Internal medicine; Demography","score_opus":0.02241229564945459,"score_gpt":0.29084579268912386,"score_spread":0.2684334970396693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406227060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378223,0.010474646,0.0018114406,0.0010154853,0.0027911344,0.0015946673,0.0045999116,0.00017647016,0.03971397],"genre_scores_gemma":[0.6737514,0.198798,0.031065516,0.016631782,0.0023702653,0.003626819,0.006181895,0.00033250515,0.06724177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655914,0.00013746967,0.0010605404,0.0010866051,0.00060985214,0.00054641167],"domain_scores_gemma":[0.9971299,0.00021802892,0.00070148165,0.0010040973,0.00072199357,0.00022446856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027820226,0.00061165466,0.0016306445,0.0002900335,0.00009698269,0.00003347808,0.00043406276,0.0006129532,0.003819905],"category_scores_gemma":[0.00008209318,0.0005395626,0.00038112784,0.0003473068,0.00018528568,0.00011967221,0.0007288152,0.0012864859,0.00000542793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006074239,0.00009502973,0.96215045,0.0037851792,0.0027140568,0.000030360477,0.0012576419,0.00217898,0.0007668144,0.00013292718,0.006566392,0.019714732],"study_design_scores_gemma":[0.004180619,0.000068636924,0.93007773,0.008496734,0.002296456,0.000001929801,0.00039512222,0.0030852281,0.03109675,0.0003480775,0.018571276,0.001381411],"about_ca_topic_score_codex":0.69776356,"about_ca_topic_score_gemma":0.21442138,"teacher_disagreement_score":0.4833422,"about_ca_system_score_codex":0.0016527493,"about_ca_system_score_gemma":0.008140267,"threshold_uncertainty_score":0.9997056},"labels":[],"label_agreement":null},{"id":"W4406227688","doi":"10.1158/1055-9965.28171803","title":"Table S4 from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary cancer; Medicine; Cancer; Cancer registry; Confidence interval; Incidence (geometry); Oncology; Primary tumor; Internal medicine; Demography; Metastasis","score_opus":0.02241229564945459,"score_gpt":0.29084579268912386,"score_spread":0.2684334970396693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406227688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379178,0.010505549,0.001792332,0.0010044221,0.0027846012,0.0015913746,0.0045812987,0.00017609923,0.039646514],"genre_scores_gemma":[0.67139,0.20098974,0.031060025,0.016633892,0.0023725706,0.0036308428,0.006188405,0.0003328708,0.06740165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965595,0.00013732974,0.0010604577,0.0010865371,0.0006097874,0.0005463629],"domain_scores_gemma":[0.9971302,0.00021800418,0.00070139626,0.0010040371,0.0007219172,0.00022443001],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027779734,0.00061163394,0.001627285,0.00028561635,0.000096953096,0.00003347481,0.00043402883,0.0006129144,0.0038135543],"category_scores_gemma":[0.00008201926,0.00053954596,0.0003811029,0.00034728542,0.00018523967,0.00011965292,0.0007287859,0.0012864231,0.0000054275356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060566305,0.00009473614,0.96242785,0.0037740571,0.0027031421,0.000030279378,0.0012497135,0.0021721546,0.00076435524,0.00013240591,0.0065274397,0.01951817],"study_design_scores_gemma":[0.004191431,0.00006881008,0.9299337,0.008517135,0.0023014767,0.0000019346867,0.00039672086,0.0030919036,0.031180706,0.00034954693,0.01858171,0.001384882],"about_ca_topic_score_codex":0.69630915,"about_ca_topic_score_gemma":0.21382214,"teacher_disagreement_score":0.48248702,"about_ca_system_score_codex":0.0016522406,"about_ca_system_score_gemma":0.008141276,"threshold_uncertainty_score":0.9997056},"labels":[],"label_agreement":null},{"id":"W4406227704","doi":"10.1158/1055-9965.c.7618152","title":"Data from Risk of Developing a Subsequent Primary Cancer among Adult Cancer Survivors","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Cancer registry; Lung cancer; Colorectal cancer; Breast cancer; Demography; Population; Internal medicine; Primary cancer; Gynecology; Oncology; Environmental health","score_opus":0.06285845171759087,"score_gpt":0.33790597548901913,"score_spread":0.27504752377142827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406227704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91594046,0.012648752,0.0026665938,0.0016632903,0.0032516802,0.0017608672,0.036351576,0.00018686063,0.025529886],"genre_scores_gemma":[0.4759989,0.34577003,0.053458605,0.021744357,0.0036730773,0.0022146173,0.061880015,0.0004039329,0.034856457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996249,0.00015596944,0.0010765907,0.0014375738,0.00062631676,0.00045452316],"domain_scores_gemma":[0.9957494,0.00026513296,0.00071017875,0.0025434194,0.0005276976,0.00020414562],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003670658,0.00057430356,0.0015095719,0.00025934904,0.00007892513,0.000032452623,0.0010956255,0.00054488034,0.003102663],"category_scores_gemma":[0.00012775417,0.0005008039,0.0002535761,0.0002577777,0.00020239087,0.00017093816,0.0025270977,0.0012951958,0.0000060817083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006514793,0.00010284758,0.9399314,0.0040412946,0.0036997444,0.000037058588,0.00080722815,0.0006810144,0.00035513888,0.00007234692,0.018383676,0.031236798],"study_design_scores_gemma":[0.003281175,0.000040726547,0.9477874,0.0074579604,0.0027236587,0.0000017052276,0.0002835027,0.0073152417,0.0057687964,0.00019486004,0.023991572,0.001153386],"about_ca_topic_score_codex":0.59945136,"about_ca_topic_score_gemma":0.32795322,"teacher_disagreement_score":0.43994159,"about_ca_system_score_codex":0.0013578506,"about_ca_system_score_gemma":0.008054046,"threshold_uncertainty_score":0.99974436},"labels":[],"label_agreement":null},{"id":"W4406414956","doi":"10.1016/s1155-1925(96)16687-8","title":"10.1016/s1155-1925(96)16687-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.007686672600693452,"score_gpt":0.19657671022764667,"score_spread":0.18889003762695322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406414956","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045073377,0.0001585576,5.343479e-7,0.0008160852,0.0000031453974,0.00030143934,0.00002400392,0.0001395025,0.9940494],"genre_scores_gemma":[0.0003523312,0.0000014647688,0.00017828752,0.0008688055,0.0002919743,0.000021583019,0.000065684464,0.000033409975,0.99818647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896944,0.00002344284,0.00020949625,0.00027742516,0.00020967294,0.00031051043],"domain_scores_gemma":[0.9992235,0.000036288446,0.000023532568,0.00038643138,0.000041455034,0.0002888411],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010366396,0.00015910152,0.0002788572,0.00008267179,0.00006383633,0.000017856486,0.00012223185,0.00007738975,0.9996043],"category_scores_gemma":[0.000026075968,0.00014700295,0.000099149576,0.0001742304,0.000038876897,0.000085574815,0.000024559866,0.00016584333,0.9924072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036136675,0.000039961342,8.3474134e-7,0.000015709846,0.000030216694,0.00002636755,0.000025213209,0.000020598349,0.00019918942,2.460594e-7,0.43396166,0.56531864],"study_design_scores_gemma":[0.001098685,0.00035267562,0.00022730378,0.0000316909,0.0000471067,0.000041840263,0.0000018772859,0.00021360652,0.0003939833,0.0000019251545,0.9974168,0.00017250908],"about_ca_topic_score_codex":0.000038666585,"about_ca_topic_score_gemma":3.1717545e-7,"teacher_disagreement_score":0.56514615,"about_ca_system_score_codex":0.000107316024,"about_ca_system_score_gemma":0.00012412418,"threshold_uncertainty_score":0.5994606},"labels":[],"label_agreement":null},{"id":"W4406506687","doi":"10.1016/s0292-062x(20)30044-1","title":"10.1016/s0292-062x(20)30044-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.007227881366099124,"score_gpt":0.19490249966938494,"score_spread":0.18767461830328583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406506687","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002167177,0.00021238886,6.792091e-7,0.0008003942,0.0000029004107,0.00029710637,0.00002720036,0.00014113072,0.996351],"genre_scores_gemma":[0.00017544009,0.0000015629237,0.00021931416,0.0007625819,0.00028696665,0.00002129657,0.000082539,0.00003331124,0.99841696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989679,0.000022546083,0.00020813827,0.0002755757,0.00021448584,0.00031135674],"domain_scores_gemma":[0.99922246,0.000035276295,0.000023495078,0.00038401238,0.000040889085,0.00029386752],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010160072,0.00015828206,0.00027707662,0.00008293584,0.00006200257,0.000017177576,0.0001198932,0.00007696727,0.9996473],"category_scores_gemma":[0.000023847417,0.00014621795,0.000099468576,0.00016479996,0.00003912533,0.00008533197,0.000023736322,0.00016648759,0.99342823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033328898,0.000038673905,6.5659475e-7,0.00001690506,0.000029074983,0.000026007907,0.000024163113,0.000016749367,0.00027759184,1.9500293e-7,0.46083316,0.5384035],"study_design_scores_gemma":[0.001111851,0.00035093472,0.00014781457,0.000037786984,0.00004749892,0.000040809766,0.00000173487,0.00017970441,0.00029201235,0.000002098101,0.9976162,0.00017155666],"about_ca_topic_score_codex":0.000028948873,"about_ca_topic_score_gemma":4.653791e-7,"teacher_disagreement_score":0.53823197,"about_ca_system_score_codex":0.00011599271,"about_ca_system_score_gemma":0.00013731481,"threshold_uncertainty_score":0.5962595},"labels":[],"label_agreement":null},{"id":"W4406552332","doi":"10.1016/s1553-3212(07)70242-x","title":"10.1016/s1553-3212(07)70242-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.007872094044023531,"score_gpt":0.1983083190956833,"score_spread":0.19043622505165977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406552332","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003458843,0.00017961279,6.705969e-7,0.0007152725,0.000003247871,0.0002992967,0.000022468308,0.00013940007,0.9951812],"genre_scores_gemma":[0.00032158443,0.0000016622654,0.00020380307,0.0006915532,0.0002989281,0.000021483354,0.000062260064,0.000033596338,0.9983651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896765,0.00002268756,0.000208996,0.00027666456,0.00021433832,0.00030966414],"domain_scores_gemma":[0.9992273,0.000035134468,0.000023413262,0.00038328857,0.000041875854,0.00028900994],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010284674,0.00015940289,0.00027809455,0.00007973513,0.00006109438,0.000018538065,0.00012107936,0.000077414785,0.99973],"category_scores_gemma":[0.000025808247,0.0001464218,0.00009931659,0.0001557913,0.000038688187,0.00008537639,0.000024563447,0.00016775606,0.99642986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036501818,0.000040528932,6.5419493e-7,0.000016240634,0.00003176467,0.00002892106,0.0000272435,0.000018861272,0.00018268418,2.521779e-7,0.4762758,0.52301204],"study_design_scores_gemma":[0.0010584645,0.00035134578,0.00025098096,0.000031877342,0.00004754338,0.000042454154,0.0000019470226,0.00021640188,0.00024114056,0.0000017943752,0.99758416,0.00017190928],"about_ca_topic_score_codex":0.000035593195,"about_ca_topic_score_gemma":2.815023e-7,"teacher_disagreement_score":0.52284014,"about_ca_system_score_codex":0.000106126,"about_ca_system_score_gemma":0.00012781497,"threshold_uncertainty_score":0.5970908},"labels":[],"label_agreement":null},{"id":"W4406578817","doi":"10.1016/s1541-9800(12)70080-7","title":"10.1016/s1541-9800(12)70080-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer therapy; Medicine; Psychology; Physical therapy; Cancer; Internal medicine","score_opus":0.008335003592968935,"score_gpt":0.19409369950540348,"score_spread":0.18575869591243455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578817","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025862176,0.00014840883,6.149039e-7,0.00069924543,0.000003056129,0.0003029705,0.00002193771,0.0001362739,0.99610126],"genre_scores_gemma":[0.00029636084,0.0000016203671,0.00021395934,0.0008114598,0.00029412057,0.000021398699,0.00006546425,0.000033397733,0.9982622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896497,0.000023275412,0.00021009585,0.0002758171,0.00021553026,0.00031033717],"domain_scores_gemma":[0.99922955,0.00003568167,0.000023611994,0.00038492426,0.000036231788,0.00029000064],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010140573,0.00015940695,0.0002788485,0.00008267641,0.00006277939,0.000017944314,0.00012141125,0.000076487915,0.99964494],"category_scores_gemma":[0.00002570475,0.00014672501,0.000098183984,0.00013687613,0.000039439044,0.00008394374,0.000024448518,0.00016501921,0.99239784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036244182,0.000038332473,8.1642975e-7,0.000014609525,0.000029469817,0.000025212756,0.000025637128,0.000012457702,0.00021479656,2.1512612e-7,0.4565636,0.54271245],"study_design_scores_gemma":[0.0011318756,0.0003698313,0.00030749218,0.000031347547,0.000046686255,0.000041816762,0.0000017897686,0.00017049182,0.00029061185,0.0000020867058,0.99743384,0.00017215264],"about_ca_topic_score_codex":0.00003922301,"about_ca_topic_score_gemma":4.85214e-7,"teacher_disagreement_score":0.54254025,"about_ca_system_score_codex":0.000104484556,"about_ca_system_score_gemma":0.00012297019,"threshold_uncertainty_score":0.5983272},"labels":[],"label_agreement":null},{"id":"W4406643508","doi":"10.1016/b978-2-294-76306-9.50232-5","title":"10.1016/b978-2-294-76306-9.50232-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.012564972392311828,"score_gpt":0.19821705125707473,"score_spread":0.1856520788647629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643508","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019557326,0.00084336405,4.6215004e-7,0.00037187285,0.000010841625,0.0007618078,0.0002463691,0.00021211428,0.9975512],"genre_scores_gemma":[0.0000010165974,0.000007642701,0.00011672334,0.0007684397,0.0010773651,0.000026088912,0.0006740523,0.00018517718,0.9971435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978966,0.000014474314,0.000499686,0.0006604895,0.0004815074,0.00044720137],"domain_scores_gemma":[0.99837345,0.00006615431,0.00012667169,0.000854792,0.0000848954,0.0004940177],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012140595,0.0005642764,0.00092693086,0.00032087593,0.00008209639,0.000031634314,0.00026161008,0.00048768552,0.9996266],"category_scores_gemma":[0.000020235515,0.0005533256,0.00036291828,0.000051065705,0.000102284605,0.00007548627,0.000087948305,0.00067027606,0.9948512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004703065,0.000018428864,1.970636e-8,0.00006076148,0.00016363563,0.00012647816,0.000012472056,0.0000034733423,0.000017182769,0.00001569983,0.4462687,0.55284286],"study_design_scores_gemma":[0.0010861465,0.0005327832,0.000004103613,0.00031397113,0.0002929848,0.000095192816,4.1982142e-7,0.000018208622,0.000024731942,0.0000592636,0.9970084,0.0005638066],"about_ca_topic_score_codex":0.000023314877,"about_ca_topic_score_gemma":7.500887e-7,"teacher_disagreement_score":0.552279,"about_ca_system_score_codex":0.00031780588,"about_ca_system_score_gemma":0.00042738792,"threshold_uncertainty_score":0.99969184},"labels":[],"label_agreement":null},{"id":"W4408089705","doi":"10.1002/mgg3.70086","title":"Prevalence of Constitutional Pathogenic Variant in a Cohort of 348 Patients With Multiple Primary Cancer Addressed in Oncogenetic Consultation","year":2025,"lang":"en","type":"article","venue":"Molecular Genetics & Genomic Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cohort; Pediatrics; Pathology","score_opus":0.00756709152305212,"score_gpt":0.2510545768292372,"score_spread":0.24348748530618508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408089705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607117,0.008814105,0.0024335578,0.00015130256,0.00012442262,0.0015328579,0.00013089438,0.000006323457,0.0007353751],"genre_scores_gemma":[0.99554735,0.0016169966,0.0018392061,0.0006339676,0.00001620157,0.00009724523,0.00017498809,0.000015095115,0.00005894548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803317,0.00009968712,0.0008280882,0.0003983768,0.00040198275,0.00023870522],"domain_scores_gemma":[0.9988754,0.00013758709,0.0002499352,0.00036124012,0.00029115521,0.000084699626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028463252,0.00020535015,0.0006161648,0.0003955352,0.000015385669,0.0000017757343,0.00014517871,0.00010454732,0.00014299441],"category_scores_gemma":[0.00017236889,0.00018011765,0.000048548045,0.00044581734,0.00063877593,0.000019581912,0.000049788545,0.00017009188,7.1447107e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093507,0.0002188438,0.72024745,0.00095803436,0.0001367299,0.00006370085,0.00035758264,0.0028650216,0.27081913,0.00009865409,0.000018914745,0.0032808883],"study_design_scores_gemma":[0.014504166,0.00040305467,0.9715364,0.0012356448,0.0003190113,0.0000069749003,0.00004145389,0.001364669,0.01023332,0.000031935426,0.00018146167,0.00014189408],"about_ca_topic_score_codex":0.00031564976,"about_ca_topic_score_gemma":0.00011468556,"teacher_disagreement_score":0.2605858,"about_ca_system_score_codex":0.00033277302,"about_ca_system_score_gemma":0.0016352715,"threshold_uncertainty_score":0.7344985},"labels":[],"label_agreement":null},{"id":"W4408403275","doi":"10.1136/oemed-2024-109924","title":"Cancer incidence in male and female Canadian Armed Forces personnel and Veterans enrolled between 1976 and 2016: a retrospective population-based cohort study","year":2025,"lang":"en","type":"article","venue":"Occupational and Environmental Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Department of National Defence; Veterans Affairs Canada","funders":"Ministère de la Défense Nationale; Veterans Affairs Canada","keywords":"Medicine; Cancer; Population; Retrospective cohort study; Cohort; Incidence (geometry); Lung cancer; Cohort study; Gynecology; Demography; Internal medicine; Environmental health","score_opus":0.011937698603405576,"score_gpt":0.2751884825629293,"score_spread":0.2632507839595237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408403275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659824,0.0013341567,0.0000081356575,0.00080285186,0.000041069645,0.0007520208,0.00012060162,0.000004847446,0.0003381022],"genre_scores_gemma":[0.9977772,0.00044343952,0.000057876932,0.0009961718,0.000063888925,0.00008253249,0.00020089488,0.000006904474,0.00037107017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990623,0.000032455446,0.00021084081,0.0003372065,0.00020568704,0.00015148702],"domain_scores_gemma":[0.9995863,0.00009716621,0.00004403098,0.00008117505,0.000007133887,0.00018419085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935076,0.00014481445,0.0003347819,0.0001926942,0.0001529882,0.000009851495,0.000027483415,0.000054052678,0.00018199872],"category_scores_gemma":[0.000032713782,0.00012062321,0.0000117672025,0.00007922311,0.00019180568,0.000084480576,0.000023899813,0.00012123969,5.1268546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024687813,0.000026999829,0.99588984,0.000044592205,0.00005845674,0.000015003033,0.0009788673,0.0000047637245,0.00019834145,0.0000048952766,0.000049288446,0.002482044],"study_design_scores_gemma":[0.004665019,0.0003144096,0.99181014,0.00016487682,0.00011799141,0.000007646973,0.0018548408,0.0008635748,0.00001022529,0.000016237978,0.000070982634,0.000104029765],"about_ca_topic_score_codex":0.14231329,"about_ca_topic_score_gemma":0.04927201,"teacher_disagreement_score":0.09304128,"about_ca_system_score_codex":0.0002977219,"about_ca_system_score_gemma":0.00009784263,"threshold_uncertainty_score":0.9680763},"labels":[],"label_agreement":null},{"id":"W4408797444","doi":"10.1016/j.labinv.2024.102347","title":"123 Pure Ductal Carcinoma in Situ Call Rate and Blocking: An Observational Study (2011-2020)","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; McMaster University","funders":"","keywords":"Observational study; Ductal carcinoma; In situ; Blocking (statistics); Medicine; Carcinoma; Oncology; Internal medicine; Chemistry; Cancer; Mathematics; Breast cancer; Statistics","score_opus":0.05404335534413566,"score_gpt":0.30667408096618565,"score_spread":0.25263072562204997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408797444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966125,0.00027718523,0.000004141337,0.0018643314,0.00020360507,0.00058325235,0.000026271937,0.00004829821,0.00038044123],"genre_scores_gemma":[0.9950276,0.000010560316,0.00025164534,0.0040190094,0.00012493781,0.00005096698,0.0002439233,0.000012999558,0.00025834312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883604,0.0001678319,0.00031075394,0.0003585474,0.00016719576,0.00015963164],"domain_scores_gemma":[0.9992943,0.00005094272,0.000071907496,0.00024030542,0.00020142851,0.00014114725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036758353,0.00014839387,0.00022680225,0.00014936071,0.00008676161,0.00003407965,0.00006438849,0.00009692064,0.000051170133],"category_scores_gemma":[0.00011119404,0.00015090939,0.000014905739,0.00039960028,0.000099411234,0.0003434744,0.000030561845,0.00023225974,0.000008554954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009454449,0.00009519194,0.92338866,0.00007757629,0.000027650776,0.00007656247,0.0015254258,0.000034270473,0.0723907,0.00036432908,0.0016386036,0.0002864829],"study_design_scores_gemma":[0.0021350123,0.0002059124,0.9897847,0.00003291105,0.000051219267,0.0000035978542,0.0007423057,0.000966717,0.004199794,0.00029734522,0.0014506187,0.00012986237],"about_ca_topic_score_codex":0.00012051592,"about_ca_topic_score_gemma":0.00073467696,"teacher_disagreement_score":0.0681909,"about_ca_system_score_codex":0.00015866522,"about_ca_system_score_gemma":0.00090547046,"threshold_uncertainty_score":0.61539066},"labels":[],"label_agreement":null},{"id":"W4411659739","doi":"10.51847/dghnln3ucn8825","title":"10.51847/dghnln3ucn8825","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Internal medicine; Oncology","score_opus":0.008562808928642036,"score_gpt":0.20813421306225996,"score_spread":0.19957140413361793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411659739","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008211749,0.00011196424,4.2944205e-7,0.0006962023,0.0000037513983,0.00022977401,0.000013184048,0.00011002678,0.99062294],"genre_scores_gemma":[0.0007668846,0.0000017841395,0.00021484212,0.0012742116,0.00019310116,0.0000144822325,0.00004129058,0.000022257946,0.99747115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992421,0.0000149821,0.00015056181,0.00020456147,0.00015810718,0.0002296696],"domain_scores_gemma":[0.999413,0.000023477509,0.000014229071,0.00029364438,0.000029770958,0.00022585965],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007242876,0.00011226908,0.00020446231,0.00006227665,0.00004443359,0.000012088944,0.00008416661,0.000052458287,0.9990818],"category_scores_gemma":[0.0000171075,0.0001032148,0.00007124715,0.00013804714,0.000025971667,0.000060434588,0.000015731282,0.0001023171,0.9767279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003653528,0.000035431367,0.000001971043,0.000012111533,0.000025272671,0.000025125406,0.000020427844,0.00001377963,0.00037439933,4.4975727e-7,0.10707269,0.892053],"study_design_scores_gemma":[0.00081805233,0.00028404137,0.0004960339,0.000020698564,0.000030954856,0.000032248547,0.0000010643369,0.00014283451,0.000119148135,6.209274e-7,0.9979338,0.000120509336],"about_ca_topic_score_codex":0.000021989523,"about_ca_topic_score_gemma":1.2791332e-7,"teacher_disagreement_score":0.8919325,"about_ca_system_score_codex":0.00007171296,"about_ca_system_score_gemma":0.000091387774,"threshold_uncertainty_score":0.42089772},"labels":[],"label_agreement":null},{"id":"W4412487641","doi":"10.1093/jnci/djaf191","title":"A prediction model for metachronous colorectal cancer: development and validation","year":2025,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Medicine; Cancer; Internal medicine; Oncology; Population; Family history; Interquartile range","score_opus":0.07162491896061111,"score_gpt":0.34797536995421313,"score_spread":0.276350450993602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412487641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751341,0.0019990434,0.012973271,0.0052513634,0.0027250685,0.00058353844,0.00015916338,0.0000112087755,0.0011632456],"genre_scores_gemma":[0.99136454,0.00040845294,0.004539212,0.0018332636,0.0005231802,0.000105594314,0.000015002453,0.00000716112,0.0012035652],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990944,0.000012188427,0.00034830868,0.000101880636,0.00035170937,0.000091480244],"domain_scores_gemma":[0.9990559,0.000033664295,0.00021987723,0.000036024456,0.0006081495,0.000046379206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002826221,0.000084603176,0.00018369066,0.00012917399,0.00017342561,0.000017637554,0.00008497707,0.000050719915,0.000014803862],"category_scores_gemma":[0.00010588249,0.0000590773,0.00008992559,0.00013321794,0.000056508106,0.0002503556,0.000023391365,0.00015004545,1.4891832e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00851797,0.000471308,0.051508162,0.0013545074,0.0045913816,0.0000064741917,0.004122641,0.48619565,0.06849834,0.007284508,0.09400874,0.2734403],"study_design_scores_gemma":[0.015405305,0.0002957831,0.12570164,0.0011967238,0.0013697625,0.00017034638,0.000085761974,0.3058596,0.14028394,0.0027127776,0.4065557,0.00036264604],"about_ca_topic_score_codex":0.000021618165,"about_ca_topic_score_gemma":0.00010363151,"teacher_disagreement_score":0.31254697,"about_ca_system_score_codex":0.0011822655,"about_ca_system_score_gemma":0.0042225276,"threshold_uncertainty_score":0.7490583},"labels":[],"label_agreement":null},{"id":"W4413774279","doi":"10.1016/s2152-2650(25)02350-x","title":"ABCL-1144: Differences in Demographic Characteristics Between Male and Female Survivors of Non-Hodgkin Lymphoma Admitted With Colorectal Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; Red Deer Regional Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; Hodgkin lymphoma; Internal medicine; Lymphoma; Cancer","score_opus":0.02479363711321702,"score_gpt":0.3133066837383166,"score_spread":0.2885130466250996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413774279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974953,0.00036213855,0.000024212242,0.0005557191,0.00020135613,0.00074197014,0.00016359173,0.000028769651,0.00042694155],"genre_scores_gemma":[0.9962664,0.0017188493,0.00012622893,0.0012445593,0.00010138092,0.00010551465,0.00023756185,0.000028505225,0.0001709883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968427,0.00040065803,0.0013065564,0.0006097935,0.00034337552,0.0004969577],"domain_scores_gemma":[0.99683267,0.0020828487,0.00034370486,0.00041754724,0.00014267994,0.00018052166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009107373,0.00036877306,0.001272871,0.0005361126,0.00008736549,0.000037501155,0.00036334444,0.00034802093,0.00007366312],"category_scores_gemma":[0.0002532489,0.00025542188,0.00014572071,0.0016300336,0.0007438405,0.00010013119,0.00010721894,0.00033419742,0.0000021587803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016868976,0.00017098038,0.84097826,0.00021696933,0.00017559927,0.00013678882,0.00063291116,0.0000035606317,0.00009795641,0.000022010801,0.00007618781,0.15580189],"study_design_scores_gemma":[0.0073357653,0.0007430524,0.9865478,0.0007151654,0.0001828387,0.000020982621,0.0009279055,0.0024231083,0.00019281253,0.00004483391,0.00059803925,0.0002676556],"about_ca_topic_score_codex":0.0071195606,"about_ca_topic_score_gemma":0.005108763,"teacher_disagreement_score":0.15553424,"about_ca_system_score_codex":0.00046183894,"about_ca_system_score_gemma":0.0016956932,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W4414574215","doi":"10.1016/j.ijrobp.2025.07.1270","title":"The Impact of National Cancer Systems on Lung Cancer Mortality","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lung cancer; Radiation therapy; Cancer; Population; Global health; Health care; Cancer registry; Human Development Index","score_opus":0.030579944334745,"score_gpt":0.4235294937481928,"score_spread":0.39294954941344784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414574215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974451,0.005631976,0.0015402455,0.00420519,0.0070554484,0.00040100716,0.00040220644,0.00001979871,0.00629313],"genre_scores_gemma":[0.9937467,0.0030597541,0.00004757639,0.00091200013,0.001893869,0.00003421081,0.000044531516,0.000012333481,0.00024905356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998323,0.0001734856,0.0007738482,0.0001644719,0.0003879396,0.00017725043],"domain_scores_gemma":[0.9965939,0.0006065578,0.0010314123,0.00013399149,0.0015576961,0.0000764696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064033957,0.00016003518,0.00044392084,0.00015799564,0.000093179995,0.000023349356,0.00033598737,0.00015966856,0.000103540675],"category_scores_gemma":[0.00026549798,0.000106424246,0.00034407826,0.00018592326,0.00018686044,0.00014996075,0.000035034496,0.0004256501,0.000002324008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012647755,0.00030417892,0.8551578,0.000032179272,0.004456032,0.000009261621,0.00021005316,0.02697853,0.0032800704,0.01812459,0.022204889,0.06797763],"study_design_scores_gemma":[0.011815221,0.0013884144,0.87336755,0.00051552267,0.00044741534,0.00005745764,0.00013398663,0.05273424,0.0027781718,0.0051779584,0.051283,0.00030108012],"about_ca_topic_score_codex":0.00056066114,"about_ca_topic_score_gemma":0.00002525177,"teacher_disagreement_score":0.06767655,"about_ca_system_score_codex":0.002935407,"about_ca_system_score_gemma":0.003920483,"threshold_uncertainty_score":0.7675987},"labels":[],"label_agreement":null},{"id":"W4415230677","doi":"10.1007/s11060-025-05272-x","title":"Premature mortality due to malignancies of the central nervous system in Japan: a nationwide descriptive analysis from 2000 to 2020","year":2025,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Central nervous system; Statistical analysis; Descriptive statistics; Disease; Survival analysis; Epidemiology","score_opus":0.017039878789428343,"score_gpt":0.29080493295081966,"score_spread":0.2737650541613913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415230677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895509,0.00031997028,0.00025077362,0.0071797897,0.00094098836,0.00040852907,0.00005803576,0.0000059961476,0.0012850529],"genre_scores_gemma":[0.99446476,0.000024189656,0.00068424566,0.0045377514,0.00013742998,0.000008702092,0.0000032143162,0.0000073204083,0.00013237575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981561,0.00030143667,0.0008189222,0.0001963258,0.00030296028,0.00022430906],"domain_scores_gemma":[0.99859697,0.00027614212,0.00040736236,0.00026521698,0.00029173354,0.00016257838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032723488,0.00013233241,0.0009051251,0.00039791607,0.000036812657,0.000010902194,0.0002576433,0.00012825851,0.00006863424],"category_scores_gemma":[0.000469471,0.000092195936,0.00030884944,0.0012508346,0.00004394136,0.000077634584,0.00007907647,0.00040824444,0.0000016542527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052251657,0.00059903733,0.6020293,0.00038223277,0.0035670847,0.0024140168,0.02118785,0.01650106,0.31068847,0.00019531783,0.027838472,0.0093719615],"study_design_scores_gemma":[0.0012690718,0.0005284551,0.97871935,0.00021423024,0.0010263551,0.00012797132,0.0026368639,0.00041827385,0.0042745,0.00001979475,0.010695038,0.00007009566],"about_ca_topic_score_codex":0.0005671458,"about_ca_topic_score_gemma":0.001972239,"teacher_disagreement_score":0.37669,"about_ca_system_score_codex":0.00104965,"about_ca_system_score_gemma":0.0014546297,"threshold_uncertainty_score":0.3759641},"labels":[],"label_agreement":null},{"id":"W4415519656","doi":"10.1016/j.jtho.2025.09.1186","title":"EP.01.02 Long-Term Survival After Curative Surgery for Stage I-III NSCLC Patients in British Columbia, 2005-2021: A Population-Based Study","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Overall survival; Survival rate; Neoplasm staging; MEDLINE","score_opus":0.022967112837508106,"score_gpt":0.38045981068222423,"score_spread":0.3574926978447161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415519656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545133,0.00031601853,0.0003124727,0.000618854,0.0017961496,0.0011953005,0.00008535545,0.0000082821125,0.00021622566],"genre_scores_gemma":[0.99562305,0.000042104075,0.0003433965,0.0010867178,0.00021450956,0.00008299671,0.00008524252,0.000022158649,0.0024998067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974011,0.0004412484,0.0011868351,0.00027711075,0.00032489348,0.00036877714],"domain_scores_gemma":[0.99759525,0.0010021795,0.0006232661,0.00019345901,0.00042387308,0.00016198901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011621953,0.00015084533,0.001099351,0.00036266726,0.00008511858,0.00006928239,0.00012751618,0.00018418729,0.0011012942],"category_scores_gemma":[0.00045119846,0.00019311352,0.00029507373,0.0002931022,0.000049972263,0.00023594646,0.000037572576,0.00045149916,0.000002015706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005159543,0.0017456837,0.8977745,0.00016141441,0.00022202513,0.0007578036,0.00017574303,0.000021979506,0.000010138164,2.0123791e-7,0.0026417675,0.09132916],"study_design_scores_gemma":[0.005990704,0.0014834226,0.9889479,0.00042278302,0.00024601055,0.000014830388,0.00046762795,0.000059222148,0.000010606985,0.000013324996,0.0021931091,0.00015040334],"about_ca_topic_score_codex":0.0027054604,"about_ca_topic_score_gemma":0.16528471,"teacher_disagreement_score":0.16257925,"about_ca_system_score_codex":0.0012151202,"about_ca_system_score_gemma":0.0019195986,"threshold_uncertainty_score":0.9998118},"labels":[],"label_agreement":null},{"id":"W4416222225","doi":"10.1186/s40779-025-00670-8","title":"Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers","year":2025,"lang":"en","type":"article","venue":"Military Medical Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Center; Brigham and Women's Hospital; Uehara Memorial Foundation; American Cancer Society; Harvard T.H. Chan School of Public Health; Japan Society for the Promotion of Science; Prevent Cancer Foundation; American Association for Cancer Research","keywords":"Incidence (geometry); Cancer incidence; Cancer; Colorectal cancer; Mortality rate; Epidemiology","score_opus":0.057418483131473685,"score_gpt":0.4074798751480839,"score_spread":0.35006139201661024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416222225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840358,0.0071959975,0.00004695206,0.0014183478,0.00024038723,0.00029986165,0.0020153052,0.00004355731,0.004703792],"genre_scores_gemma":[0.9957074,0.002226852,0.00034818644,0.0002948953,0.00007838352,0.000092390685,0.00021875821,0.000030673382,0.001002462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99164015,0.0007865529,0.0014465642,0.001124166,0.0037308645,0.0012717132],"domain_scores_gemma":[0.99573296,0.0011345305,0.00027857602,0.0012065662,0.00058171107,0.0010656582],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00291727,0.0005279468,0.0017721122,0.0013099022,0.00028402766,0.000016240223,0.0009439212,0.00040956886,0.0018317937],"category_scores_gemma":[0.0008839642,0.00044130156,0.00028011613,0.004297156,0.00460435,0.0003406098,0.0006126853,0.0014541992,0.000001931112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054514543,0.00016424619,0.9221222,0.000913484,0.0007394453,0.00023869394,0.0021478976,0.00017690545,0.00012811774,0.000028769648,0.014114908,0.053773906],"study_design_scores_gemma":[0.0041956417,0.0023766593,0.9843949,0.0021282677,0.0002817007,0.000048390706,0.0015965968,0.0028508492,0.0008141676,0.00006663715,0.00089946325,0.00034672942],"about_ca_topic_score_codex":0.32778192,"about_ca_topic_score_gemma":0.104362376,"teacher_disagreement_score":0.22341955,"about_ca_system_score_codex":0.0025441046,"about_ca_system_score_gemma":0.009416508,"threshold_uncertainty_score":0.9998039},"labels":[],"label_agreement":null},{"id":"W4417018128","doi":"10.1182/blood-2025-4556","title":"Long-term risk and racial disparities in second primary malignancies among diffuse large B-cell lymphoma survivors: A SEER-based analysis MP-SIR analysis (2000–2022)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Myeloid leukemia; Incidence (geometry); Leukemia; Lymphoma; Esophagus; Cancer; Epidemiology; Odds ratio","score_opus":0.004949746950262819,"score_gpt":0.22296740879869786,"score_spread":0.21801766184843505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913688,0.00500536,0.0006021782,0.000071699935,0.00009613373,0.00043584808,0.0006217027,0.000080424645,0.0017178662],"genre_scores_gemma":[0.99428684,0.00050998415,0.00016698269,0.00094023166,0.00006662091,0.00008234379,0.0009244613,0.00002793757,0.0029945967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732137,0.0002245894,0.00068162265,0.0007733605,0.00037624728,0.00062283664],"domain_scores_gemma":[0.9984743,0.0002915863,0.00022571516,0.00069387007,0.000097125834,0.0002174276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005259193,0.0004029676,0.0013137116,0.0017634687,0.00019144411,0.0001035222,0.00019592926,0.00024088894,0.0005736412],"category_scores_gemma":[0.00007541346,0.00038739553,0.00053157535,0.003112243,0.0002043094,0.00021649642,0.00012765786,0.00028029844,0.0000038847675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003382922,0.0033189731,0.9890786,0.00059554033,0.0041200975,0.00023589036,0.0006224081,0.000030520423,0.00049001095,0.000008385655,0.000080522506,0.0010807595],"study_design_scores_gemma":[0.021321628,0.00009591109,0.9605608,0.000067425404,0.013935213,0.0000019991933,0.00013957953,0.0014140144,0.0017486132,0.000008500659,0.0003522182,0.0003540752],"about_ca_topic_score_codex":0.0021656929,"about_ca_topic_score_gemma":0.044692397,"teacher_disagreement_score":0.042526703,"about_ca_system_score_codex":0.0002289044,"about_ca_system_score_gemma":0.00055878673,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W4417209023","doi":"10.1158/1557-3265.earlyonsetca25-b022","title":"Abstract B022: Trends in the Cumulative Incidence of Second Primary Cancers Among Survivors of Early-Onset Cancer in the United States, 1975-2022","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cumulative incidence; Incidence (geometry); Cumulative risk; Cancer; Context (archaeology); Cancer incidence; Age groups","score_opus":0.1499192146807878,"score_gpt":0.4972420291156923,"score_spread":0.34732281443490454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868879,0.002549411,0.000001360898,0.002543648,0.00025281977,0.0008956057,0.00045502596,0.000008667599,0.0064055985],"genre_scores_gemma":[0.99154574,0.004585095,0.000009869086,0.0020371436,0.00009488201,0.00036475316,0.00013877517,0.000020604393,0.0012031187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943777,0.0016344329,0.0014627983,0.00058175734,0.0012859865,0.0006573717],"domain_scores_gemma":[0.9925922,0.0056662904,0.00030650562,0.00086076336,0.00045543385,0.000118788135],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008787597,0.00022991282,0.0008276129,0.0010210135,0.00010895577,0.000026233878,0.000974017,0.00022889658,0.0022322019],"category_scores_gemma":[0.00057712337,0.00014882543,0.00022066463,0.0044367146,0.0016436332,0.00016602076,0.00019031104,0.002589404,0.0000017545995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032194005,0.00029330773,0.94928735,0.0004889116,0.00015823869,0.00007341268,0.0051801642,0.0009998569,0.0001310945,0.00004658939,0.010767492,0.029354192],"study_design_scores_gemma":[0.0025843345,0.0004057244,0.9851065,0.0006046927,0.00003675033,9.3148276e-7,0.0025653457,0.0005451773,0.00017482531,0.00014728818,0.0076988977,0.00012950513],"about_ca_topic_score_codex":0.2084673,"about_ca_topic_score_gemma":0.22620612,"teacher_disagreement_score":0.035819188,"about_ca_system_score_codex":0.00085361215,"about_ca_system_score_gemma":0.0032645457,"threshold_uncertainty_score":0.9997117},"labels":[],"label_agreement":null},{"id":"W6920494601","doi":"10.60692/1cyjt-5cz88","title":"Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria","year":2019,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Malignancy; Colorectal cancer; Clinical trial; Stage (stratigraphy); Survival analysis; Cancer; Survival rate; Overall survival","score_opus":0.09948155082614014,"score_gpt":0.39693368344277014,"score_spread":0.29745213261663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920494601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510646,0.000005430557,0.000048538994,0.000017064927,0.0007008038,0.0012800718,0.00031058915,0.000041412553,0.0024896462],"genre_scores_gemma":[0.9995569,6.6565093e-7,0.00010738074,0.00008588274,0.00013917967,0.000025232217,0.000026342126,0.00000814275,0.000050261937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974106,0.00010201256,0.0018259642,0.00015811292,0.00032194413,0.00018139686],"domain_scores_gemma":[0.99825513,0.000047727066,0.0009420012,0.00037193985,0.00029024354,0.000092954404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009974595,0.00016086674,0.0008602708,0.0001520362,0.00002737285,0.000019391737,0.00009826557,0.00013408465,0.00027543496],"category_scores_gemma":[0.00014225485,0.000113196525,0.00040463253,0.00013055453,0.000046905872,0.0002830927,0.000033802564,0.00013291465,0.00008192614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022900464,0.000007249013,0.96877784,0.001599378,0.00011540055,8.018071e-7,0.0053409263,0.000027551197,0.00006907897,0.000009853004,0.000038834103,0.001112601],"study_design_scores_gemma":[0.026880778,0.001684468,0.9673063,0.00062340894,0.00006842115,0.00000871329,0.001278098,0.0009426014,0.0010499224,1.00709364e-7,0.000037912356,0.000119244774],"about_ca_topic_score_codex":0.000068859066,"about_ca_topic_score_gemma":2.0212188e-7,"teacher_disagreement_score":0.00445047,"about_ca_system_score_codex":0.0002774631,"about_ca_system_score_gemma":0.00028006893,"threshold_uncertainty_score":0.46160203},"labels":[],"label_agreement":null},{"id":"W6928851511","doi":"10.3886/e120757v1-144681","title":"Data and Code for: Horizontal Differentiation and the Policy Effect of Charter Schools","year":2024,"lang":"en","type":"dataset","venue":"ICPSR Data Holdings","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Charter; Competition (biology); Incentive; Productivity; Quality (philosophy); School choice; Test (biology); Variation (astronomy)","score_opus":0.03381213927811302,"score_gpt":0.3418614070396432,"score_spread":0.3080492677615302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6928851511","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007675075,0.003520574,0.000015888842,0.0014434938,0.00031899987,0.0012259355,0.98576415,0.000019476345,0.000016420689],"genre_scores_gemma":[0.0031055587,0.0049265986,0.000050746417,0.00047511538,0.00082828116,0.00004700697,0.99048674,0.000031054726,0.00004889255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983079,0.00006324814,0.00036421473,0.00078084966,0.00026001944,0.00022380952],"domain_scores_gemma":[0.99657506,0.00039255718,0.00019365086,0.0027029614,0.000027345593,0.000108411725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008531271,0.00030179342,0.0007347921,0.00018472978,0.00007823692,0.00013266342,0.0008341048,0.00019652086,0.000051536634],"category_scores_gemma":[0.0006086999,0.00018660833,0.000054722932,0.0001040942,0.00023187233,0.00036559056,0.0015675126,0.00048524057,0.000017536844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008842145,0.000011944682,0.00012757155,0.0023244433,0.00034980147,0.0000057207776,0.000030377576,6.78498e-9,0.0001968911,0.00002418561,0.9887046,0.0073402203],"study_design_scores_gemma":[0.0047574695,0.00034513298,0.00037636462,0.0004487011,0.0015370753,0.000057448517,0.000022277072,0.0007021639,0.00008565008,0.000039906437,0.9914554,0.00017240563],"about_ca_topic_score_codex":0.00032640673,"about_ca_topic_score_gemma":0.00024514087,"teacher_disagreement_score":0.0071678148,"about_ca_system_score_codex":0.000048684382,"about_ca_system_score_gemma":0.00017631163,"threshold_uncertainty_score":0.76096666},"labels":[],"label_agreement":null},{"id":"W6958165636","doi":"10.60692/xtkvd-zk404","title":"Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria","year":2019,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Malignancy; Colorectal cancer; Clinical trial; Stage (stratigraphy); Survival analysis; Cancer; Survival rate; Overall survival","score_opus":0.09948155082614014,"score_gpt":0.39693368344277014,"score_spread":0.29745213261663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958165636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510646,0.000005430557,0.000048538994,0.000017064927,0.0007008038,0.0012800718,0.00031058915,0.000041412553,0.0024896462],"genre_scores_gemma":[0.9995569,6.6565093e-7,0.00010738074,0.00008588274,0.00013917967,0.000025232217,0.000026342126,0.00000814275,0.000050261937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974106,0.00010201256,0.0018259642,0.00015811292,0.00032194413,0.00018139686],"domain_scores_gemma":[0.99825513,0.000047727066,0.0009420012,0.00037193985,0.00029024354,0.000092954404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009974595,0.00016086674,0.0008602708,0.0001520362,0.00002737285,0.000019391737,0.00009826557,0.00013408465,0.00027543496],"category_scores_gemma":[0.00014225485,0.000113196525,0.00040463253,0.00013055453,0.000046905872,0.0002830927,0.000033802564,0.00013291465,0.00008192614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022900464,0.000007249013,0.96877784,0.001599378,0.00011540055,8.018071e-7,0.0053409263,0.000027551197,0.00006907897,0.000009853004,0.000038834103,0.001112601],"study_design_scores_gemma":[0.026880778,0.001684468,0.9673063,0.00062340894,0.00006842115,0.00000871329,0.001278098,0.0009426014,0.0010499224,1.00709364e-7,0.000037912356,0.000119244774],"about_ca_topic_score_codex":0.000068859066,"about_ca_topic_score_gemma":2.0212188e-7,"teacher_disagreement_score":0.00445047,"about_ca_system_score_codex":0.0002774631,"about_ca_system_score_gemma":0.00028006893,"threshold_uncertainty_score":0.46160203},"labels":[],"label_agreement":null},{"id":"W6977038642","doi":"10.60692/fq8c8-ca041","title":"The power of citizen science to advance fungal conservation","year":2024,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acadia University; Université du Québec en Abitibi-Témiscamingue; Université du Québec à Montréal; Université de Sherbrooke","funders":"","keywords":"Citizen science; Population; Conservation science; Diversity (politics); Space (punctuation); Power (physics); Fungal Diversity","score_opus":0.02246450610083955,"score_gpt":0.2501266308307397,"score_spread":0.22766212472990016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977038642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693035,0.000032180524,0.0057216277,0.0007572184,0.0008863478,0.00052484014,0.000059500082,0.00012263721,0.022592166],"genre_scores_gemma":[0.9985997,2.813786e-7,0.00021479675,0.0007128803,0.000033729986,0.000027957856,0.0000042647503,0.0000044526287,0.00040192602],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9990188,0.000011711694,0.00037382272,0.0000962181,0.0003479992,0.00015146538],"domain_scores_gemma":[0.99933094,0.000014779348,0.000073010044,0.00025796462,0.00024407519,0.00007923733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004819382,0.00007458745,0.000119630145,0.00018787025,0.00012795342,0.00011234828,0.00010721321,0.00002737087,0.000025237327],"category_scores_gemma":[0.000047134414,0.00004702831,0.00004094537,0.00044202275,0.00008604925,0.0005633917,0.000032249718,0.00006345682,0.0002473056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024016148,0.000007253131,0.31383577,0.0078000235,0.00030701724,0.000046869,0.5893347,0.00046705833,0.0021492585,0.025309773,0.012734002,0.045606665],"study_design_scores_gemma":[0.0037430641,0.0008544461,0.6956107,0.0026714925,0.00014707928,0.0005307023,0.08037396,0.02990293,0.033727366,0.000009885568,0.15174592,0.0006824625],"about_ca_topic_score_codex":0.0000040981677,"about_ca_topic_score_gemma":1.4613511e-7,"teacher_disagreement_score":0.5089607,"about_ca_system_score_codex":0.00017613645,"about_ca_system_score_gemma":0.00028017513,"threshold_uncertainty_score":0.31786957},"labels":[],"label_agreement":null},{"id":"W7093098728","doi":"10.5281/zenodo.13357029","title":"Measurements and Scripts for \"Spectro-temporal analysis of ultra-fast radio bursts using per-channel arrival times\" paper","year":2025,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Scripting language; Channel (broadcasting); Arrival time; Burst error; Time of arrival; Pipeline (software); Documentation","score_opus":0.05786657618838863,"score_gpt":0.29181977980764356,"score_spread":0.23395320361925492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093098728","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021774184,0.000697533,0.0009626768,0.00031481395,0.00024075831,0.0014356758,0.98937905,0.00015210618,0.0046399483],"genre_scores_gemma":[0.008932535,0.00036142746,0.00029403256,0.00034101418,0.00018062863,1.6093144e-7,0.98872167,0.0004297489,0.00073878566],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976156,0.00020643609,0.0005142353,0.00066436885,0.00059032586,0.00040904016],"domain_scores_gemma":[0.99804366,0.000031412936,0.0002402127,0.0007015563,0.0007417207,0.00024146611],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066675176,0.00030386593,0.00074792554,0.0009643465,0.00080924656,0.00021500254,0.0005305716,0.00018364392,0.009049483],"category_scores_gemma":[0.00045031033,0.00031220992,0.00023748876,0.00077403616,0.00020185564,0.0001748346,0.0003356336,0.00037473865,0.00003734438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054405903,0.00014663742,0.000010698698,0.0007335936,0.0021179698,0.000011553376,0.00022416892,0.00010882341,0.005006756,0.000008433119,0.9884349,0.0026523953],"study_design_scores_gemma":[0.0018173456,0.00039070807,0.00020317992,0.00016774275,0.002163555,0.00004182231,0.00013191998,0.0009400682,0.00036480185,0.00000580314,0.9935098,0.0002631956],"about_ca_topic_score_codex":0.0001822342,"about_ca_topic_score_gemma":0.0000057755874,"teacher_disagreement_score":0.0090121385,"about_ca_system_score_codex":0.00041129137,"about_ca_system_score_gemma":0.00005413924,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W7117264168","doi":"10.14740/jmc5184","title":"Delayed Presentation of Metachronous Ascending Colonic Adenocarcinoma in Early-Onset Colorectal Cancer Undergoing Curative Resection","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; FOLFOX; Adenocarcinoma; Ascending colon; Colorectal adenocarcinoma; Adjuvant therapy; Cancer; Metastasis","score_opus":0.03156747381368083,"score_gpt":0.3657244250493804,"score_spread":0.33415695123569955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117264168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908773,0.0053962776,0.00027369818,0.0024806524,0.0005227677,0.00019971626,0.00001005662,0.000005186509,0.0002343716],"genre_scores_gemma":[0.99792725,0.0014501876,0.00012176483,0.00027643234,0.00014434157,0.000009222664,0.000006112203,0.000007505567,0.000057200996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981669,0.00018427262,0.000665005,0.00012297361,0.0006923785,0.00016847895],"domain_scores_gemma":[0.9983727,0.00089871045,0.00034039727,0.00006802053,0.00018191503,0.00013826521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063140935,0.000099666795,0.00043826387,0.00038267006,0.000045786346,0.000010780311,0.000103153514,0.0001315445,0.0003862143],"category_scores_gemma":[0.0013927097,0.000081253995,0.00012550944,0.00036954932,0.00011210592,0.00018980233,0.00003230075,0.0005166945,6.1316575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014322936,0.00048976886,0.9499248,0.0006807166,0.0010632504,0.0031377724,0.0031481157,0.0003070511,0.005209514,0.00011408165,0.008418444,0.01318352],"study_design_scores_gemma":[0.010280169,0.004069986,0.9467404,0.0022466504,0.00047820213,0.0015668683,0.0029374228,0.00250092,0.028536016,0.000105944586,0.0003923587,0.00014509751],"about_ca_topic_score_codex":0.001189743,"about_ca_topic_score_gemma":0.002583778,"teacher_disagreement_score":0.023326501,"about_ca_system_score_codex":0.000587309,"about_ca_system_score_gemma":0.0025419723,"threshold_uncertainty_score":0.45093495},"labels":[],"label_agreement":null},{"id":"W749808638","doi":"10.1016/j.clcc.2015.05.008","title":"Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Saskatchewan Cancer Agency","keywords":"Medicine; Hazard ratio; Asymptomatic; Primary tumor; Colorectal cancer; Surgery; Proportional hazards model; Stage (stratigraphy); Confidence interval; Chemotherapy; Cancer; Multivariate analysis; Internal medicine; Metastasis","score_opus":0.04383241966405802,"score_gpt":0.3403864873302258,"score_spread":0.29655406766616776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W749808638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933708,0.00040451504,0.0000011289145,0.0002611253,0.0006150342,0.0020215677,0.00020378028,0.000059824095,0.0030622561],"genre_scores_gemma":[0.9973848,0.000123818,0.0002874723,0.00072378194,0.0001989007,0.00066219957,0.00006110421,0.000056855628,0.0005010794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614257,0.00026975793,0.0013382923,0.000737984,0.0008007704,0.00071062165],"domain_scores_gemma":[0.99722576,0.0005107543,0.0004674221,0.00031435385,0.0004650689,0.0010166279],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067364005,0.00037172667,0.0012210803,0.00027339262,0.00007829138,0.000027811273,0.00029319988,0.00024391372,0.00067376334],"category_scores_gemma":[0.00060514687,0.0002752876,0.00015613614,0.00071858754,0.00059494236,0.0003219838,0.00008733088,0.000604645,0.000012796961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024676606,0.0005177032,0.96561074,0.0004922756,0.000119213895,0.00036939987,0.00085923076,0.000065494,0.00010550681,0.000004758486,0.0006964839,0.0064825895],"study_design_scores_gemma":[0.014491744,0.0084604435,0.96983546,0.000849418,0.000107359,0.000033443597,0.0003926187,0.0016367371,0.00070342683,0.0000037679126,0.0030374469,0.00044815868],"about_ca_topic_score_codex":0.036326077,"about_ca_topic_score_gemma":0.34773487,"teacher_disagreement_score":0.31140882,"about_ca_system_score_codex":0.0027541986,"about_ca_system_score_gemma":0.01298475,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null}]}